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Abstract 
 
Aziridines, the smallest saturated aza-heterocycle, are not only prevalent in several 
natural products, but also represent a versatile synthetic tool for the chemist via 
exploitation of the strained ring system. Research described in this thesis concerns the 
chemistry of N-N ylides (aminimines), which were utilised in a novel tertiary amine-
promoted organocatalytic approach to the aziridination of α,β-unsaturated carbonyl 
compounds. Through the use of modified conditions two important classes of substrates, 
dienones and alpha-enolizable enones, both of which had previously shown poor 
reactivity with the system, can now be aziridinated in good yields. Studies have also 
focused on the development of an asymmetric variant of the methodology using chiral 
tertiary amine promoters. A variety of novel chiral six-membered 1,4-heterocycles and 
cinchona alkaloid derivatives have been synthesised and their utility towards 
asymmetric alkene aziridination has been assessed, aiding the understanding of the 
proposed transition state model for the reaction.  
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Abbreviations 
 
The following abbreviations are used in this thesis: 
 
Ac  acetyl 
Ar  aromatic 
atm  atmosphere(s) 
ATR  attenuated total reflection 
aq.  aqueous 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn  benzyl 
Boc  t-butyloxycarbonyl 
b.p.  boiling point 
br  broad (NMR and IR spectroscopy) 
Bu  butyl 
Cbz  carbobenzyloxy 
CI  chemical ionisation 
d  day(s) 
d  doublet (NMR Spectroscopy) 
DABCO 1,4-diazabicyclo[2.2.2]octane 
dba  dibenzylideneacetone 
DBU  1,8-diazabicyclo[5.4.0]undec-7-ene 
DIAD  diisopropyl azodicarboxylate 
DMAP  4-dimethylaminopyridine 
DMF  dimethylformamide 
DMSO  dimethylsulfoxide 
Dpp  diphenylphosphinyl 
dr  diastereomeric ratio 
ee  enantiomeric excess 
EI  electron impact 
Eq.  equation 
eq.  equivalent 
er  enantiomeric ratio 
ES  electrospray ionisation 
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Et  ethyl 
EWG  electron withdrawing group 
GCMS  gas chromatography mass spectrometry 
h  hour(s) 
Hz  Hertz 
i  iso 
IPA  isopropyl alcohol 
IR  infra-red 
HMBC heteronuclear multiple bond coherence 
HPLC  high performance liquid chromatography 
HRMS  high resolution mass spectrometry 
J  coupling constant 
KIE  kinetic isotope effect 
L  ligand 
lit.  literature 
LTMP  lithium-2,2,6,6-tetramethylpiperidine 
M  molar 
m  moderate intensity (IR spectroscopy) 
m  multiplet (NMR spectroscopy) 
Me  methyl 
min.  minute(s) 
m.p.  melting point 
MS  mass spectrometry 
Ms  mesyl (methanesulfonyl) 
MSH  O-mesitylenesulfonyl hydroxylamine 
n  primary 
ND  not determined 
NMM  N-methylmorpholine 
NMP  N-methylpyrrolidine 
NMR  nuclear magnetic resonance 
NNTA  nucleophilic nitrogen transfer agent 
NOESY nuclear Overhauser effect spectroscopy 
NR  no reaction 
p  para 
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Ph  phenyl 
ppm  part(s) per million 
Pr  propyl 
PTC  phase transfer catalyst 
Py  pyridine 
R  alkyl group 
Rf  retention factor 
RSM  residual starting material 
rt  room temperature 
s  singlet (NMR spectroscopy) 
s  strong intensity (IR spectroscopy) 
sec  secondary 
sept.  septet (NMR spectroscopy) 
T  temperature 
t  tertiary 
t  time 
t  triplet (NMR spectroscopy) 
TBAI  tetra-n-butylammonium iodide 
TBAF  tetra-n-butylammonium fluoride 
TBDPS t-butyldiphenylsilyl 
TES  triethylsilyl 
Tf  trifluoromethanesulfonyl 
TFA  trifluoroacetic acid 
TFPAA trifluoroperacetic acid 
THF  tetrahydrofuran 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
TPAP  tetrapropylammonium perruthenate 
tR  retention time 
Ts  tosyl (4-methylphenylsulfonyl) 
vs  very strong intensity (IR spectroscopy) 
w  weak intensity (IR spectroscopy) 
X  undefined substituent 
Y  undefined substituent  
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1.1 General Introduction 
 
This thesis concerns the synthesis of aziridines. Aziridines are three-membered 
saturated aza-heterocycles and are the nitrogenous analogues of epoxides. Being the 
smallest aza-cycle, aziridines consequently possess significant ring strain and as a result 
their chemistry is driven by relief of this strain. The aziridine functionality is present in 
several natural products, which often possess significant biological activity. 
Furthermore aziridines, driven by this strain-relief, represent a valuable motif for the 
synthetic chemist. As a consequence, aziridines have received widespread attention 
since their first reported synthesis by Gabriel in 1888.(1) They have proved a versatile 
amine building block which can be readily manipulated and as a result lend themselves 
to a wide range of synthetic applications. However, there is in general a lack of robust 
synthetic methods for their preparation, and in particular their enantioselective 
preparation, that are applicable to a wide range of substrates. This thesis entails work 
aimed at developing a novel method for the direct preparation of aziridines from 
alkenes. Research described herein concerns the chemistry of N-N ylides (aminimines), 
which can be utilised in a novel tertiary amine-promoted organocatalytic approach to 
the aziridination of α,β-unsaturated carbonyl compounds. 
 
Section 1.2 will provide an overview of aziridines and their associated chemistry, 
focussing on their occurrence in nature, physical properties and reactivity. Particular 
focus will be placed upon approaches to aziridine synthesis and in particular their 
enantioselective preparation from alkenes. This account will summarise the key areas 
but does not attempt to provide a comprehensive review; however, a variety of reviews 
concerned with specific aspects of aziridine chemistry are available for a more detailed 
account which will be highlighted to the reader where appropriate. 
 
1.2 Aziridines and their Chemistry 
 
1.2.1 Aziridine-Containing Natural Products 
 
In comparison to epoxides, there exist only very few examples of naturally occurring 
aziridines (Figure 1). However various aziridine-containing natural products have been 
13 
 
shown to exhibit potent biological activity, making aziridines worthwhile targets in their 
own right. The mode of action of many of the aziridine natural products is closely 
associated with the reactivity of the strained heterocyclic ring. The mitomycin and 
azinomycin families are the most well studied and the chemistry of aziridine-containing 
natural products has been recently reviewed by Lowden (2006)(2) and Dembitsky 
(2009).(3) 
  
Figure 1. Select Aziridine-Containing Natural Products 
 
The mitomycin family of aziridines (the mitosanes), which includes mitomycins 
A-C,
 
porfiromycin, mitiromycin (inactive, not shown) and also structurally related 
FR900842 and FR66979, represent an important class of aziridine-containing natural 
product. Mitomycins A and B were first isolated 1956 from the soil extracts of 
Streptomyces caespitosus,(4,5) with the other members isolated in the early 1960s and the 
FR products in the late 1980s. The mitosanes exhibit both antitumor and antibiotic 
activity and mitomycin C has been used clinically for almost 50 years.(6) Structure-
activity relationships have identified the aziridine ring as necessary for activity, with 
their mode of action related to their ability to cross-link to DNA via reduction of the 
quinone and subsequent ring-opening.(7)  A vast number of studies have focussed on 
derivatives of the mitosanes and related compounds, such as the PBI and FK 
compounds classes which both possess promising anti-cancer activity.  
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The azinomycin family of aziridines,(8) were first isolated from Streptomyces 
griseofuscus in 1986 and shown to contain both electrophilic epoxide and aziridine 
moieties.(9) The azinomycins possess activity against a range of tumours, based upon 
their ability to cross-link DNA(10) via nucleophilic ring opening of both the aziridine and 
epoxide moieties. The structural requisites for the activity of the azinomycins have been 
well studied however their precise covalent binding and mode of action are yet to be 
unambiguously elucidated.
 
 
Miraziridine A and its related dicarboxy aziridine residue (not shown) have also 
been identified. Miraziridine A was isolated in 2000 from a marine sponge related to 
Theonella mirabilis and its biological activity has been shown to include cysteine 
protease inhibition, where the aziridine functionality has been shown to be crucial to 
activity, attributed to thiol alkylation via nucleophilic ring-opening.(11) 
Maduropeptin is a complex of macromolecular antitumor agents of the 
chromoprotein antitumor antibiotics, isolated from the broth filtrate of Actinomadura 
madurae in 1991.(12) As a result of recent structural revision, it is likely that the most 
active component of maduropeptin, believed to be that containing the enediyne 
structure, is that of 1.(13) Maduropeptin has been shown to cleave double-stranded DNA, 
with its mode of action most likely via a Bergman-type cyclization to afford a para-
benzyne biradical.(14) 
A small number of other aziridine-containing natural products have also been 
isolated, but are in general less well studied; including ficellomysin (believed to be 
related to the azinomycins), azicemicins A and B and madurastatin A; and the reader is 
pointed to the recent summary by Lowden for further discussion of the area.(2) 
 
As a consequence of the potent biological activity of aziridine natural products it 
follows that facile, efficient and in particular enantioselective methods for the 
preparation of aziridines are an important requisite. 
 
1.2.2 Ring-Strain in Aziridines 
 
The chemistry of aziridines is dominated by the strained three-membered ring. The C-
N-C bond angle is severely distorted from the optimal 109.5
o
 tetrahedral angle with the 
ring strain of aziridine itself (ethyleneimine), ca. 109-113 kJ mol
-1
,(15) comparable to 
cyclopropanes. Considering the likely hybridisation, as a result of the decreased C-N-C 
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bond angle, the C-N bonds experience increased p-character, with the N-X and N-lone 
pair experiencing greater s-character, and a larger degree of pyramidalisation around the 
nitrogen atom is assumed.(16) This has a significant impact on the basicity of aziridines 
and aziridine, a secondary amine, exhibits weaker basicity (pKaH = 8.04) than that 
typical of other secondary amines such as homologues pyrrolidine and piperidine.(17) 
Moreover, the barrier to N-inversion is also considerably higher than acyclic analogues. 
The inversion barrier of aziridine itself is ca. 81 kJ mol
-1
 and although this is not 
sufficient to prevent racemisation at room temperature, addition of an electronegative 
substituent at N can sufficiently raise the barrier.(15) For example N-chloro aziridine 2 
can be isolated and characterised by X-ray crystallography and exists exclusively as the 
Z-isomer, which dominates even after heating at 50
o
C (Figure 2).(18) 
 
 
Figure 2. Z-N-Chloro Aziridine, 2 
 
The associated strain in aziridines, as shown, has a dramatic effect on their physical 
properties and as would be expected, relief of this strain drives their chemistry, with 
reactions of aziridines dominated by nucleophilic ring-opening. 
 
1.2.3 Synthetic Transformations of Aziridines 
 
A range of reviews concerning the reactivity and synthetic applications of aziridines are 
available for a comprehensive overview of the area,(19-22) with this section focusing on 
important general points applicable to aziridine reactivity with the aim of highlighting 
their significance as a privileged amine motif. 
 
1.2.3.1 Ring-Opening Reactions 
 
Due to the ring-strain present in aziridines, coupled with electronegativity of the 
nitrogen heteroatom, aziridines undergo nucleophilic ring-opening reactions under 
relatively mild conditions. Aziridines can be opened either inter- or intra-molecularly 
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with a wide variety of nucleophiles thus providing access to high value amine products, 
including amino alcohols, diamines and amino acid derivatives (Scheme 1). 
  
Scheme 1. Ring-Opening Reactions of Aziridines 
 
The nature of the N-substituent has a profound effect upon ring-opening 
processes. Aziridines can be broadly classified into two groups based on their reactivity 
towards nucleophiles: „activated‟ and „non-activated‟ (see Scheme 1).(23) Activated 
aziridines contain substituents capable of stabilising the developing partial negative 
charge at N during the ring-opening process, and commonly include sulfonamide, 
sulfinamide, phosphoramide, amide and carbamate groups. Whilst N-deprotection can 
be achieved without disruption to the ring, often these groups require harsh acidic or 
reductive conditions for cleavage, such as the tosyl group, a commonly used protecting 
group in aziridine synthesis. In contrast, ring-opening reactions with non-activated 
aziridines,(22) such as N-H or -alkyl aziridines, are less facile and usually require either 
protonation, quaternisation or formation of a Lewis acid adduct. The ring-opening 
reactions of non-activated aziridines, including NH-aziridines, in contrast to activated 
aziridines, have been much less studied. 
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A further problem encountered with activated aziridines, such as N-carbonyl 
aziridines, lies in the fact that nucleophilic attack at the electrophilic activating group 
may also occur. This is understood by a lack of resonance interaction between the N-
lone pair and carbonyl moiety, since this exerts additional strain on the system; as a 
result the carbonyl displays reactivity more accustomed to that of a ketone than of an 
amide. Consequently N-acyl aziridines, such as 3, have been demonstrated to be 
effective acylation agents (Scheme 2).(24-26) 
 
 
Scheme 2. C-Acylation of β-Ketoesters with N-Acylaziridine 3 by Lygo 
 
Nucleophilic ring-opening of aziridines proceeds via an SN2-like mechanism 
with inversion at C; where the aziridine is unsymmetrically substituted, reaction can 
lead to two possible regio-isomers. As would be expected, preferential attack occurs at 
the site of lesser substitution, although electronic influences of the substituent may 
perturb this outcome.(27) Regiochemistry can also be affected by neighbouring group 
participation, frequently via coordination of a heteroatom substituent to an incoming 
organometallic nucleophile.(21) Intramolecular aziridine ring-opening is also strongly 
affected by the size of the ring formed and is often different from that expected from 
intermolecular attack. For example, Bergmeier showed that intramolecular allylation of 
4 formed only the 6-membered ring, via attack at the more substituted C2 position 
(Scheme 3).(28) 
 
 
Scheme 3. Intramolecular Allylation of N-Ts Aziridine 4 
 
A further point concerning aziridine ring-opening is that chiral amines can be 
generated via asymmetric ring-opening utilising chiral catalysts, with significant recent 
progress achieved in this area.(29,30) For instance, Shibasaki, in 2006, showed that 
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activated meso-aziridines, such as 5, can be opened by azides in high ee via the 
employment of a chiral ytterbium complex (Scheme 4).(31) 
 
 
Scheme 4. Asymmetric Ring-Opening of Meso-Aziridines by Shibasaki 
 
1.2.3.2 Rearrangement, Ring-Expansion and Cycloaddition Reactions 
 
The chemistry of aziridines is also characterised by their rearrangement and 
cycloaddition chemistry, again driven by strain relief.(19,22) As a result aziridines can 
provide routes to various complex, multi-functionalised, heterocyclic frameworks in a 
single step. The rearrangement chemistry of the vinyl aziridine motif is particularly 
noteworthy, as discussed later (see Section 2.1.1).(32) 
Aziridines can also undergo ring-expansion. For example a variety of transition 
metal-mediated processes have been developed which show that aziridines can act as 
precursors to β-lactams, such as the regiospecific Pd-catalysed carbonylation of α-
methylene aziridines by Alper (Scheme 5).(33)
 
 
 
Scheme 5. Pd-Catalysed Carbonylation of α-Methylene Aziridines to form β-Lactams 
 
A particularly significant use of aziridines is as azomethine ylides. Aziridines 
are known to undergo cycloaddition reactions through the formation of a 1,3-dipole, 
commonly formed either via thermolysis, or via Lewis acid or transition metal 
mediation and they can react in a [3+2](34) and [3+3](35) manner, leading to 5- and 6- 
membered aza-heterocycles. One application of aziridines in this manner was the 
enantioselective synthesis of acromelic acid A by Takano (Scheme 6).(36) 
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Scheme 6. Asymmetric Synthesis of Acromelic Acid A by Takano Employing an Intramolecular 
1,3-Dipolar Cycloaddition of Aziridine 6 
 
1.2.3.3 Transformations without Ring-Opening 
 
In addition to ring-opening processes it is also possible to perform both a variety of side 
chain reactions and also selective transformations at the ring atoms, both N and C, 
whilst leaving the ring system intact; this is particularly the case for non-activated 
aziridines.  
NH-Aziridines are able to partake in a range of N-functionalization reactions 
which can be achieved in a variety of manners, by exploiting the basic N, including 
alkylation, halogenation and „activation‟ reactions, but reductive aminations are 
problematic due to the presence of the intermediate activated aziridinium ion which can 
be easily opened. NH-Aziridines, as demonstrated by Yudin, can also take part in 
various transition metal-mediated processes(37) including cross-coupling reactions 
(Scheme 7).(38) 
 
 
Scheme 7. Pd-Catalysed N-Alkenylation by Yudin 
 
NH-Aziridine-2-aldehydes also display interesting chemistry. Due to the 
resistance of the aziridine ring to undergo imine formation Yudin (2006) demonstrated 
NH-aziridine-2-aldehydes act as „unprotected amino aldehydes‟, which exist as bench-
stable dimers, 7, which do not epimerise.(39) The dimers display orthogonal reactivity at 
the aziridine and aldehyde moieties and as a result they can be exploited in a variety of 
synthetic transformations including homologation,(40) to afford alkynyl aziridines, and 
iterative carbonyl allylation and NH-aziridine ring-opening, to afford syn-β-amino 
alcohols (Scheme 8).(41)  
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Scheme 8. Dimeric NH-Aziridine-2-aldehydes as ‘Unprotected Amino Aldehydes’ 
 
Selective transformations of aziridines at the ring carbon can also be achieved 
via nucleophilic displacement. The first successful examples were demonstrated with 
non-activated aziridines, such as 8, by Deyrup in 1965, with clean inversion at C 
(Scheme 9).(42)
 
 
 
Scheme 9. Nucleophilic Displacement at C of Non-Activated Aziridine 8 
 
The diverse chemistry of aziridines is further highlighted by α-aziridinyl anions 
and this area has been comprehensively reviewed recently by Florio and Luisi (2010).(43) 
For instance, various N-protected aziridines are able to undergo α-deprotonation and 
electrophilic trapping reactions keeping the ring intact, as demonstrated recently by 
several groups.(44-46) For example Aggarwal, in 2009, showed that N-Boc and N-Bus 
(Bus = tert-butylsulfonyl) aziridines, for example 9, can be α-lithiated and trapped with 
boronic esters to provide access to syn-β-amino alcohols (Scheme 10).(47) 
 
 
Scheme 10. α-Lithiation and Trapping of N-Bus Aziridine 9 with a Boronic Ester 
 
1.2.4 Synthetic Approaches to Aziridines 
 
As has been highlighted aziridines represent an important amine class, both in 
biologically active compounds and also as a synthetic motif. As such, it is important 
that aziridines can be generated in a robust manner from a range of substrates and with 
control of relative and absolute stereochemistry. The synthesis of aziridines has been 
and still is the subject of much research. 
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Common synthetic approaches to aziridines involve: electrophilic nitrene 
addition to alkenes, carbenoid/carbanion/ylide addition to imines, conjugate addition of 
a nucleophilic nitrogen source, conjugate addition to α-bromoacrylates (the Gabriel-
Cromwell reaction), cyclization of 1,2-amino-alcohols and -halides, via ring opening-
cyclization of an epoxide and also by addition to azirines. Schematically the general 
approaches to the synthesis of aziridines can be summarised as follows (Scheme 11): 
 
 
Scheme 11. General Approaches to Aziridine Synthesis 
 
As can be seen few of these methods involve the direct synthesis of the aziridine 
ring from an alkene precursor. This section will provide focus on the direct synthesis of 
aziridines from alkenes, where emphasis is placed upon asymmetric strategies. A brief 
overview of the other main strategies towards the synthesis of aziridines is included but 
the reader is directed to a range of reviews concerning the general synthesis of 
aziridines for a comprehensive overview.(21,48-50) 
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1.2.4.1 Aziridine Synthesis via Cyclisation 
 
Gabriel, in 1888, reported the first aziridine synthesis,(1) cyclising ethanolamines via 
prior chlorination with thionyl chloride, and as such the synthesis of aziridines via 
cyclization has historically been adopted to prepare aziridines. Chiral aziridines can be 
readily prepared by cyclization of various chiral amines, including 1,2-amino-alcohols 
and -halides, with the former commonly derived from the chiral pool. Recent examples 
of the use of this strategy have been reviewed by Pellissier.(49) 
Due to the significant developments in the asymmetric synthesis of epoxides it is 
possible to utilise epoxides as intermediates for the asymmetric synthesis of aziridines, 
via a ring-opening-cyclization process. Typically epoxides are opened with azides 
followed by a phosphine-mediated ring-closure to generate the NH-aziridine.(51) In a 
sense the synthesis of aziridines from epoxides provides an indirect synthesis of 
aziridines from a range of alkene substrates. Whilst this route is notable, a direct 
enantioselective preparation of aziridines from alkenes is clearly more attractive and as 
a result the preparation of aziridines from epoxides will not be discussed further here. 
 
1.2.4.2 Carbenoid, Carbanion and Ylide Addition to Imines 
 
As will be seen the direct preparation of aziridines from alkenes has, until recently, 
remained little developed. One attractive alternative for the direct preparation of 
aziridines is the addition of carbene equivalents to imines (Scheme 12). 
 
 
Scheme 12. Aziridination via Addition of Carbene Equivalents to Imines 
 
This strategy has become increasingly popular of late and involves the reaction between 
carbenoids or carbanions (aza-Darzens-type reactions) (Eq. A) or the reaction between 
C-X ylides and imines (Eq. B). The reactions create both a C-C and C-N bond which 
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occurs via a stepwise addition-cyclization process. The latter strategy has often been 
used for the preparation of vinyl aziridines. For asymmetric aziridination, control is 
most commonly achieved via addition to chiral imines (typically chiral sulfinyl imines), 
or by addition of a chiral nucleophile and often excellent diastereomeric excess can be 
achieved. However, significant advances to the preparation of aziridines from imines 
have recently emerged via the use of chiral catalysts. Whilst a brief overview is 
presented here the reader is pointed to recent reviews of this field by Aggarwal,(52)  
Sweeney(53) and Pellissier(49) for detailed discussions. 
 The aza-Darzens reaction of α-diazoacetates and N-protected imines is a useful 
method for the preparation of aziridine-2-carboxylates. Pioneering studies by Wulff 
over the last decade or so have shown that Lewis acid catalysed asymmetric 
aziridination using α-diazoacetates and benzhydryl imines, with catalysts prepared from 
B(OPh)3 and either VANOL or VAPOL ligands afforded cis-aziridines with excellent 
levels of observed enantioselectivity (75-97% ee).(54) Unprecedented trans-selectivity 
has also recently been demonstrated by Maruoka (2008) with α-diazoacetamides and N-
Boc imines using an axially chiral dicarboxylic acid to afford trans-aziridine-2-
carboxamides with excellent levels of ee (89-99% ee), albeit in moderate yields and 
with competing amounts of unwanted of enamide side-product.(55) Similar studies have 
also been reported by Zhong (2009),(56) which via the use of an axially chiral phosphoric 
acid achieved increased yields with similar enantioselectivities. Moreover, Akiyama 
(2009) has shown that cis-aziridine-2-carboxylates can be prepared in excellent ee (92-
97% ee) via the use of a similar catalyst using imines generated in situ from 
arylgyloxals and p-anisidine.(57) Whilst these studies are impressive, often leading to 
aziridine-2-carboxylates in high enantioselectivities and diastereoselectivities using low 
catalyst loadings (typically <5 mol%), these methods are often restricted to aromatic 
imines thus limiting the scope of aziridines that can be prepared via this process. 
In terms of C-X ylide mediated asymmetric aziridinations with imines, whilst in 
principle it has been demonstrated that chiral catalysts can be utilised, the use of chiral 
catalysts is less well developed than that using carbenoids derived from α-diazoacetates. 
The classical aza-Darzens reaction, between α-bromoketones and imines, can be 
rendered asymmetric, as shown by Yadav (2009), via the use of quinine as a chiral 
catalyst to generate an ammonium ylide in situ to afford trans-aziridines (1 example, 
92% ee), although relatively high catalyst loadings are required (20 mol%).(58) Aggarwal 
(2001) has also demonstrated the catalytic use of a chiral terpene-derived sulfide (20 
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mol%), generated in situ via the Rh-mediated decomposition of tosylhydrazones, for the 
generation of trans-aziridines in high ee (73-98% ee), albeit in moderate dr (2:1-8:1) 
and with limited C-substituent scope.(59) The stoichiometric use of C-X ylides for 
asymmetric aziridination is much more advanced but has been limited due to 
complexities in the synthesis of the ylide. Aggarwal (2010) has recently reported the use 
of a chiral sulfide derived in one step from limonene in order to address this issue.(60) 
Whilst the ylide can be used to generate 2,3-aryl aziridines or 2-aryl-3-vinyl aziridines 
in excellent ee (96-98% ee) again moderate diastereoselectivity (3:1->99:1) and 
substrate scope is observed. 
 
1.2.4.3 Nitrene Addition to Alkenes 
 
A potentially powerful method for aziridine synthesis is the direct addition of a nitrogen 
source to alkenes and the electrophilic addition of nitrenes to an alkene has been well 
documented. Free nitrenes are often generated by thermal or photochemical 
decomposition of azides but there can be severe limitations to this approach, which 
include often harsh reaction conditions, competitive insertion of the nitrene into CH 
bonds and the generation of a mixture of both singlet and triplet state nitrenes. Whereas 
singlet nitrenes insert in a concerted stereospecific manner, triplet nitrenes insert in a 
stepwise manner and do not react with the alkene stereospecifically. Triplet state 
nitrenes are generally more stable than singlet state nitrenes hence conversion of the 
singlet to triplet state nitrene is facile, thus resulting in the formation of the aziridine as 
a diastereomeric mixture. As a result metal-stabilised nitrenoids are frequently 
employed for alkene aziridination offering milder reaction conditions and providing 
greater control of stereopecificity. Metal-nitrenoid aziridination has the further 
advantage of allowing the use of chiral ligands to enable the direct enantioselective 
preparation of aziridines from alkenes and significant research has been focussed on this 
area since the early 1990s. A range of metals are now able to facilitate nitrene-addition 
to alkenes and the focus in this section will be placed upon the most broadly applicable 
methods in terms of substrate scope, reaction yield and levels of observed asymmetric 
induction. The reader is directed to reviews by Müller(61) and by Pellissier(49) for further 
discussion. 
The most commonly employed asymmetric metal-nitrenoid systems are based 
on Cu-catalysed processes. One of the first synthetically useful methods for 
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enantioselective aziridination via metal-nitrenoids was developed by Evans in 1993 
(Scheme 13).(62) The method employed CuOTf with bisoxazoline ligands using N-
tosyliminobenzyliodinate (PhI=NTs) as the nitrogen source for the aziridination of 
cinnamate esters in excellent ee (94-97% ee) and in moderate-to-good yield (60-76%). 
However, poorer ee was observed with styrene and trans-β-methylstyrene (63% and 
70% ee respectively). 
  
 
Scheme 13. Aziridination of Cinnamate Esters Using Cu-Bisoxazoline-Nitrenoids by Evans 
 
Simultaneously to Evans, Jacobsen, also in 1993, showed that CuOTf with a salen-
derived Schiff base ligand and PhINTs could aziridinate a range of aromatic olefins.(63) 
In general only moderate levels of enantioselectivity were observed, again including 
styrenes, but in the case of a chromene substrate >98% ee could be achieved.
 
Later work 
by Scott (2002) showed that C2-symmetric biaryl Schiff bases could also be used for the 
Cu-catalysed asymmetric aziridination of cinnamate esters (Scheme 14).(64) The reaction 
proceeded in moderate-to-good yield (32-89%) and with high ee (88-98% ee), selective 
for the opposite aziridine enantiomer to that reported by Evans. Again poorer ee was 
observed for simple olefins including styrene (66% ee) and other aromatic olefins. 
Moreover, the olefin substrate in these reactions was used in excess (1-5 eq.) and the 
reactions were conducted at low temperature (-40
o
C). 
 
Scheme 14. Aziridination of Cinnamate Esters Using Cu-Biaryl Schiff Base-Nitrenoids by Scott 
 
More recently Xu has developed both AnBOX (2004)(65) and cHBOX (2005)(66) 
bisoxazoline ligands for the asymmetric aziridination of a range of chalcones. The 
cHBOX ligands were more effective and in general excellent levels of observed ee were 
achieved (80->99% ee) with good yields (50-80%) (Scheme 15). The cHBOX ligands 
were also found to be substrate independent, in contrast to the AnBOX ligands, and 
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both electron-rich and -deficient chalcones could be aziridinated with comparable ee. A 
disadvantage of the system is that the alkene is used in slight excess (1.5 eq.); 
furthermore the ligands were not applicable to styrenes, where very low ee was obtained 
(6-15% ee). Both sets of ligands have also been evaluated for the aziridination of 1,3-
dienes to afford vinyl aziridines but in general these were formed with modest yield and 
ee and in some instances low diastereoselectivity.(67) 
 
 
Scheme 15. Asymmetric Aziridination of Cinnamate Esters Using Cu-cHBOX-Nitrenoids by Xu 
 
Ding (2006) has also realised an asymmetric aziridination of cinnamate esters using a 
Cu-diimine ligand system, with similar ee levels to that previously obtained for this 
transformation (80->99% ee).(68) But whilst the asymmetric aziridination of cinnamate 
esters and chalcones via Cu-nitrenoid aziridination can frequently be achieved with high 
levels of observed ee, other aromatic olefins lacking a co-ordinating group, including 
styrenes, have proved significantly more difficult. Hutchings has utilised a Cu-
exchanged zeolite in the presence of Evans‟ bisoxazoline ligand for the asymmetric 
aziridination of various styrenes with moderate-to-excellent levels of observed 
enantioselectivity (64-95% ee),(69) but in general other metal-nitrenoids have proved 
more applicable for this transformation. 
Chiral Cu-systems have received the most attention and remain the most 
developed, in terms of asymmetric metal-nitrenoid aziridination, but a variety of other 
metals have also been employed, including Mn, Rh, Ru, Co and Fe. Katsuki has 
reported the use of both Mn and, more recently, Ru based systems for the asymmetric 
aziridination of styrenes. It was shown that a Mn-salen complex could facilitate the 
aziridination of styrene with excellent levels of observed ee (94% ee), however 
substituted styrenes were aziridinated with lower levels of ee and the substrates were 
used in excess.(70) However, Katsuki (2006) has more recently utilised a Ru-salen 
complex for the aziridination of a range of alkenes, often with excellent levels of ee 
(Scheme 16).(71,72) Alkenes including styrenes, an ene-yne, indene and also an enoate and 
an enamide could all be aziridinated with excellent levels of observed ee (92->99% ee); 
furthermore, unfunctionalised 1-octene could also be aziridinated with good levels of ee 
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(77% ee). Notably the developed process can employ a variety of azides as the nitrogen 
source, including 2-(trimethylsilyl)ethanesulfonyl azide (SESN3) which can be cleaved 
under milder conditions than NTs-aziridines. 
 
 
Scheme 16. Asymmetric Aziridination of Various Alkenes Using a Ru(salen*)CO Complex by 
Katsuki 
 
Komatsu (2002) has also utilised a Mn-salen-nitrodo complex in conjunction with a 
silver salt additive to aziridinate trans-substituted styrenes in good ee (4 examples, 83-
93% ee) and with moderate yield (50-70%).(73) Selectivity was lower for styrene (40% 
ee) and cis-methylstyrene (24% ee); furthermore, the process employed 10 eq. of olefin. 
More recently Zhang (2009) has developed a chiral Co-porphyrin based asymmetric 
aziridination of styrenes in high ee (80-99% ee) and generally high yield (43-93%) 
using trichloroethoxysulfonyl azide (TcesN3) as the nitrogen source (Scheme 17).
(74) 
The process was applicable to a range of substituted styrenes, although the yield for α-
methyl styrenes was significantly lower (43-48%). Particularly noteworthy is the 
applicability to a range of terminal alkyl substituted olefins which could be aziridinated 
in high ee (90-94% ee), albeit with low yields (26-42%); a rare example of this 
transformation. 
 
 
Scheme 17. Asymmetric Aziridination of Styrenes and Terminal Alkenes Using a Co-Porphyrin 
System by Zhang 
 
Although the direct aziridination of certain alkenes can be achieved with 
excellent levels of observed asymmetric induction, methods for enantioselective 
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aziridination of alkenes via nitrene addition are far from generally applicable to a wide 
scope of substrates and frequently rely on the presence of a co-ordinating group. 
Unfunctionalised alkenes, in particular terminal alkyl substituted alkenes are 
particularly challenging. It is also worth mentioning that many of the methods 
frequently deliver N-sulfonyl aziridines, typically as N-Ts-aziridines, protecting groups 
which are often non trivial to remove without disruption to the aziridine ring. It is likely 
that the search for new catalytic systems, including the use of Rh and Ru systems, along 
with alternative nitrogen sources will further develop the area of metal-nitrenoid alkene 
aziridination.  
 
1.2.4.4 Conjugate Addition Approaches to the Aziridination of Electron-Deficient 
Alkenes 
 
1.2.4.4.1 Gabriel-Cromwell Reaction 
 
The Gabriel-Cromwell reaction involves the conjugate addition-cyclization of amines 
with α-haloacrylates and can be used to form chiral aziridines either via the use of a 
chiral amine or through the employment of a suitable chiral auxiliary appended to the 
olefin substrate. The method has historically been used to prepare chiral aziridines and 
whilst this method will not be reviewed here the reader is pointed to previous 
discussions by Sweeney(48) and recent examples covered by Pellissier.(49) However, it is 
worth mentioning that chiral NH-aziridines can be prepared by utilising ammonia with 
chiral substrates.(75) 
 
1.2.4.4.2 Use of Nucleophilic Nitrogen-Transfer Agents 
 
The use of nucleophilic nitrogen-transfer agents (NNTAs; also described as „nitrenoid 
equivalents‟) for the aziridination of electron-deficient alkenes has, until recently, been 
less well developed than that of electrophilic nitrogen-transfer reagents (nitrenes), but 
potentially represents a powerful method for the generation of aziridines from electron-
deficient alkenes in both high yield and ee. Typically the nucleophilic reagent (of 
structure 10) possesses a substituted nitrogen attached to a good leaving group (LG) 
(Scheme 18). Under basic conditions, the reagent can undergo conjugate addition to the 
electron-deficient alkene, generating an intermediate enolate which then undergoes ring-
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closure to afford the aziridine. A variety of NNTAs are known, which include 
sulfimides,(76) hydroxylamines,(77) azides,(78) hydroxamic acid(79-81) and ester derivatives(82-
86) and hydrazines;(87-91) through employment of a chiral catalyst enantioselectivity can be 
inferred. Focus in this section will again be placed on enantioselective methods via the 
use of chiral catalysts rather than diastereoselective syntheses. 
 
 
Scheme 18. Aziridination Using Nucleophilic Nitrogen-Transfer Agents 
 
Phase-Transfer Catalysed (PTC) Processes: 
Phase-transfer catalysts (PTCs), typically organic salts, such as a quaternary ammonium 
salt, have been employed for the asymmetric aziridination of various electron-deficient 
alkenes with NNTAs. Tardella and co-workers have developed N-nosyloxycarbamates, 
11, as novel reagents and in 2004 showed they could be used in the PTC aziridination of 
a range of cyclic enones of varying ring size.(84) Employing the cinchona alkaloid 
derived PTC 12, 11 and CaO afforded the corresponding aziridines in moderate yield 
and ee (Scheme 19). 
 
 
Scheme 19. PTC Aziridination of Cyclic Enones with NNTA 11 by Tardella 
 
Early studies by Prabhakar (1996) utilised N-aryl-hydroxamic acids (of type 13) 
and related cinchona alkaloid PTCs for the aziridination of a range of acyclic electron 
deficient alkenes including α,β-unsaturated esters and vinyl sulfoxides to afford N-aryl 
aziridines, but only moderate yields and ee were obtained (11-61% ee).(79,80) However, 
Murugan (2005) developed these conditions and showed that by employing PTC 14 and 
N-aryl-hydroxamic acids, 13, with a low concentration of NaOH allowed the 
corresponding N-aryl aziridines to be formed in good yield (53-92%) and with good ee 
(75-95% ee) (Scheme 20).(81) Employment of the pseudoenantiomeric PTC afforded the 
30 
 
opposite aziridine enantiomer in comparable yield and ee. The reaction is believed to 
proceed via initial deprotonation of the hydroxamic acid which rearranges, via an 
oxaziridine intermediate, to form the active NNTA.  
 
 
Scheme 20. PTC Aziridination of Electron-Deficient Olefins by Employment of 14 and N-Aryl-
Hydroxamic Acids, 13, by Murugan 
 
More recently Minakata (2008) has utilised an N-chloro-N-sodio carbamate for 
the PTC aziridination of several α,β-unsaturated amides with various cinchona alkaloid 
derived PTCs.(92) Whilst good yields could be obtained (3 examples, 83-98%) observed 
ee was only moderate (63-71% ee) unless the reaction was conducted at -20
o
C and with 
2 equivalents of alkene (up to 87% ee). 
  
Aminocatalysed Processes: 
Whilst the use of PTCs with NNTAs has only led to the formation of aziridines in good 
enantioselectivity in relatively few examples, employment of aminocatalysts with 
NNTAs has led to the aziridination of a range of electron deficient alkenes with, in 
general, excellent levels of observed enantioselectivity. Typically aminocatalysis 
involves a primary or secondary amine that is used to facilitate reaction via the initial 
formation of an active substrate-derived electrophilic iminium ion. Typically 
hydroxamic esters have been used as the NNTAs agent in these processes. 
In 2007 Córdova reported the aziridination of α,β-unsaturated aldehydes (enals) 
based on an aminocatalysed process (Scheme 21).(86) The reaction proceeded in 
moderate-to-good yields (54-78%) with good-to-excellent levels of asymmetric 
induction (84-99% ee) via the employment of chiral prolinol catalyst 15 and acylated 
hydroxycarbamates as the NNTA, to afford N-carbamate protected aziridines. However, 
the diastereoselectivity observed was only moderate (4:1-10:1). The reaction was found 
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to be tolerant of a range enals with β-alkyl substituents, including homo-benzyl, ester 
and protected alcohol groups. 
 
 
Scheme 21. Aminocatalysed Aziridination of Enals by Córdova 
 
Hamada (2009) developed this method further by showing that the use of 
sulfonylhydroxycarbamates as NNTAs in the presence of a base and a similar 
diarylprolinol catalyst, 16, could be used to attain improved diastereoselectivity and 
allowed an extension to the reaction scope (Scheme 22).(82) Whilst the aziridination of 
aromatic enals provided generally good yields and excellent levels of observed 
enantioselectivity (94-99% ee) and diastereoselectivity (>99:1) the reaction was only 
applicable to electron deficient aromatic substrates and the reaction was conducted at -
20
oC. The aziridination of β-alkyl enals and acrolein was less efficient. 
  
 
Scheme 22. Aminocatalysed Aziridination of Enals by Hamada 
 
It is important to note that both the Córdova and Hamada processes use the substrate, 
with the exception of aromatic enals, in a slight excess which would be less desirable 
for more valuable substrates. 
In a similar manner Melchiorre (2008) recently reported the asymmetric 
aziridination of enones utilising a primary amine aminocatalyst (Scheme 23).(85) 
Employing the primary amine salt of a cinchona alkaloid derivative and D-N-Boc 
phenyl-glycine as the aminocatalyst 17 with a sulfonylhydroxycarbamate as the NNTA 
and NaHCO3 afforded trans-carbamate-protected aziridines. The aziridines were formed 
in good yield (74-96%) and in general excellent ee (73-99% ee), although long reaction 
times were often necessary (up to 72 h). The reaction was found tolerant of a variety of 
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β-substituents including alkyl, ester and aryl, although in the case of a β-phenyl 
substituent the reaction proceeded in a significantly lower ee (73% ee).  
 
Scheme 23. Aminocatlalysed Aziridination of Enones by Melchiorre 
 
Significantly, examples of the aziridination of cyclic enones were also presented (2 
examples, 73-98% ee) and this has recently been extended by Melchiorre (2010) to 
cover further examples of cyclic enones (Scheme 24).(83) These studies provided the first 
examples of the aziridination of cyclic enones in high ee. It was shown that a range of 
cyclic enones, with either 5-, 6- or 7-membered rings could undergo aziridination by 
employment of 17 in generally good yield (33-93%) and with good to excellent levels 
of asymmetric induction observed (85-99% ee). Employment of the pseudoenantiomeric 
aminocatalyst, 18, gave the opposite aziridine enantiomer in comparable yield and ee. 
The reaction tolerated β-trisubstituted cyclic enones but did not tolerate substituents at 
the α-position. 
 
Scheme 24. Aminocatlalysed Aziridination of Cyclic Enones by Melchiorre 
 
Whilst the aziridination of acyclic enones by Melchiorre employed the substrate as the 
yield-limiting reagent, the aziridination of cyclic enones, in a similar manner to the 
Córdova and Hamada systems, utilised a slight excess of the enone (1.2 eq.). 
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Tertiary Amine-Promoted Processes: 
Recent studies have demonstrated that N-N ylides (aminimines) can also act as NNTAs. 
Since the use of aminimines for the aziridination of alkenes, described by Armstrong,(87) 
forms the basis for studies reported in this thesis, this section will provide a detailed 
introduction of the background studies, including racemic syntheses, that have led to the 
development of this method. Subsequently the initial research aims that were identified 
at the outset of this thesis are outlined. 
In 1980 Ikeda reported the in situ formation of a N-N ylide (which has been 
referred to in the literature as an aminimide or aminimine) that could directly aziridinate 
chalcones to afford NH-aziridines (Scheme 25).(89) The ylide 19, which was prepared 
directly from 1,1-dimethylhydrazine and propene oxide, undergoes conjugate addition 
to the substrate and, following ring closure, generated the trans-aziridine. The reaction 
was applied to the aziridination of several chalcones in good yield (4 examples, 67-
89%). 
 
 
Scheme 25. Aziridination of Chalcones with Ikeda’s Aminimide 19 
 
However, since this initial report little has been described on the use of 
aminimines for aziridination. Studies by Xu (2002) showed that other aminimines, 
derived from an isolated bishydrazinium salt, 20, as a ylide precursor, could also be 
used to facilitate the aziridination of a variety of chalcones (Scheme 26).(91) Salt 20, 
prepared from diazabicyclo[2.2.2]octane (DABCO), was shown to facilitate 
aziridination in the presence of NaH, via the presumed ylide.  High yields of the trans-
aziridine were shown to require 2 eq. of the bis-hydrazinium salt (4 eq. if both N-atoms 
in DABCO are considered). In general the aziridines were prepared in high yield for 
both β-alkyl and -aryl substrates (76-99%), but nitro-substituted chalcones were only 
aziridinated in low yield (15-17%) and aliphatic enones, enoates and enamides were not 
aziridinated. 
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Scheme 26. Aziridination of Chalcones by Xu with Bishydrazinium Salt 20 
 
The process was further developed by Armstrong in 2006. It was shown that N-
methylmorpholine (NMM) hydrazinium salts, 21, as aminimine precursors, were highly 
reactive reagents for the aziridination of a variety of chalcones (Scheme 27).(88) Two 
sets of reaction conditions were developed which displayed differing reactivity. Method 
A, which utilised the iodide salt, with KO
t
Bu as the base and DMSO as the reaction 
solvent, displayed higher reactivity with electron-rich substrates, whereas Method B, 
using the nitrate salt, with NaOH in MeCN, displayed greater reactivity with electron 
deficient substrates. However, neither condition was applicable to the aziridination of 
alkyl-substituted enones. 
 
 
Scheme 27. Chalcone Aziridination by Armstrong with Hydrazinium Salts 21a and 21b 
 
In both the Xu and Armstrong methods the co-product of the aziridination 
reaction, following ring closure, is a tertiary amine. A significant development to the 
aziridination of enones using the chemistry of aminimines was realised when it was 
shown that aminimines could be generated via in situ amination of simple tertiary 
amines. The groups of Armstrong and Shi independently and simultaneously realised 
this development. In 2006 Shi reported an amine promoted organocatalytic aziridination 
of chalcones using NMM (Scheme 28).(90) The in situ generation of an aminimine, 22, 
was achieved via aminination of NMM, with the electrophilic aminating agent O-
mesitylenesulfonyl hydroxylamine (MSH), to form a hydrazinium salt which is then 
deprotonated in situ with base. The Shi method was found to be tolerant of chalcones 
with a variety of aromatic substituents to afford aziridines in moderate-to-good yields 
when stoichiometric amounts of NMM were employed (8 examples, 49-85%). In a 
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further development the loading of the amine catalyst could be reduced to 20 mol%, 
although the yields of aziridine obtained were lower (21-80%) and further additions of 
MSH and base were required with longer reaction times. Moderate levels of asymmetric 
induction were observed via the employment of the chiral tertiary amine Trögers base 
(up to 67% ee). 
 
 
Scheme 28. Aziridination of Chalcones by Shi via in situ Aminimine Generation 
 
In 2007 Armstrong showed that the tertiary amine NMM (or in some instances N-
methylpyrrolidine (NMP)), with O-diphenylphosphinyl hydroxylamine (DppONH2) as 
an electrophilic aminating agent, generates aminimine 22 in situ under basic 
conditions.(87) The aminimine was able to aziridinate aromatic enones, with either β-
alkyl or -aryl substituents and also examples of ,-unsaturated esters, in generally 
high yields and in all cases with trans-selectivity (Scheme 29). Initial investigations 
also showed that via the use of the cinchona alkaloid quinine as the tertiary amine, 
moderate levels of asymmetric induction could be achieved for the aziridination of 
chalcone (64%, 56% ee). Significantly this process, along with other studies concerning 
aminimines, delivers the NH-aziridine which allows flexibility in terms of further 
functionalisation with the choice of activating group. 
 
 
Scheme 29. Aziridination of Various Enones and Enoates by Armstrong via in situ Aminimine 
Generation 
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1.3 Development of an Amine-Promoted Alkene Aziridination 
 
The Armstrong method provides the basis for studies reported in this thesis and earlier 
work within the group will now be discussed in detail.(87) 
 
1.3.1 Proposed Reaction Mechanism 
 
In analogy to previous studies concerning aziridination of electron deficient olefins with 
aminimines, the method likely proceeds via a conjugate addition-ring closure 
mechanism (Scheme 30). Following initial amination of NMM with DppONH2 to form 
a hydrazinium species, 23, under basic conditions the presumed aminimine, 22, 
intermediate is generated. Conjugate addition of the aminimine to the substrate, 
followed by ring closure, affords the aziridine and also regenerates the tertiary amine 
NMM. 
 
 
Scheme 30. Proposed Reaction Mechanism 
 
Since the process allows regeneration of the amine promoter, the system in principle can 
be rendered catalytic with respect to the amine. In support of the proposed mechanism 
sub-stoichiometric quantities of amine can be utilised (Table 1). 
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Entry
a
 NMM /mol% Solvent Yield /%
b
 
1 100 MeCN 88 
2 50 MeCN 75 
3 25 CH2Cl2 49 
a
 Reaction performed on a 0.12 mmol scale; 
b
 Isolated yields after purification by column 
chromatography. 
Table 1. Demonstration of Catalytic Turnover with NMM
(87)
 
 
Whilst the principle of a catalytic system has therefore been demonstrated, the yield of 
aziridine is lower than that obtained with stoichiometric amine. It has been postulated 
that this may be due to the relative instability of the aminating agent under the basic 
reaction conditions. Aziridination was shown not to occur in the absence of the tertiary 
amine NMM, returning only the substrate, and in further support of the proposed 
reaction mechanism, as mentioned, morpholine, a secondary amine does not promote 
the reaction. 
Whilst the limited solubility of DppONH2 (and likely the intermediate 
hydrazinium salt) in the reaction solvent has thus far prevented any detailed kinetic 
studies of the reaction, circumstantial evidence indicates that the cyclization step may 
be rate-limiting. The general trend observed is that cyclic tertiary amines with a lower 
pKaH value provide higher yields of aziridine, which may be related to the leaving group 
ability of the promoter in the final ring closing step, i.e. the more electron-withdrawing 
NMM is thus identified as the most competent promoter. More nucleophilic cyclic 
tertiary amines, such as quinuclidine, which could be expected to have advantages in the 
conjugate addition step of the aminimine, if this were rate-limiting, provide lower 
yields. 
 
1.3.2 Nature of the Amine and Base and Reaction Solvent 
 
In the development of the methodology a range of amine promoters were initially 
screened. Several key points from these studies were identified:  
i. As mentioned, tertiary amines are required for the process; secondary 
amines, either morpholine or acyclic 
i
Pr2NH, do not promote the reaction. 
ii. Aromatic tertiary amines (DMAP, pyridine) do not promote the reaction. 
38 
 
iii. Cyclic (aliphatic) tertiary amines generally provided higher yields of 
aziridine than acyclic Et3N. 
iv. In general, cyclic tertiary amines with a lower pKaH value provided higher 
yields of aziridine (cf. pKaH NMM = 7.4). 
DABCO, quinuclidine, NMP and NMM were identified as competent promoters for the 
reaction with NMM (but in some cases NMP) proving optimal. A screen of several 
solvents identified that the polar aprotic solvents MeCN, CH2Cl2, THF or DMF proved 
effective for the reaction, with certain solvents more competent with certain amines. It 
should be noted that the solubility of the aminating agent DppONH2 (and likely the 
intermediate hydrazinium salt) is extremely poor in apolar solvents such as toluene and 
hexane. In terms of the base for the reaction various hydroxide bases (NaOH, 
CsOH.H2O and KOH) were effective, as was the use of NaH/
i
PrOH to generate 
isopropoxide. DBU and various metal carbonate bases were completely ineffective, 
suggesting that the intermediate hydrazinium ion, which is required to be deprotonated 
to form the aminimine, has a sufficiently high pKa value. 
In summary, the optimal set of conditions for the aziridination of enones, herein 
referred to as the „standard conditions‟ was identified as: NMM (1.05 eq.) as the 
promoter, NaOH (2 eq.) as the base and MeCN as the reaction solvent (Scheme 31). 
 
 
Scheme 31. ‘Standard Conditions’ Identified for Enone Aziridination(87) 
 
1.3.3 Reaction Scope 
 
The scope of the reported methodology is as follows (Table 2): 
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Entry
a
 Aziridine R3N Solvent Time /h Yield /%
b
 
1 
 
NMM MeCN 16 88 
2 
 
NMM MeCN 10 75 
3 
 
NMM MeCN 10 62 
4 
 
NMM MeCN 10 78 
5 
 
NMP CH2Cl2 24 79 
6 
 
NMM MeCN 10 90 
7 
 
NMM MeCN 24 86 
8 
 
NMM MeCN 24 97 
9 
 
NMP CH2Cl2 24 67 
10 
 
NMM MeCN 6 90 
11 
 
NMM CH2Cl2 22 83 
12 
 
NMM CH2Cl2 22 78 
13 
 
NMM CH2Cl2 16 62 
14
c
 
 
NMM CH2Cl2 40 32 
15 
 
NMM CH2Cl2 10 80 
a
 Reaction performed on a 0.24 mmol scale; 
b
 Isolated yields after purification by column 
chromatography;
 c
 Reaction performed on a 0.12 mmol scale; NMP = N-methylpyrrolidine. 
Table 2. Substrate Scope Reported for the Developed Aziridination
(87)
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As can be seen chalcone could be aziridinated in high yield (88%) (entry 1). High yields 
were also obtained with both electron-rich and -poor chalcones, substituted at either the 
β-position (entries 2-5, 62-79%) or at the ketone (entries 6-8, 86-97%). Furthermore, it 
is noteworthy that β-alkyl enones can be aziridinated using the methodology, in similar 
yields (entries 11-13, 62-83%), as is the extension to ,-unsaturated esters (entries 14 
and 15) which demonstrates the first examples of the aziridination of this class of 
substrate using aminimines. In all cases the aziridines were obtained with trans-
selectivity. In general the chemistry provides high yields of aziridine in moderate 
reaction times (6-40 h). 
 Following the disclosure of this report a co-worker has also extended the 
reaction scope by application of the standard conditions to both heteroaromatic 
substituted chalcones and also to dienone substrates (5 examples) (Table 3):(93) 
 
 
Entry Aziridine Yield /%
a
 
1 
2 
 
73 
22 
3 
4 
 
40 
59 
5 
6 
 
25 
41 
7 
8 
 
22 
27 
9 
 
42 
a
 Isolated yields after purification by column chromatography. 
Table 3. Extension of the Substrate Scope to Heteroaromatic Substituted Enones and Dienones
(93)
 
 
In general heteroaromatic substituted enones and dienones gave the aziridine in only 
moderate yields, with the exception of 2-furyl enone (entry 1, 73%). However, the 
aziridination of dienones via the use of NNTAs was unprecedented and although the 
aziridines are only formed in moderate yield (5 examples, 22-59%) the vinyl aziridine 
motif is of significant synthetic value.  
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1.3.4 Employment of Chiral Tertiary Amines 
 
A significant advancement of the developed methodology would be the development of 
an asymmetric aziridination by utilising a chiral tertiary amine and initial studies have 
focused upon this aim (Scheme 32). 
 
 
Scheme 32. Chiral Tertiary Amines Previously Screened for the Aziridination of Chalcone 
 
Readily accessible chiral tertiary amine targets have been screened for the aziridination 
of chalcone but as yet have failed to achieve sufficiently high levels of asymmetric 
induction. Based upon the reactive NMP framework, and in conjunction with the strong 
track record of chiral pyrrolidine derivatives in organocatalysis, various prolinol and 
pyrrolidine derivatives have been screened, including C2 symmetric derivatives. 
However, only low levels of asymmetric induction were observed, with varying levels 
of reactivity.(94) The alkaloid (-)-sparteine has also been screened in the reaction but 
provided only low levels of aziridine and moderate levels of observed asymmetric 
induction.(94) The cinchona alkaloid class of tertiary amine, based upon the reactive 
quinuclidine framework, have thus far delivered the highest levels of asymmetric 
induction. Employing quinine as promoter for the aziridination of chalcone affords 
moderate levels of ee (56% ee) and good yield (64%), with optimum yield and ee 
obtained with NaH/
i
PrOH as the base with CH2Cl2 as the reaction solvent (Scheme 33). 
 
 
Scheme 33. Optimal Conditions for the Asymmetric Aziridination of Chalcone with Quinine
(87)
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Various other cinchona alkaloid derivatives have been screened, but proved less 
successful (refer to Section 2.3.1 for detailed discussion).(93) Considering the high levels 
of reactivity that NMM displays as a promoter in the racemic aziridination it was 
interesting to note at the start of the work presented here, that chiral NMM derivatives 
had not yet been screened.  
 
1.4 Outline of Initial Studies 
 
As has been discussed an approach to enone aziridination had been realised by the 
Armstrong group based upon in situ aminimine generation. These promising results 
provided the basis for studies reported in this thesis. Two aims were identified for the 
development of this methodology: 
i. expansion of the reaction substrate scope 
ii. development of the methodology towards an asymmetric aziridination 
The initial aim, to expand upon the scope of substrates that can be aziridinated with our 
amine-promoted alkene aziridination methodology, will be discussed first, followed by 
the second stage of investigation that focused on the synthesis and screening of 
alternative chiral amine promoters with the aim of improving levels of observed 
asymmetric induction in the reaction.   
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2 Results and Discussion  
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2.1 Expansion of the Substrate Scope for Amine-Promoted Alkene 
Aziridination 
 
As discussed in Section 1.4 the initial aim of this project was to expand upon the scope 
of substrates that can be aziridinated with our amine-promoted alkene aziridination 
methodology. This chapter describes the investigations towards that aim. Initial studies 
focussed on the aziridination of α,β,γ,δ-unsaturated ketones (dienones) to afford vinyl 
aziridines. 
 
2.1.1 Aziridination of Dienones 
 
Vinyl aziridines are a particularly interesting class of aziridine that lend themselves to a 
host of highly useful synthetic transformations (Scheme 34).(32)  
 
 
Scheme 34. Selected Transformations of Vinyl Aziridines 
 
They are versatile electrophiles and notably undergo regioselective ring-opening via 
addition at either the vinyl terminus(95-98) or directly at the aziridine,(99-101) depending on 
the reagents employed. Moreover, vinyl aziridines can be exploited in a variety of ring-
expansion reactions to afford a range of heterocyclic products, including 
piperidines,(102,103) pyrrolines,(104-106) imidazolidinones,(107) β-lactams(108-110) and azepines.(111-
113) Strategies for the synthesis of vinyl aziridines include aza-Darzens-type reactions,(114-
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116) nitrenoid additions to 1,3-dienes,(117-120) cyclization of amino- or azido-alcohols,(121-123) 
guanidinium ylide addition to α,β-unsaturated aldehydes,(99) Wittig reactions of 
aziridine-2-carbaldehydes(124) and recently via cross-coupling with α-metalated 
aziridines,(125) with the most common strategy involving allyl-ylide addition to 
imines.(126-135) However, it is notable that few methods provide the desired vinyl 
aziridines with consistently high levels of cis/trans diastereoselectivity for a broad range 
of substrates. 
As a result we were keen to extend the application of our developed 
aziridination to the aziridination of dienones for the diastereoselective synthesis of 
unprotected-NH-vinyl aziridines. To the best of our knowledge there exist only two 
isolated instances of the regioselective aziridination of α,β,γ,δ-unsaturated carbonyl 
compounds (Scheme 35). Ito presented complementary conditions for either the cis- or 
trans-selective aziridination of an α,β,γ,δ-unsaturated amide, selective for the α,β-
alkene, via conjugate addition, with stereoselectivity governed by choice of lithiated 
diaziridine reagent (Eq. A).(136) Additionally, Xu has reported two examples of the 
electrophilic aziridination of α,β,γ,δ-unsaturated esters, via a Cu-catalysed nitrene 
addition in the presence of the bisoxazoline cHBOX ligand, with the reaction 
regioselective for the γ,δ-alkene of the substrate and providing the cis-aziridine in high 
diastereoselectivity (Eq. B).(67) 
 
 
Scheme 35. Previous Known Aziridinations of α,β,γ,δ-Unsaturated Carbonyls 
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Initial investigations (as previously discussed) by a former co-worker had shown 
that the previously developed standard conditions for the aziridination of enones (using 
NMM, NaOH in MeCN) could be applied to several dienones to afford moderate yields 
of vinyl aziridine (Scheme 36).(93) 
 
 
Scheme 36. Previous Aziridination of Dienones Using the Standard Aziridination Conditions 
 
The reaction was found to be selective for the α,β-unsaturation of the substrate and, as 
expected, complete diastereoselectivity was observed for the trans-aziridine. These 
initial results formed the basis for further studies and two key aims were identified: 
i. Optimisation of reaction yield 
ii. Expansion of the reaction substrate scope 
 
2.1.1.1 Reaction Optimisation 
 
In order to improve upon previously disclosed yields, reaction optimisation was 
undertaken, with diphenyl substituted dienone cinnamylideneacetophenone 24 selected 
as the model substrate (Table 4). 
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Entry
a
 Base Eq. 
Base 
Solvent Concentration 
/M 
Eq. 
DppONH2 
Yield /%
b
 
1 NaOH 2 MeCN 0.06 1.05 42
c
 
2 NaOH 2 MeCN 0.12 1.05 41 
3 NaH/IPA 2 CH2Cl2 0.06 1.05 45 
4 NaH/IPA 2 CH2Cl2 0.12 1.05 37 
5 KO
t
Bu (1M in THF) 2 MeCN 0.06 1.05 34 
6 TMSOK 2 MeCN 0.06 1.05 40 
7 P4-
t
Bu (1M in hexane) 2 MeCN 0.06 1.05 - 
8 NaH/IPA 2 CH2Cl2 0.06 1.5 54 
9 NaH/IPA 3 CH2Cl2 0.06 1.5 62 
10 NaH/IPA 3 CH2Cl2 0.06 2.0 67 
11 NaH/IPA 4 CH2Cl2 0.06 2.0 68 
12
d
 NaH/IPA 4 CH2Cl2 0.06 2.0 69 
13 KO
t
Bu (1M in THF) 3 CH2Cl2 0.06 2.0 83, (79)
e
 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Yield determined by 
1
H NMR using Bn2O as the internal 
standard; 
c
 Isolated yield after flash column chromatography; 
d
 40 h reaction time; 
e
 Isolated yield in 
parentheses. 
Table 4. Optimisation of the Reaction Conditions for the Aziridination of Dienone 24 
 
As can be seen, the previously developed standard conditions pleasingly afforded a 
moderate level of the desired vinyl aziridine (42%) (entry 1). It is notable that the 
reactivity of the dienone was lower than that of the enones previously studied (cf. 
chalcone can be aziridinated in 88% yield under the same conditions).(87) Keen to 
optimize the yield of the vinyl aziridine, the alternative base and solvent combination of 
NaH/
i
PrOH in CH2Cl2, which had afforded high product yields in our previous work 
with amine-promoted aziridination, was screened. Only a minimal improvement in the 
yield of vinyl aziridine was observed (45%) (entry 3), but the majority of remaining 
material was returned as unreacted starting material. These low conversions prompted 
re-investigation of the conditions at doubled concentration, but disappointingly this had 
little effect (entries 2 and 4). A range of different bases were then screened in MeCN at 
the lower concentration of 0.06M. Both KO
t
Bu (1M in THF) and TMSOK were found 
to provide no further improvement to previous conditions (entries 5 and 6), with the 
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sterically hindered, non-nucleophilic P4 phosphazene base,(137) which has a similar 
basicity to that of hydroxide, also failing to successfully promote the reaction (entry 7).  
Of the conditions screened it was found that the combination of NaH/
i
PrOH in 
CH2Cl2 at a concentration of 0.06M in substrate gave the best combined yield of 
product (45%) and return of starting material (entry 3) and optimization continued with 
these conditions. It was decided to investigate the effect of varying the equivalents of 
aminating agent DppONH2. Pleasingly, it was found that an increase from 1.0 to 1.5 
equivalents, still with 2.0 equivalents of base, gave an increased yield of vinyl aziridine 
to 54% (entry 8) and this could be improved further to 62% by using 3.0 equivalents of 
base (entry 9). This could further be enhanced (to 67%) utilizing 2.0 equivalents of 
DppONH2 with 3.0 equivalents of base (entry 10). Further increase in base to 4.0 
equivalents failed to improve the yield further, even after prolonged reaction time 
(entries 11 and 12). Although previously KO
t
Bu (1M in THF) in MeCN was found to be 
less successful than the use of NaH/
i
PrOH in CH2Cl2 (entries 5 vs. 3), the use of this 
base in CH2Cl2 (3 eq., with 2 eq. DppONH2) was however more successful, and 
pleasingly gave an increase to 83%, with the vinyl aziridine 25 isolated in an excellent 
yield of 79% (entry 13). 
 
2.1.1.2 Expansion of the Substrate Scope 
 
It was decided at this point, with two effective sets of reaction conditions in hand 
(entries 10 and 13), to investigate the aziridination of a range of different dienone 
substrates. While either KO
t
Bu (1M in THF) (referred to as conditions A) or 
NaH/
i
PrOH (referred to as conditions B) were generally effective as bases, it will be 
shown that KO
t
Bu gave slightly better results with electron-deficient substrates and also 
those possessing alkyl groups. 
Initially exploration of the scope focussed on a range of heteroaromatic 
dienones, 26-29, (previously synthesised by a co-worker in our laboratories)(93) which 
were screened under the optimised conditions (Table 5). 
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Entry
a
 Substrate Base Product Isolated Yield /%
b
 
1 
 
B 
 
64 
2 
 
B 
 
75 
3 
 
B 
 
70 
4 
 
A 
 
67 
a
 Reactions performed on a 0.10-0.13 mmol scale; 
b
 Isolated by flash column chromatography. 
Table 5. Aziridination of Heteroaromatic Dienones 26-29 
 
Pleasingly, the heteroaromatic dienones, including furyl substituted dienone 26 (entry 1) 
and various thiophenyl substituted dienones 27-29 (entries 2-4) also performed well 
(64-75%), with the use of NaH/
i
PrOH as the base generally proving optimal. 
Keen to also examine the tolerance of the methodology to both electron-rich and 
-deficient substrates, 4-methoxyphenyl dienone 37 and 4-nitrophenyl dienone 36 were 
selected as substrates. Both substrates required prior preparation. Initial attempts to 
prepare dienone 36 via an aldol condensation using acetophenone and trans-4-
nitrocinnamaldehyde, with NaH, however failed to afford satisfactory conversion to the 
desired product despite employing conditions previously used for this 
transformation.(138) An alternative synthetic strategy for the synthesis of dienones was 
therefore employed,(139) which used a Wittig reaction with the commercially available 
stabilised phosphorane 34 (Scheme 37).
 
Pleasingly this allowed both dienone substrates 
36 and 37 to be prepared rapidly, in acceptable yields, via microwave irradiation, solely 
as the E,E isomers. 
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Scheme 37. Preparation of Dienones 36 and 37 
 
Additionally commercially available 4-fluorophenyl dienone 35, with an electron 
deficient aromatic at the carbonyl, was also selected for screening (Table 6). 
 
 
Entry
a
 Substrate Base Product Isolated Yield 
/%
b
 
1 
 
A 
 
46 
2 
 
A
c
 
 
30 
3 
 
B 
 
78
d
 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Isolated by flash column chromatography; 
c 
2 eq. base 
used;
 d
 Yield determined by 
1
H NMR using Bn2O as the internal standard; The product underwent a 
rearrangement on attempted purification (see Scheme 38). 
Table 6. Aziridination of Electron-Rich and -Deficient Dienones 35-37 
 
Whilst the reaction was tolerant of electron deficient aromatics both at the carbonyl and 
at the δ-terminus, with 4-F substituted dienone 35 affording vinyl aziridine 38 and 4-
nitrophenyl substituted dienone 36 affording aziridine 39, lower isolated yields were 
observed (46% and 30% respectively) (entries 1 and 2). The optimal yield for both these 
substrates were obtained using KO
t
Bu, and the aziridination of 36 appeared to benefit 
from a reduced amount of base (2 eq. gave 30% yield, 3 eq. gave 23% yield). It seems 
the aziridination of dienones appears to be less tolerant of electron-deficient substrates, 
which is in contrast to the previously observed reactivity of α,β-unsaturated carbonyl 
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compounds.(87)
 
With most of the dienone substrates investigated it was possible to 
recover unreacted starting material but this was not possible with substrates 35 and 36 
and the lower yields for these reactions could be the result of partial decomposition of 
the more electron-deficient compounds. The strongly electron-rich 4-methoxyphenyl 
dienone 37 gave very good conversion to vinyl aziridine 40 (78%) (entry 3). 
Interestingly, the product was found to rearrange to diene 41 upon attempted flash 
column chromatography purification, either using silica gel or neutral alumina, 
presumably via either a Bronsted or Lewis acid-promoted ring opening via a stabilized 
allyl cation (Scheme 38).  
 
 
Scheme 38. Rearrangement of Vinyl Aziridine 37 to Diene 41 
 
The originally developed methodology, concerning the aziridination of enones, 
has shown that enones possessing various alkyl groups at the β-position of the alkene 
could undergo successful aziridination in good yield utilising the standard conditions, 
and it was hoped that alkyl substitution on the dienone would also be tolerated using the 
newly developed methodology. Initially dienone 42, bearing an 
nbutyl chain at the δ-
terminus was selected as a substrate, which was prepared in good yield (74%) in a 
similar manner to dienones 36 and 37 (Scheme 39). 
 
 
Scheme 39. Preparation of Dienone 42 
 
Initial attempts to aziridinate 42 using either set of developed conditions (KO
t
Bu or 
NaH/
i
PrOH) however surprisingly failed to afford more than trace amounts of the 
desired vinyl aziridine, with low levels of residual starting material also observed 
(entries 1 and 2) (Table 7). Since this substrate contains allylic protons, it was reasoned 
that the substrate may be sensitive to the base in the reaction. Pleasingly, though, a 
decision to reduce the amount of base in the reaction from 3 eq. to 2 eq. allowed the 
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reaction to proceed with a good isolated yield of vinyl aziridine, with optimal yields 
obtained using KO
t
Bu as the base (62%) (entry 3). 
 
 
Entry
a
 Base Eq. Base Isolated Yield /%
b
 
1 A 3 traces 
2 B 3 traces 
3 A 2 62 
4 B 2 56 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Isolated by flash column chromatography. 
Table 7. Aziridination of Alkyl Substituted Dienone 42 
 
The effect of branching at the γ-position of the substrate was also considered and 
accordingly dienone 44 along with the δ-alkyl substituted cyclic derivative 45, were 
synthesised, again via a Wittig reaction (in 90% and 67% respectively). Satisfyingly 
upon screening both the corresponding vinyl aziridines 46 and 47 were isolated in 
respectable yield (60-67%) (Table 8). In a similar manner to 
n
butyl dienone 42, the δ-
alkyl substituted cyclic dienone 45 was synthesised utilising 2 eq. of KO
t
Bu as the base.  
 
 
Entry
a
 Substrate Base Product Isolated Yield /%
b
 
1 
 
B
c
 
 
67 
2 
 
A
d
 
 
60 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Isolated by flash column chromatography; 
c 
3 eq. base 
used;
 d 
2 eq. base used. 
Table 8. Aziridination of Dienones 44 and 45 Bearing γ-Substituents 
 
For all dienones the reaction was found to be completely regioselective for the 
α,β-alkene of the substrate, as determined by strong 2J and 3J HMBC correlations 
between the carbonyl carbon and the CH protons of the aziridine ring, and an absence of 
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carbonyl carbon correlations to either olefinic proton. The reaction was also completely 
diastereoselective for the trans-aziridine, as determined by 
3
J2H-3H coupling constants of 
the aziridine ring (e.g. 25, 
3
J2H-3H = 2.6 Hz; generally cis = ca. 7-9 Hz, trans = ca. 2-4 
Hz), consistent with our previous studies.(87) In no cases was the cis-aziridine observed. 
The complete control of diastereoselectivity observed is in contrast with many of the 
preparations of vinyl aziridines, where consistently high levels of diastereocontrol are 
often rare. 
A concise account of this work concerning the synthesis of vinyl aziridines from 
dienones is detailed in the The Journal of Organic Chemistry.(140) 
 
2.1.2 Attempted Aziridination of Dienoates 
 
Application of the developed regioselective aziridination of dienones to the aziridination 
of their ester counterparts, α,β,γ,δ-unsaturated esters (dienoates) would afford a vinyl 
aziridine-2-carboxylate motif, 48 (Scheme 40), which could potentially provide access 
to interesting α-amino acid derivatives (via nucleophilic ring opening at the β-position) 
Moreover, the motif could also represent a key intermediate for the synthesis of several 
bioactive lipidic compounds, such as the azirine-containing marine natural product 
(4E)-R-dysidazirine 49 (or related members of its family)(141) or to D-erythro-
sphingosine 50, a glycolipid component.(142) As a result of this potential significance we 
were keen to apply the developed chemistry to the potential aziridination of dienoates. 
 
 
Scheme 40. Potential Applications of Vinyl Aziridine-2-Carboxylates 
 
Initially methyl dienoate 51 was selected as a preliminary substrate for screening, but 
since there was a concern regarding the potential lability of the ester to either 
transesterification or hydrolysis, tert-butyl dienoate 52, which was likely to be less 
48 
49 
50 
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prone to potential hydrolysis was also selected for screening. Furthermore, α,β-
unsaturated tert-butyl esters (enoates) have previously been shown to undergo 
aziridination in our developed chemistry.(87) Both dienoates were prepared via Wittig 
reaction from trans-cinnamaldehyde with commercial phosphoranes in good yields 
(Scheme 41). Whilst after purification 51 was isolated as solely the desired E,E isomer 
(from a ratio E,E:E,Z 71:29 in the crude product), 52 was isolated as an inseparable 
mixture of E,E and E,Z isomers (62:38). 
 
 
Scheme 41. Preparation of Dienoates 51 and 52 
 
Initial screening of these substrates employed KO
t
Bu (1M in THF) as the base with 
CH2Cl2 as the reaction solvent, one of the two sets of developed conditions employed 
for the synthesis of vinyl aziridines from dienones (Table 9). 
 
 
Entry
a
 Substrate, R Base Solvent T /
o
C Yield /%
b
 RSM /%
b
 
1 51, Me KO
t
Bu (1M in THF) CH2Cl2 rt traces 25 
2 51, Me MeOH/NaH CH2Cl2 rt NR 34 
4 51, Me NaOMe (1M in MeOH) CH2Cl2 rt NR 45 
5 51, Me NaOMe (s) CH2Cl2 rt NR 60 
6 52, 
t
Bu KO
t
Bu (1M in THF) CH2Cl2 rt traces 71 
7 52, 
t
Bu KO
t
Bu (1M in THF) CH2Cl2 40 7 80 
8 52, 
t
Bu KO
t
Bu (1M in THF) CH2Cl2 80 NR 99 
9 52, 
t
Bu KO
t
Bu (1M in THF) MeCN rt NR 96 
10 52, 
t
Bu NaOH
c
 MeCN rt NR 98 
11
d
 52, 
t
Bu KO
t
Bu (1M in THF) CH2Cl2 rt NR quant. 
12
e
 52, 
t
Bu KO
t
Bu (1M in THF) CH2Cl2 rt NR 87 
a
 Reactions performed on a 0.12-0.14 mmol scale; 
b
 Yield determined by 
1
H NMR spectroscopy using 
Bn2O as the internal standard; 
c
 NaOH (2 eq.) and DppONH2 (1.05 eq.) used; 
d
 LiClO4 (1.5 eq.) added; 
e
 
Al2O3 (1.5 eq.) added. 
Table 9. Conditions Employed for the Potential Aziridination of Dienoates 51 and 52 
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Initial screening of methyl dienoate 51 with KO
t
Bu as the base however showed only 
traces of potential product and with only low levels of residual substrate remaining, 
which also appeared to show, via analysis of the integrals in the 
1
H NMR spectrum of 
the reaction, significant cleavage of the methyl ester (ca. 59%) (entry 1). As a result it 
was decided to investigate the use of methoxide as a base in order to circumvent any 
potential issues regarding transesterification. However, again variable and often low 
levels of residual substrate were recovered, again with indications of cleavage of the 
methyl ester (entries 2-4). It may be likely that much of the substrate is lost during 
aqueous work-up after hydrolysis of the labile ester. Switching to the tert-butyl dienoate 
52 with KO
t
Bu as the base again failed to deliver significant amounts of the desired 
vinyl aziridine, but levels of returned substrate were significantly higher than with the 
methyl dienoate and no indications of hydrolysis of the ester were observed (entry 6). 
Increasing the reaction temperature failed to impact the reaction to any significant 
extent (entries 7-8); similarly a switch in the solvent to MeCN (entry 9) and also 
examination of the standard conditions employed for the aziridination of α,β-
unsaturated esters (entry 10),(87) again failed to afford more than trace amounts of the 
aziridine. However, analysis of the 
1
H NMR spectrum of the crude reaction showed that 
all returned dienoate substrate in the reactions were of the same E,E:E,Z ratio, 
suggesting that no 1,4-addition of the desired aminimine (or indeed of the alkoxide 
base), which may allow interconversion of the alkene isomers, had occurred. With this 
in mind strategies were considered that could potentially enhance the electrophilicity 
(and hence reactivity) of the dienoate substrate, such as the use of a Lewis acid. For 
example Al2O3 had been previously used as an additive for the nucleophilic epoxidation 
of an α-cyano methyl dienoate with NaOCl,(143) which to the best of our knowledge is 
the only example of a nucleophilic epoxidation of a dienoate. The potential problem 
with this strategy was that unactivated aziridine-2-carbonyls have been shown to 
undergo ring-opening with alcohols and certain Lewis acids, for example with 
BF3.OEt2.
(144,145) Disappointingly, addition of either 1.5 equivalents of LiClO4 or Al2O3 
in the reaction mixture again failed to promote the reaction (entries 11-12). 
 At this point considering the lack of reactivity of the alkyl dienoates, attention 
was turned to the potential use of an aromatic dienoate ester, which could be regarded as 
a potentially more reactive substrate, indeed aromatic enoates have also been previously 
epoxidized nucleophilically.(146) Phenyl dienoate 55 was thus selected as a substrate. 
Preparation of the dienoate, again via a Wittig reaction, required prior preparation of the 
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phosphorane 54, which was prepared in two steps from phenyl bromoacetate via 
reported procedures (Scheme 42).(147) The ylide was then used to prepare the substrate, 
which was isolated in moderate yield (59%) solely as the E,E isomer (crude E,E:E,Z 
84:16).  
 
 
Scheme 42. Preparation of Ylide 54 and Dienoate 55 
 
Phenyl dienoate 55 was subsequently screened using either KO
t
Bu (1M in THF) or 
NaH/
i
PrOH as the base, with CH2Cl2 as the reaction solvent, both of the two sets of 
developed conditions employed for the synthesis of vinyl aziridines from dienones 
(Scheme 43). 
 
 
Scheme 43. Attempted Aziridination of Dienoate 55 
 
Disappointingly this dienoate also failed to undergo aziridination with 
1
H NMR analysis 
of the crude reaction mixture indicating partial cleavage of the ester. The employment 
of a more sterically bulky aromatic dienoate, such as mesitylene dienoate, may be an 
alternative. Whilst investigations detailed in Section 2.1.1 show dienones to be a less 
reactive substrate class than enones, it seems that that dienoates are less reactive still. 
 
2.1.3 Aziridination of Alpha-Enolizable Substrates 
 
As discussed in Section 1.3.3 the original developed amine-promoted alkene 
aziridination methodology demonstrated that enones possessing various alkyl groups at 
the β-position of the alkene can undergo successful aziridination in good yield (Eq. 
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A).(87) Moreover, the developed methodology for the aziridination of dienones was 
found to be tolerant of alkyl substitution at the δ-position of the substrate (Eq. B). 
Considering that both substrate classes possess allylic protons, that could potentially be 
deprotonated under the basic reaction conditions employed, it was envisaged that it may 
be possible to extend the scope of the amine-promoted aziridination methodology to 
substrates that possessed alpha-enolizable groups, a substrate class that has previously 
proved unsuccessful with our methodology (Scheme 44). 
 
 
Scheme 44. Previous Aziridinations of Alkyl-Substituted Enones 
 
 As discussed in Section 1.2.4, the aziridination of aromatic enones (chalcones) 
can be achieved via a variety of methods. However the aziridination of simple acyclic 
alkyl enones is surprisingly less well covered with relatively few studies concerning the 
aziridination of this class of substrate. Whilst examples do exist in the literature via 
electrophilic nitrogen addition, the aziridines are afforded in N-protected form,(148-152) and 
furthermore are often formed in moderate yields and often utilise the enone in excess. A 
notable study by Melchiorre in 2008 (as earlier discussed), using aminocatalysis with 
NNTAs, did provide several examples of N-carbamate protected aziridines in both good 
yield and high ee.(85) 
Initially commercially available trans-4-phenyl-3-buten-2-one, 56, was selected 
as a model substrate for examination using both the conditions detailed for the 
aziridination of alkyl substituted enones (the standard aziridination conditions) and the 
modified conditions for alkyl substituted dienones examined (Table 10). 
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Entry
a
 Base Eq. 
Base 
Eq. 
DppONH2 
Yield /%
b
 RSM /%
b
 Isolated Yield 
/%
c
 
1 NaOH (s)
d
 2 1.05 32 20 ND 
2 KO
t
Bu (1M in THF) 2 2.0 78 21 75 
3 KO
t
Bu (1M in THF) 3 2.0 31 <5 ND 
4 NaH/IPA 2 2.0 84 13 80 
5 NaH/IPA 3 2.0 30 10 ND 
a
 Reaction performed on a 0.12 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as the 
internal standard; 
c
 Isolated by flash column chromatography, ND = not determined; 
d
 Solvent = MeCN. 
Table 10. Initial Conditions Screened for the Aziridination of 56 
 
Application of the standard aziridination conditions gave only poor product conversions 
(32%) and with only low levels of observed residual starting material (entry 1). 
However, on application of the conditions developed for the synthesis of alkyl-
substituted vinyl aziridines, a very good isolated yield of the desired aziridine 57 was 
isolated (75%) (entry 2). Furthermore, utilising 3 eq. of base, conditions previously 
unsuccessful for the aziridination of alkyl-substituted dienones, provided only a low 
yield of the aziridine, highlighting a common feature with both substrate classes (entry 
3). Pleasingly the use of NaH/
i
PrOH as the base gave a further increase in yield to 80% 
(entry 4). It is interesting to note that of the conditions screened, those that employed an 
excess of base relative to the aminating agent provided poor yields of the aziridine.  
 
2.1.3.1 Investigations into DppONH2 Variability 
 
As outlined in the preceding section it had been found that for the efficient aziridination 
of trans-4-phenyl-3-buten-2-one, 56, (and in a similar manner δ-alkyl-substituted 
dienones) crucially two equivalents of base, employed with two equivalents of 
aminating agent were required. A third equivalent of base provided only low yields of 
aziridine. However, at this point in time it was found that variable and significantly 
reduced yields for the aziridination of 56 using these former conditions was observed. 
Importantly reaction variability was observed with a switch to subsequent batches of the 
aminating agent, DppONH2, and it is worth noting that previous studies concerning the 
aziridination of both alkyl-substituted dienones 42 and 45 and also enolizable enone 56 
59 
 
were conducted with a single batch of DppONH2. It was also notable that for substrates 
that did not bear allylic or enolizable protons (such as chalcone or dienone 
cinnamaldehyde acetophenone, 24) the reaction remained unaffected, i.e. similar results 
were still obtained to those previously. It seemed that only base-sensitive substrates 
were affected by the current batches of aminating agent. This reactivity can be 
summarised below (Scheme 45): 
 
Scheme 45. Summary of the Variable Results for the Aziridination of 56 
 
As can be seen it became apparent that in order to achieve efficient aziridination of 56, 
and indeed to similar yields to those previously observed, a third equivalent of base was 
now required in the reaction. Importantly, these conditions were found to be 
reproducible and gave consistent yields of aziridine. Moreover, the aziridination of 
alkyl-substituted 
n
butyl dienone 42 was also found to now require a third equivalent of 
base in order to achieve results comparable to these previously discussed in Section 
2.1.1.2. The apparent change in the conditions required for a reproducible reaction was 
concerning. A range of experiments were therefore conducted aimed at confirming the 
source of reaction variability. Initial investigations via the use of alternative sources of 
base, solvent and NMM revealed that indeed the aminating agent likely led to the source 
of variability.  
DppONH2, 58, is synthesised from diphenylphosphinic chloride (DppCl) and 
hydroxyamine hydrochloride under basic conditions via a procedure reported by Colvin 
(Scheme 46).(153) 
 
Scheme 46. Procedures Used for the Routine Preparation of DppONH2 
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The preparation has been routinely employed during our group‟s studies concerning 
amine-promoted alkene-aziridination for a number of years, on either a 5 g or 10 g 
scale; moreover, a review of the literature reveals that the most common procedure for 
the preparation of DppONH2 is also via this route.
(154) 
Multiple tests were conducted in order to ascertain the potential reasons for the 
observed differences in reactivity of the reagent. Analytically, by 
1
H and 
31
P NMR 
spectroscopy, all batches of DppONH2, as well as the starting material DppCl, were 
found to be identical with no significant impurities evident. Furthermore re-synthesis 
with DppCl from an alternative supplier did not alter results. Qualitatively, however, the 
appearance and consistency of the new batches of reagent were noticeably different to 
the previous batch, appearing less crystalline. It was postulated that this could be due to 
higher water content. As a result the aziridination of 56 was repeated, with two 
equivalents of base, in the presence of pre-activated 4Å molecular sieves. However, this 
had no effect and poor yields of aziridine 57 were still obtained. Several attempts were 
also made to re-dry the reagent after synthesis, including dehydration using freeze-
drying, but again this had no effect upon the performance. Another postulate was that 
diphenylphosphinic acid impurities, derived from either hydrolysis of any residual 
starting material (DppCl) or the hydroxylamine reagent, could be the reason that with 
these subsequent batches an extra equivalent of base with 56 was required for efficient 
aziridination. Indeed, the pH of a 0.1M solution of the reagent (although the reagent is 
insoluble) was found to be ca. pH 6. A few reports detail recrystallization of the reagent 
(from MeOH or EtOH, but with substantial loss of material),(155,156) but it is worth noting 
that this is far from commonplace within the literature for the reagent‟s purification. 
Recrystallization was nonetheless performed, although the recrystallised material gave 
no benefits in the reaction, i.e. poor yields of aziridine were again obtained with 2 eq. of 
base. Elemental analysis was undertaken on one of the subsequent newer batches of 
DppONH2 (although unfortunately the initial batch had been exhausted preventing 
comparative analysis), with results found to be in excellent agreement to theoretical 
values (see Scheme 46) ((%): C, 61.87 (+0.07), H, 5.15 (-0.04), N, 5.93 (-0.08)). If the 
sample had greater water content an increased H content with reduced C and N content 
would be expected; but alternatively if the sample had an increased presence of 
diphenylphosphinic acid it would be expected to show an increase C content with 
reduced H and N content. Although the latter is consistent with the above elemental 
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analysis results, they are in very good agreement with the theoretical values and it is 
unlikely this accounts for the variability in the aziridination results. 
Although the root cause of the problems outlined could not be ascertained 
conclusively, the decision was taken to re-investigate the aziridination of alpha-
enolizable substrates since: i. consistent high-yielding results for the aziridination of 
enolizable enone 56 could be achieved simply by the addition of a further equivalent of 
base with all subsequent batches of DppONH2; ii. previous studies concerning the 
aziridination of both alkyl-substituted dienones and enolizable enone 56 were conducted 
with a single batch of DppONH2. The products are of synthetic value and the 
aziridination represented a significant extension to our methodology. 
 
2.1.3.2 Reaction Optimisation 
 
In order to extend the scope of amine-promoted alkene aziridination methodology to a 
practical, robust and efficient synthesis of enolizable enones, the aziridination of trans-
4-phenyl-3-buten-2-one, 56, was revisited (Table 11).  
 
 
Entry
a
 Base Eq. Base Eq. DppONH2 Solvent Yield /%
b
 
1 NaOH 2 1.05 MeCN traces 
2 NaH/IPA 2 1.05 CH2Cl2 45 
3 NaH/IPA 3 2.0 CH2Cl2 85, (80)
c
 
4 KO
t
Bu (1M in THF) 3 2.0 CH2Cl2 28 
5 NaH/MeOH 3 2.0 CH2Cl2 79 
6 NaH/EtOH 3 2.0 CH2Cl2 85 
7 NaH/
t
BuOH 3 2.0 CH2Cl2 80 
8 NaH/IPA 3 2.0 MeCN 55 
9 NaH/IPA 3 2.0 1,4-dioxane 69 
10 NaH/IPA 3 2.0 DMSO traces 
a
 Reaction performed on a 0.12 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as the 
internal standard; 
c
 Isolated yield in parentheses. 
Table 11. Optimisation of the Aziridination of Enone 56 
 
Reinvestigation of the standard conditions for enone aziridinations (which utilised 1.05 
eq. DppONH2 and 2 eq. base) gave only traces of aziridine 57 (entry 1) and switching to 
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NaH/
i
PrOH as the base with CH2Cl2 as the reaction solvent, but still using 1.05 eq. 
DppONH2 and 2 eq. base, provided only moderate levels of aziridine (entry 2). As 
mentioned previously, utilising a second equivalent of DppONH2 with 3 eq. base gave 
consistently high yields of the aziridine (85%) (entry 3). Seemingly this alkyl 
substituted enone 56 was less reactive than its corresponding phenyl substituted 
counterpart chalcone which can be aziridinated in high yields (88%) with the conditions 
of entry 1.(87) Switching to KO
t
Bu (1M in THF), which had previously been competent 
for the synthesis of vinyl aziridines from dienones, surprisingly did not prove efficient 
in this transformation (entry 4). As a result NaH was then screened as the base in 
combination with others alcohols and provided aziridine 57 in uniformly very good 
yield (entries 5-7). Various polar aprotic solvents were subsequently screened to see if 
any further improvements in the yield could be obtained. In MeCN and dioxane 
moderate levels of aziridine were observed but in DMSO only traces of the aziridine 
was detected (entries 8-10), with the optimal solvent remaining CH2Cl2 (entry 3). 
 
2.1.3.3 Investigation of Substrate Scope 
 
It was decided at this point, with an effective set of reaction conditions in hand 
(NaH/
i
PrOH (3 eq.), DppONH2 (2 eq.)) (entry 3), to investigate a range of different 
alkyl substituted enones. 
Initially exploration of the scope focussed on alkyl substituted enones with 
various degrees of steric bulk at the carbonyl. Commercially available isopropyl 
substituted enone 61 and also tert-butyl substituted enone 62, which required prior 
preparation, were initially selected. Although 62 clearly did not possess any enolizable 
protons, the substrate was selected since it was anticipated its corresponding aziridine 
may have particular use in subsequent synthetic elaborations. It was decided to prepare 
62 via a Wittig reaction, which required preparation of phosphorane 60. This was 
prepared in high yield in two steps, using a reported procedure.(157) The ylide was then 
used to prepare tert-butyl enone 62, from benzaldehyde, in moderate yield (49%) 
(Scheme 47). 
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Scheme 47. Preparation of Ylide 60 and Enone 62 
 
Enones 61 and 62 were then screened under the optimised conditions (Table 12). 
 
 
Entry
a
 Substrate Product Conversion /%
b
 Isolated Yield /%
c
 
1 
  
>95 80 
2 
  
>95 49 
3 
  
>95 79, (91)
d
 
a
 Reactions performed on a 0.10-0.12 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as 
the internal standard; 
c
 Isolated by flash column chromatography, 
d
 Reaction performed on a 0.56 mmol 
scale. 
Table 12. Aziridination of Enones 56, 61 and 62 
 
As has been discussed aziridination of 56 gave methyl substituted aziridine 57 in 
excellent yield (80%) (entry 1); however, isopropyl derivative 63 was only isolated in 
moderate yield (49%), despite excellent conversion of the substrate (entry 2). No further 
products could be isolated from the reaction mixture and whilst this difference in 
reactivity is unclear the moderate yield proved reproducible (3 reactions, 46-51%). tert-
Butyl enone 62 was aziridinated in excellent yield (79%), which was further improved 
to 91% upon reaction scale-up (entry 3).  
 Various other enolizable substrates were also identified for investigation, 
including commercially available enone 65, which allowed investigation of the 
tolerance of the reaction to α-substitution (Scheme 48). 
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Scheme 48. Aziridination of Enone 65 
 
Pleasingly enone 65 could be aziridinated in good yield (63%), allowing the formation 
of a stereogenic centre, although by 
1
H NMR analysis of the crude reaction mixture 
unreacted enone remained. The product was formed exclusively as the isomer depicted, 
which was confirmed by NOESY analysis. 
 We were also keen to screen dialkyl-substituted enones in the reaction, which, 
containing both allylic and enolizable protons, may be anticipated to be sensitive to the 
basic reaction conditions. Three substrates (68-70) were thus selected for screening, 
which possessed aromatic, olefinic and also hetero-atom functionalities in the β-alkyl 
chain. All three substrates were synthesised via a Wittig reaction (52-99%) with 
commercially available aldehydes and commercially available phosphorane 67 (Scheme 
49). 
 
 
Scheme 49. Preparation of Enones 68-70 
 
Screening of enones 68-70 then followed under the optimised conditions (Table 13). 
 
 
Entry
a
 Substrate Product Conversion /%
b
 Isolated Yield /%
c
 
1 
  
>95 60 
2 
  
>95 61 
3 
  
>95 ND 
a
 Reactions performed on a 0.12-0.19 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as 
the internal standard; 
c
 Isolated by flash column chromatography. 
Table 13. Aziridination of Dialkyl Substituted Enones 68-70 
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Pleasingly the aziridination of dialkyl substituted enone 68 proceeded in good yield 
(60%) (entry 1). In a similar manner enone 69, possessing a terminal olefin, could also 
be aziridinated in good yield (61%). The latter example demonstrates the 
chemoselectivity of the methodology, where the electron deficient alkene is aziridinated 
in preference to the alkyl-substituted terminal alkene. In contrast an electrophilic nitrene 
addition to this substrate may be likely to lead to competitive olefin aziridination. β-
Benzyloxymethyl substituted enone 70 seemed to show poor compatibility with the 
reaction conditions and although aziridine 73 was observed in the 
1
H NMR spectrum of 
the crude reaction (ca. 25% yield), the product could not be isolated in sufficient purity. 
As a result it was considered whether homologating the alkyl chain of the substrate 
would be beneficial. It was therefore decided to synthesise the tris-homo analogue 77 
for screening. Enone 77 was envisaged to be prepared from 1,5-pentanediol, via the 
intermediary of a benzyl-protected aldehyde which could subsequently be utilised in a 
Wittig reaction (Scheme 50). 
 
Scheme 50. Preparation of Enone 76 
 
1,5-Pentanediol was first mono-protected with benzyl bromide using NaH and TBAI to 
afford the desired benzyl ether 74 in good yield (60%),(158) along with the undesired bis-
protected benzyl ether, 75, (21%), which was removed upon column chromatography 
purification. At this point a one-pot in situ oxidation-Wittig reaction, utilising 
procedures developed by Taylor for the transformation of unactivated alcohols was 
subsequently attempted (route A).(159) However, the desired enone was only detected as a 
minor component of the reaction mixture. Whilst some residual alcohol 74 could be 
recovered (35%), an unexpected side-product was identified as trans-4-phenyl-3-buten-
2-one 56, which is presumably formed via benzylic oxidation and C-O cleavage to give 
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benzaldehyde which then undergoes the oxidation-Wittig protocol. As a result the 
desired enone was obtained via a two-step process from 74 instead (route B). Oxidation 
of alcohol 74 via a TPAP/NMO oxidation(160) provided aldehyde 76 in moderate yield 
(46%), which was then transformed via a Wittig reaction to provide enone 77 in good 
yield (60%). With the desired substrate now in hand, enone 77 was screened with the 
optimised conditions (Scheme 51). 
 
 
Scheme 51. Aziridination of Enone 77 
 
Enone 77 was aziridinated in a 58% yield, which was in line with yields obtained for 
dialkyl enones 68 and 69 (Table 13). Whilst the developed methodology gratifyingly 
was applicable to these three dialkyl enones, with good yields obtained (58-61%), the 
isolated yields were slightly disappointing given that 
1
H NMR analysis of the reaction 
indicated almost complete substrate conversion with little evidence of any further 
significant side-products. Whilst it was suspected that under the basic reaction 
conditions the enones, with both allylic and enolizable protons, could potentially 
undergo dimerization and oligomerization reactions, which could account for loss of 
material, it was important to determine whether the aziridine products were stable under 
the reaction conditions. As a result dialkyl substituted aziridine 71 was exposed to the 
reaction conditions in place of the enone substrate. Aziridine 71 was recovered in 
quantitative yield, indicating that it is likely that degradation of the enone substrates 
accounts for the discrepancies between the observed conversions and the isolated yields 
of aziridine. 
 It was also hoped that the dienone aziridination methodology could be extended 
to an example of a dialkyl substituted vinyl aziridine. As a result dienone 79 (which was 
prepared via a Wittig reaction ((33%)) was screened under the optimised conditions, 
which pleasingly afforded a good yield of vinyl aziridine 80 (70%), with the remainder 
of material being unreacted dienone (Scheme 52). 
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Scheme 52. Aziridination of Dienone 79 
 
 Gratifyingly the developed conditions for the aziridination of enolizable enones 
had proven applicable to a range of acyclic substrates (8 examples, 49-80%). However, 
we were keen to explore the potential applicability of the methodology to cyclic 
substrates. There are fewer studies concerning the nucleophilic aziridination of cyclic 
enones, but methods for this transformation include the use of NNTAs, using either a 
PTC,(84) or notably enantioselective aziridination via aminocatalysis,(83) and via the 
Gabriel-Cromwell reaction.(161) In terms of our own methodology, the standard 
conditions for enone aziridination had previously shown incompatibility with the six-
membered cyclic enones cyclohexenone, 81 and 4,4-dimethylcyclohexenone, 82; in 
both cases degradation of the substrate was reported with no evidence of aziridine 
formation.(93) However, Ikeda‟s aminimine(89) has previously been applied by Gotor to 
the stereoselective aziridination of (S)-carvone, affording the bicyclic product in 
moderate yield (Scheme 53).(162) 
 
 
Scheme 53. Aziridination of Cyclic Enone (S)-Carvone Using Ikeda’s Aminimine 
 
Six-membered cyclic enones cyclohexenone, 81, and 4,4-dimethylcyclohexenone, 82, 
were selected as initial substrates to apply the newly developed aziridination conditions 
to (Table 14). 
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Entry
a
 Substrate Product Conversion /%
b
 Isolated Yield /%
c
 
1 
  
>95 35 
2 
  
52 ND 
3 
  
>95 ND 
4 
  
>95 ND 
a
 Reactions performed on a 0.12-0.27 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as 
the internal standard; 
c
 Isolated by flash column chromatography. 
Table 14. Aziridination of Cyclic Enones 81-84 
 
Aziridination of cyclohexenone, 81, was initially attempted and satisfyingly was 
successful under the developed conditions, albeit with the product isolated in only 
moderate yield (35%). Nevertheless, this represents the first successful example of 
aziridine formation from a cyclic enone utilising our amine-promoted methodology 
(entry 1). 4,4-Dimethylcyclohexenone 82, however, failed to undergo reaction, which 
could potentially be attributed to steric hindrance from the geminal dimethyl moiety to 
the incoming aminimine nucleophile (entry 2). Following successful aziridination of 81, 
both five-membered cyclopentenone, 83, and larger seven-membered cycloheptenone, 
84, were screened as substrates. Disappointingly both substrates showed almost 
complete conversion under the reaction conditions but with only suspected traces of the 
aziridines observed by 
1
H NMR of the crude reaction (entries 3 and 4). However, 
further analysis of the crude reaction mixture from the attempted aziridination of 
cycloheptenone by GCMS did show a significant peak that corresponded to the dimer of 
the enone (m/z = 220), likely promoted by the basic reaction conditions. 
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2.1.3.4 Application of DppONHBoc to the Aziridination of Enolizable Substrates 
 
Pleasingly the developed conditions for the aziridination of enolizable substrates had 
proved applicable to a range of examples, with generally good yields obtained. 
However, as alluded to, these substrates could potentially suffer from unwanted side-
reactions under the basic reaction conditions and high substrate conversions are often 
observed which do not always reflect the yield of isolated aziridine. As has been 
discussed in the introductory section of this thesis, our methodology requires bases with 
a sufficiently high pKaH value, such as hydroxide or alkoxide bases (pKaH ca. 15.5-17), 
in order to promote successful aziridination via deprotonation of the intermediate 
hydrazinium salt.
1
 However, it could be anticipated that if a weaker base, such as a 
metal carbonate (pKaH ca. 10.3), could be employed in the reaction this may allow 
increased yields to be obtained for the aziridination of base sensitive substrates, such as 
enones that possess enolizable or allylic protons. A potential strategy that was 
considered was to therefore increase the acidity of the hydrazinium proton by suitable 
N-fuctionalisation of the aminating agent with an electron-withdrawing group, such as 
an N-Boc moiety. We considered using DppONHBoc, 89, as an aminating agent 
potentially to form the hydrazinium salt which could then undergo deprotonation 
(Scheme 54). 
 
 
Scheme 54. Potential Aziridination with DppONHBoc 
 
There was one report of DppONHBoc in the literature,(163) but to the best of our 
knowledge this had never previously been utilised in any synthetic transformation. The 
                                                          
1
 Attempts were made to determine the pKa value of the N-aminomorpholinium and N-aminoquininium 
hydrazinium salts via potentiometric titrations. Titrations were undertaken using equipment with upper 
limits of pH = 12.5, however the pKa values of the hydrazinium moieties were unmeasurable with this 
equipment. See Appendix (Section 4.2) for further details. 
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reagent was successfully synthesised in near quantitative yield from N-Boc-
hydroxylamine and DppCl (Scheme 55). 
 
 
Scheme 55. Preparation of DppONHBoc 
 
DppONHBoc was then screened in the aziridination of dialkyl substituted enone 68, 
which possesses both allylic and enolizable protons, in place of the usual aminating 
agent DppONH2, utilising the developed conditions for the aziridination of enolizable 
substrates but with a range of weaker carbonate bases (Table 15). 
 
 
Entry
a
 Base t /h Solvent Conversion /%
b
 Yield /%
b
 
1 NaHCO3 16 CH2Cl2 <5 - 
2 K2CO3 16 CH2Cl2 40 traces 
3 Cs2CO3 16 CH2Cl2 63 63 
4 Cs2CO3 40 CH2Cl2 85 85, (74)
c
 
5
d
 Cs2CO3 40 CH2Cl2 76 76 
a
 Reaction performed on a 0.10-0.12 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as 
the internal standard; 
c
 Isolated yield in parentheses; 
d
 Reaction performed in the absence of NMM. 
Table 15. Aziridination of 68 Employing DppONHBoc as the Aminating Agent 
 
Initial screening of the reagent in the reaction with NaHCO3 as the base however gave 
minimal conversion of the enone substrate and did not result in any detectable signs of 
the expected aziridine (entry 1). Switching to K2CO3 gave moderate conversion of the 
enone (40%) but only traces of the aziridine were observed (entry 2). However, 
employing Cs2CO3 as the base did result in significant conversion of the enone to the 
desired N-Boc aziridine 90 (63%) (entry 3). The effect of the electron-withdrawing N-
Boc moiety on the aminating agent may have also been expected to reduce the 
nucleophilicity of the corresponding aminimine in the conjugate addition step to the 
enone and as a result the reaction with Cs2CO3 was again repeated but with an increased 
reaction time from 16 h to 40 h. Pleasingly this gave a very good conversion of the 
enone solely to the aziridine (85%), with no further side-products detected (entry 4). 
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Whilst this was gratifying, an important control reaction required the repetition but in 
the absence of the amine promoter NMM, i.e. could DppONHBoc be utilised as an 
NNTA without prior activation? As a result the reaction was repeated using the 
conditions outlined in entry 4 but in the absence of NMM which gave a conversion of 
76% to the desired aziridine (entry 5). This latter result seemingly indicated, within 
experimental error, a minimal role of the amine. As a result investigations with 
DppONHBoc were concluded at this stage. 
 
2.1.4 Attempted Oxidations of Aziridines to Aziridine-2-Carboxylates 
 
2.1.4.1 Baeyer-Villiger Oxidations 
 
Whilst disappointingly the synthesis of vinyl aziridines was not able to be extended to 
dienoates which would have resulted in the formation of aziridine-2-carboxylates, an 
alternative strategy towards this motif was considered. It was potentially envisaged that 
a Baeyer-Villiger oxidation of the synthesised aziridines could be employed to form 
aziridine-2-carboxylates. To the best of our knowledge there exists only one isolated 
example of the Baeyer-Villiger oxidation of aziridine-2-carbonyls in the literature, 
which was observed as an unwanted side-reaction of an N-carbamate aziridine, 91, 
whilst using trifluoroperacetic acid (TFPAA) during a synthetic scheme (Scheme 
56).(164)  
 
 
Scheme 56. Undesired Baeyer-Villiger Oxidation of Aziridine 91 
 
However, the corresponding Baeyer-Villiger oxidation of epoxy ketones is well known 
and many examples exist in the literature. Both electrophilic and nucleophilic oxidants 
for this transformation have been used, with meta-chloroperbenzoic acid (mCPBA)(165) 
and aq. H2O2
(166) both commonly employed. Epoxy ketones that have undergone this 
transformation include both acyclic and cyclic substrates and both aryl and alkyl 
migrating groups are known. However, unlike epoxy ketones, aziridines could suffer 
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from undesired N-oxidation thus making the desired Baeyer-Villiger oxidation 
potentially more challenging. 
In order to access the aziridine-2-carboxylate motif, Baeyer-Villiger oxidation 
was therefore attempted. In the first instance it was decided to use chalcone aziridine, 
92, as a model substrate since the analogous epoxide has been shown to undergo 
successful oxidation. A range of conditions were thus investigated (Table 16): 
 
 
Entry
a
 R Conditions Product(s)
b
 
1 H, 92 (a) mCPBA (3.5 eq.), CH2Cl2, 40
o
C, 16 h complex mixture 
2 H, 92 (b) mCPBA
c
 (1.05 eq.), CH2Cl2, 40
o
C, 16 h chalcone 
3 Cbz, 93 (c) mCPBA
c
 (1.05 eq.), CH2Cl2, 40
o
C, 16 h complex mixture 
4 H, 92 (d) TFPAA (1.05 eq.), 0
o
C to rt, 2.5 h chalcone 
5 H, 92 (e) Oxone (2.5 eq.), Al2O3, CH2Cl2, 40
o
C, 16 h complex mixture; chalcone 
a
 Performed on a 0.10-0.21 mmol scale; 
b
 Analysis by TLC and 
1
H NMR spectroscopy;
 c
 washed with 
NaH2PO4/NaOH buffered solution at pH = 7.4. 
Table 16. Attempted Baeyer-Villiger Oxidation of Aziridine 92 and 93 
 
Initially mCPBA (3.5 eq.) was utilised as the oxidant, which was used as supplied and 
followed a representative procedure for the oxidation of epoxy ketones, which had also 
been used for chalcone epoxide.(165) However, use of these conditions, whilst consuming 
all aziridine substrate, afforded only traces of suspected product and revealed a complex 
mixture in the crude reaction (entry 1). It was suspected that the excess of oxidant could 
potentially form the aziridine-N-oxide as an unwanted side-product and as a result it 
was decided to reduce the equivalents of oxidant (to 1.05 eq.) and in addition to purify 
the commercial mCPBA by washing with a buffered solution. Whilst this system still 
failed to afford the desired product the crude reaction mixture now showed a major 
product, which was interestingly identified as the enone chalcone (entry 2). Due to the 
lack of resonance interaction between an aziridine N-lone pair and a carbonyl protecting 
group (as discussed in Section 1.2.3.1), N-protection, for example as a carbamate, in 
order to prevent potential N-oxidation cannot be achieved. However, in an attempt to 
mimic aziridine 91, that underwent unwanted Baeyer-Villiger reaction, N-Cbz chalcone 
aziridine, 93, was also exposed to the reaction conditions, although this again gave a 
complex mixture of products with complete consumption of the aziridine (entry 3). 
Alternative oxidants including TFPAA also afforded chalcone as the major product, as 
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indicated by its gradual appearance by TLC (entry 4). Commercial Oxone (active 
component being potassium peroxymonosulfate), was also investigated, but again the 
major product was identified as chalcone (entry 5). It appears that the use of 
electrophilic oxidants (mCPBA, TFPAA and Oxone) degrades the aziridine substrate, 
with the major side-product identified as chalcone. Whilst to the best of our knowledge 
there are no reports of the N-oxidation of aziridines in the literature, a potential 
decomposition pathway may involve N-oxidation, followed by elimination (Scheme 
57). 
 
 
Scheme 57. Potential Decomposition Pathway of Aziridine 92 and 93 
 
As a result of this unwanted side-reaction the use of nucleophilic oxidants for 
potential Baeyer-Villiger oxidation of chalcone aziridine, 92, were also investigated 
(Table 17). 
 
 
Entry
a
 Conditions Product(s)
b
 
1 30% aq. H2O2 (12 eq.), NaOH (15 eq.), MeOH, 
rt to 80
o
C, up to 18 h 
NR 
2 (b) TMS2O2 (2 eq.), TMSOTf (0.2 eq.), CH2Cl2, -40
o
C, 2 h NR 
3 (b) TMS2O2 (3 eq.), TMSOTf (0.4 eq.), CH2Cl2, 0
o
C, 48 h decomposition 
4 (d) TMS2O2 (2 eq.), SnCl4/DA (0.25 eq.), CH2Cl2, 
0
o
C to rt, up to 16 h 
some decomposition 
a
 Performed on a 0.09-0.13 mmol scale; 
b
 Analysis by TLC and 
1
H NMR spectroscopy; NR = no reaction. 
Table 17. Attempted Baeyer-Villiger Oxidation of 92 Using Nucleophilic Oxidants 
 
Using an alkaline solution of 30% aq. H2O2, again commonly employed conditions for 
the Baeyer-Villiger oxidation of epoxy ketones,(166) failed to promote any reaction, even 
at increased temperatures (entry 1). As an alternative bis(trimethylsilyl) peroxide, with 
catalytic amounts of Lewis acids were also investigated. Using TMSOTf, which had 
been reported for the Baeyer-Villiger oxidation of aliphatic ketones,(167) again failed to 
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promote the reaction and increased addition of reagents with slight warming of the 
reaction led to decomposition of material (entries 2 and 3). Modified procedures using 
SnCl4 in combination with trans-1,2-diaminocyclohexane (DA) as a ligand, applicable 
for the Baeyer-Villiger oxidation of aromatic ketones,(168) also failed to promote the 
reaction (entry 4). 
 
2.1.4.2 Beckmann Rearrangements 
 
Whilst the attempted Baeyer-Villiger reactions failed to provide the desired aziridine-2-
carboxylates, it was considered that a Beckmann rearrangement of the corresponding 
oxime, may also lead to the desired carboxyl aziridines as an alternative oxidation 
strategy. However, to the best of our knowledge, the Beckmann rearrangement of 
aziridine-2-carbonyls, or indeed epoxy ketones, was not known. As a result initial 
investigations were undertaken. Aziridine 64 was used as a model substrate as it was 
hypothesised that its sterically bulky tert-butyl group may help promote the desired 
formation of the Z-oxime isomer, required in order to facilitate the desired selective 
migration of the 
t
Bu-group rather than the aziridine carbon (Scheme 58). 
 
 
Scheme 58. Potential Beckmann Rearrangement of Aziridine 64 
 
Initially hydroxylamine hydrochloride in either EtOH or pyridine,(169,170) both 
commonly used for conversion of a ketone to an oxime, were employed. The desired 
oxime 94 was obtained only after using 10 equivalents of hydroxylamine with heating 
in EtOH at 30
o
C (70%, crude), with lower temperatures and less reagent found not to 
promote conversion (Scheme 59). The use of pyridine with 10 equivalents of 
hydroxylamine hydrochloride was also found to promote the reaction but crude yields 
were slightly lower (59%, crude) with larger amounts of side-products also evident. At 
this stage attempted determination of the oxime geometry could not be obtained by 
NOESY analysis due to unambiguous determination of the OH vs. NH peak. Attempts 
to form the oxime tosylate, in order to either allow further analysis or to promote 
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rearrangement, using para-toluenesulfonyl chloride and pyridine,(170) led only to 
decomposition of the oxime with no signs of the rearranged amide. 
 
 
Scheme 59. Synthesis of Oxime 93 and Attempted Rearrangement to Amide 94 
 
As a result an alternative approach was sought for the overall transformation. 
One interesting strategy has employed O-mesitylenesulfonyl hydroxylamine (MSH), 
which is commonly used as an electrophilic aminating agent, for an alumina-promoted 
Beckmann rearrangement.(171) Accordingly, aziridine 64 was exposed to MSH(172,173) in 
CH2Cl2, which after concentration of solvent indicated complete conversion to the 
desired oxime, 96 (Scheme 60). However, exposure of the oxime to basic alumina in 
C6H6/MeOH did not promote the desired rearrangement but instead gave quantitative 
hydrolysis back to aziridine 64. 
 
Scheme 60. Synthesis of Oxime 96 and Attempted Rearrangement to Amide 95 
 
Whilst disappointing results for the Beckmann rearrangement of aziridine-2-
carbonyls were obtained, only initial investigations were undertaken and it may be that 
other aziridine substrates, with different potential migrating groups or indeed alternative 
conditions may provide more fruitful results. 
 
2.1.5 Summary of the Extension of the Reaction Scope for Amine-Promoted 
Alkene Aziridination 
 
Investigations have led to an expansion of the scope of substrates that can be 
aziridinated with our amine-promoted alkene aziridination methodology, with the 
results summarised below. Through the use of newly developed conditions two 
important classes of substrates can now be aziridinated in generally good yields: 
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i. Dienones, to afford vinyl aziridines (11 examples, 30-79%) 
 
 
Entry
a
 Substrate Base Product Isolated Yield /%
b
 
1 
 
A 
 
79 
2 
 
B 
 
64 
3 
 
B 
 
75 
4 
 
B 
 
70 
5 
 
A 
 
67 
6 
 
A
c
 
 
46 
7 
 
A
c
 
 
30 
8 
 
B 
 
78
d
 
9 
 
A
c
 
 
62 
10 
 
B 
 
67 
11 
 
A
c
 
 
60 
a
 Reactions performed on a 0.10-0.24 mmol scale; 
b
 Isolated by flash column chromatography; 
c
 2 eq. of 
base employed. 
Table 18. Summary of the Aziridination of Dienones 
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ii. Enolizable substrates (9 examples, 35-80%) 
 
 
Entry
a
 Substrate Product Conversion 
/%
b
 
Isolated Yield /%
c
 
1 
  
>95 80 
2 
  
>95 49 
3 
  
>95 79, (91)
d
 
4 
  
70 63 
5 
  
>95 60 
6 
  
>95 61 
7 
  
>95 58 
8 
  
83 70 
9 
  
>95 35 
a
 Reactions performed on a 0.11-0.24 mmol scale; 
b
 Determined by 
1
H NMR spectroscopy using Bn2O as 
the internal standard; 
c
 Isolated by flash column chromatography; 
d
 Performed on a 0.56 mmol scale. 
Table 19. Summary of the Aziridination of Alpha-Enolizable Enones  
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2.2 Synthesis and Screening of Chiral Six-Membered 1,4-Heterocycles 
 
As outlined in Section 1.4 the second major focus of this project was the development 
of the methodology towards an asymmetric amine-promoted alkene aziridination, via 
the synthesis and screening of various chiral tertiary amines. As discussed, one class of 
chiral tertiary amines as yet to be screened in the reaction were amines based upon the 
N-methylmorpholine (NMM) framework. NMM has been shown to be an efficient 
promoter for the (racemic) aziridination process and functionalised chiral morpholines 
were therefore an attractive target. Section 2.2 describes the approaches used to 
synthesise a range of chiral 1,4-heterocycles, along with screening results and 
discussion of relevant observations. 
 
2.2.1 Synthesis and Screening of C2 Symmetric Morpholines 
 
A review of the literature presented a range of structurally diverse morpholines,(174) 
synthetically accessible with varying degrees of efficiency (in terms of number of 
reaction steps, overall yield and enantiopurity). One initial target emerged; C2-
symmetric morpholine 97, which could be accessed from the known C2-symmetrical 
morpholine, 98, synthesised from an L-serine derivative and a glycerol derivative to 
provide the chirality in the target morpholine (Scheme 61).(175) 
 
Scheme 61. C2-Symmetric NMM 97 from Morpholine 98 
 
It was envisaged that the C2-axis in the amine may have particular advantages in 
achieving asymmetric induction in the aziridination, by reducing the number of 
competing undesired diastereomeric transition states due to avoidance of chiral centre 
formation at nitrogen in the intermediate hydrazinium salt and ylide. Moroverer the 
strategy also provided a handle for further derivatisation of the morpholine via choice of 
O-protecting group. Synthesis of this chiral morpholine, 97, was therefore the first goal. 
The starting point of the synthetic scheme was N-Boc-L-serine methyl ester, 99, 
which provides the functionality for one hydroxymethyl moiety in the target and was 
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synthesised in two steps from L-serine using literature procedures (Scheme 62).(176,177) N-
Boc protection was accomplished efficiently (92%) using di-tert-butyldicarbonate, with 
subsequent esterification using iodomethane, accomplished in a moderate yield (58%) 
to afford 99 as required in multigram quantities. 
 
 
Scheme 62. Synthesis of N-Boc-L-Serine Methyl Ester, 99 
 
To provide the second hydroxymethyl moiety of the target, coupling with (2R)-
1,2-isopropylidene-3-O-trifluoromethanesulfonyl glycerol 100 was required, which is in 
turn obtained from the corresponding primary alcohol, 2,3-O-isopropylideneglycerol, 
103. Alcohol 103 could be derived from a three-step elaboration of cheap and readily-
available D-mannitol, via a reported procedure, employing double acetonide protection 
followed by oxidative cleavage and reduction (Scheme 63).(178)  
 
 
Scheme 63. Preparation of 2,3-O-Isopropylideneglycerol, 103 
 
The reported yield for the two-pot, three-step procedure for alcohol 103 was 45% but 
the attained yield was significantly lower (8%, 3 steps); all three reaction steps required 
a duration significantly longer than reported procedures, with each step incomplete, as 
judged by TLC, even after longer reaction time. As a result alcohol 103 was 
subsequently obtained commercially. The corresponding glycerol triflate 100 was 
synthesised from 103 via a literature procedure, using triflic anhydride under basic 
conditions (Scheme 64), in quantitative yield.(179) The triflate was found to require fresh 
preparation prior to use and had to be stored in a freezer to prevent decomposition. 
 
Scheme 64. Preparation of (2R)-1,2-Isopropylidene-3-O-trifluoromethanesulfonyl glycerol 100 
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The remainder of the synthetic scheme (outlined in Scheme 65) is based upon 
the literature procedures. Hydroxyl protection of the methyl ester 99, via treatment with 
imidazole and TBDPSCl, followed and was achieved in near quantitative yield (99%) to 
afford 104 which was subsequently reduced with LiBH4 to the corresponding alcohol 
105 in good yield (77%). However, the reaction required five equivalents of the 
reducing agent and a much increased reaction time from that reported, with residual 
starting material (18%) also recovered (although this was recycled back into the 
reaction). Subsequent exposure of alcohol 105 to NaH before addition of triflate 100, 
afforded ether 106 in a yield of 31% (Scheme 65), in contrast to the reported yield of 
83%.(175) However, after both NMR and MS analysis of the residual reaction material, 
oxazolidinone 107 was identified as the major reaction product (54%), likely formed as 
a result of base-mediated cyclisation of the starting alcohol 105. In order to counter this 
intramolecular process it was envisaged that addition of NaH to a pre-mixed solution of 
both 105 and 100 would promote the desired intermolecular reaction and thus 
circumvent oxazolidinone formation. Indeed, this modification did successfully limit 
formation of oxazolidinone 107 to only trace amounts as indicated by GCMS analysis 
of the crude reaction material. However, the desired coupled ether 106 was only 
obtained in a slightly increased yield of 42%. Analysis of the remainder of the crude 
reaction material by both NMR and GCMS did not allow the identification of any other 
side-products, with all starting material consumed. Subsequent acid hydrolysis of the 
acetonide protecting group provided diol 108 in good yield (77%). Regioselective 
TBDPS protection of the primary alcohol was now required. Initial attempts failed, with 
only starting material recovery, despite following the reported conditions, near identical 
to those conditions used for the previous efficient protection of 104. Repetition again 
failed to yield any of the desired product, as judged by TLC, but increasing the amount 
of TBDPSCl from 1.1 to 1.6 equivalents did afford the desired silylated product 109 in 
64% yield, albeit along with the tris-protected product arising from additional silylation 
of the secondary alcohol (12%). It was subsequently found that increasing the reaction 
concentration from 0.1M to 0.3M, whilst employing 1.1 equivalents of TBDPSCl, gave 
an optimal yield of 73% of the desired bis-protected alcohol 109. Mesylation of the 
secondary alcohol, employing methanesulfonyl chloride and Et3N, was then achieved in 
excellent yield (94%) to afford 110. Synthesis of 110 set the stage for the completion of 
morpholine target 98 by first removal of the N-Boc protecting group with TFA and 
subsequent base-mediated cyclisation under reflux to afford the literature compound 98 
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in 81% yield over 2 steps in a one-pot procedure. The measured optical rotation was 
identical to that reported and chiral HPLC analysis (in accordance with the reported 
literature conditions) showed excellent enantiomeric purity of the synthesised 
morpholine (>95% ee).(175) 
 
Scheme 65. Preparation of Morpholine 98 from 99 and 100 
 
In order to afford the desired NMM target 97, since it has been demonstrated 
that a tertiary amine is a crucial structural requirement for a promoter in the 
aziridination process,(87) methylation of the N-centre of 98 was now attempted. A variety 
of methods were available for this transformation, including N-Boc protection followed 
by LiAlH4 reduction, but the potential lability of the TBDPS group under these 
conditions was a concern. The method of choice was a reductive amination utilising 
catalytic hydrogenation. Using Pearlman‟s catalyst in the presence of formaldehyde, 
acetic acid and H2 (g) efficiently provided the desired novel tertiary amine 97 in good 
yield (81%) (Scheme 66). 
 
 
Scheme 66. Reductive Amination to Afford NMM Target 97 
82 
 
2.2.1.1 Screening of Morpholine 97 
 
NMM 97 was screened for the aziridination of chalcone, utilising the standard 
conditions developed for the reaction utilising NMM as the amine promoter (1.05 eq. 
amine, 1.05 eq. DppONH2, MeCN, 0.5 h then 2 eq. NaOH, chalcone, rt, 16 h) (Scheme 
67).(87)  
 
Scheme 67. Screening of C2-Symmetric NMM 97 
 
Aziridination of chalcone, however, did not proceed under these conditions, as judged 
by TLC, even after increased reaction times of 72 h. Analysis of the 
1
H NMR spectrum 
of the crude reaction mixture indicated the absence of the desired aziridine product with 
chalcone starting material present.  Interestingly, morpholine 97 was not evident either, 
although peaks at and 7.75, 7.38 and 1.09 ppm, likely due to a 
t
BuPh2Si group were 
present. Furthermore, GCMS analysis of this crude reaction mixture indicated the 
presence of 
t
BuPh2SiOH; both sets of data indicate protecting group cleavage of the 
catalyst. This was thought to be likely to be caused by the base in the reaction mixture 
and therefore consumption of the base (2 eq.) in this bis-deprotection reaction may 
prevent the desired aziridination. As a result it was decided to synthesise and screen 
dihydroxy morpholine 111. Treatment of NMM 97 with 1M tetra-n-butylammonium 
fluoride (TBAF) solution facilitated the desired silyl-deprotection to afford the desired 
bis-hydroxy NMM, 11, in good yield (80%) (Scheme 68).  
 
 
Scheme 68. Deprotection of NMM 97 to Afford Bis-hydroxy NMM 111 
 
NMM 111 was screened for the aziridination of chalcone employing standard 
conditions (Scheme 69). Unfortunately, only a low yield of aziridine product was 
afforded (5%) with recovery of the remaining unreacted chalcone. The ee of the 
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aziridine, as determined by chiral HPLC analysis, was also disappointingly low (14%, 
(3R,2S)). 
 
 
Scheme 69. Screening of C2 Symmetric Bis-hydroxy NMM 111 
 
Considering the arduous nature of the synthesis of 97, coupled with the poor 
aziridination results of 97 and 111, alternative morpholine structural classes which 
could be accessed in shorter synthetic sequences were also selected for investigation. 
 
2.2.2 Synthesis and Screening of Morpholines with Pendant Chiral Groups at N  
 
Returning to the literature it was revealed that morpholines with pendant chiral groups 
at the N-centre, such as 112, could be accessed in a one-pot procedure.(180) It was 
envisaged that the proximal chiral centre of such compounds would provide an 
interesting alternative morpholine structural class for screening. Synthesis of 
morpholine 112 involved ozonolysis of 2,5-dihydrofuran, which following quenching of 
the ozonide by NaBH3(CN) forms a dialdehyde which undergoes a reductive amination 
with enantiopure (S)-α-methylbenzylamine to form the morpholine (Scheme 70, 
conditions a).(180) 
 
 
Scheme 70. Synthesis of Chiral Morpholine 112 
 
Synthesis of 112 was initially attempted by following the reported reaction 
conditions and resulted in a yield of 43% (lit.(180) 55%). Attempts to optimise the 
procedure, by increasing the equivalents of 2,5-dihydrofuran from one to two (1 
equivalent of amine) coupled with an increased reaction time after amine addition to 16 
h (Scheme 70, conditions b), only resulted in a slightly improved yield of 48%.  
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Initial screening of morpholine 112 as a promoter for the aziridination, utilising 
the standard conditions, failed to afford any isolable aziridine product, with 92% of 
chalcone starting material recovered. It was postulated that the N-centre of the 
morpholine may be too sterically congested to efficiently undergo successful reaction. 
In this scenario it is possible that the steric bulk may hinder either initial amination of 
the promoter (step i.) and/or subsequent conjugate addition of the aminimine to the 
chalcone substrate (step ii.) (Scheme 71). 
 
 
Scheme 71. Possible Scenarios that may Account for the Failure of Morpholine 112 to Promote 
Aziridination 
 
The extent of amination was initially probed by 
1
H NMR analysis (Table 20). The 
standard amination conditions (step i.) were followed after which the reaction solvent 
was concentrated in vacuo, with the resultant solid diluted in D6-DMSO and analysed 
by 
1
H NMR spectroscopy. It was found that conversion to the hydrazinium salt was just 
23% (entry 1). Amination was judged by integration of the 3H Me doublet which was 
shifted downfield upon hydrazinium salt formation (1.70 ppm) relative to that of the 
non-aminated morpholine 112 (1.28 ppm). It was envisaged that by increasing the 
reaction time higher conversion could be obtained, and indeed amination could be 
achieved in a 67% conversion after 16 h (entry 2). Furthermore, by utilising a second 
equivalent of the aminating agent, DppONH2, amination could be achieved in 97% 
conversion after 16 h (entry 3). 
 
 
Entry
a
 t /h Eq. DppONH2 Conversion /%
b
 
1 0.5 1.05 23 
2 16 1.05 67 
3 16 2.0 97 
a
 Reaction performed 0.08-0.13 mmol scale; 
b
 Determined by 
1
H NMR analysis. 
Table 20. Investigation into the Amination of Morpholine 112 
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With this latter result in hand (entry 3), investigations into the feasibility of the 
subsequent conjugate addition of the corresponding aminimine to chalcone (step ii.) 
were conducted. After replicating the amination conditions used in entries 2 and 3, 
NaOH (2 eq.) and chalcone were then added and the reaction stirred at room 
temperature for 16 h. Disappointingly in each case attempted aziridination failed to 
afford any product as judged by both TLC and analysis of the 
1
H NMR spectrum of the 
crude reaction mixture. Thus, it seems likely that the limiting factor of morpholine 112 
as a promoter was due to the failure of its corresponding aminimine to act as a proficient 
conjugate donor for the addition to chalcone. This was reasoned to be due to steric 
crowding at the morpholine N-centre. As a result it was decided to synthesise a 
morpholine with a sterically less demanding pendant chiral group at nitrogen. The novel 
morpholine (S)-2-morpholin-4-yl-propan-1-ol 113, was selected as the target and was 
synthesised from 2,5-dihydrofuran in a 33% yield via the employment of enantiopure 
(S)-2-aminopropan-1-ol (Scheme 72). 
 
 
Scheme 72. Synthesis of Chiral Morpholine 113 
 
Screening of 113 with chalcone afforded the desired aziridine in low yield (12%) with 
ee disappointingly determined to be only 2% by HPLC analysis (Scheme 73). 
 
 
Scheme 73. Screening of Morpholine 113 
 
2.2.2.1 Investigations into Steric Tolerance at the Morpholine N-Centre 
 
As a result of the failure of morpholines 112 and 113 to promote aziridination to any 
significant extent, deemed to be due to steric bulk at the N-centre, it was decided to 
conduct investigations in order to determine the tolerance of the aziridination reaction to 
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varying steric bulk at that position. A range of morpholines were selected including N-
Et, 114, N-
i
Pr, 116, and N-
sec
Bu, 117. Additionally morpholine 115 was also selected 
since it would provide an interesting comparison to quinine, both of which contain a β-
aminoalcohol functionality (Figure 3). Aziridination results with quinine have shown 
that removal of the alcohol severely diminishes aziridine yield.(93) 
 
 
Figure 3. Morpholines Possessing Varying Degrees of Steric Bulk at the N-Centre 
 
Morpholines 114 and 115 were available commercially with 116 and 117 readily 
accessible via a reductive amination with morpholine. Using Pearlman‟s catalyst in the 
presence of acetone or 2-butanone respectively, acetic acid and H2 (g) efficiently 
provided the desired tertiary amines in moderate to good yields (Scheme 74).  
 
 
Scheme 74. Synthesis of Morpholines 116 and 117 
 
All morpholines (114-117) were screened employing the standard aziridination 
conditions with both extent of amine amination and overall yield of aziridine 
investigated (Table 21). The standard reaction solvent, MeCN, was however replaced 
with CD3CN to allow an easier determination of hydrazinium conversion (amination) by 
1
H NMR analysis. This was conducted by removing an aliquot of the reaction mixture 
after the initial amination step which could then be analysed by 
1
H NMR. After analysis 
NaOH (2 eq.) and chalcone were then added and the reaction stirred at room 
temperature for 16 h and the overall yield of aziridine then determined after flash 
column chromatography purification. 
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Entry
a
 Morpholine R Amination /%
b
  Yield aziridine /%
c
 
1 NMM Me 82 86 
2 114 Et quant.  71 
3 115 -CH2CH2OH 66 61 
4 116 
i
Pr 45 47 
5 117 
sec
Bu 34 44 
6 113 -(S)-CH(CH3)CH2OH 73 12 
7 112 -(S)-CH(CH3)Ph 23 <5 
a
 Reaction performed on a 0.12 mmol scale; 
b
 Determined by 
1
H NMR analysis;
 c
 After flash column 
chromatography purification. 
Table 21. Investigations to Determine the Tolerance of the Aziridination Reaction to Steric bulk at 
the Morpholine N-Centre 
 
When the standard promoter NMM is utilised amination was determined at 82% and 
high yields (86%) of chalcone aziridine are obtained (entry 1). The yield of aziridine is 
reduced when the R group is ethyl (Entry 2). In a similar system it has previously been 
noted that the nitrate salt of aminated N-ethylmorpholine, 119, achieves only poor 
yields of chalcone aziridine (14%) (Scheme 75).(94) The low yield, with respect to the 
corresponding NMM salt, 118, in the same system (95%), was attributed as being due to 
increased steric hindrance between the morpholine ethyl group and the chalcone 
substrate. Although the two systems are only indirectly comparable, entry 2 is in 
agreement with this observation as both ethyl compounds afford the aziridine with a 
reduced yield in comparison to that of their corresponding N-methyl substituted 
counterparts. 
 
 
Scheme 75. Aziridination of Chalcone Using N-Amino-N-alkylmorpholinium Nitrates 
 
Morpholine 115, bearing an N-hydroxyethyl group, was found to afford both poorer 
yields of aziridine and poorer amination conversion than the corresponding ethyl 
compound, although both are of similar steric size (entry 3 vs. 2). Indeed the presence of 
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the β-aminoalcohol functionality had no beneficial effect on its activity as a promoter, 
thus the result is in contrast to quinine where the free hydroxyl group has been shown to 
be beneficial for catalyst activity.(93) The effect of branching at the N-centre was 
investigated with N-
i
Pr and N-
sec
Bu morpholines 116 and 117 respectively (entries 4 and 
5). In agreement with the results for the previously screened chiral morpholines 112 and 
113, branching was found to afford substantially reduce yields of aziridine; amination 
was also significantly decreased, with the exception of chiral morpholine 113 where 
amination was observed to be 73%.  
It is evident from the above results that as steric bulk at the N-centre increases, 
the yield of the desired aziridine decreases. The results do however show that the 
reaction can tolerate substituents other than Me at the N-centre. The increased steric 
bulk also appears to have a negative effect on the initial amine amination, although the 
correlation is less clear. From analysis of entry 5 (and to a lesser extent entries 1 and 4) 
it is evident that initial amination conversion does not determine the final yield of the 
product, and these observations are in support of the proposed organocatalytic reaction 
mechanism in which amine amination can continue to take place during the course of 
the aziridination process (see section 1.3.1).  
 In order to allow a more direct comparison of the effect of steric bulk at the 
morpholine N-centre on the conjugate addition step, it was necessary to achieve 
complete conversion in the amination step. Since it had earlier been demonstrated with 
morpholine 112 that this was possible by the employment of a second equivalent of 
DppONH2 and a longer reaction time of 16 h, it was decided to employ these 
conditions. Morpholines 114-116 were exposed to two equivalents of DppONH2 in 
CD3CN and stirred for 16 h. Amination was then determined by 
1
H NMR spectroscopy. 
NaOH (2 eq.) and chalcone were then subsequently added and the reaction stirred at 
room temperature for 16 h. The overall yield of aziridine was then determined after 
flash column chromatography purification (Table 22). 
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Entry
a
 Morpholine R Amination /%
b
 Yield Aziridine /%
c
 
1 114 Et quant. <5 
2 115 -CH2CH2OH quant. 10 
3 116 
i
Pr quant. 11 
a
 Reaction performed on a 0.12 mmol scale; 
b
 Determined by 
1
H NMR analysis; 
c
 After flash column 
chromatography purification.  
Table 22. Investigations into Varying Steric Bulk at the Morpholine N-Centre and its Effect Upon 
Aminimine Conjugate Addition to Chalcone 
 
Upon screening it quickly became evident that aziridine formation reduced substantially 
upon the utilisation of these conditions. The above reactions were carried out with an 
excess of aminating agent and, supported by previous observations,(87) it was 
hypothesised that the excess aminating agent may be susceptible to attack from NaOH.
 
If this were indeed the case NaOH would thus be consumed in this reaction and the base 
would no longer be available in the aziridination procedure for deprotonation of the 
hydrazinium salt, which could account for the diminished yields observed. To test this 
hypothesis DppONH2 (1 eq.) was exposed to one equivalent of NaOH in CD3CN for 2 h 
before the addition of one equivalent of NMM to the mixture and further stirring for 0.5 
h. 
1
H NMR analysis was then undertaken to determine amination. The observed value 
of 56% is lower than the 82% achieved when the analogous amination was conducted 
with the absence of base (Table 21), which would seem to indicate partial reaction of 
the base with the aminating agent. Further support for the hypothesis would be gained if 
further addition of NaOH reinstated the yield of aziridine. Morpholines 114-116 were 
therefore reexposed to the conditions that were required for complete amination (2 eq. 
DppONH2, 16 h) followed by subsequent addition of chalcone and now three 
equivalents of NaOH (Table 23), in analogy to conditions utilised during studies into 
substrate scope exploration (see Section 2.1). Screening of chiral morpholine 112 was 
also revisited employing these conditions. 
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Entry
a
 Morpholine R Yield Aziridine /%
b
 
1 114 Et 79 
2 115 CH2CH2OH 55 
3 116 
i
Pr 39 
4 112 -(S)-CH(CH3)Ph
 
<5 
a
 Reaction performed on a 0.12 mmol scale; 
b
 After flash column chromatography purification.  
Table 23. Aziridination of chalcone Using 2 Equivalents of DppONH2 and 3 Equivalents of NaOH. 
 
Indeed via employment of these conditions yields of aziridine did increase for 
morpholines 114-116; although to levels that did not necessarily surpass those achieved 
whilst employing the standard aziridination conditions (Table 21). Disappointingly, 
morpholine 112 still failed to provide any detectable aziridine. It can be concluded that 
this promoter is simply too sterically congested at its N-centre to undergo conjugate 
addition. Overall it can be seen that increased steric bulk at the N-centre disfavours the 
overall aziridination reaction and this is attributed to a reduced ability of the 
corresponding aminimines to undergo conjugate addition to the substrate. The results 
detailed in Table 22  and Table 23 also support the notion that DppONH2 is sensitive to 
base, which is in support of previous observations.(87) A key issue for future optimisation 
of an organocatalytic system, in order to increase turnover number, will be to address 
this issue. One solution is potentially via the employment of a more stable aminating 
agent. 
 
2.2.2.2 Unexpected Substrate and Product Deuteration 
 
As discussed many of the reactions detailed were conducted in CD3CN as the reaction 
solvent in order to allow easy investigation of amination by 
1
H NMR analysis. 
However, an unexpected deuteration of both aziridine product and recovered chalcone 
starting material was observed when employing CD3CN with certain amine promoters 
(Scheme 76).  
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Scheme 76. Unexpected Deuteration of Aziridine and Recovered Chalcone 
 
After analysis by 2D NMR spectroscopy it was found that α-deuteration had occurred in 
both compounds. It would seem apparent from these observations that a disruption to 
the mechanism of the aziridination process involving proton (or in this case deuterium) 
exchange was occurring. 
Deuteration was found to occur with several amine promoters but occurred to 
greater extent when occurred when aziridination was conducted with promoters that 
possessed an alcohol functionality, such as with N-(2-hydroxyethyl)morpholine 115. 
Incorporation of deuterium was observed in all recovered chalcone but only in up to 
90% of aziridine. It was found that submission of α-H-aziridine back into the 
aziridination reaction conditions, with N-(2-hydroxyethyl)morpholine, 115, DppONH2 
and NaOH in CD3CN, but in the absence of chalcone, resulted in no product deuteration 
of the aziridine thus confirming deuteration as a pre-aziridination process (substrate 
deuteration). A variety of reactions were conducted in order to address the requirements 
for deuteration. It was found that omission of aminating agent DppONH2 from the 
aziridination reaction still gave total α-deuteration of chalcone, but with omission of 
NaOH deuteration was not observed, indicating the crucial role of the base. The 
necessity of alcohol, base (NaOH) and deuterated solvent (CD3CN) is consistent with 
reported procedures for the α-deuteration of chalcones.(181,182) The process involves initial 
conjugate addition of the base, followed by deuteration from the (now deuterated) 
alcohol, preferential abstraction of the α-proton (vs. D, KIE), with final hydroxide 
elimination to reform the base and to afford α-deuterated chalcone (Scheme 77). The 
observation that NaOH plays a competing role with the aminimine for the conjugate 
addition to chalcone provides further insights into the reaction process. 
 
Scheme 77. Mechanism for the Deuteration of Chalcone and Aziridine 
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2.2.3 Synthesis and Screening of Piperazines 
 
Since NMM has proved to be such an effective (racemic) aziridination promoter it was 
reasoned that other six-membered 1,4-heterocycles, such as tertiary piperazines, which 
have not previously been screened as potential promoters,(87) may also prove effective as 
a result of their similar steric size and electronic nature. If this were indeed the case it 
may also prove feasible to screen chiral tertiary piperazines, such as commercially 
available (S)-2-methylpiperazine.  
As a result both N-methylpiperazine, 120, and N,N’-dimethylpiperazine, 121, 
were initially screened for the aziridination of chalcone (Table 24). 
 
 
Entry
a
 R3N X Yield /%
b
 
1 NMM O 88 
2 120 NH 52 
3 121 NMe 71 
4 122 NTs 67 
a
 Reaction performed as detailed above on a 0.12 mmol scale; 
b
 Isolated yields after column 
chromatography purification. 
Table 24. Piperazine-Promoted Aziridination of Chalcone  
 
Utilising N-methylpiperazine (entry 2), only a moderate yield of aziridine was achieved 
(52%). This could potentially be explained by a competing amination of the secondary 
amine resulting in formation of a hydrazine which cannot affect aziridination. As 
previously discussed, it has been demonstrated that tertiary amines are essential for 
efficient aziridination.(87) N,N’-Dimethylpiperazine (entry 3), which would circumvent 
this potential problem, afforded a significant increase in the yield of aziridine (71%). 
Piperazines, although more nucleophilic (wrt NMM), including N,N’-
dimethylpiperazine displayed lower reactivity than that of NMM (entry 3 vs. 1). This 
discrepancy between the promoters may lie in the leaving group ability of the promoter 
in the final ring closing step to form the aziridine (refer to 1.3.2), i.e. the more electron-
withdrawing morpholine is the more proficient leaving group. This result is consistent 
with previous observations, as earlier discussed. It was therefore envisaged that N-
protection of N-methylpiperazine with an electron-withdrawing moiety, for example a 
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tosyl (para-toluenesulfonyl) group, may render the piperazine a more effective 
promoter. N-Methylpiperazine was therefore tosylated, utilising para-toluenesulfonyl 
chloride under basic conditions, to afford 122 in good yield (75%). Screening of 
piperazine 122 afforded a good yield of aziridine (67%) (entry 5), but comparable to 
that when N,N’- dimethylpiperazine was employed (entry 4), and therefore offered no 
further support for this hypothesis. 
As an application of these results it was decided that (S)-2-methylpiperazine, 
123, would be transformed into its corresponding tertiary amine derivative, which could 
be screened for asymmetric induction (Scheme 78). It was hoped that protection could 
be selectively achieved with one equivalent of para-toluenesulfonyl chloride at the 4-N 
position due to a slight steric preference for protection at this position. Indeed, 
protection was achieved in near-quantitative yield (97%), with the 
1
H NMR spectrum 
indicating the presence of one compound (124), which via analysis of the integrals was 
mono-protected. Analysis of the shift values however did not allow unambiguous 
assignment of the site of protection and unfortunately the signal from the 1-NH 
exchangeable proton was not observed in either CDCl3 or D6-DMSO thus preventing 
the use of 2D NMR analysis for structure determination. However, analysis by X-ray 
crystallography clearly showed the desired selective 4-N tosyl protected piperazine 124. 
Reductive amination was achieved using Pearlman‟s catalyst, formaldehyde, acetic acid 
and H2(g) to afford chiral tertiary piperazine 125 in good yield (77%). 
 
 
Scheme 78. Synthesis of Chiral Piperazine 125 
 
Screening of piperazine 125 pleasingly afforded a good yield of chalcone aziridine 
(67%) with ee determined to be a promising 23% ((2R,3S)) by chiral HPLC analysis 
(Scheme 79). 
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Scheme 79. Screening of Chiral Piperazine 125 
 
2.2.4 Synthesis and Screening of Chiral 3-Substituted N-Methylmorpholines 
 
Encouraged by with the finding that chiral piperazine 125, bearing only a methyl group 
adjacent to the reacting tertiary N-centre, could afford moderate levels of asymmetric 
induction in the aziridination reaction, it was hoped that screening of various other 
chiral 1,4-heterocycles, namely morpholines, with substituents α-to-N may afford higher 
levels of asymmetric induction.  
The most efficient method for the construction of chiral 3-substituted 
morpholines with high enantiopurity is via the reaction of enantiopure amino alcohols 
with a vicinal two-carbon electrophile. Although 1,2-dihalo derivatives have been 
employed for this transformation,(183) low yields and side-reactions are often reported. α-
Halo acid halides have also been employed in a three-step procedure.(184) A recent report 
at this time of research highlighted the use of a stable diphenylvinyl sulfonium salt, 128, 
for this operation in a one step procedure, with high yields reported (Scheme 80).(185) 
This was selected as the method of choice for the synthesis of chiral 3-substituted N-
methylmorpholines. 
 
 
Scheme 80. Synthesis of Chiral 3-Substituted Morpholines Using a Vinylsulfonium Salt 
 
The requisite vinyl sulfonium salt 128 was available from 2-bromoethanol in 
three steps and was prepared following the reported literature procedures as outlined 
(Scheme 81) (it is worth noting that it has subsequently been shown that 
bromoethylsulfonium salt 127 can be used directly instead of vinylsulfonium salt 128 in 
the heterocycle formation step(186)). 
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Scheme 81. Synthesis of Diphenylvinylsulfonium Salt 128 
 
The preparation of 128 was reported to require careful attention. Reaction times for 
preparation of bromotriflate 126 must not exceed 10 min.; moreover, 126 is unstable 
and needs to be consumed immediately without further purification. Additionally, the 
elimination step en route to the synthesis of 128 again must not be left longer than 20 
min. in order to prevent the addition of water across the double bond of the product, and 
the reaction solvent must be immediately removed under vacuum. The product is 
reported to be stable but hygroscopic. The preparation of both 126 and 127 proceeded 
smoothly by following the reported conditions. However, synthesis of 128 was found 
not to be facile and was initially prepared in only a ca. 74% conversion from unreacted 
127. (although the addition of water to the product was not observed). Re-submission of 
this material to the reaction conditions achieved acceptable conversion (95%) and good 
yield (93% (combined)), providing multigram quantities of sulfonium salt 128. At this 
point a range of structurally diverse aminoalcohols, to provide morpholines with 3-aryl, 
3-alkyl and also 2,3-disubstitution were selected for coupling. N-Tosyl-protection of the 
aminoalcohols was required and this was uniformly achieved in excellent yield (88-
91%), via the use of para-toluenesulfonyl chloride and Et3N. Coupling then proceeded 
with vinyl sulfonium salt 128 to provide the desired morpholines in moderate-to-good 
yield (54-74%), including compounds 133 and 134 which were not described in the 
initial report (Table 25). 
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Entry
a
 Aminoalcohol Morpholine Yield /%
b
 
1 
  
74 
2 
  
54 
3 
  
74 
a
 Reaction performed on a 0.99-1.17 mmol scale; 
b
 Isolated yields after column chromatography 
purification. 
Table 25. Synthesis of 3-Substituted Morpholines 132-134  
 
In order to obtain the desired NMMs, tosyl deprotection followed by a reductive 
amination was required. A literature search revealed that sodium naphthalenide, 
commonly used for N-tosyl deprotection, had previously been employed for an N-tosyl 
morpholine deprotection.(187) However, attempted deprotection of 3-phenyl morpholine 
133 employing these conditions failed to facilitate the desired transformation. A further 
search of the literature revealed several other protocols for N-tosyl morpholine 
deprotection, including by Birch reduction, Red-Al (sodium bis(2-
methoxyethoxy)aluminumhydride) and HBr/AcOH.(188,189) Other common procedures for 
N-tosyl deprotection including reduction by SmI2 and Na/Hg amalgam were also 
selected.(190,191) At this point it was decided to utilise N-tosyl piperazine 122 as a test 
substrate; whilst cleavage of the sulfonamide was thought to be slightly less labile than 
that of an N-tosyl morpholine, this strategy allowed for preservation of the valuable 
chiral morpholines (Table 26). 
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Entry
a
 Conditions Yield
b
 
1 (a) Na/naphthalene, 1,2-DME, rt, 16 h NR, 68% RSM 
2 (b) 5% Na/Hg amalgam, Na2HPO4, MeOH, 70
o
C, 4 h  NR 
3 (c) SmI2, THF, rt 16h then pyrrolidine/H2O NR 
4 (d) Red-Al, PhMe, 80
o
C, 16 h NR, 62% RSM 
5 (e) 45% HBr/AcOH, rt, 16 h Partial deprotection 
a
 Performed on a 0.13-0.20 mmol scale, 
b
 NR = no reaction, RSM = recovered starting material. 
Table 26. Deprotection of Model Substrate 122 
 
As can be seen, N-tosyl piperazine 122 proved inert under most conditions employed, as 
indicated by TLC analysis and with quantitative recovery of starting material not always 
observed. However, upon exposure of 122 to 45% HBr/AcOH the cleaved tosyl by-
product was observed in the 
1
H NMR spectrum of the crude reaction thus indicating a 
degree of deprotection had occurred. As a result these conditions were subsequently 
applied to the deprotection of morpholines 132-134 (Table 27). 
 
 
Entry
a
 Substrate T / 
o
C t /h Yield /%
b
 RSM /%
b
 
1 133 rt 16 quant. - 
2 134 rt 16 26 52 
3 134 50 24 56 24 
4 134 110 16 47 0 
5 132 rt 16 0 quant. 
6 132 110 24 82
c
 0 
a
 Reaction performed on a 0.08-0.24 mmol scale; 
b
 Isolated yield after flash column chromatography, 
c
 
Characterised as the TFA salt. 
Table 27. Deprotection of Morpholines 132-134 using 45% HBr/AcOH 
 
3-Phenyl substituted morpholine 133 proved to be the most labile compound to undergo 
deprotection and pleasingly could be deprotected under these conditions in quantitative 
yield. Morpholines 134 and 132 required progressively more forcing conditions 
respectively, but eventually all N-tosyl morpholines could be deprotected in acceptable 
98 
 
yields. Following successful deprotection NH-morpholines 135-137 were transformed 
to their NMM counterparts via a reductive amination, employing conditions that had 
been previously successfully applied to morpholine reductive aminations in the course 
of this project (Scheme 82). NMMs 138-140 were synthesised in moderate-to-good 
yield and could therefore be screened as promoters for asymmetric aziridination. 
 
 
Scheme 82. Reductive Amination to Afford NMMs 138-140 
 
2.2.4.1 Screening of Morpholines 138-140 
 
Morpholines 138-140 were screened according to the standard conditions previously 
developed when using NMM as a promoter as detailed (Table 28). 
 
 
Entry
a
 Morpholine Yield /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 138 40 30 2R,3S (-) 
2 139 <5 - - 
3 140 47 27 2R, 3S (-) 
a
 Reaction performed on a 0.04-0.10 mmol scale; 
b
 Isolated yields after column chromatography 
purification; 
c
 Enantiomeric excess (ee) measured by HPLC analysis; 
d
 Configuration of major enantiomer 
determined by comparison to the literature.
(192)
 
Table 28. Asymmetric Aziridination of Chalcone with Chiral NMMs 138-140 
 
As can be seen, both 3-
i
Pr-substituted morpholine 138 and tricyclic oxazine 140 
promoted the aziridination of chalcone in moderate yield and with moderate levels of 
ee. Disappointingly, 3-phenyl substituted morpholine 139 failed to promote the reaction 
to any measurable degree. This latter result could again be potentially attributed to an 
increased steric bulk α-to-nitrogen, in a similar manner to chiral N-pendant morpholine 
112 which bears this same α-Ph relationship. It was decided to employ the previously 
developed quantitative amination aziridination conditions [i.e. DppONH2 (2 eq.), NaOH 
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(3 eq.)] with 139, with the hope of promoting the reaction to some extent. Whilst 
amination could be achieved in 91% conversion, disappointingly morpholine 139 still 
failed to promote the aziridination reaction. 
 
2.2.5 Summary of Chiral 1,4-Heterocycle-Promoted Aziridination 
 
Whilst a diverse range of chiral 1,4-heterocycle promoters have been synthesised, via 
various strategies, their screening results for the asymmetric aziridination of chalcone in 
general displayed low levels of asymmetric induction and often poor levels of reactivity. 
Their results are summarised below (Table 29). However from the results conclusions 
can be drawn into the relationship between the structure of the promoter and the 
observed reactivity, namely: 
i. N-Substitution, other than small linear alkyl substituents, is not well 
tolerated. α-Branching severely impairs reactivity levels. 
ii. α-Substitution on the heterocyclic ring can be tolerated but as steric bulk 
increases at this position, reactivity is again severely impaired. 
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Entry
a
 Promoter Yield Aziridine /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 
 
<5 - - 
2 
 
5 14 3R,2S (+) 
3 
 
<5 - - 
4 
 
12 <5 3R,2S (+) 
5 
 
67 23 2R,3S (-) 
6 
 
40 30 2R,3S (-) 
7 
 
<5 - - 
8 
 
47 27 2R,3S (-) 
a
 Reactions performed on a 0.04-0.24 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis (conditions: 93:7 hexane:IPA, 
0.8 mL/min., 254 nm, AD-H) (3R,2S, tR = 16.0 min., 2R,3S, tR = 18.8 min.); 
d
 Configuration of major 
enantiomer is determined by comparison to the literature.
(192)
 
Table 29. Summary of Chiral 1,4-Heterocycle-Promoted Asymmetric Aziridination of Chalcone  
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2.3 Cinchona Alkaloid-Promoted Asymmetric Aziridination 
 
Since six-membered chiral 1,4-heterocycle promoters in general displayed low levels of 
asymmetric induction and often poor levels of reactivity, it was decided to pursue 
investigations with other chiral tertiary amines as promoters, with the overall aim of 
developing an asymmetric amine-promoted alkene aziridination. As discussed in 
Section 1.3.4 a range of different classes of chiral tertiary amine have been previously 
screened, but owing to the fact that quinine (and its derivatives) have thus far afforded 
highest levels of asymmetric induction, focus was directed to this class of promoter.  
 
2.3.1 Previous Studies 
 
Previous screening has shown quinine to afford a good yield and moderate levels of 
enantioselectivity for the aziridination of chalcone (64%, 56% ee) (Scheme 83). As 
discussed previously, the optimal conditions, in terms of yield and ee, were found to be 
obtained using NaH/
i
PrOH as the base with CH2Cl2 as the reaction solvent, in contrast 
to NaOH/MeCN which is optimal for the NMM system.(87) 
 
Scheme 83. Asymmetric Aziridination of Chalcone with Quinine 
 
Quinine is a member of the cinchona alkaloids, isolated from the bark of the 
cinchona family of trees, and the most common members include the diastereoisomers 
quinine and quinidine, and cinchonidine and cinchonine (Figure 4). The alkaloids can 
be readily modified to produce a range of semi-synthetic derivatives which collectively 
are known to affect a wide range of asymmetric transformations.(193,194) The 
diastereomeric alkaloid pairs, which differ at the C8 and C9 centres, are described as 
„pseudoenantiomers‟ and significantly they usually provide the opposite enantiomers of 
a product.  
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Figure 4. Pseudoenantiomeric Cinchona Alkaloids 
 
Understandably, previous studies within our group have focussed upon the 
screening of various derivatives of quinine, the results are summarised below (Table 
30).(93,94) This included: commercially available pseudoenantiomer quinidine, the 
cinchonidine/cinchonine pair, various other commercially available derivatives and a 
variety of semi-synthetic derivatives. However, no previously screened alkaloid has 
been able to surpass the levels of asymmetric induction that has been achieved with 
quinine.  
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Entry R3N Yield /%
a
 ee /%
b
 Aziridine 
Enantiomer
c
 
1 quinine, 141 64 56 2R,3S (-) 
2 quinidine, 142  31 50 3R,2S (+) 
3 cinchonidine, 143 38 42 2R,3S (-) 
4 cinchonine, 144 42 41 3R,2S (+) 
5 hydroquinine, 145 49 50 2R,3S (-) 
6 hydroquinidine, 146 32 30 3R,2S (+) 
7 hydrocinchonine, 147 50 26 3R,2S (+) 
8 quincorine, 148 44 rac. - 
9 quincoridine, 149 85 rac. - 
10 quincorine-O-benzoate, 150 10 6 3R,2S (+) 
11 quinine-derived methyl ether, 151 8 7 2R,3S (-) 
12 quinidine benzyl ether, 152 10 9 3R,2S (+) 
13 cinchonidine benzyl ether, 153 9 28 3R,2S (+) 
14 hydroquinidine-9-phenanthryl ether, 154 15 10 3R,2S (+) 
15 hydroquinine-4-methyl-2-quinoyl ether, 155 6 27 3R,2S (+) 
16 hydroquinidine-4-methyl-2-quinoyl ether, 156 7 8 3R,2S (+) 
17 (DHQD)2PHAL, 157 10 <5 3R,2S (+) 
18 quinone, 158 16 <5 3R,2S (+) 
19 9-epiquinine, 159 28 11 3R,2S (+) 
20 9-epiquinine thiourea, 160 <5 - - 
21 9-acetamido-9-deoxyquinine, 161 <5 - - 
22 9-acetamido-9-deoxyepiquinine, 162 8 14 3R,2S (+) 
a
 Isolated yield after purification by column chromatography; 
b
 Enantiomeric excess (ee) measured by 
HPLC analysis (conditions: 93:7 hexane:IPA, 0.8 mL/min., 254 nm, AD-H) (3R,2S, tR = 16.0 min., 
2R,3S, tR = 18.8 min.), rac. = racemic; 
c
 Configuration of major enantiomer determined by comparison to 
the literature.
(192)
 
Table 30. Previous Results for the Asymmetric Aziridination of Chalcone with Various Cinchona 
Alkaloids 
 
As would be expected, the pseudoenantiomeric pairs of quinine/quinidine and 
cinchonidine/cinchonine provided the opposite aziridine enantiomers, with the 
quinine/quinidine pair, which possess the 6-methoxy group on the quinoline ring, giving 
higher ee (entries 1-4). The corresponding hydro derivatives of quinine, quinidine and 
cinchonine were less effective promoters in terms of both yield and ee compared to their 
parent vinyl derivatives (entries 5-7 vs. 1,2 and 4). The alkaloid pair quincorine and 
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quincoridine, devoid of the aromatic quinoline, both gave racemic products indicating 
the importance of this moiety in terms of asymmetric induction (entries 8 and 9). 
Interestingly, O-functionalisation of various alkaloids, via methylation, benzylation or 
arylation resulted in a dramatic decline in both yield and ee (8 examples, 6-15%, <5-
28% ee) suggesting a clear importance of the hydroxyl functionality (entries 10-17). 
Furthermore, oxidised quininone afforded both poor yields of aziridine and minimal 
levels of asymmetric induction (entry 18). In general the pseudoenantiomeric alkaloid 
pairs provided (as expected) the opposite enantiomer (entries 1 vs. 2, 3 vs. 4, 5 vs. 6) 
and other alkaloids, related to quinine (entry 11) and quinidine (entries 7, 12, 14, 16 and 
17) gave rise to the expected aziridine enantiomer. However, there are a few anomalous 
results where the opposite aziridine enantiomer would be expected, that at present have 
not been explained, although in each case yield and ee are poor (entries 10, 13 and 15). 
Epimerisation of the C9 hydroxyl of quinine reduced both the yield and ee significantly 
(28%, 11% ee) and also resulted in the opposite enantiomer to quinine (entry 19 vs. 1). 
Studies have also focussed on substitution of the hydroxyl moiety with a small number 
of hydrogen bond donors, but in general the derivatives displayed extremely poor 
activity as a promoter (entries 20-22). By summarising the results, a range of 
conclusions can be drawn regarding the structural requirements of the alkaloids that lead 
to higher levels of asymmetric induction: 
i. Alkaloids with the C8,C9 configuration of quinine give slightly higher levels 
of asymmetric induction than those of the quinidine configuration.  
ii. The aromatic moiety of the alkaloids is necessary for asymmetric induction. 
iii. The presence of the 6-methoxy substituent on the quinoline ring gives higher 
levels of asymmetric induction. 
iv. Unsaturation at the pendant C3 quinuclidine substituent leads to higher 
levels of asymmetric induction. 
v. Derivatization of the C9 hydroxyl functionality lowers both yield and 
asymmetric induction. 
Quinine satisfies these five points and as a result remains our optimal promoter to date. 
This wide background study though does provoke some further interesting questions: 
i. Does the decrease in yield and asymmetric induction upon removal of the 
hydroxyl functionality indicate the requirement of a hydrogen bond donor at 
this position in order to achieve efficient catalysis, via co-ordination to the 
enone substrate? 
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ii. Does the decrease in yield and asymmetric induction achieved with 9-
epiquinine indicate the requirement of the „natural‟ C9 configuration in order 
to achieve efficient catalysis? 
 
Consequently, studies outlined herein focussed upon addressing these points with the 
hope of finding a more efficient catalyst than quinine for asymmetric aziridination. It 
was decided that the first point could be addressed via synthesis of a range of cinchona 
alkaloid catalysts that possessed hydrogen bond donor functionalities at the C9 position 
of quinine. The second point was anticipated to be addressed via synthesis of the donor 
alkaloids with both the natural C9 and the C9-epi configuration of quinine.  
 
2.3.2 Commercial Compound Screening 
 
On review of the previous studies it was noted that several commercially available 
derivatives had not been screened and at this preliminary point, before studies 
commenced towards the synthesis of a range of C9 and C9-epi hydrogen bond donor 
alkaloids, these commercially available derivatives were obtained and subsequently 
screened for the asymmetric aziridination of model substrate chalcone. 
 The first derivatives screened, using the conditions previously developed for 
cinchona alkaloid-promoted asymmetric aziridination, were hydroquinine-4-
chlorobenzoate, 163, and also its pseudoenantiomeric partner hydroquinidine-4-
chlorobenzoate, 164, promoters absent of the C9 hydroxyl moiety (Table 31). 
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Entry
a
 R3N Yield /%
b
 ee /%
c
 Aziridine 
Enantiomer
d
 
1 hydroquinine-4-chlorobenzoate, 163 26 36 2R,3S (-) 
2 hydroquinidine-4-chlorobenzoate, 164  40 17 3R,2S (+) 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis; 
d
 Configuration of major 
enantiomer determined by comparison to the literature.
(192)
 
Table 31. Asymmetric Aziridination of Chalcone with Cinchona Alkaloids 163 and 164 
 
Hydroquinine-4-chlorobenzoate, 163, and hydroquinidine-4-chlorobenzoate, 164, 
afforded low yields of 26% and 40% and with low ee, determined to be 36% ee and 
17% ee, respectively and were, as expected, each selective for the opposite aziridine 
enantiomer. The results again highlight that cinchona alkaloids with the C8,C9 
configuration of quinine give a slightly higher level of asymmetric induction that those 
of the quinidine configuration (cf. Table 30). Their results can be compared to those of 
their free-hydroxy derivatives hydroquinine, 145, (49%, 50% ee, (2R,3S)) and 
hydroquinidine, 146, (32%, 30% ee (3R,2S)) respectively, which provide slightly higher 
levels of asymmetric induction than 163 and 164. However, close inspection of the 
reaction mixtures using 163 and 164 revealed that an additional compound was present 
in both of the crude reaction mixtures (and also observed by TLC). The compound was 
subsequently determined, by both 
1
H NMR
 
spectroscopy(195) and GCMS analysis, to be 
4-chlorobenzoic acid isopropyl ester, which is likely formed by transesterification of the 
promoters with the isopropoxide base, which would reveal hydroquinine and 
hydroquinidine. Therefore, as a result of the lability of the benzoyl group little can be 
inferred with respect to the importance of the C9 hydroxyl moiety from these results.   
The second set of derivatives obtained and screened were the dimeric cinchona 
alkaloids (DHQ)2AQN, 165, and (DHQD)2AQN, 166 (Table 32). (DHQD)2PHAL, 157, 
has previously been screened but with poor results obtained (10%, 16% ee). It had been 
postulated that this may be due to competitive amination at the nucleophilic N-centre of 
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the aromatic phthalazine moiety. Since aromatic tertiary amines do not promote the 
aziridination (see Section 1.3.2),(87) this would simply result in unproductive 
consumption of the aminating agent. Therefore, it was hoped that the AQN compounds, 
devoid of the phthalazine, may prove more successful. 
 
 
Entry
a
 R3N Yield /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 (DHQ)2AQN, 165 <5 - - 
2 (DHQD)2AQN, 166  <5 - - 
a
 Reactions performed on a 0.12 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis; 
d
 Configuration of major 
enantiomer determined by comparison to the literature.
(192)
 
Table 32. Asymmetric Aziridination of Chalcone with Cinchona Alkaloids 165 and 166 
 
However, both compounds proved to be poorly active, with no more than trace amounts 
of aziridine observed. It can therefore be concluded that their poor results, and that of 
(DHQD)2PHAL, are likely as a result of the removal of the hydroxyl functionality 
which is in agreement with previous observations that etherified cinchona alkaloid 
derivatives are less active than their free-hydroxyl analogues (Table 30). 
 
2.3.3 Synthesis and Screening of Cinchona Alkaloid Hydrogen Bond Donor 
Derivatives 
 
Studies then turned to the synthesis and screening of various cinchona alkaloids, related 
to quinine, which possessed hydrogen bond donor moieties at the C9 centre, both with 
the natural C9 and epi-C9 configuration. It was hoped this focus would determine 
whether efficient catalysis required both the following; i. a hydrogen bond donor group 
at the C9 position of the alkaloid, and ii. the „natural‟ quinine-like C9 configuration. 
Indeed, previous postulates have considered whether the C9 hydroxyl is able to co-
ordinate the carbonyl O of the enone substrate;(93) in a similar manner Jørgensen has 
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postulated this mode as a transition state for aza-Michael additions of hydrazones to 
cyclic enones promoted by various cinchona alkaloids.(196)  
Previous studies, as outlined in Table 30, have screened both quinine, 141, and 
9-epiquinine, 159, and also a select number of alternative hydrogen bond donor 
derivatives related to quinine (Scheme 84).(93) 
 
Scheme 84. Previous Hydrogen Bond Donor Alkaloids Screened for the Asymmetric Aziridination 
of Chalcone 
 
As discussed use of 9-epiquinine, 159, the epimer at the C9 hydroxyl, reduces both the 
yield and ee of the aziridine significantly (28%, 11% ee vs. 64%, 56% ee) and also 
forms the opposite enantiomer to quinine. Both the natural and 9-epi acetamide 
derivatives were poor promoters of the reaction, with 161 not promoting the reaction 
and 9-epi derivative 162 providing the aziridine in very low yield and poor ee (8%, 14% 
ee), with the expected same sense of asymmetric induction to 9-epiquinine. The thiourea 
derivative, 160, which, along with closely related derivatives, has received considerable 
interest as a „bifunctional organocatalyst‟ (which contains both Lewis basic tertiary 
amine and hydrogen bond donor moieties) and has been employed for a range of highly 
asymmetric transformations (including conjugate additions),(197) was unable to promote 
aziridination, which may be due to competitive S-amination.(93) 
Based on these results it was decided to select C9 and C9-epi primary amine 
derivatives, since the primary amine donor moiety is of a similar steric size to the 
hydroxyl functionality of quinine, and also sulfonamide derivatives since these provide 
a strong donor ability, for potential hydrogen bond donor alkaloids promoters (Figure 
5). 
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Figure 5. Cinchona Alkaloid Hydrogen Bond Donor Derivatives Selected for Synthesis 
 
2.3.3.1 Synthesis of C9-Epi Derivatives 
 
Initially the 9-epi amino and sulfonamide derivatives were selected for study with 9-
amino-9-deoxy-epiquinine, 167, the first target. Primary amine salts of 167 have 
recently attracted substantial interest in the field of organocatalysis and have been 
applied in several highly asymmetric transformations, including the epoxidation of both 
cyclic(198) and acyclic(199) aliphatic enones where they are believed to act as typical 
aminocatalysts. Amine 167 is obtained via a Mitsunobu inversion of quinine with 
diphenyl phosphoryl azide (DPPA) followed by Staudinger azide reduction, conditions 
reported by Brunner.(200) Synthesis of 167 was undertaken and proceeded smoothly 
following the reported conditions, allowing gram quantities of the amine to be obtained 
(Scheme 85). 
 
 
Scheme 85. Synthesis of 9-Amino-9-deoxyepiquinine, 167 
 
The novel 9-epi-para-toluenesulfonamide derivative 168 was also selected for 
screening and synthesis proceeded from amine 167, using para-TsCl and K2CO3, 
providing the compound in good yield (69%) (Scheme 86). 
 
Scheme 86. Synthesis of 9-Epi-para-toluenesulfonamide Cinchona Alkaloid 168 
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Interestingly, 168 displayed atropisomerism. The steric barrier to rotation in the 
compound was sufficiently high to allow detection of two individual compounds, in a 
1.5:1 ratio at rt by 
1
H NMR spectroscopy. However, by preforming elevated 
temperature 
1
H NMR spectroscopy (at 130
o
C in 1,1,2,2-CD2Cl4) full coalescence was 
observed allowing ready characterisation of the compound. Initial molecular modelling 
suggested that the two low energy conformers (Δ 1.5 kJ mol-1) occurred due to 
restricted rotation around the C9-C4‟(quinoline) axis.(201) At the time of study, to the best 
of our knowledge, there were no reports of any 9-epiamino-9-deoxy sulfonamide 
cinchona alkaloids that were related to quinine in the literature; however, after the 
preparation of 168, related examples were reported by Song and co-workers, who used 
them for the highly enantioselective desymmetrization of various cyclic anhydrides with 
methanol. These compounds also displayed atropisomerism.(202-204) 
The novel 9-epi-methanesulfonamide derivative 170 was also selected for 
screening. However, its attempted synthesis, in a similar manner to 168, employing 
MsCl under basic conditions proved extremely problematic, with both low recovery of 
material and incomplete conversion of starting material. As a result an alternative 
strategy towards its synthesis was investigated, based upon a Mitsunobu reaction. 
However, the so called “pKa restriction” of the Mitsunobu reaction (whereby 
nucleophiles employed necessitate an acidic hydrogen of pKa ca. <11),
(205) prevents use 
of certain sulfonamides; moreover, the Mitsunobu conditions also fail in the alkylation 
of primary sulfonamides, para-toluenesulfonamide for example, has been shown to 
form Ph3P=NTs.
(206) A common solution to both these problems is to employ N-Boc 
protected sulfonamides,(207) and as a result it was decided to use the N-Boc-protected 
methanesulfonamide 169 for the synthesis of 170. Synthesis of the N-Boc-protected 
methanesulfonamide Mitsunobu nucleophile 169 was accessed in good yield, via simple 
N-Boc protection of methanesulfonamide, following a literature procedure (Scheme 
87).(208) 
 
 
Scheme 87. Synthesis of N-Boc Sulfonamide 169 
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Quinine was subsequently exposed to Mitsunobu conditions using N-Boc-
methanesulfonamide, 169, allowing the 9-epi product to be obtained in moderate yield. 
N-Boc deprotection with TFA followed to afford the novel 9-epi-methanesulfonamide 
cinchona alkaloid 170 (Scheme 88). 
 
Scheme 88. Synthesis of 9-Epi-methanesulfonamide Cinchona Alkaloid 170 
 
In a similar manner to sulfonamide 168, 170 also displayed atropisomerism with a 1.8:1 
ratio of compounds detected at rt by 
1
H NMR spectroscopy. However, upon iterative 
elevated temperature 
1
H NMR spectroscopy only partial resonance coalescence was 
observed which was accompanied by significant compound decomposition. At this 
stage, before the potential preparation of further derivatives, it was decided to synthesise 
the „natural‟ hydrogen bond donor alkaloid series. 
  
2.3.3.2 Synthesis of C9-‘Natural’ Derivatives 
 
In order to complement the C9-epi series of hydrogen bond donor alkaloids the natural 
derivatives (of C9 quinine configuration) were also to be synthesised and screened. 
Their synthesis required a double C9 inversion from quinine. The first proceeds via the 
synthesis of 9-epiquinine, 159, which can be achieved from quinine via hydrolysis of its 
mesylate, 171, using conditions reported by Hoffmann.(209) The synthesis of 9-epiquinine 
consequently followed these conditions and was prepared in excellent yields on a 
multigram scale (Scheme 89). 
 
 
Scheme 89. Synthesis of 9-Epiquinine, 159 
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It is interesting to review the literature with regards to the preparation of similar 
cinchona alkaloid derivatives, via C9 inversion strategies. Cinchona alkaloids have 
received considerable interest for their use in a range of asymmetric transformations, 
being employed as ligands, PTCs, aminocatalysts and chiral bases, for example.(193,194) 
However, they have also received significant recent attention as bifunctional 
organocatalysts, with a number of novel synthetic derivatives reported over the past 
decade or so.(197,210,211) There are numerous examples of the natural-to-epi C9 inversion 
(for instance several examples have been presented in this thesis), and these 9-epi 
derivatives are often competent asymmetric organocatalysts. However, there is limited 
literature available for the epi-to-natural C9 inversion and the outcome of latter this 
transformation is not quite so obvious, with several examples of 9-epiquinine 
derivatives undergoing nucleophilic substitution with retention (i.e. C9-epi-to-epi).(209,212) 
9-Amino-9-deoxy-quinine 172, which to the best of our knowledge had not been 
described in the literature, was selected as the first target and required the epi-to-natural 
C9 inversion. Several attempted syntheses from 9-epiquinine by following the protocols 
adopted for the synthesis of the corresponding 9-epi-amino-derivative 167 surprisingly 
failed to afford any detectable traces of the desired compound 172 (Scheme 90). 
However, a side-product, subsequently identified as alkene 173, was isolated in 
significant yield (47%), which was presumably formed via elimination of the 
intermediate oxyphosphonium ion. Although undesired, alkene 173 could also be 
screened as a novel promoter for aziridination.  
 
Scheme 90. Formation of Alkene 173 via Attempted Synthesis of 172 
 
As an alternative strategy to access 172, 9-epiquinine mesylate, 174, was synthesised in 
order to attempt a nucleophilic displacement with sodium azide which could then be 
reduced to desired amine 172. However, attempted substitution with sodium azide, with 
in situ Staudinger reduction, also failed to provide the desired amine (Scheme 91). 
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Scheme 91. Attempted Synthesis of 172 from 9-Epiquinine Mesylate 174 
 
Despite the perceived difficulty in the desired synthesis of amine 172 via the epi-to-
natural C9 inversion, further experimentation found that the crucial factor for the 
Mitsunobu inversion seemed to be that after addition of the azide (DPPA), prolonged 
heating was necessary and pleasingly this allowed, albeit in low yield (22%), the 
synthesis of 172 (Scheme 92). 
 
 
Scheme 92. Synthesis of 172 
 
With 172 in hand the novel 9-para-toluenesulfonamide derivative 175 was also 
synthesised, in a similar manner to the synthesis of 168 using para-TsCl and K2CO3, 
providing the compound in good yield (71%), which incidentally did not exist in 
rotameric forms, unlike 168 (Scheme 93). 
 
 
Scheme 93. Synthesis of Sulfonamide 175 
 
With limited material of 172 in hand, at this point it was decided to screen all current 
cinchona hydrogen bond donor derivatives before potential further synthesis of 
derivatives. 
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2.3.3.3 Screening of Cinchona Alkaloid Hydrogen Bond Donor Derivatives 
 
All C9 and C9-epi amino and sulfonamide derivatives as well as elimination product 
173 were screened for the aziridination of chalcone, using the procedures previously 
developed for cinchona alkaloid-promoted asymmetric aziridination (Table 33). 
 
 
Entry
a
 R3N X C9 Configuration Yield /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 167 H Epi 62 <5 3R,2S (+) 
2 170  Ms Epi <5 - - 
3 168 Ts Epi <5 - - 
4 173 elimination product <5 - - 
5 172 H Natural (quinine-like) 42 35 3R,2S (+) 
6 175 Ts Natural (quinine-like) <5 - - 
a
 Reactions performed on a 0.04-0.14 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis; 
d
 Configuration of major 
enantiomer determined by comparison to the literature.
(192)
 
Table 33. Asymmetric Aziridination of Chalcone with Hydrogen Bond Donor Cinchona Alkaloids 
 
The 9-epiquinine derivatives were initially screened. 9-Amino-9-deoxyepiquinine, 167, 
was found to promote aziridination in good yield (62%), indeed to the same level as 
quinine, although ee was poor (<5% ee) (entry 1). The poor ee for this 9-epi derivative 
is also in accordance with both 9-epiquinine, 159 (11% ee), and 9-epi acetamide 162 
(14% ee); all three 9-epi derivatives also show the same sense of asymmetric induction 
(3R,2S), opposite to quinine (2R,3S). The site of amination with 167 was also a point of 
interest since it has previously been shown that primary amines (and indeed aromatic 
tertiary amines) do not function as successful promoters (see Section 1.3.2).(87) 
Amination of 167 was probed by 
1
H NMR spectroscopy, in a similar manner to 
morpholines 112-117 (Table 21), which after 30 min. (to replicate reaction conditions) 
was determined at 48%. Utilising a second equivalent of DppONH2 and increasing 
reaction time to 16 h afforded full amination. Analysis of the change in chemical shifts 
indicated (as expected) amination at the nucleophilic quinuclidine nitrogen moiety. 9-
Episulfonamide derivatives 170 and 168 both failed to promote the reaction to any 
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detectable extent (entries 2 and 3). Alkene 173 also failed to promote aziridination 
(entry 4). 9-Amino-9-deoxyquinine, 172, of the same natural configuration to quinine, 
promoted the reaction in moderate yield (42%) and with also moderate levels of ee 
(35% ee) (entry 5). However, 172 unexpectedly showed the opposite sense of 
asymmetric induction to quinine (both are C9 natural), i.e. 172 showed the same sense 
of induction as the 9-epiquinine derivatives. In a similar manner to 9-episulfonamides 
170 and 168, „natural‟-C9 sulfonamide, 175, also failed to promote aziridination (entry 
6), including when the reaction was conducted with an extra equivalent of DppONH2 
and base (2 eq. and 3 eq. respectively). 
In general, the hydrogen bond donor alkaloids displayed low levels of reactivity. 
However, the results obtained for sulfonamides  170, 168 and 175, all which possess a 
sterically bulky C9 hydrogen bond donor moiety, are in accordance with previous 
cinchona alkaloid quinine-derivatives (151, 153, 155 and 165, and indeed also O-
functionalised quinidine derivatives), where derivatization of the C9 hydroxyl 
functionality by (often sterically bulky) etherification lowered both yield and 
asymmetric induction. Furthermore, the results are also in accordance with the low 
yields obtained with acetamides 161 and 162, again sterically bulkier hydrogen bond 
donor groups than a hydroxyl. Additionally, free amines 167 and 172, of similar steric 
size to the hydroxyl, do not seem to provide any distinct advantages in terms of 
asymmetric induction. Taken together these results all seem to indicate a negligible role 
of the hydroxyl functionality in terms of a hydrogen bond donor. It is believed that the 
failure of etherified derivatives, the acetamide and sulfonamide hydrogen bond donor 
alkaloids can be attributed to the fact that they simply possess groups in close proximity 
to the reacting quinuclidine N-centre (β-to-N) that are sterically too bulky. The low 
levels of observed asymmetric induction may be a result of an alteration in the promoter 
conformation. 
The role of the C9 configuration is less clear but it is notable that all 9-
epiquinine derivatives screened thus far display low levels of asymmetric induction in 
the reaction. The C9 natural alkaloids, quinine and 9-amino-9-deoxyquine, 172, both 
display significantly higher levels of asymmetric induction than their 9-epi derivatives 
but give an unexpected opposite sense of induction to one another. It is likely that firm 
conclusions with regards to the role of the C9 centre can only be drawn after further C9 
derivative screening.  
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2.3.4 Screening of 9-Fluoro-9-Deoxy Quinine Derivatives 
 
An interesting derivatization of a variety of cinchona alkaloids was recently reported by 
Gilmour. Treatment of certain cinchona alkaloids with diethylaminosulfur trifluoride 
(DAST) afforded a number of fluorinated derivatives, including both C9 fluoro epimers, 
176 and 177, and also a further ring-expanded derivative 177 (Scheme 94).(213) 
 
 
Scheme 94. Fluorinated Cinchona Alkaloids Obtained by Treatment of Quinine with DAST 
 
Investigations undertaken at this time by an Undergraduate co-worker led to the 
preparation and screening of several derivatives,(214) which generally displayed 
extremely low reactivity. Whilst these investigations led to the synthesis and screening 
of 9-fluoro-9-deoxyepiquinine, 177, its natural C9-epimer, 176, could not be prepared 
for direct comparison. However, by kind donation from the Gilmour laboratories, C9-
fluorinated epimers, 176 and 177, derived from quinine were obtained. Both derivatives 
were then screened for the aziridination of chalcone (Table 34). 
 
 
Entry
a
 R3N C9 Configuration Yield /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1
e
 177 Epi 8 10 3R,2S (+) 
2 176 Natural <5 - - 
a
 Reactions performed on a 0.04 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis; 
d
 Configuration of major 
enantiomer determined by comparison to the literature;
(192)
 
e
 Result previously obtained by a co-
worker.
(214)
 
Table 34. Asymmetric Aziridination of Chalcone with Fluorinated Cinchona Alkaloids 
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The fluorinated 9-epi alkaloid, 177, promoted aziridination in very low yield (8%) and 
in accordance with all previously screened 9-epiquinine derivatives, very low levels of 
asymmetric induction were observed (10% ee, selective as expected for the 3R,2S 
enantiomer) (entry 1). Disappointingly, the C9-natural fluoro derivative, 176, failed to 
provide the aziridine in more than trace amounts (entry 2). It may be that the presence 
of the β-fluorine reduces electron density sufficiently at the reacting quinuclidine N-
centre to diminish nucleophilicity, accounting for the poor levels of reactivity with both 
examples. Unfortunately, due to lack of material it was not determined whether this 
affected the initial amination of the promoter or the conjugate addition of the 
corresponding aminimine to the substrate. 
 
2.3.5 Synthesis and Screening of Rigid Cinchona Alkaloids 
 
Considering further derivatization of the cinchona alkaloid motif, we were interested in 
derivatives that may be less conformationally flexible but yet without presenting undue 
steric hindrance around the reacting quinuclidine N-centre, which was believed to be a 
problem (as discussed) when the C9 moiety is functionalised. Although there are limited 
options for this, one potential cinchona alkaloid derivative considered was β-
isocupreidine (β-ICD), 179, which possesses a rigid tricyclic structure with the C9 
centre twisted away from the quinuclidine N. It is considered a typical bifunctional 
chiral organocatalyst and in 1999 was described for a highly enantioselective Morita-
Baylis-Hillman reaction by Hatakeyama,(215) who showed that both the phenolic OH and 
tricyclic framework were necessary to achieve high levels of asymmetric induction as 
well as rate acceleration.(215,216) Consequently β-ICD and its derivatives have been shown 
to be effective catalysts in a range of highly asymmetric transformations.(217) 
β-ICD is obtained from quinidine, 142, via heating at reflux in acid and 
improved procedures for its synthesis were described by Hatakeyama.(216) The process 
not only promotes the cyclization but also demethylates the 6-methoxy group to afford 
the hydroxyl moiety. Keen to synthesise and screen this alkaloid derivative, β-ICD was 
accordingly prepared, in a yield of 54% (lit.(216) 61%), by following the reported 
procedures (Scheme 95). 
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Scheme 95. Synthesis of β-Isocupreidine, 179 
 
β-ICD was then screened for the aziridination of chalcone (Scheme 96): 
 
Scheme 96. Asymmetric Aziridination of Chalcone with β-Isocupreidine, 179 
 
Disappointingly, the compound promoted the reaction in only moderate yield (28%) and 
with only 5% ee. Quinidine, 142, its parent compound, promotes the reaction in a 31% 
yield with 50% ee
 
(Table 30) and it should also be noted that β-ICD shows a very slight 
preference for formation of the 2R,3S enantiomer, the opposite enantiomer to that of 
quinidine. However, under the reaction conditions the phenolic moiety of β-ICD is 
likely to be deprotonated (for ca. comparison, pKa 2-napthol = 9.5, pKa 
i
PrOH = 17.1) 
and this competing deprotonation with the desired deprotonation of the hydrazinium salt 
may have an effect on the subsequent reactivity of the alkaloid. Therefore, in order to 
alleviate the potential problem of the acidic phenolic proton it was decided to synthesise 
the β-ICD methyl ether, 180. Moreover, this would also present a derivative that has 
closer resemblance to quinidine, which also possesses the 6-methoxy group. Initial 
efforts to promote methylation, via exposure of β-ICD to NaH and reaction with either 
MeI or the more reactive methylating agent Me2SO4, however failed to provide the 
desired product, affording only a complex mixture in both instances (Scheme 97). 
 
 
Scheme 97. Attempted Synthesis of β-Isocupreidine Methyl Ether, 180 
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As a result an alternative reagent was sought to afford the desired transformation and 
trimethylsilyldiazomethane (TMSCHN2) was selected. Following reported conditions 
for the alkylation of a phenolic moiety,(218) the desired transformation was pleasingly 
achieved in a moderate yield (43%) (Scheme 98). 
 
 
Scheme 98. Synthesis of β-Isocupreidine Methyl Ether, 180, using TMSCHN2 
 
β-ICD methyl ether, 180, was then screened for the aziridination of chalcone (Scheme 
99): 
 
Scheme 99. Asymmetric Aziridination of Chalcone with β-ICD Methyl Ether, 180 
 
Upon screening, 180 showed a substantial increase in both yield and ee of the aziridine 
and whilst both are moderate they are in significant contrast to that of β-ICD (54%, 37% 
ee vs. 28%, 5% ee respectively). Encouraged by this result we were also keen to screen 
further O-alkyl β-ICD derivatives, including the sterically bulkier aromatic O-benzyl 
ether, 181. Synthesis of the novel derivative was accomplished with benzyl bromide, 
using NaH with TBAI, albeit in poor yield (20%) but sufficient compound was obtained 
for screening (Scheme 100). 
 
 
Scheme 100. Synthesis of β-ICD Benzyl Ether, 181 
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β-ICD benzyl ether, 181, was then screened for the aziridination of chalcone (Scheme 
101): 
 
Scheme 101. Asymmetric Aziridination of Chalcone with β-ICD Benzyl Ether, 181 
 
The sterically bulkier β-ICD benzyl ether, 181, in comparison to methyl ether 180, 
again provided a moderate yield (47%) and although again moderate, the ee (43% ee) 
was found to be slightly higher and approaches the level of asymmetric induction 
achieved with quinidine (50% ee). The results obtained for the aziridination of chalcone 
by both β-ICD methyl and benzyl ethers are also notable since they provide further 
evidence that the presence of a C9-hydrogen bond donor moiety in the cinchona 
alkaloids may not be necessary to achieve significant levels of asymmetric induction 
(wrt quinine). Keen to access further sterically bulkier derivatives synthesis of the novel 
O-
t
BuPh2Si-β-ICD 182 derivative was considered. This derivative again, like the benzyl 
ether 181, possesses aromatic phenyl groups which may provide some advantage in 
terms asymmetric induction through potential substrate-catalyst aromatic-aromatic 
interactions. Concerned by the lability that a primary TBDPS group had previously 
shown with NaOH when NMM 97 was screened as a promoter (Scheme 67), it was 
decided to synthesise O-2-
t
BuPh2Si-naphthol as a structurally similar model to 182 in 
order to examine stability of the functionality to the reaction conditions. Silyl protection 
of 2-naphthol was accomplished, using 
t
BuPh2SiCl with imidazole in DMF, in good 
yield (79%). This derivative was then exposed to NaH/
i
PrOH in CH2Cl2 for 16 h in 
order to replicate the conditions for cinchona-alkaloid promoted asymmetric 
aziridination and pleasingly the silyl ether was recovered in quantitative yield with no 
signs of deprotection. Accordingly, synthesis of O-
t
BuPh2Si-β-ICD 182 was attempted 
(Scheme 102), utilising the same conditions for the protection of 2-naphthol (Eq. A). 
Although employment of these conditions failed to afford any detectable signs of the 
desired product, increasing the equivalents of 
t
BuPh2SiCl (from 1.1 to 4.0 eq.) and 
imidazole (2.0 to 6.0 eq.) pleasingly afforded the desired product 182 in near 
quantitative yield (96%) (Eq. B).  
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Scheme 102. Synthesis of O-
t
BuPh2Si-β-ICD, 182 
 
Silyl ether 182 was then screened for the asymmetric aziridination of chalcone (Scheme 
103). 
 
Scheme 103. Asymmetric Aziridination of Chalcone with β-ICD TBDPS Ether, 182 
 
However, 182 disappointingly only promoted the aziridination of chalcone in both a low 
yield and ee (17%, 20% ee). Moreover, the catalyst surprisingly seemed to undergo 
decomposition, as observed by both TLC and analysis of the 
1
H NMR spectrum of the 
crude reaction mixture. Deprotection would reveal β-ICD, which showed only minimal 
levels of asymmetric induction and it is likely that the low ee observed with 182 can be 
accounted for by its decomposition. 
 At this point, due to consumption of β-ICD and coupled with time constraints, 
further investigation of β-ICD derivatives was not pursued. However, further 
derivatization of β-ICD could lead to potentially interesting promoters related to 
catalysts that have previously been described for several highly enantioselective 
transformations. For example, Deng has previously outlined a three-step synthesis (43% 
overall) to amine 183 (Scheme 104).(219) This amine could not only be screened but 
could readily be converted to further amine, sulfonamide and also amide(220) derivatives 
for screening. 
 
122 
 
 
Scheme 104. Potential β-ICD Derivatives Suggested for Future Synthesis and Screening 
 
2.3.4 Investigations into the Relationship between Substrate and Observed 
Enantioselectivity with Quinine 
 
2.3.4.1 Previous Substrate Screening  
 
Previous studies have screened a range of electron-rich and -poor chalcones with 
quinine and surveyed the relationship between substrate structure and observed ee.(93) A 
representative summary is presented below (Table 35): 
 
 
Entry R
1
 R
2
 Yield /%
a
 ee %
b,c
 
1 H H 64 56 
2 MeO H 35 55 
2 Me H 55 52 
4 Cl H 54 48 
5 NO2 H 43 37 
6 H MeO 48 66 
7 H Me 68 59 
8 H Cl 62 46 
9 H NO2 <5 25 
a
 Isolated yield after purification by column chromatography; 
b
 Enantiomeric excess (ee) measured by 
HPLC analysis; 
c
 Configuration of major enantiomer assigned 2R,3S in analogy to the aziridination of 
chalcone with quinine.  
Table 35. Asymmetric Aziridination of Electron-Rich and -Poor Chalcones with Quinine 
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As shown the observed levels of asymmetric induction are consistently higher for 
substrates that possess electron donating groups, either at the β-aromatic (entries 2-5) or 
at the ketone aromatic, where the effect is more pronounced (entries 6-9). A variety of 
enones that possessed electron rich heteroaromatics at the ketone have also been 
screened in order to probe this latter effect further (Table 36).(93) 
 
 
Entry R Yield /
a
 ee /
b,c
 
1 2-furyl 41 71 
2 2-thiophenyl 47 72 
3 4-methyl-2-thiphenyl 46 77 
4 5-chloro-2-thiophenyl 27 64 
a
 Isolated yield after purification by column chromatography; 
b
 Enantiomeric excess (ee) measured by 
HPLC analysis; 
c
 Configuration of major enantiomer assigned 2R,3S in analogy to the aziridination of 
chalcone with quinine. 
Table 36. Asymmetric Aziridination of Heteroaromatic-Substituted Enones with Quinine 
 
Again, as shown, the observed levels of asymmetric induction indicate that varying the 
substituent at the ketone with an electron rich aromatic leads to higher levels of 
asymmetric induction (up to 77% ee) (entries 1-4).  
 
2.3.4.2 Proposed Transition State Model 
 
The combined results in Table 35 and Table 36, coupled with the fact that the aromatic 
moiety of the cinchona alkaloids is necessary for asymmetric induction (Table 30), 
support the notion that aromatic-aromatic substrate-catalyst interactions between the 
quinoline ring of quinine and the aromatic adjacent to the ketone of the substrate are 
important for asymmetric induction. Furthermore, the solid state conformation of N-
aminated quinine has also been determined previously. The tetraphenylborate salt of N-
aminated quinine has been isolated and characterised by X-ray crystallography (Figure 
6) (221) and its conformation is in accordance with the favoured conformation of quinine 
in both solution(222,223) and solid state,(224) the so called anti-open conformation. Taken 
together, a preliminary transition state model has previously been proposed(93) based 
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upon catalyst and substrate screening and also conformational studies which accounts 
for the formation of the 2R,3S major aziridine enantiomer- as observed with quinine 
(Table 30). The model is devoid of any hydrogen bond interactions between the C9 
hydroxyl and the ketone carbonyl (with the hydroxyl positioned towards the back face 
away from the carbonyl) which is in agreement with experimental results. The model 
also demonstrates an interaction between the aromatic quinoline ring of quinine and the 
adjacent ketone aromatic of the substrate. Increasing the steric bulk at the C9 position 
predicted that the group would no longer be able to occupy the back face, resulting in a 
significant conformational change and disruption of the proposed aromatic-aromatic 
interactions and lead to a lower activity for these promoters. 
  
 
Figure 6. X-Ray Crystal Structure of N-Aminoquininium and Preliminary Transition State Model 
for Asymmetric Aziridination with Quinine 
 
2.3.4.3 Screening of Alpha-Alkyl Enones 
 
Since studies detailed in this thesis have led to the extension of our aziridination 
methodology to alpha-enolizable enones (devoid of an aromatic at the ketone), we were 
keen to explore this proposed model further by screening these substrates. It may be 
expected that enones with alkyl substituents at the ketone may result in lower levels of 
observed asymmetric induction if a strong aromatic-aromatic interaction between the 
substrate and catalyst exist. As a result alkyl enones 61, 62 and 65, which possess 
varying degrees of steric bulk at the ketone, were screened for asymmetric aziridination 
with quinine (Table 37). 
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Entry
a
 Substrate Product Yield /
b
 ee /
c,d
 
1 
  
37 58 
2 
  
17 49 
3 
  
6 76 
a
 Reactions performed on a 0.11-0.12 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
b
 Enantiomeric excess (ee) measured by HPLC analysis; 
c
 Configuration of major 
enantiomer assigned 2R,3S in analogy to the aziridination of chalcone with quinine. 
Table 37. Asymmetric Aziridination of Alkyl Substituted Enones with Quinine 
 
Of the three alkyl enones screened it is evident that as the steric bulk of the ketone 
substituent increases the yield of the reaction significantly declines. Isopropyl 
substituted enone 61 underwent aziridination in moderate yield (37%) and also 
moderate ee (58% ee) (entry 1), which within errors of integration is analogous to the 
observed levels of asymmetric induction with chalcone (56% ee). The sterically bulky 
tert-butyl substituted enone 62 underwent aziridination with lower yield (17%) but in 
comparable ee (49% ee) (entry 2). Trisubstituted enone 65 underwent aziridination in 
extremely poor yield (6%), but the aziridine formed was of significantly higher ee (76% 
ee) (entry 3). To further investigate this latter result, in terms of whether the α-
substituent of 65 led to the increase in observed ee, an acyclic trisubstituted enone, 184, 
to bear resemblance to enone 65 was also screened in the asymmetric aziridination with 
quinine (Scheme 105). 
 
 
Scheme 105. Attempted Asymmetric Aziridination of Trisubstituted Enone 184 with Quinine 
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Whilst the aziridination of 184 proceeds in good yield with NMM (58%), quinine failed 
to promote this reaction; this observation is consistent with a previous attempt to 
aziridinate the substrate with quinine.(93) 
The observed levels of asymmetric induction for all three alkyl substituted 
enones were higher than may have been predicted, based upon the earlier suggestion 
that an Ar-Ar interaction may play a key role. Further screening of enones with alkyl 
substituents at the ketone, including methyl-substituted enones such as trans-4-phenyl-
3-buten-2-one, 56, may help provide further insights into the postulated substrate-
catalyst interaction. Moreover, in the search for a promoter that delivers the overall aim 
of developing an asymmetric amine-promoted alkene aziridination, screening of further 
cinchona alkaloid derivatives with variation of the aromatic moiety, both sterically and 
also electronically, may further help us in the understanding of our proposed transition 
state model of the reaction. 
 
2.3.5 Summary of Cinchona Alkaloid-Promoted Astmmetric Aziridination 
 
A range of cinchona alkaloids, both synthetic and commercial, were screened as chiral 
promoters for asymmetric aziridination. Whilst quinine remains the optimal promoter in 
terms of asymmetric induction, conclusions can now be drawn into the effect of the C9 
alkaloid substituent, namely; 
i.  Steric bulk at this position is severely detrimental to reaction yield 
ii. Results indicate a negligible role of the hydroxyl as a hydrogen bond donor 
iii. The „natural‟ C9 stereochemistry seems optimal for alkaloid promoters. 
Through further catalyst screening, and correlations with substrate structure, it is hoped 
that this will further aid understanding of the proposed transition state model and in turn 
afford a highly asymmetric alkene aziridination. 
 
A summary of screened alkaloids are presented in the ‘Experimental Details’, Section 
3.2, page 201. 
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2.4 Conclusions and Future Perspectives 
 
2.4.1 Summary 
 
i. Expansion of the Substrate Scope for Amine-Promoted Alkene Aziridination 
 
Investigations detailed in this thesis have led to the expansion of the scope of substrates 
that can be aziridinated with our amine-promoted alkene aziridination methodology. 
Through the use of newly developed conditions two important classes of substrates can 
now be diastereoselectively aziridinated in generally good yields: 
i. Dienones, to afford vinyl aziridines (11 examples, 30-79%)(140) 
 
ii. Alpha-enolizable enones (9 examples, 35-80%) 
 
 
ii. Studies towards an Asymmetric Amine-Promoted Alkene Aziridination 
 
A structurally diverse range of chiral 1,4-heterocycle promoters have been synthesised, 
and whilst their screening results for the asymmetric aziridination of chalcone in general 
displayed low levels of asymmetric induction and often poor levels of reactivity, 
conclusions could be drawn into the relationship between the structure of the promoter 
and the observed reactivity. 
 A range of cinchona alkaloids, both synthesised and commercial, were screened 
as chiral promoters for asymmetric aziridination. Whilst quinine remains the optimal 
promoter in terms of asymmetric induction, firm conclusions can now be drawn into the 
effect of C9 alkaloid substituent, in terms of both sterics and also hydrogen bond donor 
requirements and also provide insights into importance of the C9 stereochemistry. 
Through further catalyst screening, and correlations with substrate structure, it is hoped 
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that this will further aid understanding of the proposed transition state model and in turn 
afford a highly asymmetric alkene aziridination. 
 
2.4.2 Proposed Areas for Future Studies: 
 
i. Development of an Organocatalytic System 
 
Whilst the use of sub-stoichiometric quantities of amine have demonstrated the potential 
for catalytic turnover in the reaction, lower yields are obtained compared to the use of 
stoichiometric amine (see Section 1.3.1).(87) Moreover, all amine promoters detailed in 
this thesis have been used in stoichiometric quantities. Whilst the use of stoichiometric 
NMM is less of an issue (on economic grounds), it would certainly be preferable to use 
sub-stoichiometric quantities of chiral amines. Several observations, as discussed in this 
report, support the notion that the aminating agent DppONH2 is sensitive to base and a 
key consideration for future optimisation of an organocatalytic system, in order to 
increase turnover number, will be to address this issue. One solution is potentially via 
the employment of a more stable aminating agent. This could potentially be achieved 
via variation of the aryl moiety of the reagent in order to increase electron density at P. 
Several diarylphosphinic acids, with various substituted aromatics (such as 4-OMe, 4-
Me etc.), are commercially available which would allow quick access to a range of 
diarylphosphinyl hydroxylamines, 185. By screening of these aminating agents with 
various sub-stoichiometric levels of NMM, correlations between observed yield (a 
potential indicator of reagent stability) and reagent structure could then be made. The 
overall aim would be to reduce the quantity of amine-promoter required to achieve 
efficient aziridination (Scheme 106). 
 
 
Scheme 106. Potential Development of an Organocatalytic System via Employment of Alternative 
Diarylphosphinyl Hydroxylamines 
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ii. Expansion of Reaction Scope: Aziridination of α,β,γ,δ-Unsaturated 
Thioesters: 
 
Whilst disappointingly the methodology could not be extended to dienoates, which 
seem a particularly unreactive class of substrate towards aziridination, α,β,γ,δ-
unsaturated thioesters (and indeed their monounsaturated analogues) may prove more 
fruitful. Thioates can be regarded as a potentially more reactive substrate than their 
enoate equivalent, due to the reduced electron delocalization in the thioester moiety, and 
have shown greater reactivity to various conjugate additions.(225,226) Aziridination of these 
substrates followed by hydrolysis could afford the aziridine-2-carboxylate motif 
(Scheme 107). 
 
 
Scheme 107. Potential Aziridination of Unsaturated Thioates to Access Aziridine-2-Carboxylates 
 
iii. Screening of Aromatic Cinchona Alkaloid Derivatives 
 
In the search for a promoter that delivers the overall aim of developing an asymmetric 
amine-promoted alkene aziridination, several opportunities exist for further 
derivatization of the cinchona alkaloid framework, for example, via additional 
elaboration of the β-ICD motif (Scheme 104). However, focussing on quinine, which 
remains our most selective promoter, further screening of its derivatives seems 
desirable. 
In order to both probe the importance of the C9 stereochemistry further and to 
supplement our understanding of the proposed reaction transition state model, the 
screening of cinchona alkaloid derivatives with variation of the aromatic moiety is an 
attractive aim. Steric variation of the aromatic (for example, anthracenyl, phenanthrenyl 
and pyrenyl groups etc.) and also electronic variation are proposed. Studies indicate that 
both the 6-MeO moiety of the quinoline ring of quinine (a promoter with a more 
electron rich aromatic) and also substrates that have either electron rich aromatic or 
alkyl groups at the ketone lead to higher levels of observed enantioselectivity. It would 
therefore be desirable to screen both quinine derivatives with varying degrees of 
electron density in the aromatic of the alkaloid. The results should aid in the 
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understanding of the transition state model in terms of proposed substrate-catalyst 
interactions. It may be possible to combine the optimal aryl moiety in terms of steric 
bulk and also electronic nature to achieve a cumulative effect in relation to the observed 
levels of asymmetric induction. 
Access to these aromatic derivatives could be envisaged to be achieved via an 
aryl organometallic addition to an oxidised form of (commercial) quincorine, 148 
(Scheme 108). There are few examples that exist in the literature for this type of 
transformation with quincorine derivatives, but aryllithium addition to quincorine 
aldehyde 186 has been achieved.(227) A further attraction of this strategy is the fact that 
the addition leads to both C9 epimers which would then be separated by 
chromatography and screened individually to provide further understanding of the 
importance of the alkaloid C9 stereochemistry. 
 
 
Scheme 108. Potential Access to Aromatic Cinchona Alkaloid Derivatives via Quincorine Aldehyde  
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3 Experimental Section  
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3.1 General Procedures 
 
All reactions were carried out under an argon atmosphere in pre-dried glassware, oven-
dried at 160
o
C unless otherwise stated.  
Solvents: DMF was dried over MgSO4 before distillation over 4Å molecular sieves; 
acetone, acetonitrile, benzene, 1,4-dioxane and ethanol were used as commercially 
supplied. CH2Cl2, Et2O, MeOH, THF and toluene were purified by Innovative 
Technology Inc. PureSolvTM Solvent Purification System. In cases where mixtures of 
solvents were used, the ratios refer to the component volumes. 
Reagents: 1M NaOMe in MeOH was prepared by dissolving freshly cut sodium (0.46 
g) in dry MeOH (20 mL). Solid NaOMe was prepared by concentration of the former 
solution in vacuo and drying under vacuum at 50
o
C for 24 h. All other reagents were 
used as supplied commercially unless otherwise stated.  
Microwave assisted reactions: All reactions were carried out using a Biotage Initiator 
instrument. 
Chromatography: Flash column chromatography was carried out using silica gel 40-
63 µm (VWR Prolabo) or using neutral aluminium oxide particle size 63-200 µm 
(Merck). Analytical thin layer chromatography (TLC) was performed using glass 
backed plates pre-coated with silica gel 60 F254 or Merck aluminium backed silica gel 60 
F254 plates and visualised by UV radiation at 254 nm, phosphomolybdic acid in ethanol, 
potassium permanganate in water and ninhydrin in ethanol.  
Automated column chromatography purification was carried out using a Teldyne ISCO 
CombiFlash Rf machine UV detection at 254 nm using RediSep Rf pre-packed silica gel 
cartridges. 
Compounds purified by mass directed reverse phase HPLC were performed using a 
mixed trigger of UV with ES
+
 on a Waters Fraction Lynx system, eluting with (0.05% 
TFA in MeCN/H2O) or (0.05% NH3HOAc in MeCN/H2O). 
IR Spectroscopy: Infra-red spectra were recorded on a Perkin Elmer Spectrum 100 FT-
IR Spectrometer. Absorption maxima (max) are reported in wavenumbers (cm
-1
).  
NMR Spectroscopy: 
1
H NMR spectra were recorded at 400 and 500 MHz in CDCl3, 
D6-DMSO, CD3OD, CD3CN or 1,1,2,2-C2D2Cl4, on a Bruker AV400 or AV500 
spectrometer respectively and reported as follows; chemical shift, , (reported to the 
nearest 0.01 ppm) (number of protons, multiplicity, coupling constant J (Hz, reported to 
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the nearest 0.1 Hz), assignment). Residual protic solvent was used as the internal 
reference: CDCl3 (H = 7.26 ppm), D6-DMSO (H = 2.50 ppm), CD3OD (H = 3.31 
ppm), CD3CN (H = 1.94 ppm) and 1,1,2,2-CD2Cl4 (H = 6.00 ppm). 
13
C NMR spectra 
were recorded at 100 MHz and 126 MHz, with complete proton decoupling, in CDCl3, 
D6-DMSO, CD3OD or 1,1,2,2-C2D2Cl4, on a Bruker AV400 or AV500 spectrometer 
respectively with the chemical shift, , reported to the nearest 0.1 ppm. The internal 
reference used: CDCl3 (C = 77.0 ppm), D6-DMSO (C = 39.5 ppm), CD3OD (C = 49.1 
ppm) and 1,1,2,2-CD2Cl4 (C = 73.4 ppm). 
19
F NMR and 
31
P spectra were recorded at 
376 MHz and 162 MHz respectively on a Bruker AV400 spectrometer. All chemical 
shifts are quoted in parts per million relative to tetratrimethylsilane (H = 0.00 ppm) and 
coupling constants given in Hertz (Hz).  
Mass Spectrometry: Mass spectrometry was carried out using CI
+
 (NH3), ES
+
 or EI
+ 
and were recorded using Micromass Platform II or AutoSpecQ instruments. Gas 
chromatography mass spectrometry was carried out using either CI
+
 (NH3) or EI
+
. Only 
molecular ions and fragments from molecular ions are reported. 
Optical Rotation: Specific rotations (α‟) were recorded on an Optical Activity 
Autopolarimeter, 0.5 dm, at the stated temperature (°C) and concentration (c) measured 
in units of g/100 mL; specific rotations were converted to optical rotations [α]D via the 
equation: [α]D = (100.α‟)/(l.c), where l is the path length of the cell in dm. 
Melting Points: Melting points were obtained using a Reichert hot plate microscope 
and are uncorrected. 
HPLC: HPLC analyses were performed on an Agilent 1100.  
Elemental Analysis: Were performed by Stephen Boyer using a Perkin Elmer 2400 
CHN analyser, London Metropolitan University. 
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3.2 Experimental Details 
 
Preparation of Aminating Agent: O-Diphenylphosphinyl hydroxylamine 
(DppONH2), 58
(153) 
 
 
 
According to the procedure of Colvin,(153) aq. NaOH solution (14 mL, 7.0M) was added 
to a stirred solution of hydroxylamine hydrochloride (7.92 g, 114.2 mmol) in water (17 
mL). 1,4-Dioxane (60 mL) was then added and the solution cooled to -15
o
C. 
Diphenylphosphinic chloride (8.0 mL, 42.2 mmol) in 1,4-dioxane (50 mL) was then 
added in one portion with vigorous stirring which continued for 8 min. Water (60 mL) 
was then added, the slurry filtered and washed with water (60 mL). The white 
amorphous solid was dried under vacuum for 3 h, and purified by stirring as a slurry 
with aq. NaOH solution (100 mL, 0.25M) at 0
o
C for 30 min. The slurry was again 
filtered, washed with water (60 mL) and dried in a vacuum desiccator to afford 58 (6.45 
g, 66%) as a white solid; m.p. >130
o
C (gradual decomposition) (lit.(87) >135
o
C); H (400 
MHz, CDCl3) 7.87-7.82 (4H, m, 4 x PhH), 7.58-7.54 (2H, m, 2 x PhH), 7.50-7.47 (4H, 
m, 4 x PhH), 5.84 (2H, br, NH2). All data were in agreement with those reported.
(87)  
 
Preparation of Dienones Substrates: 
 
(E,E)-4-Nitrocinnamalylideneacetophenone, 36(138) 
 
 
 
Trans-4-nitrocinnamaldehyde (67 mg, 0.38 mmol) was added to a solution of 
(benzoylmethylene)triphenylphosphorane (217 mg, 0.57 mmol) in THF (1.9 mL) and 
stirred under microwave irradiation at 140
o
C for 30 min. The solvent was then 
concentrated in vacuo and the residue purified by automated column chromatography 
(20% EtOAc/
i
hexane) to afford 36 (54 mg, 51%) as a yellow solid; Rf: (20% 
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EtOAc/
i
hexane) 0.45; m.p. 170-173 
o
C [lit.(138) 171-173 
o
C (ethanol)]; H (400 MHz, 
CDCl3); 8.28-8.21 (2H, m), 8.02-7.98 (2H, m), 7.66-7.46 (6H, m), 7.24-7.11 (2H, m), 
7.05 (1H, d, J 16.0, RCH=CR2); C (100 MHz, CDCl3) 190.1, 147.6, 143.3, 142.3, 
138.5, 137.8, 133.0, 131.1, 128.7, 128.4, 127.8, 127.7, 124.2; m/z (ES
+
) 280 (MH
+
, 
100%). All data were in agreement with those reported.(138) 
 
(E,E)-4-Methoxycinnamalylideneacetophenone, 37(138) 
 
 
 
Trans-4-methoxycinnamaldehyde (130 mg, 0.80 mmol) was added to a solution of 
(benzoylmethylene)triphenylphosphorane (503 mg, 1.2 mmol) in ethanol (4 mL) and 
stirred under microwave irradiation at 140
o
C for 30 min. The solvent was then 
concentrated in vacuo and the residue purified by flash column chromatography (20% 
EtOAc/
i
hexane) to afford 37 (148 mg, 70%) as a bright yellow solid; Rf: (20% 
EtOAc/
i
hexane) 0.50; m.p. 113-116
o
C [lit.(138) 113-115 
o
C (ethanol)]; H (400 MHz, 
CDCl3); 8.00-7.95 (2H, m), 7.64-7.53 (2H, m), 7.51-7.43 (4H, m), 7.05 (1H, d, J 14.9, 
RCH=CR2), 7.00-6.86 (4H, m), 3.83 (3H, s, CH3); C (100 MHz, CDCl3) 190.5, 160.6, 
145.4, 141.8, 138.4, 132.5, 128.9, 128.8, 128.5, 128.3, 124.8, 124.2, 114.3, 55.3; m/z 
(ES
+
) 265 (MH
+
, 100%). All data were in agreement with those reported.(138) 
 
(E,E)-1-Phenyl-nona-2,4-dien-1-one, 42(228) 
 
 
 
Trans-2-heptenal (50 µL, 0.38 mmol) was added to a solution of 
(benzoylmethylene)triphenylphosphorane (145 mg, 0.38 mmol) in ethanol (1.9 mL) and 
stirred under microwave irradiation at 120
o
C for 30 min. The solvent was then 
concentrated in vacuo, and the residue dissolved in 
i
hexane and diethyl ether (1:1, 10 
mL) and filtered through a plug of silica (x3) and the solvents concentrated in vacuo. 
136 
 
Purification by flash column chromatography (
i
hexane to 5% EtOAc/
i
hexane) afforded 
42 (60 mg, 74%) as a yellow oil; Rf: (5% EtOAc/
i
hexane) 0.40; H (400 MHz, CDCl3) 
8.03-7.84 (2H, m, PhH), 7.58-7. 52 (1H, m, PhH), 7.50-7.37 (3H, m, 2 x PhH and 
RCH=CR2), 6.88 (1H, d, J 15.0, RCH=CR2), 6.37-6.21 (2H, m, 2 x RCH=CR2), 2.22 
(2H, q, J 7.1, -CH2CH3), 1.49-1.30 (4H, m, 2 x -CH2-), 0.92 (3H, t, J 7.0, -CH3); C 
(100 MHz, CDCl3) 191.0, 146.7, 145.5, 138.3, 132.5, 129.1, 128.5, 128.3, 123.5, 32.9, 
30.8, 22.3, 13.9; m/z (ES
+
) 215 (MH
+
, 100%). All data were in agreement with those 
reported.(228) 
 
(E,E)-γ-Methylcinnamalylideneacetophenone, 44(229)  
 
 
 
α-Methyl-trans-cinnamaldehyde (0.52 mL, 3.7 mmol) was added to a solution of 
(benzoylmethylene)triphenylphosphorane (2.05 g, 5.4 mmol) in ethanol (16 mL) and 
stirred under microwave irradiation at 140
o
C for 30 min. The solvent was then 
concentrated in vacuo and the residue purified by flash column chromatography (5% 
EtOAc/
i
hexane) to afford 44 (0.83 g, 90%) as a pale yellow solid; Rf: (5% 
EtOAc/
i
hexane) 0.45; m.p. 70-72 
o
C [lit.(229) 70-71
o
C (ethanol)]; H (400 MHz, CDCl3); 
8.02-7.97 (2H, m, PhH), 7.64 (1H, d, J 15.0, -CHR=CHR), 7.58 (1H, m, PhH), 7.53-
7.47 (2H, m, PhH), 7.43-7.27 (m, 5H, PhH), 7.06 (1H, d, J 15.3, CHR=CHR), 6.98 (1H, 
s, PhCH=C(CH3)R), 2.17 (3H, s, CH3); C (100 MHz, CDCl3) 190.9, 150.2, 140.5, 
138.5, 136.7, 134.7, 132.6, 129.5, 128.5, 128.4, 128.3, 127.9, 121.5, 13.9; All data were 
in agreement with those reported.(229) 
 
(E)-3-Cyclohex-1-enyl-1-phenyl-propenone, 45 
 
 
 
1-Cyclohexene-1-carboxaldehyde (0.31 mL, 2.72 mmol) was added to a solution of 
(benzoylmethylene)triphenylphosphorane (1.55 g, 4.08 mmol) in ethanol (27 mL), 
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heated to reflux and the mixture stirred for 16 h. The solvent was then concentrated in 
vacuo and the crude residue purified by flash column chromatography (10% 
EtOAc/
n
hexane) to afford 45 (389 mg, 67%) as a yellow solid; Rf: (10% 
EtOAc/
n
hexane) 0.40; m.p. 51-53 
o
C; max (ATR) 3054 w, 2965 m, 2931 m, 2863 m, 
1661 s, 1626 s, 1588 vs, 1451 m, 1439 m, 1259 s, 1184 m, 1158 m, 1003 vs, 839 m, 767 
m, 694 vs cm
-1
; H (400 MHz, CDCl3); 7.96-7.93 (2H, m, PhH), 7.54 (1H, m, PhH), 
7.48-7.44 (2H, m, PhH), 7.42 (1H, d, J 15.5, RCH=CHC(O)), 6.84 (1H,d, J 15.5, 
RCH=CHC(O)), 6.30 (1H, br, CH2CH=CR2), 2.32-2.20 (4H, m, 2 x -CH2-), 1.77-1.62 
(4H, m, 2 x -CH2-); C (100 MHz, CDCl3) 191.3, 148.5, 140.8, 138.6, 135.5, 132.4, 
128.4, 128.3, 118.8, 26.7, 24.3, 22.1, 22.0; m/z (EI
+
) 212 (M
+
, 95%), 183 (100); HRMS 
(EI
+
) M
+
 calculated for C15H16O 212.1201 observed 212.1201. 
 
(E,E)-5-phenylpenta-2,4-dienoic acid methyl ester, 51(230) 
 
 
 
Trans-cinnamaldehyde (0.41 mL, 3.30 mmol) was added to a solution of 
methoxycarbonylmethylenetriphenylphosphorane (551 mg, 1.65 mmol) in ethanol (17 
mL), heated to reflux and the mixture stirred for 20 h. The solvent was then 
concentrated in vacuo and the crude residue, having an E,E:E,Z ratio of 71:29, was 
purified by flash column chromatography (7% EtOAc/
n
hexane) to afford 51 (201 mg, 
65%) as a white solid exclusively as the E,E isomer; Rf: (7% EtOAc/
n
hexane) 0.35; m.p. 
53-54
o
C; H (400 MHz, CDCl3); 7.48-7.43 (3H, m), 7.38-7.29 (3H, m), 6.93-6.84 (2H, 
m, 2 x CR2=CHR), 6.00 (1H, d, J 15.3, CR2=CHR), 3.78 (3H, s, CH3); C (100 MHz, 
CDCl3) 167.5, 144.8, 140.5, 136.0, 129.1, 128.8, 127.2, 126.2, 120.8, 51.6; All data 
were in agreement with those reported.(230)
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(E,E)-5-Phenylpenta-2,4-dienoic acid tert-butyl ester, 52(231) 
 
 
 
Trans-cinnamaldehyde (0.31 mL, 2.50 mmol) was added to a solution of tert-
butoxycarbonylmethylenetriphenylphosphorane (1.41 g, 3.75 mmol) in ethanol (25 
mL), heated to reflux and the mixture stirred for 20 h. The solvent was then 
concentrated in vacuo and the crude residue, having an E,E:E,Z ratio of 62:38, was 
purified by flash column chromatography (10% EtOAc/
n
hexane) to afford 52 (0.53 mg, 
91%) as a colourless oil as an inseparable mixture of isomers; Rf: (10% EtOAc/
n
hexane) 
0.55; H (400 MHz, CDCl3); 8.15 (1HZ, ddd, J 15.7, 11.3 and 1.0, PhH), 7.53-7.50 (2HZ, 
m, 2 x PhH), 7.47-7.44 (2HE, m, 2 x PhH), 7.38-7.27 (4HE and 3HZ, 2 x PhHE, 
CR2=CHER and 3 x PhHZ, CHZ=CR2), 6.90-6.85 (2HE, m, 2 x RCH=CR2), 6.78 (1HZ, d, 
J 15.7, RCH=CR2), 6.66 (1HZ, td, J 11.2 and 0.8, RCH=CR2), 5.92 (1HE, d, J 15.3, 
RCH=CR2), 5.65 (1HZ, d, J 11.3, RCH=CR2), 1.54 (9HZ, s, 
t
Bu) 1.51 (9HE, s, 
t
Bu); All 
data were in agreement with those reported.(231) 
 
Phenoxycarbonylmethyl-triphenyl-phosphonium bromide, 53(147) 
 
 
 
According to the procedure of Miller,(147) phenyl bromoacetate (5.45 g, 25.3 mmol) in 
CHCl3 (12.5 mL) was added dropwise (slight exotherm) to a solution of PPh3 (6.64 g, 
25.3 mmol) in CHCl3 (12.5 mL) and the reaction was stirred at room temperature for 45 
min. The reaction was then concentrated in vacuo and the resulting gum triturated with 
Et2O (100 mL) and the solution stood for 15 mins. The precipitate was filtered and 
washed with copious Et2O and dried under vacuum to afford 53 (12.5 g, quant.) as a 
powdery white solid; m.p. 171-173
o
C (lit.(232)
 
172-173
o
C); H (400 MHz, CDCl3); 7.99-
7.93 (6H, m, 6 x PhH), 7.81-7.75 (3H, m, 3 x PhH), 7.70-7.64 (6H, m, 6 x PhH), 7.28-
7.23 (2H, m, 2 x PhH), 7.16 (1H, m, PhH), 6.83-6.80 (3H, m, 3 x PhH), 5.95 (2H, d, J 
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13.7, Ph3PCH2CO); P (162 MHz, CDCl3); 22.1. All data were in agreement with those 
reported.(147,232)
 
 
(Triphenylphosphoranylidene)-acetic acid phenyl ester, 54(147) 
 
 
 
According to the procedure of Miller,(147) phosphonium bromide 53 (6.50 g, 13.6 mmol) 
was dissolved in CH2Cl2 (100 mL) and transferred to a separating funnel containing aq. 
NaOH (2N, 80 mL). Following agitation the organic layer was separated and extracted 
with CH2Cl2, dried (Na2SO4), filtered and concentrated in vacuo to afford 54 (4.7 g, 
87%) as a white foam; m.p. 124-126
o
C; H (400 MHz, CDCl3) major rotamer; 7.75-7.66 
(10H, m, 10 x PhH), 7.59-7.46 (6H, m, 6 x PhH), 7.28 (1H, m, PhH), 7.14 (1H, m, 
PhH), 7.05 (1H, t, J 7.2, PhH), 6.63 (1H, d, J 7.5, PhH), 3.18 (1H, d, J 21.4, 
Ph3PCH=C(O)); P (162 MHz, CDCl3) major rotamer; 18.7. 
1
H and 
31
P NMR 
spectroscopic data were in agreement with those reported.(147)
 
 
(E,E)-5-Phenylpenta-2,4-dienoic acid phenyl ester, 55(233) 
 
 
 
Trans-Cinnamaldehyde (0.21 mL, 1.66 mmol) was added to a solution of ylide 54 (790 
mg, 1.99 mmol) in THF (15 mL) and heated to 60
o
C which was maintained for 8 h. The 
solvent was then concentrated in vacuo and the crude residue, having an E,E:E,Z ratio 
of 84:16, was by flash column chromatography (5% EtOAc/
n
hexane) to afforded 
dienone 55 (247 mg, 59%) as pale yellow solid exclusively as the E,E isomer; Rf: (5% 
EtOAc/
n
hexane) 0.40; m.p. 75-78
o
C; H (400 MHz, CDCl3) 7.64 (1H, ddd, J 15.3, 8.2 
and 2.1, -CH=CH-), 7.52-7.50 (2H, m), 7.43-7.32 (5H, m), 7.25 (1H, m), 7.17-7.14 (2H, 
m), 7.02-6.93 (2H, m), 6.19 (1H, d, -CH=CH-); All data were in agreement with those 
reported.(233)
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General Procedures for the Aziridination of Dienones: Synthesis of Vinyl 
Aziridines 
 
N-Methylmorpholine (NMM) (1.05 eq.) was added dropwise over 1 min. to a solution 
of O-diphenylphosphinyl hydroxylamine (DppONH2) (2 eq.) in CH2Cl2 (0.06 M in 
substrate) at room temperature and the mixture stirred for 0.5 h. Either NaH (60% 
dispersion in mineral oil, 3 eq.) and 
i
PrOH (3 eq.) or KO
t
Bu (1M in THF, 3 eq.) was 
then added followed by addition of the dienone substrate (1 eq.) as a solution in CH2Cl2 
(0.12 M) and the mixture allowed to stir at room temperature overnight. The reaction 
was quenched by the addition of saturated aq. NH4Cl solution and the aq. layer 
separated and extracted with CH2Cl2, dried (Na2SO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography afforded the vinyl aziridines. 
Note: The vinyl aziridines are relatively unstable and should be stored in a freezer. 
 
(E)-(2R*,3S*)-Phenyl-[3-(styryl)-aziridin-2-yl]-methanone, 25(93)
 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(27.7 µL, 0.25 mmol), DppONH2 (112 mg, 0.48 mmol), KO
t
Bu (0.60 mL, 1M in THF, 
0.60 mmol) and cinnamylideneacetophenone (56 mg, 0.24 mmol) in CH2Cl2 (6.0 mL), 
after purification by flash column chromatography (20% EtOAc/
i
hexane) afforded 25 
(49.3 mg, 79%) as a yellow oil; Rf: (20% EtOAc/
i
hexane) 0.40; H (400 MHz, CD3OD); 
8.05-8.10 (2H, m, 2 x PhH), 7.63-7.69 (1H, m, PhH), 7.52-7.57 (2H, m, 2 x PhH), 7.40-
7.45 (2H, m, 2 x PhH), 7.28-7.34 (2H, m, 2 x PhH), 7.23 (1H, m PhH), 6.81 (1H, d, J 
16.0, PhCH=CHR), 6.05 (1H, dd, J 16.0 and 8.2, PhCH=CH-), 3.76 (1H, d, J 2.6, 2-
CHN), 2.86 (1H, dd, J 8.2 and 2.6, 3-CHN); C (100 MHz, CD3OD) 197.1, 137.9, 
137.4, 135.3, 135.2, 130.2, 129.8, 129.5, 129.2, 128.7, 127.6, 44.4, 42.1; m/z (ES
+
) 250 
(MH
+
, 100%), 272 (MNa
+
, 30). All data were in agreement with those reported.(93) 
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(E)-(2R*,3S*)-Furan-2-yl-[(3-(styryl)-aziridin-2-yl]-methanone, 30(93)
 
  
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), NaH (14.4 mg, 0.36 mmol), 
i
PrOH (27.6 µl, 0.36 mmol) and dienone 26 (26.9 mg, 0.12 mmol) in CH2Cl2  (3.0 mL), 
after purification by flash column chromatography (5% EtOAc/
i
hexane) afforded 30 
(18.5 mg, 64%) as a pale yellow oil; Rf: (5% EtOAc/
i
hexane) 0.30; H (400 MHz, 
CD3OD) 7.88 (1H, s, ArH), 7.56 (1H, d, J 3.6 ArH), 7.40 (2H, d, J 7.4, ArH), 7.35-7.20 
(3H, m, ArH), 6.79 (1H, d, J 15.9, PhCH=CH-), 6.70 (1H, dd, J 3.6 and 1.5, ArH), 6.00 
(1H, dd, J 16.0 and 8.2, PhCH=CH-), 3.60 (1H, br, 2-CHN), 2.92 (1H, dd, J 8.1 and 2.4, 
3-CHN), 2.30 (3H, s, CH3); C (100 MHz, CD3OD) 185.6, 153.5, 149.8, 137.9, 135.2, 
129.8, 129.1, 128.5, 127.5, 120.7, 114.0, 44.2, 41.7; m/z (ES
+
) 240 (MH
+
, 100%). All 
data were in agreement with those reported.(93) 
 
 (E)-(2R*,3S*)-[(3-(styryl)-aziridin-2-yl]-thiophen-2-yl-methanone, 31(93)
 
  
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(12.0 µL, 0.11 mmol), DppONH2 (48.5 mg, 0.21 mmol), NaH (12.5 mg, 60% dispersion 
in mineral oil, 0.31 mmol), 
i
PrOH (23.9 µL, 0.31 mmol) and 5-phenyl-1-(2-thienyl)-2,4-
pentadien-1-one (25.0 mg, 0.10 mmol) in CH2Cl2 (1.8 mL), afforded 31 (20.0 mg, 75 
%) as a yellow oil; H (400 MHz, CDCl3); 7.90 (1H, dd, J 3.8 and 0.9, ArH), 7.74 (1H, 
dd, J 4.9 and 0.9, ArH), 7.39-7.31 (4H, m, 4 x ArH), 7.25 (1H, m, ArH), 7.20 (1H, m, 
ArH), 6.75 (1H, d, J 16.0, PhCH=CHR-), 6.02 (1H, dd, J 16.0 and 7.7, PhCH=CHR-), 
3.41 (1H, d, J 2.2, 2-CHN), 2.92 (1H, dd, J 7.7 and 2.1, 3-CHN), 2.37 (1H, br, NH); C 
(100 MHz, CDCl3) 188.5, 142.7, 136.2, 134.7, 133.3, 132.7, 128.6, 128.5, 127.9, 127.7, 
126.3, 43.3, 42.1. All data were in agreement with those reported.(93) 
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(E)-(2R*,3S*)-(5-Chlorothiophen-2-yl)-[(3-styryl)-aziridin-2-yl]-methanone, 32(93) 
  
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(15.1 µL, 0.138 mmol), DppONH2 (61.1 mg, 0.26 mmol), NaH (15.6 mg, 0.39 mmol), 
i
PrOH (29.9 µL, 0.39 mmol) and dienone 28 (35.7 mg, 0.13 mmol) in CH2Cl2  (3.3 mL), 
after purification by flash column chromatography (5% EtOAc/
i
hexane) afforded 32 
(24.4 mg, 70%) as a yellow oil; Rf: (5% EtOAc/
i
hexane to 10% EtOAc/
i
hexane) 0.25; 
H (400 MHz, CD3OD) 7.96 (1H, d, J 4.0, ArH), 7.43-7.37 (2H, m, ArH), 7.34-7.27 
(2H, m, ArH), 7.26-7.20 (1H, m, ArH), 7.15 (1H, d, J 4.2, ArH), 6.80 (1H, d, J 16.0, 
PhCH=CHR), 6.00 (1H, dd, J 16.0 and 8.2, PhCH=CHR), 3.63 (1H, d, J 2.2, 2-CHN), 
2.93 (1H, dd, J 8.2 and 2.3, 3-CHN); C (100 MHz, CD3OD) 189.1, 143.1, 141.8, 137.9, 
135.2, 135.0, 129.9, 129.8, 129.1, 128.5, 127.5, 44.4, 41.6. All data were in agreement 
with those reported.(93) 
 
(E)-(2R*,3S*)-(4-Methylthiophen-2-yl)-[3-(styryl)-aziridin-2-yl)]-methanone, 33(93) 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), KO
t
Bu (0.36 mL, 1M in 
THF, 0.36 mmol) and dienone 29 (30.5 mg, 0.12 mmol) in CH2Cl2 (3.0 mL), after 
purification by flash column chromatography (15% EtOAc/
i
hexane) afforded 33 (21.6 
mg, 67%) as an orange oil; Rf: (15% EtOAc/
i
hexane) 0.10; H (400 MHz, CD3OD) 7.91 
(1H, s, ArH), 7.52 (1H, s, ArH), 7.41 (2H, d, J 7.5, ArH), 7.30 (2H, t, J 7.5, ArH), 7.26-
7.20 (1H, m, ArH), 6.79 (1H, d, J 16.0, PhCH=CHR), 6.01 (1H, dd, J 15.9 and 8.3, 
PhCH=CHR), 3.63 (1H, br, 2-CHN), 2.90 (1H, dd, J 8.2 and 2.3, 3-CHN), 2.30 (3H, s, 
CH3); C (100 MHz, CD3OD) 189.8, 143.6, 141.2, 137.9, 137.0, 135.2, 132.5, 129.8, 
129.1, 128.6, 127.6, 44.2, 42.1, 15.6. All data were in agreement with those reported.(93) 
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(E)-(2R*,3S*)-(4-Fluorophenyl)-[(3-(styryl)-aziridin-2-yl]methanone, 38 
  
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), NaH (14.4 mg, 0.36 mmol), 
i
PrOH (27.6 µL, 0.36 mmol) and (E,E)-1-(4-fluorophenyl)-5-phenyl-penta-2,4-dien-1-
one (30.3 mg, 0.12 mmol) in CH2Cl2  (3.0 mL), after purification by flash column 
chromatography (10% EtOAc/
i
hexane) afforded 38 (15.0 mg, 47%) as a yellow oil; Rf: 
(10% EtOAc/
i
hexane) 0.20; max (ATR) 3271 w, 3037 w, 1665 s, 1596 s, 1511 m, 1417 
m, 1358 m, 1253 m, 1230 vs, 1026 m, 964 m, 848 s, 787 m, 752 s, 691 s cm
-1
; H (400 
MHz, CD3OD); 8.20-8.13 (2H, m, ArH), 7.44-7.39 (2H, m, ArH), 7.34-7.21 (5H, m, 
ArH), 6.81 (1H, d, J 16.0, PhCH=CHR), 6.05 (1H, dd, J 16.0 and 8.2, PhCH=CHR), 
3.75 (1H, d, J 2.3, 2-CHN), 2.87 (1H, dd, J 8.2 and 2.6, 3-CHN); C (100 MHz, 
CD3OD) 195.6, 167.8 (d, 
1
JF,C 254), 137.9, 135.3, 134.0, 132.6 (d, 
3
JF,C 10), 129.8, 
129.2, 128.6, 127.6, 117.2 (d, 
2
JF,C 22), 44.4, 41.9; F (376 MHz, CD3OD): 106.3; m/z 
(ES
+
) 268 (MH
+
, 100 %), 290 (MNa
+
, 15); m/z HRMS (ES
+
) MH
+
 calculated for 
C17H15FNO 268.1129, observed 268.1138. 
 
(E)-(2R*,3S*)-{3-[2-(4-Nitrophenyl)-vinyl]-aziridin-2-yl}-phenylmethanone, 39 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), KO
t
Bu THF (0.24 mL, 1M in 
THF, 0.24 mmol) and dienone 36 (33.5 mg, 0.12 mmol) in CH2Cl2 (3.0 mL), after 
purification by flash column chromatography (25% EtOAc/
n
hexane) afforded 39 (10.8 
mg, 30%) as an orange solid; Rf: (25% EtOAc/
n
hexane) 0.40; m.p. 133-135 
o
C; max 
(ATR) 3274 br, 3038 w, 2932 w, 2864 w, 1675 m, 1612 m, 1510 vs, 1459 m, 1248 vs, 
1174 s, 1029 s, 1093 m, 1070 m, 967 m, 820 m, 736 s, 896 vs cm
-1
; H (400 MHz, 
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CDCl3); 8.19 (2H, d, J 8.8, ArH), 8.08 (2H, d, J 7.2, ArH), 7.65 (1H, t, J 7.4, ArH), 
7.55-7.50 (4H, m, ArH), 6.83 (1H, d, J 16.0, ArCH=CHR), 6.25 (1H, dd, J 16.0 and 
7.65, ArCH=CHR), 3.57 (1H, br, 2-CHN), 2.87 (1H, d, J 7.6, 3-CHN), 1.96 (1H, br, 
NH); C (100 MHz, CDCl3) 195.6, 147.1, 142.6, 135.8, 134.0, 132.9, 131.1, 128.9, 
128.3, 126.8, 124.1, 42.9, 41.7; m/z HRMS (ES
+
) MH
+
 calculated for C17H15N2O3 
295.1083, observed 295.1072. 
 
(E)-(2R*,3S*)-{3-[2-(4-Methoxyphenyl)-vinyl]-aziridin-2-yl}-phenylmethanone, 40 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), dibenzyl ether (11.4 µL, 0.06 
mmol), NaH (14.4 mg, 0.36 mmol), 
i
PrOH (27.6 µL, 0.36 mmol) and dienone 37 (31.7 
mg, 0.12 mmol) in CH2Cl2 (3.0 mL), afforded crude 40 (78% conversion determined by 
1
H NMR using Bn2O as the internal standard) as an orange oil; max (ATR) 3270 w, 
3030 m, 2960 m, 2859 w, 1661 vs, 1599 m, 1450 m, 1409 m, 1360 w, 1256 vs, 1221 m, 
1150 w, 1003 m, 964 m, 855 m, 804 m, 698 s cm
-1
; H (400 MHz, CDCl3); 8.03-8.00 
(2H, m, ArH), 7.62 (1H, m, ArH), 7.52-7.48 (2H, m, ArH), 7.33-7.31 (2H, m, ArH), 
6.87-6.84 (2H, m, ArH), 6.69 (1H, d, J 15.9, ArCH=CHR), 5.90 (1H, dd, J 15.9 and 7.7, 
ArCH=CHR), 3.80 (3H, s, CH3), 3.51 (1H, d, J 1.7, 2-CHN), 2.81 (1H, dd, J 7.7 and 
1.5, 3-CHN), 2.51 (1H, br, NH); C (100 MHz, CDCl3) 196.3, 159.5, 136.1, 133.7, 
132.8, 129.0, 128.8, 128.2, 127.5, 125.6, 114.1, 55.2, 43.8, 41.8; m/z HRMS (ES
+
) MH
+
 
calculated for C18H18NO2 280.1338, observed 280.1328. 
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(4E)-2-Amino-5-(4-methoxyphenyl)-1-phenylpenta-2,4-dien-1-one, 41 
 
 
 
Attempted purification by flash column chromatography of crude vinyl aziridine 40 
(30% EtOAc/
n
hexane) afforded diene 41 (17.5 mg, 52%) as an orange oil; max (ATR) 
3458 w, 3362 m, 3000 w, 2932 w, 2836 w, 1595 s, 1559 s, 1508 s, 1403 m, 1292 m, 
1247 vs, 1173 s, 1070 m, 1028 s, 961 m, 817 m, 725 s, 697 s cm
-1
; H (400 MHz, 
CDCl3); 7.66-7.64 (2H, m, ArH), 7.53 (1H, m, ArH), 7.46-7.43 (2H, m, ArH), 7.39-7.36 
(2H, m, ArH), 6.93-6.85 (3H, m, 2 x ArH and 1H, dd, J 15.4 and 11.5, 4-CH ), 6.61 
(1H, d, J 15.4, 5-CH), 6.02 (1H, dd, J 11.5 and 0.9, 3-CH), 4.37 (2H, br, NH2),3.82 (3H, 
s, CH3); C (100 MHz, CDCl3) 193.3, 159.8, 139.0, 137.9, 134.8, 131.2, 129.9, 129.0, 
128.0, 128.0, 120.4, 119.5, 114.3, 55.3, 43.8, 41.8; m/z HRMS (ES
+
) MH
+
 calculated for 
C18H18NO2 280.1338, observed 280.1337. 
 
(E)-(2R*,3S*)-[(3-Hex-1-enyl)-aziridin-2-yl]-phenylmethanone, 43 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), KO
t
Bu in THF (0.24 mL, 1M 
in THF, 0.24 mmol) and dienone 42 (26.0 mg, 0.12 mmol) in CH2Cl2 (3.0 mL), after 
purification by flash column chromatography (10% EtOAc/
n
hexane) afforded 43 (17.3 
mg, 62%) as colourless oil; Rf: (10% EtOAc/
n
hexane) 0.20; max (ATR) 3275 w, 2961 
m, 2935 m, 2863 w, 1666 vs, 1600 m, 1450 m, 1409 m, 1362 w, 1254 vs, 1223 m, 1154 
w, 1009 m, 966 m, 857 m, 809 m, 703 vs, 686 s cm
-1
; H (500 MHz, CD3OD); 8.05-8.03 
(2H, m, PhH), 7.66 (1H, m, PhH), 7.56-7.52 (2H, m, PhH), 5.92 (1H, dt, J 16.4 and 6.9, 
n
C4H9CH=CHR), 5.29 (1H, ddt, J 15.5, 8.2 and 1.5, 
n
C4H9CH=CH-), 3.59 (1H, d, J 2.4, 
2-CHN), 2.65 (1H, dd, J 8.1 and 2.3, 3-CHN), 2.12-2.07 (2H, m, CH2), 1.43-1.31 (4H, 
m, 2 x CH2), 0.92 (3H, t, J 7.1, CH3); C (126 MHz, CD3OD) 197.2, 137.3, 137.1, 
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135.0, 130.0, 129.4, 129.1, 44.1, 41.7, 33.2, 32.4, 23.3, 12.3; m/z HRMS (ES
+
) MH
+
 
calculated for C15H20NO 230.1544, observed 230.1544. 
 
(E)-(2R*,3S*)-[3-(1-Methyl-2-phenyl-vinyl)-aziridin-2-yl]-phenylmethanone, 46 
  
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), NaH (14.4 mg, 0.36 mmol), 
i
PrOH (27.6 µL, 0.36 mmol) and dienone 44 (29.8 mg, 0.12 mmol) in CH2Cl2  (3.0 mL), 
after purification by flash column chromatography (15% EtOAc/
n
hexane) afforded 46 
(21.1 mg, 67%) as a colourless oil; Rf: (15% EtOAc/
n
hexane) 0.40; max (ATR) 3271 br, 
3067 w, 3029 w, 1663 vs, 1600 m, 1583 m, 1494 m, 1456 s, 1413 m, 1345 m, 1257 vs, 
1232 s, 1171 m, 1013 s, 903 m, 832 m, 803 m, 748 m, 697 vs  cm
-1
; H (400 MHz, 
CD3OD); 8.08 (2H, d, J 8.0, PhH), 7.66 (1H, m, PhH), 7.55 (2H, d, J 7.7, PhH), 7.35-
7.29 (4H, m, PhH), 7.23-7.19 (1H, m, PhH), 6.68 (1H, s, PhCH=CHR), 3.73 (1H, d, J 
2.5, CHN), 2.84 (1H, d, J 2.4, CHN), 1.37 (3H, s, CH3); C (100 MHz, CD3OD) 197.6, 
138.6, 137.3, 135.7, 135.1, 130.1, 130.0, 129.8, 129.4, 129.3, 127.8, 48.9, 40.4, 14.0; 
m/z HRMS (ES
+
) MH
+
 calculated for C18H18NO 264.1378, observed 264.1388. 
 
(E)-(2R*,3S*)-[(3-Hex-1-enyl)-aziridin-2-yl]-phenylmethanone, 47 
 
 
 
Following the general procedures for the preparation of vinyl aziridines, using NMM 
(13.7 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), KO
t
Bu (0.24 mL, 1M in 
THF, 0.24 mmol) and dienone 45 (25.5 mg, 0.12 mmol) in CH2Cl2 (3.0 mL), after 
purification by flash column chromatography (10% EtOAc/
n
hexane) afforded 47 (16.3 
mg, 60%) as colourless oil; Rf: (10% EtOAc/
n
hexane) 0.30; max (ATR) 3263 w, 2934 
m, 2866 w, 2840 w, 1664 vs, 1601 m, 1456 m, 1417 m, 1357 m, 1256 vs, 1226 s, 1173 
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m, 1010 vs, 926 m, 879 m, 857 m, 807 m, 756 m, 781 m, 707 vs, 687 s cm
-1
; H (400 
MHz, CD3OD); 8.04 (2H, d, J 8.0, 2 x PhH), 7.66 (1H, m, PhH), 7.56-7.52 (2H, m, 2 x 
PhH), 5.87 (1H, br, CH2CH=CR2), 3.64 (1H, d, J 2.6 2-CHN), 2.61 (1H, br, 3-CHN), 
2.07-1.90 (4H, m, 2 x CH2), 1.75-1.58 (4H, m, 2 x CH2); C (126 MHz, CDCl3) 197.0, 
136.1, 134.3, 133.6, 128.8, 128.2, 126.2, 46.7, 39.3, 25.1, 24.2, 22.4, 22.3; m/z HRMS 
(ES
+
) MH
+
 calculated for C15H18NO 228.1388, observed 228.1387. 
 
Preparation of Enones Substrates: 
 
(3,3-Dimethyl-2-oxobutyl)triphenylphosphonium Bromide, 59 
 
 
 
α-Bromopinacolone (4.76 g, 26.6 mmol) in toluene (20 mL) was added dropwise to a 
solution of PPh3 (6.97 g, 26.6 mmol) in toluene (20 mL) and the reaction was stirred at 
40
o
C for 36 h. The resulting precipitate was filtered and washed with toluene and dried 
under vacuum to afford 59 (9.45 g, 80%) as a powdery white solid; m.p. >200
o
C 
(decomposition); max (ATR) 2959 w, 2769 w, 2932 w, 1697 s, 1590 w, 1439 s, 1367 m, 
1305 m, 1157 w, 1112 s, 1058 s, 997 m, 863 s, 747 vs, 718 s, 687 vs cm
-1
; H (400 
MHz, CDCl3); 7.90-7.85 (6H, m, 6 x PhH), 7.76-7.70 (3H, m, 3 x PhH), 7.66-7.61 (6H, 
m, 6 x PhH), 5.93 (2H, d, J 11.9, Ph3PCH2CO), 1.23 (9H, s, -C(CH3)3); C (100 MHz, 
CDCl3) 208.7 (d, J 6.8, CO), 134.6, 133.9 (d, J 10.5), 130.0 (d, J 12.6), 119.0 (d, J 
88.7), 45.7 (d, J 4.8, -C(CH3)3), 37.4 (d, J 60.1, Ph3PCH2CO), 26.2 (-C(CH3)3); P (162 
MHz, CDCl3) 22.2; m/z HRMS (ES
+
) M
+
 calculated for C24H26OP 361.1721, observed 
361.1725. 
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(3,3-Dimethyl-1-(triphenylphosphoranylidene)-2-butanone, 60(234) 
 
 
  
According to the procedure of Lam,(157) Na2CO3 (0.47 g, 4.40 mmol) was added to a 
stirred solution of phosphonium bromide 59 (1.30 g, 2.93 mmol) in a mixture of CH2Cl2 
(9 mL) and water (9 mL) and the reaction was stirred at room temperature for 36 h. The 
aq. layer was separated and extracted with CH2Cl2, dried (Na2SO4), filtered and 
concentrated in vacuo to afford 60 (1.06 g, quant.) as an off-white solid; m.p. 178-180 
o
C [lit.(234) 180-181 
o
C (MeCN)]; H (400 MHz, CDCl3); 7.66-7.59 (6H, m, 6 x PhH), 
7.55-7.50 (3H, m, 3 x PhH), 7.45-7.41 (6H, m, 6 x PhH), 3.77 (1H, d, J 27.2, 
Ph3P=CHCO), 1.20 (9H, s, -C(CH3)3); P (162 MHz, CDCl3) 16.0. All data were in 
agreement with those reported.(234)
 
 
(E)-4,4-Dimethyl-1-phenyl-pent-1-en-3-one, 62(235) 
 
 
 
Benzaldehyde (0.22 mL, 2.16 mmol) was added to a solution of ylide 60 (935 mg, 2.59 
mmol) in ethanol (15 mL) and heated to 60
o
C which was maintained for 16 h. The 
solvent was then concentrated in vacuo and the residue purified by flash column 
chromatography (10% EtOAc/
n
hexane) to afforded enone 62 (200 mg, 49%) as pale 
yellow oil; Rf: (10% EtOAc/
n
hexane) 0.60; H (400 MHz, CDCl3) 7.68 (1H, d, J 15.6, -
CH=CH-), 7.59-7.56 (2H, m, 2 x PhH), 7.42-7.37 (3H, m, 3 x PhH), 7.13 (1H, d, J 15.6, 
-CH=CH-), 1.23 (9H, s, -C(CH3)3). All data were in agreement with those reported.
(235) 
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(E)-6-Phenyl-3-hexen-2-one, 68(236) 
 
 
 
3-Phenylpropionaldehyde (0.3 mL, 2.2 mmol) was added to a solution of 1-
triphenylphosphoranylidene-2-propanone (700 mg, 2.2 mmol) in ethanol (20 mL) and 
heated to 45
o
C which was maintained for 36 h. The solvent was then concentrated in 
vacuo and the residue purified by flash column chromatography (15% EtOAc/
n
hexane) 
to afforded enone 68 (334 mg, 87%) as colourless oil; Rf: (15% EtOAc/
n
hexane) 0.40; 
H (400 MHz, CDCl3) 7.32-7.18 (5H, m, 5 x PhH), 6.82 (1H, dt, J 15.9 and 6.8,  -
CH2CH=), 6.10 (1H, m, =CHC(O)), 2.82-2.78 (2H, m, PhCH2-), 2.59-2.53 (2H, m, 
PhCH2CH2-), 2.23 (3H, s, CH3); C (100 MHz, CDCl3) 198.6, 147.1, 140.6, 131.7, 
128.5, 128.3, 126.2, 34.4, 34.1, 26.9. All data were in agreement with those reported.(236) 
 
(E)-Hepta-6,3-dien-2-one, 69 
 
 
 
4-Pentenal (0.3 mL, 3.0 mmol) was added to a solution of 1-
triphenylphosphoranylidene-2-propanone (965 mg, 3.0 mmol) in ethanol (30 mL) and 
heated to 45
o
C which was maintained for 16 h. The solvent was then concentrated in 
vacuo and the residue purified by flash column chromatography (15% EtOAc/
n
hexane) 
to afforded enone 69 (193 mg, 52%) as colourless oil; Rf: (15% EtOAc/
n
hexane) 0.40; 
max (ATR) 3087 w, 2987 w, 2927 w, 1698 m, 1673 vs, 1641 m, 1626 m, 1433 w, 1360 
m, 1252 s, 1177 w, 981 s, 913 s, 606 w cm
-1
; H (400 MHz, CDCl3) 6.79 (1H, dt, J 16.2 
and 6.8, -CH=CHC(O)), 6.08 (1H, d, J 16.2, =CHC(O)), 5.80 (1H, m, CH2=CH-), 5.08-
5.00 (2H, m, CH2=CHR), 2.37-2.31 (2H, m, =CHCH2-), 2.26-2.20 (5H, m, -CH2CH= 
and CH3); C (100 MHz, CDCl3) 198.6, 147.4, 137.0, 131.6, 115.7, 32.1, 31.6, 26.9; m/z 
(CI
+
 (NH3)) 142 (100%, MNH4
+
 ), 125 (20, MH
+
); m/z HRMS (CI
+ 
(NH3)) MNH4
+
 
calculated for C8H16NO 142.1432, observed 142.1231. 
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(E)-5-Benzyloxy-pent-3-en-2-one, 70(237) 
 
 
 
Benzyloxy-acetaldehyde (0.35 mL, 2.5 mmol) was added to a solution of 1-
triphenylphosphoranylidene-2-propanone (796 mg, 2.5 mmol) in ethanol (25 mL) and 
heated to 45
o
C which was maintained for 16 h. The solvent was then concentrated in 
vacuo and the residue purified by flash column chromatography (15% EtOAc/
n
hexane) 
to afforded enone 70 (473 mg, 99%) as colourless oil; Rf: (15% EtOAc/
n
hexane) 0.25; 
H (400 MHz, CDCl3) 7.39-7.29 (5H, m, 5 x PhH), 6.81 (1H, dt, J 16.1 and 4.4, -
CH2CH=), 6.35 (1H, dt, J 16.1 and 1.8, =CHC(O)), 4.58 (2H, s, PhCH2-), 4.20 (2H, dd, 
J 4.4 and 1.9, -OCH2=), 2.27 (3H, s, CH3); C (100 MHz, CDCl3) 198.2, 143.0, 137.6, 
130.3, 128.5, 127.9, 127.7, 72.9, 68.8, 27.3. All data were in agreement with those 
reported.(237)
 
 
5-(Benzyloxy)pentan-1-ol, 74(158) 
 
 
 
According to the procedure of Kumaraswamy,(158) NaH (458 mg, 60% dispersion in 
mineral oil, 11.5 mmol) was added portionwise to a solution of 1,5-pentanediol (1 mL, 
9.5 mmol) in THF (24 mL) at 0
o
C and was stirred for 10 min. Benzylbromide (1.13 mL, 
9.5 mmol) was then added dropwise followed by tetra-n-butylammonium iodide (350 
mg, 0.95 mmol) and the mixture then stirred at 40
o
C for 16 h. The reaction was 
quenched at 0
o
C by the addition of saturated aq. NH4Cl solution and the aq. layer 
separated and extracted with EtOAc, dried (Na2SO4), filtered and concentrated in vacuo. 
Purification by flash column chromatography (45% EtOAc/
n
hexane) afforded both the 
dibenzyl protected ether (0.58 g, 21%) and the desired mono-protected alcohol 74 (1.12 
g, 60%) as a colourless oil, oil; Rf: (45% EtOAc/
n
hexane) 0.45; H (400 MHz, CDCl3) 
7.37-7.26 (5H, m, 5 x PhH), 4.50 (2H, s, -CH2Ph), 3.64 (2H, td, J 6.4 and 1.0, -CH2-), 
3.48 (2H, t, J 6.5, -CH2-), 1.69-1.55 (4H, m, 2 x -CH2-), 1.49-1.41 (2H, m, -CH2-); C 
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(100 MHz, CDCl3) 138.5, 128.3, 127.6, 127.5, 72.9, 70.3, 62.8, 32.5, 29.4, 22.4. All 
data were in agreement with those reported.(158)
 
 
5-Benzyloxy-pentanal, 76(158) 
 
 
 
Tetra-n-propylammonium perruthenate (TPAP) (49 mg, 0.14 mmol) was added to a 
solution of alcohol 74 (270 mg, 1.39 mmol), NMO (244 mg, 2.08 mmol) and pre-
activated 4 Å molecular sieves in CH2Cl2 (7 mL) and stirred at room temperature until 
the reaction was completed as indicated by TLC (ca. 2 h). The residue was filtered 
through a pad of silica and concentrated in vacuo. Purification by flash column 
chromatography (15% EtOAc/
n
hexane) afforded aldehyde 76 (123 mg, 46%) as a 
colourless oil; Rf: (15% EtOAc/
n
hexane) 0.50; H (400 MHz, CDCl3) 9.76 (1H, t, J, 1.8, 
CHO), 7.37-7.27 (5H, m, 5 x PhH), 4.50 (2H, s, -CH2Ph), 3.49 (2H, t, J 6.1, 
PhCH2OCH2-), 2.46 (2H, td, J 7.1 an6 1.7, -CH2CHO), 1.79-1.61 (4H, m, 2 x -CH2-), 
1.49-1.41 (2H, m, -CH2-); C (100 MHz, CDCl3) 202.5, 138.4, 128.4, 127.6, 127.6, 
72.9, 69.7, 43.6, 29.1, 18.9; All data were in agreement with those reported.(158)
  
 
(E)-8-Benzyloxy-oct-3-en-2-one, 77 
 
 
 
Aldehyde 76 (133 mg, 0.69 mmol) was added to a solution of 1-
triphenylphosphoranylidene-2-propanone (264 mg, 0.83 mmol) in ethanol (5 mL) and 
heated to 60
o
C which was maintained for 16 h. The solvent was then concentrated in 
vacuo and the residue purified by flash column chromatography (15% EtOAc/
n
hexane) 
to afforded enone 77 (96 mg, 60%) as colourless oil; Rf: (15% EtOAc/
n
hexane) 0.30; 
max (ATR) 3031 w, 2935 m, 2858 m, 1697 m, 1672 vs, 1626 m, 1454 w, 1360 m, 1253 
s, 1100 s, 1028 m, 979 s, 736 s, 697 s cm
-1
; H (400 MHz, CDCl3) 7.37-7.27 (5H, m, 5 x 
PhH), 6.79 (1H, dt, J 16.0 and 6.9, -CH=CHC(O)), 6.07 (1H, dt, J 15.9 and 1.4, 
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=CHC(O)), 4.50 (2H, s, -CH2Ph), 3.48 (2H, t, J 6.2, PhCH2OCH2-), 2.28-2.22 (5H, m, -
CH2- and -CH3), 1.69-1.54 (4H, m, 2 x -CH2-); C (100 MHz, CDCl3) 198.7, 149.4, 
138.5, 131.5, 128.4, 127.6, 127.6, 73.0, 69.9, 32.2, 29.3, 26.9, 24.8; m/z (EI
+
) 232 (2%, 
M
+
), 91 (100, PhCH2
+
); m/z HRMS (EI
+
) M
+
 calculated for C15H20O2 232.1463, 
observed 232.1460. 
 
(E)-4-Cyclohex-1-enyl-but-3-en-2-one, 79 
 
 
 
1-Cyclohexene-carboxaldehyde (0.25 mL, 2.2 mmol) was added to a solution of 1-
triphenylphosphoranylidene-2-propanone (768 mg, 2.4 mmol) in ethanol (15 mL) and 
heated to 40
o
C which was maintained for 20 h. The solvent was then concentrated in 
vacuo and the residue purified by flash column chromatography (15% EtOAc/
n
hexane) 
to afford dienone 79 (106 mg, 33%) as colourless oil; Rf: (15 % EtOAc / 
n
hexane) 0.35; 
max (ATR) 2929 m, 2861 w, 1688 m, 1664 vs, 1623 s, 1592 vs, 1434 w, 1358 m, 1253 
vs, 1167 m, 1136 w, 972 s, 925 w, 793 m, 673 w, 579 s, 565 s cm
-1
 H (400 MHz, 
CDCl3) 7.11 (1H, d, J 16.1, -CH=), 6.22 (1H, m, -CH2CH=), 6.05 (1H, d, J 16.1, -
CH=), 2.28 (3H, 2, CH3), 2.23-2.13 (4H, m, 2 x CH2), 1.73-1.60 (4H, m, 2 x CH2); C 
(100 MHz, CDCl3) 199.1, 147.1, 139.9, 135.2, 124.2, 27.2, 26.6, 24.2, 22.0, 22.0; m/z 
(CI
+
) 150 (M
+
, 35%), 73 (100); m/z HRMS (EI
+
) M
+
 calculated for C10H14O 150.1045, 
observed 150.1041. 
 
General Procedures for the Aziridination of Alpha-Enolizable Enones:  
 
N-Methylmorpholine (NMM) (1.05 eq.) was added dropwise over 1 min. to a solution 
of O-diphenylphosphinyl hydroxylamine (DppONH2) (2 eq.) in CH2Cl2 (0.06 M in 
substrate) at room temperature and the mixture stirred for 0.5 h. 
i
PrOH (3 eq.) followed 
by NaH (60% dispersion in mineral oil, 3 eq.) was then added sequentially followed by 
addition of the enone substrate (1 eq.) as a solution in CH2Cl2 (0.12 M) and the mixture 
allowed to stir at room temperature overnight. The reaction was quenched by the 
addition of saturated aq. NH4Cl solution and the aq. layer separated and extracted with 
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CH2Cl2, dried (Na2SO4), filtered and concentrated in vacuo. Purification by flash 
column chromatography afforded the aziridines. 
 
(2R*,3S*)-1-[-3-Phenyl-aziridin-2-yl]-ethanone, 57(238) 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.9 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH (27.6 µl, 0.36 
mmol), NaH (14.4 mg, 0.36 mmol) and trans-4-phenyl-3-buten-2-one (17.5 mg, 0.12 
mmol), in CH2Cl2  (3 mL), after purification by flash column chromatography (15% 
EtOAc/
i
hexane) afforded 57 (15.6 mg, 80%) as a colourless oil; Rf: (15% 
EtOAc/
n
hexane) 0.30; H (400 MHz, CDCl3); 7.38-7.27 (5H, m, 5 x PhH), 3.04 (1H, d, 
J 2.0, CHN), 2.86 (1H, d, J 2.1, CHN), 2.38 (3H, s, CH3), 2.29 (1H, br, NH); C (100 
MHz, CDCl3) 204.5, 138.2, 128.5, 127.8, 126.1, 46.8, 43.0, 29.6. All data were in 
agreement with those reported.(238)
 
 
2-Methyl-1-[(2R*,3S*)-3-Phenyl-aziridin-2-yl]-propan-1-one, 63(238) 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.2 µL, 0.12 mmol), DppONH2 (53.3 mg, 0.23 mmol), 
i
PrOH (26.2 µl, 0.34 
mmol), NaH (13.7 mg, 0.34 mmol) and trans-4-methyl-1-phenyl-pent-1-en-3-one (19.9 
mg, 0.11 mmol), in CH2Cl2  (2.9 mL), after purification by flash column 
chromatography (15% EtOAc/
n
hexane) afforded 63 (10.5 mg, 49%) as a colourless oil; 
Rf: (15% EtOAc/
n
hexane) 0.30; H (400 MHz, CDCl3); 7.35-7.27 (5H, m, 5 x PhH), 
2.98 (1H, d, J 2.1, CHN), 2.86 (1H, d, J 2.2, CHN), 2.84 (1H, sep., J 6.9, -CH(CH3)2), 
2.28 (1H, br, NH), (6H, d, J 6.9, -CH(CH3)2); C (100 MHz, CDCl3) 210.3, 138.3, 
128.5, 127.8, 126.1, 45.1, 42.9, 40.5, 17.9, 17.5. All data were in agreement with those 
reported.(238)  
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2,2-Dimethyl-1-[(3R*,2S*)-3-phenyl-aziridin-2-yl]-propan-1-one, 64 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.9 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH (27.6 µl, 0.36 
mmol), NaH (14.4 mg, 0.36 mmol) and enone 62 (23.0 mg, 0.12 mmol), in CH2Cl2  (3 
mL), after purification by flash column chromatography (20% EtOAc/
n
hexane) afforded 
64 (19.6 mg, 79%) as a white solid; Rf: (20% EtOAc/
n
hexane) 0.55; m.p. 54-56 
o
C; max 
(ATR) 3264 m, 2979 m, 2937 m, 2878 w, 1686 vs, 1605 w, 1455 m, 1410 s, 1367 m, 
1250 m, 1206 m, 1187 s, 1162 m, 1083 s, 1071 s, 1021 s, 1008 s, 840 s, 785 m, 754 vs, 
728 vs, 699 vs cm
-1
; H (400 MHz, CDCl3); 7.35-7.27 (5H, m, 5 x PhH), 3.00 (1H, d, J 
2.3, CHN), 2.91 (1H, d, J 2.3, CHN), 2.19 (1H, br, NH), 1.23 (9H, s, -(CH3)3; C (100 
MHz, CDCl3) 211.3, 138.3, 128.5, 127.7, 126.1, 43.3, 43.0, 42.8, 25.9; m/z HRMS 
(ES
+
) MH
+
 calculated for C13H18NO 204.1388, observed 204.1396. 
 
(2R*,3S*)-2-Phenyl-1-aza-spiro[2.5]octan-4-one, 66 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.9 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), NaH (14.4 mg, 0.36 
mmol), 
i
PrOH (27.6 µl, 0.36 mmol) and 2-benzylidenecyclohexanone (22.3 mg, 0.12 
mmol), in CH2Cl2  (3 mL), after purification by flash column chromatography (15% 
EtOAc/
n
hexane) afforded 66 (15.2 mg, 63%) as a white solid; Rf: (15% EtOAc/
n
hexane) 
0.20; m.p. 87-88 
o
C; max (ATR) 3285 m, 2943 m, 2860 w, 1684 s, 1495 w, 1448 m, 
1409 m, 1318 m, 1280 w, 1136 m, 1119 m, 1054 w, 1028 w, 948 m, 861 m, 739 s, 698 s 
cm
-1
; H (400 MHz, CDCl3); 7.40-7.24 (5H, m, 5 x PhH), 3.10 (1H, s, 2-H), 2.76 (1H, 
br, NH), 2.70 (1H, ddt, J 16.8, 4.6 and 2.4, -C(O)CHH-), 2.43 (1H, ddd, J 16.9, 12.9 
and 6.6, -C(CO)HH-), 2.04 (1H, m, -C(O)CH2HH-), 1.84 (1H, td, J 13.7 and 4.1, -
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C(N)CHH-), 1.80-1.64 (2H, m, -C(O)CH2CHH- and -C(N)CH2CHH-), 1.46-1.32 (2H, 
m, -C(N)CHH- and C(N)CH2HH-); C (100 MHz, CDCl3) 209.4, 135.4, 128.1, 128.0, 
127.6, 49.0, 48.3, 27.2, 24.4, 23.1; m/z HRMS (ES
+
) MH
+
 calculated for C13H16NO 
202.1232, observed 202.1231. 
 
1-[(3R*,2S*)-3-Phenethyl-aziridin-2-yl]-ethanone, 71 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.9 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH (27.6 µl, 0.36 
mmol), NaH (14.4 mg, 0.36 mmol), and enone 68 (21.0 mg, 0.12 mmol), in CH2Cl2  (3 
mL), after purification by flash column chromatography (30% EtOAc/
n
hexane to 
EtOAc) afforded 71 (15.2 mg, 60%) as a colourless oil; Rf: (EtOAc) 0.40; max (ATR) 
3275 w, 3026 w, 2925 w, 2858 w, 1700 s, 1496 w, 1454 m, 1421 m, 1361 m, 1249 m, 
1184 s, 941 w, 844 m, 744 s, 698 vs, 606 m, 568 m cm
-1
; H (400 MHz, CDCl3); 7.31-
7.27 (2H, m, 2 x PhH), 7.22-7.17 (3H, m, 3 x PhH), 2.84 (1H, m, PhCHH-), 2.69 (1H, 
m, -PhCHH-), 2.45 (1H, d, J 2.1, 3-CHN), 2.16 (3H, s, CH3), 2.01 (1H, m, 2-CHN), 
1.93-1.67 (3H, m, PhCH2CH2- and NH); C (100 MHz, CDCl3) 205.9, 141.0, 128.5, 
128.4, 126.1, 42.9, 41.7, 34.5, 33.3, 29.1; m/z HRMS (ES
+
) MH
+
 calculated for 
C12H16NO 190.1224, observed 190.1232. 
 
1-[(3R*,2S*)-3-But-3-enyl-aziridin-2-yl]-ethanone, 72 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (21.7 µL, 0.20 mmol), DppONH2 (88.0 mg, 0.38 mmol), 
i
PrOH (43.2 µl, 0.56 
mmol), NaH (22.6 mg, 0.56 mmol), and enone 69 (23.4 mg, 0.19 mmol), in CH2Cl2  
(4.5 mL), after purification by flash column chromatography (50% EtOAc/
n
hexane to 
EtOAc) afforded 72 (15.9 mg, 61%) as a colourless oil; Rf: (50% EtOAc/
n
hexane) 0.40; 
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max (ATR) 3324 br, 2926 m, 2856 m, 1718 vs, 1641 m, 1438 m, 1358 m, 1293 m, 1160 
m, 994 m, 912 vs, 747 m cm
-1
; H (400 MHz, CDCl3); 5.87 (1H, m, -CH=CH2), 5.07-
4.98 (2H, m, -CH=CH2), 2.58 (1H, d, J 2.4 3-CHN), 2.32 (3H, s, CH3), 2.27 - 2.12 (2H, 
m, -CH2-), 2.03 (1H, td, J 6.2 and 2.4, 3-CHN), 1.97 (1H, br, NH), 1.66-1.47 (2H, m, -
CH2-); C (100 MHz, CDCl3) 205.9, 137.5, 115.4, 42.8, 41.9, 32.4, 31.4, 29.2; m/z 
HRMS (ES
+
) MH
+
 calculated for C8H14NO 140.1075, observed 140.1072. 
 
1-[(2R*,3S*)-3-(4-Benzyloxy-butyl)-aziridin-2-yl]-ethanone, 78 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (13.9 µL, 0.125 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH (27.6 µl, 0.36 
mmol), NaH (14.4 mg, 0.36 mmol) and enone 77 (27.9 mg, 0.12 mmol), in CH2Cl2  (3 
mL), after purification by flash column chromatography (70% EtOAc/
n
hexane) afforded 
78 (17.1 mg, 58%) as a colourless oil; Rf: (70% EtOAc/
n
hexane) 0.30; max (ATR) 3271 
w, 2937 m, 2857 m, 1700 vs, 1496 w, 1454 m, 1420 m, 1361 s, 1251 m, 1185 s, 1099 
vs, 841 m, 735 vs, 698 s cm
-1
; H (400 MHz, CDCl3); 7.36-7.25 (5H, m, 5 x PhH), 4.50 
(2H, s, PhCH2-), 3.47 (2H, t, J 6.3, PhCH2OCH2-), 2.56 (1H, d, J 2.0, CHN), 2.31 (3H, 
s, CH3), 2.02 (1H, br, CHN), 1.76 (1H, br, NH), 1.69-1.62 (2H, m, -CH2-), 1.58 - 1.43 
(4H, m, 2 x -CH2-); C (100 MHz, CDCl3) 206.0, 138.5, 128.3, 127.6, 127.5, 72.9, 70.0, 
42.6, 42.3, 232.9, 29.4, 29.2, 23.9; m/z HRMS (ES
+
) MH
+
 calculated for C15H22NO2 
248.1651, observed 248.1662. 
 
1-[(2S*,3R*)-3-Cyclohex-1-enyl-aziridn-2-yl]-ethanone, 80 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (19.2 µL, 0.17 mmol), DppONH2 (77.6 mg, 0.33 mmol), 
i
PrOH (38.1 µL, 0.50 
mmol), NaH (19.9 mg, 0.50 mmol), and dienone 79 (25 mg, 0.7 mmol), in CH2Cl2  (4.2 
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mL), after purification by flash column chromatography (35% EtOAc/
n
hexane) afforded 
80 (19.1 mg, 70%) as a colourless oil; Rf: (35% EtOAc/
n
hexane) 0.40; max (ATR) 3266 
w, 2927 m, 2858 w, 2836 w, 1698 vs, 1410 m, 1358 m, 1248 m, 1183 s, 1111 w, 1045 
w, 823 m, 788 s, 663 w, 608 m cm
-1
; H (400 MHz, CDCl3); 5.77 (1H, m, -CH=), 2.79 
(1H, d, J 2.4, 3-CHN), 2.48 (1H, br, 2-CHN), 2.33 (3H, s, CH3), 2.04-1.99 (2H, m, -
CH2CH=), 1.96-1.69 (3H, m, -CH2- and NH), 1.68-1.50 (4H, m, 2 x –CH2-); C (100 
MHz, CDCl3) 205.8, 134.2, 126.1, 46.0, 41.9, 29.3, 25.1, 23.8, 22.3, 22.2; m/z HRMS 
(ES
+
) MH
+
 calculated for C10H16NO 166.1232, observed 166.1232. 
 
7-Aza-bicyclo[4.1.0]heptan-2-one, 85 
 
 
 
Following the general procedures for the aziridination of alpha-enolizable enones, using 
NMM (27.7 µL, 0.25 mmol), DppONH2 (112.0 mg, 0.48 mmol), 
i
PrOH (55.1 µl, 0.72 
mmol), NaH (28.8 mg, 0.72 mmol), and cyclohexenone (23.0 mg, 0.24 mmol), in 
CH2Cl2  (6 mL), after purification by flash column chromatography (EtOAc) afforded 
85 (9.3 mg, 35%) as a colourless oil; Rf: (EtOAc) 0.30; max (ATR) 3311 br, 2933 m, 
2873 m, 1699 s, 1438 m, 1438 m, 1345 m, 1242 m, 1135 m, 1043 m, 990 m, 922 m, 879 
m, 836 m cm
-1
; H (400 MHz, CDCl3); 2.85 (1H, br, NH), 2.80 (1H, dt, J 5.6 and 3.5, 6-
CHN), 2.57 (1H, d, J 5.7, 1-CHN), 2.50 (1H, dt, J 17.9 and 4.7, -CHH-), 2.14 - 1.80 
(4H, m, 2 x -CH2-), 1.63 (1H, m, -CHH-); C (100 MHz, CDCl3) 207.9, 38.0, 36.5, 34.6, 
22.8, 16.9; m/z (CI
+
) 112 (MH
+
, 100%), 129 (MNH4
+
, 25); HRMS (ES
+
) MH
+
 
calculated for C6H10NO 112.0762, observed 112.0762. 
 
N-Boc-O-Diphenylphosphinyl hydroxylamine, 89(163) 
 
 
 
tert-Butyl N-hydroxycarbamate (1.49 g, 11.2 mmol) was dissolved in CH2Cl2 (40 mL) 
and cooled to 0
o
C. Triethylamine (1.9 mL, 13.5 mmol) was then added before the 
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dropwise addition of diphenylphosphinic chloride (2.15 mL, 11.2 mmol) in CH2Cl2 (5 
mL). The mixture was warmed to room temperature and stirred for 3 h. Water (50 mL) 
was then added and the aq. layer separated and extracted with CH2Cl2, dried (Na2SO4), 
filtered and concentrated in vacuo to afford 89 (3.70 g, 99%) as a white solid which was 
used without further purification; m.p. 172-174
o
C; max (ATR) 3084 w, 2985 w, 2908 
w, 1750 s, 1485 m, 1482 m, 1370 m, 1276 m, 1250 m, 1216 s, 1159 m, 1132 m, 1079 s, 
1020 m, 896 m, 835 s, 730 vs, 692 vs; δH (400 MHz, CDCl3) 8.48 (1H, s, -NH), 7.98-
7.93 (4H, m, 4 x PhH), 7.57-7.53 (2H, m, 2 x PhH), 7.48-7.44 (4H, m, 4 x PhH), 1.39 
(9H, s, -C(CH3)3); C (100 MHz, CDCl3) 155.8, 132.8 (d, 
4
JP,C 2.5), 132.4 (d, 
3
JP,C 
10.1), 128.7 (d,
 1
JP,C 135.7), 128.4 (d, 
2
JP,C 13.5), 82.9, 27.9; P (162 MHz, CDCl3) 40.0; 
HRMS (ES
+
) M
+
 calculated for C17H21NO4P 334.1208, observed 334.1211. 
 
(2R*,3S*)-2-Acetyl-3-phenethyl-aziridine-1-carboxcylic acid-tert-butyl ester, 90(239) 
 
 
 
N-Methylmorpholine (NMM) (18.5 µL, 0.17 mmol) was added dropwise over 1 min. to 
a solution of N-Boc-O-diphenylphosphinyl hydroxylamine 89 (90.7 mg, 0.27 mmol) in 
CH2Cl2 (2.3 mL) at room temperature and the mixture stirred for 0.5 h. Cs2CO3 (132.9 
mg, 0.41 mmol) was then added followed by addition of enone 68 (23.7 mg, 0.14 
mmol) as a solution in CH2Cl2 (1.1 mL) and the mixture allowed to stir at room 
temperature overnight. The reaction was quenched by the addition of saturated aq. 
NH4Cl solution and the aq. layer separated and extracted with CH2Cl2, dried (Na2SO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography (20% 
EtOAc/
n
hexane) afforded 90 (29.2 mg, 74%) as a colourless oil; Rf: (20% 
EtOAc/
n
hexane) 0.45; δH (400 MHz, CDCl3) 7.31-7.26 (2H, m, 2 x PhH), 7.22-7.17 
(3H, m, 3 x PhH), 2.93-2.73 (2H, m, PhCH2-), 2.88 (1H, d, J 2.6, 2-CHN), 2.70 (1H, dt, 
J 6.2 and 2.6, 3-CHN), 2.12 (3H, s, C(O)CH3), 2.00 (1H, m, PhCH2CHH-), 1.71 (1H, 
m, PhCH2CHH-), 1.46 (9H, s, -C(CH3)3); C (100 MHz, CDCl3) 202.2, 159.0, 140.6, 
128.5, 128.4, 126.2, 81.7, 46.6, 44.9, 33.0, 33.0, 29.3, 27.9. All data were in agreement 
with those reported.(239) 
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(2R*,3S*)-2-Benzoyl-3-phenyl-aziridine-1-carboxcylic acid benzyl ester, 93 
 
 
 
CbzCl (26 µL, 0.19 mmol) was added to a solution of aziridine 92 (34.5 mg, 0.15 
mmol) and NaHCO3 (19.4 mg, 0.23 mmol) in CH2Cl2 (0.9 mL) at 0
o
C before warming 
to room temperature. Further portions of NaHCO3 (5 eq. total) and CbzCl (4 eq. total) 
were added over a period of 24 h until the reaction was complete. After this time 
saturated aq. NH4Cl solution was added (3 mL) and the aq. layer separated and 
extracted with EtOAc, washed with saturated aq. NaCl solution, dried (Na2SO4), filtered 
and concentrated in vacuo. Purification by flash column chromatography (15% 
EtOAc/
n
hexane) afforded aziridine 93 (38.1 mg, 69%) as a colourless oil; Rf: (15% 
EtOAc/
n
hexane) 0.40; max (ATR) 3075 w, 3034 w, 1774 w, 1729 vs, 1674 s, 1597 m, 
1581 w, 1498 m, 1449 m, 1416 m, 1300 m, 1285 m, 1214 vs, 1770 vs, 1081 m, 1024 m, 
841 m, 751 s, 696 vs cm
-1
; δH (400 MHz, CDCl3) 8.00-7.97 (2H, m, 2 x PhH), 7.62 (1H, 
m, PhH), 7.51-7.47 (2H, m, 2 x PhH), 7.41-7.28 (10H, m, 10 x PhH), 5.28 (1H, d, J, 
12.2, -CHHPh), 5.19 (1H, d, J 12.2, -CHHPh), 4.07  (1H, d, J 2.5, CHN), 3.95 (1H, d, J 
2.4, CHN); C (100 MHz, CDCl3) 192.0, 160.0, 136.2, 135.6, 135.5, 134.0, 128.9, 
128.8, 128.7, 128.5, 128.5, 128.4, 128.2, 126.4, 68.5, 47.5, 47.2; HRMS (ES
+
) MH
+
 
calculated for C23H30NO3 358.1443, observed 358.1451. 
 
N-Boc-O-Mesitylenesulfonyl hydroxylamine, 187(172,173) 
 
 
 
According to the procedure of Krause,(172) Triethylamine (1.3 mL, 9.23 mmol) was 
added to a solution of mesitylenesulfonyl chloride (2.0 g, 9.14 mmol) and tert-butyl N-
hydroxycarbamate (1.22 g, 9.14 mmol) in Et2O (37 mL) at 0
o
C and stirred for 30 min. 
After this time the mixture was concentrated in vacuo to afford 187 (2.83 g, 98%) as a 
white solid which was used without further purification; m.p. 102-105
o
C (lit.(172)
 
102-
104
o
C); δH (400 MHz, CDCl3) 7.58 (1H, s, -NH), 6.99 (2H, s, 2 x ArH), 2.67 (6H, s, 2- 
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and 6- CH3), 2.32 (3H, s, 4-CH3), 1.22 (9H, s, -C(CH3)3); All data were in agreement 
with those reported.(172,173)
 
 
O-Mesitylenesulfonyl hydroxylamine (MSH), 188(172,173) 
 
 
 
N-Boc hydroxylamine 187 (2.83 g, 8.97 mmol) was added to a solution of TFA (10 mL) 
at 0
o
C and the mixture was stirred for 1.5 h. Crushed ice and water (100 mL) were then 
added precipitating a white solid. The solid was then filtered and washed with water 
(100 mL) and dried under vacuum to afford 188 (1.51 g, 78%) as a white solid; m.p. 93-
95
o
C (lit.(240)
 
93-94
o
C); δH (400 MHz, D6-DMSO) 9.27 (2H, br, -ONH2), 6.78 (2H, s, 2 x 
ArH), 2.52 (6H, s, 2- and 6- CH3), 2.19 (3H, s, 4-CH3); All data were in agreement with 
those reported.(173,240)
 
 
Preparation of Chiral 1,4-Heterocycles: 
 
N-(tert-Butoxycarbonyl)-L-Serine, 101(177) 
 
 
 
L-Serine (2.50 g, 23.8 mmol) was dissolved in aq. NaOH solution (50 mL of a 1M 
solution) and cooled to 0
o
C, after which di-tert-butyldicarbonate (6.23 g, 28.6 mmol) 
was dissolved in 1,4-dioxane (30 mL) and added dropwise over 10 mins. The resulting 
solution was stirred for a further 30 min. at 0
o
C. The solution was warmed to room 
temperature and stirred for a further 14 h eliciting a white precipitate. The solution was 
reduced to half volume in vacuo and acidified to pH 2 using 1M H2SO4 (N.B. 
Precipitate is soluble at pH 7 and reappears at pH 2). The aq. layer was separated, 
extracted with EtOAc, dried (MgSO4), filtered and concentrated in vacuo to afford 101 
(4.50 g, 92%) as a colourless viscous oil, which was used without further purification; 
H (400 MHz, CDCl3) 5.63 (1H, br, NH), 4.36 (1H, br, NCH), 4.08 (1H, m, CHHOH), 
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3.87 (1H, d, J 8.9, CHHOH), 1.46 (9H, s, C(CH3)3). Data were in agreement with those 
reported.(177)  
 
N-(tert-Butoxycarbonyl)-L-Serine methyl ester, 99(176) 
 
 
 
Carbamate 101 (4.50 g, 21.93 mmol) was dissolved in dry DMF (25 mL) and cooled to 
0
o
C after which K2CO3 (2.39 g, 24.12 mmol) was added and the solution stirred for 10 
mins., upon which a white precipitate was observed. Iodomethane (2.73 mL, 43.86 
mmol) was added and the reaction stirred for 40 mins. at 0
o
C before being allowed to 
warm to room temperature and stirred for a further 16 h. The solution was filtered and 
the filtrate partitioned between EtOAc (150 mL) and water (100 mL). The organic layer 
was washed with saturated sodium chloride solution (2 x 50 mL) and concentrated in 
vacuo to afford 99 (2.81 g, 58%) as a yellow oil which was used without further 
purification; H (400 MHz, CDCl3) 5.46 (1H, br, NH), 4.39 (1H, br, NCH), 3.97 (1H, 
dd, J 11.0 and 3.6 CHHOH), 3.90 (1H, dd, J 11.0 and 3.6, CHHOH), 3.79 (3H, s, 
CO2CH3), 1.45 (9H, s, C(CH3)3); m/z (CI
+
) 220 (MH
+
, 55%), 237 (MNH4
+
, 50), 181 
(100). All data were in agreement with those reported.(176)  
 
(2S)-2-(tert-Butoxycarbonylamino)-3-(tert-butyldiphenylsiloxy)methyl propanoate, 
104(175) 
 
 
 
To a stirred solution of ester 99 (2.81 g, 12.83 mmol) in dry DMF (50 mL), imidazole 
(4.37 g, 64.15 mmol) and tert-butyldiphenylchlorosilane (3.67 mL, 14.11 mmol) were 
added at 0
o
C. The mixture was subsequently allowed to warm to room temperature and 
stirred for 16 h. The mixture was diluted with EtOAc (300 mL) and washed sequentially 
with water (50 mL), 1M HCl solution (50 mL), saturated NaHCO3 solution (50 mL) and 
saturated sodium chloride solution (50 mL). The organic layer was separated, dried 
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(Na2SO4), filtered and concentrated in vacuo to afford a pale yellow oil. Purification by 
flash column chromatography (10% EtOAc/
n
hexane) afforded 104 (6.34 g, 99%) as a 
colourless oil; Rf: (10% EtOAc/
n
hexane) 0.30; [α]21D +15.1 (c 1.90, CHCl3); H (400 
MHz, CDCl3) 7.62-7.59 (4H, m, 4 x PhH), 7.45-7.36 (6H, m, 6 x PhH), 5.41 (1H, d, J 
8.7, NH), 4.40 (1H, m, NCH), 4.07 (1H, dd, J 10.4 and 2.8 CHHOH), 3.89 (1H, dd, J 
10.0 and 2.8, CHHOH), 3.74 (3H, s, CO2CH3), 1.46 (9H, s, OC(CH3)3) 1.03 (9H, s, 
SiC(CH3)3); m/z (CI
+
) 458 (MH
+
, 100%), 475 (MNH4
+
, 30). All data were in agreement 
with those reported.(175) 
 
(2R)-2-(tert-Butoxycarbonylamino)-3-(tert-butyldiphenylsiloxy)propan-1-ol, 105(175) 
 
 
 
To a stirred solution of silyl ether 104 (6.34 g, 13.87 mmol) in diethyl ether (100 mL), 
LiBH4 (151 mg, 6.94 mmol) was added at 0
o
C, before being allowed to warm to room 
temperature and stirred for a further 2 h. The mixture was again cooled to 0
o
C and 
quenched with water (40 mL) containing 6M HCl solution (5 mL). The aq. layer was 
separated and extracted with diethyl ether, dried (Na2SO4), filtered and concentrated in 
vacuo to afford a yellow residue. Purification by flash column chromatography (20% 
EtOAc/
n
hexane) afforded 105 (4.56 g, 77%) as a white solid with recovery of ester 104 
(1.15 g, 18%); Rf: (20% EtOAc/
n
hexane) 0.25; m.p. 73-74 
o
C [lit.(175) 73 
oC]; [α]21D +6.0 
(c 1.00, CHCl3); H (400 MHz, CDCl3) 7.66-7.63 (4H, m, 4 x PhH), 7.47-7.37 (6H, m, 6 
x PhH), 5.07 (1H, br, NH), 3.84-3.67 (5H, m, NCH, CH2OH, CH2OTBDPS), 1.44 (9H, 
s, OC(CH3)3) 1.07 (9H, s, SiC(CH3)3); m/z (CI
+
) 430 (MH
+
, 100%). All data were in 
agreement with those reported.(175) 
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(1,2S,5S,6)-Diisopropylidene-D-mannitol, 102(178) 
 
 
 
According to the procedure of Eibl,(178) ZnCl2 (20.2 g, 148.2 mmol) was dissolved in 
acetone (125 mL) and stirred for 30 mins., after which D-mannitol (15.0 g, 82.3 mmol) 
was added to the solution and stirred for a further 3 h. Saturated aq. sodium chloride 
solution  (50 mL) was added and the aq. layer separated and extracted with CHCl3, 
dried (MgSO4), filtered and concentrated in vacuo to afford 102 (5.86 g, 27%) as a pale 
yellow solid which was used without further purification; H (400 MHz, CDCl3) 4.19 
(2H, dd, J 12.4 and 6.0), 4.12 (2H, dd, J 8.6 and 6.0), 3.97 (2H, dd, J 8.6 and 5.6), 3.75 
(2H, t, J 6.3) 2.58 (2H, d, J 6.5, OH), 1.42 (6H, s, 2 x CH3), 1.36 (6H, s, 2 x CH3); m/z 
(GCMS CI
+
) 263 (MH
+
, 100%), 280 (MNH4
+
, 20). 
 
(2S)-1,2-Isopropylidene glycerol, 103(178) 
 
 
 
According to the procedure of Eibl,(178) acetal 102 (5.80 g, 22.11 mmol) was dissolved in 
methanol (50 mL) and added dropwise to a stirred solution of NaIO4 (7.09 g, 33.17) in 
water (70 mL) with the pH adjusted to 6 by the addition of LiOH. The rate of addition 
was controlled by the temperature of the reaction mixture which was never allowed to 
exceed 35
o
C. After the addition the reaction mixture was stirred for 2 h. Methanol (70 
mL) was added and the pH of the resulting solution adjusted to 8 by the addition of 5M 
KOH solution. The mixture was cooled to 10
o
C and filtered to remove NaIO3 and 
NaIO4. NaBH4 (0.84 g, 22.11 mmol) was added to the stirred filtrate until the aldehyde 
was completely reduced. The reaction mixture was extracted with 
n
hexane to remove 
1,2,3,4,5,6-triisopropylidene-D-mannitol. Saturated sodium chloride solution (50 mL) 
was added, the aq. layer separated and extracted with CHCl3, dried (MgSO4), filtered 
and concentrated in vacuo. Distillation of the residue gave 103 (1.78 g, 30% (2 steps)) 
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as a colourless oil; b.p. 80
o
C at 16 mbar;(178) [α]20D +12.5 (c 1.07); H (400 MHz, CDCl3) 
4.27-4.22 (1H, m, 2-H), 4.04 (1H, dd, J 8.2 and 6.8, 1-HH), 3.80 (1H, dd, J 8.2 and 6.8, 
1-HH), 3.75 (1H, m, 3-HH), 3.58 (1H, m, 3-HH), 1.83 (1H, t, J 6.4, OH), 1.45 (3H, s, 
CH3), 1.38 (3H, s, CH3). All data were in agreement with those reported.
(178) 
 
(2R)-1,2-Isopropylidene-3-O-trifluoromethanesulfonyl glycerol, 100(179) 
 
 
 
Trifluoromethanesulfonic anhydride (1.91 mL, 11.36 mmol) was added dropwise to a 
stirred solution of alcohol 103 and triethylamine (2.32 mL, 16.65 mmol) in CH2Cl2 (80 
mL) at -15
o
C. The mixture was stirred for 2 h keeping the temperature below -10
o
C. 
The solution was concentrated in vacuo before being diluted with EtOAc (80 mL) and 
washed with saturated NaHCO3 solution (50 mL) and water (50 mL). The aq. layer 
separated and extracted with EtOAc, dried (MgSO4), filtered and concentrated in vacuo 
to afford 100 (2.00 g, quant.) as a maroon oil which was used without further 
purification. Nb. The compound must be stored in a freezer and consumed within two 
days of preparation; H (400 MHz, CDCl3) 4.48-4.46 (2H, m, 3-HH), 4.46 (1H, m, 2-
H), 4.14 (1H, dd, J 9.0 and 6.2, 1-HH), 3.87 (1H, dd, J 8.8 and 6.2, 1-HH), 1.45 (3H, s, 
CH3), 1.37 (3H, s, CH3);  m/z (GCMS CI
+
) 265 (MH
+
, 100%), 282 (MNH4
+
, 12). All 
data were in agreement with those reported.(179) 
 
[(2R)-2-(tert-Butoxycarbonylamino)-3-(tert-butyldiphenylsiloxy)propanoxy]-(4S)-
methyl-2’,2’-dimethyl-[1’,3’]-dioxolane, 106(175) 
 
 
 
To a stirred solution of alcohol 105 (1.93g, 4.49 mmol) and triflate 100 (2.00 g, 7.57 
mmol) in THF (45mL) at 0
o
C, NaH (0.36 g, 60% dispersion in mineral oil, 8.98 mmol) 
165 
 
was added. The solution was allowed to warm to room temperature and stirred for 2 h, 
until the solution became brown. The mixture was again cooled to 0
o
C and quenched 
with water (5 mL) and concentrated in vacuo before the addition of 1M KHSO4 (65 mL) 
solution. The aq. layer was separated and extracted with EtOAc, dried (Na2SO4), filtered 
and concentrated in vacuo to afford a brown residue. Purification by flash column 
chromatography (20% EtOAc/
n
hexane containing 1% Et3N) afforded 106 (1.02 g, 42%) 
as a yellow oil; Rf: (20% EtOAc/
nhexane) 0.70; [α]21D +5.5 (c 1.10, CHCl3); H (400 
MHz, CDCl3) 7.65-7.63 (4H, m, 4 x PhH), 7.45-7.36 (6H, m, 6 x PhH), 4.86 (1H, br, 
NH), 4.19 (1H, m, 4‟-H), 4.00 (1H, dd, J 8.0 and 6.4, CHHOR), 3.87 (1H, br, NCH), 
3.75 (1H, dd, J 9.8 and 4.0, CHHOR), 3.70-3.64 (3H, m, 3 x CHHOR), 3.51-3.43 (2H, 
m, CH2OR), 3.54 (1H, dd, J 9.2 and 6.2, CHHOR) 1.43 (9H, s, OC(CH3)3), 1.39 (3H, s, 
CH3), 1.35 (3H, s, CH3), 1.05 (9H, s, SiC(CH3)3); m/z (CI
+
) 544 (MH
+
, 100%), 561 
(MNH4
+
, 5). All data were in agreement with those reported.(175)  
 
(4R)-4-(tert-butyldiphenylsilanoxymethyl)-oxazolidin-2-one, 107 
 
 
 
Oxazolidinone 107 is can be isolated as a side-product during the preparation of 106; 
isolated as a tacky amorphous dark orange solid; Rf: (EtOAc) 0.80; [α]
22
D -0.01 (c 1.13, 
CHCl3); max (neat) 3247 m, 3076 w, 2934 m, 2857 m, 1736 vs, 1476 m, 1431 m, 1372 
m, 1260 m, 1222 m, 1134 m, 1110 vs, 1051 s, 1005 s, 941 m 841 m, 825 m, 729 m, 700 
vs, 687 s cm
-1
; H (400 MHz, CDCl3) 7.64-7.61 (4H, m, 4 x PhH), 7.48-7.37 (6H, m, 6 x 
PhH), 5.13 (1H, br, NH), 4.43 (1H, t, J 8.8, CHHOC(O)), 4.15 (1H, dd, J 8.8 and 5.2, 
CHHOC(O)), 3.95 (1H, m, CHN), 3.64 (2H, t, J 5.6, CH2OTBDPS), 1.06 (9H, s, 
SiC(CH3)3); C (100 MHz, CDCl3) 159.5, 135.5, 135.5, 132.6, 132.6, 130.0, 127.9, 66.9, 
65.3, 53.5, 26.7, 19.1; m/z (GCMS CI
+
) 355 (MH
+
, 10%), 373 (MNH4
+
, 74), 278 (100); 
HRMS (CI
+
) MNH4
+
 calculated for C20H29N2O3Si 373.1949, observed 373.1947. 
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3-[(2’R)-2-(tert-Butoxycarbonylamino)-3’-(tert-butyldiphenylsiloxy)propanoxy]-
(2R)-propane-1,2-diol, 108(175) 
 
 
 
Acetal 106 (1.20 g, 2.21 mmol) was dissolved in 80% acetic acid (30 mL) and stirred at 
room temperature for 12 h. The mixture was concentrated in vacuo below 50
o
C to 
afford a yellow residue. Purification by flash column chromatography (EtOAc) afforded 
108 (0.86 g, 77%) as a colourless oil; Rf: (EtOAc) 0.60; [α]
20
D +1.6 (c 1.25, CHCl3); H 
(400 MHz, CDCl3) 7.64-7.62 (4H, m, 4 x PhH), 7.46-7.37 (6H, m, 6 x PhH), 4.86 (1H, 
d, J 8.8, NH), 3.90 (1H, br, NCH), 3.79 (1H, br, OH), 3.75-3.45 (9H, m, 4 x CH2OR, 2‟-
H), 2.20 (1H, br, OH), 1.44 (9H, s, OC(CH3)3), 1.06 (9H, s, SiC(CH3)3); m/z (CI
+
) 504 
(MH
+
, 45%), 261 (100). All data were in agreement with those reported.(175) 
  
3-[(2’R)-2’-(tert-Butoxycarbonylamino)-3’-(tert-butyldiphenylsiloxy)propanoxy]-
(2S)-1-(tert-butyldiphenylsiloxy)propan-2-ol, 109(175) 
 
 
 
tert-Butyldiphenylchlorosilane (0.17 mL, 0.67 mmol) was added to a stirred solution of 
diol 108 (0.31 g, 0.61 mmol) and imidazole (0.21 g, 3.07 mmol) in DMF (1.9 mL) at 
room temperature and stirred for 16 h. The mixture was diluted with EtOAc (50 mL) 
and washed sequentially with water (10 mL), 1M HCl solution (10 mL), saturated 
NaHCO3 solution (10 mL) and saturated sodium chloride solution (10 mL). The organic 
layer was separated, dried (Na2SO4), filtered and concentrated in vacuo to afford a 
colourless oil. Purification by flash column chromatography (20% EtOAc/
n
hexane) 
afforded 109 (0.33 g, 73%) as a colourless oil; Rf: (20% EtOAc/
nhexane) 0.50; [α]21D -
2.3 (c 1.75, CHCl3); H (400 MHz, CDCl3) 7.65-7.62 (8H, m, 8 x PhH), 7.44-7.34 (12H, 
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m, 12 x PhH), 4.81 (1H, br, NH), 3.84 (1H, br, CHN), 3.83 (1H, m 2-H), 3.72 (1H, dd, J 
9.6 and 4.0, CHHOR), 3.64 (4H, m, 2 x CH2OR) 3.55-3.51 (2H, m, CH2OR), 3.47 (1H, 
dd, J 10.0 and 6.0, CHHOR), 2.46 (1H, br, OH), 1.43 (9H, s, OC(CH3)3), 1.06 (9H, s, 
SiC(CH3)3), 1.05 (9H, s, SiC(CH3)3); m/z (ES
+
) 764 (MNa
+
, 100%). All data were in 
agreement with those reported.(175) 
 
3-[(2’R)-2’-(tert-Butoxycarbonylamino)-3’-(tert-butyldiphenylsiloxy)propanoxy]-
(2S)-1-(tert-butyldiphenylsiloxy)-2-(methanesulfonyloxy)propane, 110(175)
 
 
 
 
Methanesulfonyl chloride (0.14 mL, 0.96 mmol) was added to a stirred solution of 
alcohol 109 (0.33 g, 0.44 mmol), triethylamine (0.40 mL, 1.43 mmol) and DMAP (175 
mg, 1.43 mmol) in CH2Cl2 (10 mL) at -30
o
C. After addition the solution was allowed to 
warm to room temperature and was stirred for a further 2 h. The mixture was diluted 
with CH2Cl2 (10 mL) and washed sequentially with water (5 mL), 1M HCl solution (5 
mL), saturated aq. NaHCO3 solution (5 mL) and saturated aq. sodium chloride solution 
(5 mL). The organic layer was separated, dried (Na2SO4), filtered and concentrated in 
vacuo to afford an orange oil. Purification by flash column chromatography (15% 
EtOAc/
n
hexane) afforded 110 (0.74 g, 94%) as a colourless oil; Rf: (15% 
EtOAc/
nhexane) 0.20; [α]21D -5.0 (c 1.20, CHCl3); H (400 MHz, CDCl3) 7.65-7.61 (8H, 
m, 8 x PhH), 7.46-7.35 (12H, m, 12 x PhH), 4.78 (1H, d, J 8.6, NH), 4.77 (1H, m, 
CHSO2CH3), 3.90-3.20 (9H, m, CHN and 4 x CH2OR), 2.91 (3H, s, SO2CH3), 1.43 (9H, 
s, OC(CH3)3), 1.06 (9H, s, SiC(CH3)3), 1.05 (9H, s, SiC(CH3)3); m/z (CI
+
) 820 (MH
+
, 
38%), 720 (83), 624 (M(-SO2CH3, -CO2C(CH3)3)H
+
, 100). All data were in agreement 
with those reported.(175) 
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(3R,5R)-3,5-Bis(tert-butyldiphenylsiloxymethyl)morpholine, 98(175) 
 
 
 
Trifluoroacetic acid (2.2 mL, 30 mmol) was added to a stirred solution of mesylate 110 
(0.74 g, 0.90 mmol) in CH2Cl2 (7.5 mL) at 0
o
C. The mixture was allowed to warm to 
room temperature and stirred for 1 h after which TLC revealed consumption of the 
starting material. The solution was concentrated in vacuo and the residue was washed 
with saturated aq. NaHCO3 solution (20 mL), extracted with CH2Cl2, dried (Na2SO4), 
filtered and concentrated in vacuo to afford an orange residue. The residue was 
dissolved in methanol (7.5 mL) and triethylamine (0.75 mL, 5.40 mmol) and di-iso-
propylethylamine (0.66 mL, 5.40 mmol) were added at room temperature before being 
refluxed at 80
o
C for 24 h. The solution was cooled, concentrated in vacuo, washed with 
water (20 mL) and extracted with EtOAc before being washed with saturated aq. 
sodium chloride solution (10 mL). The organic layer was separated, dried (Na2SO4), 
filtered and concentrated in vacuo to afford a yellow residue. Purification by flash 
column chromatography (10% EtOAc/
n
hexane) afforded 98 (0.45 g, 81%) as a 
colourless oil; Rf: (10% EtOAc/hexane) 0.45; [α]
21
D +10.9 (c 1.10 CHCl3); H (400 
MHz, CDCl3) 7.69-7.65 (8H, m, 8 x PhH), 7.45-7.35 (12H, m, 12 x PhH), 3.75-3.71 
(4H, m, 2 x CH2OR), 3.57 (2H, dd, J 10.0 and 5.6, CH2OR), 3.41 (2H, dd, J 11.2 and 
5.6, CH2OR), 3.14-3.09 (2H, m, 2 x CHN), 2.60 (1H, br, NH), 1.05 (18H, s, 2 x 
SiC(CH3)3); m/z (CI
+
) 624 (MH
+
, 100%), 641 (MNH4
+
, 1); >95% ee (measured by 
HPLC analysis (conditions: 99:1 hexane:IPA, 1 mL/min., 220 nm, Chiralcel OD, 3R,5R, 
tR: 9.2 min.). All data were in agreement with those reported.
(175) 
 
4-Methyl-(3R,5R)-3,5-bis(tert-butyldiphenylsiloxymethyl)morpholine, 97 
 
 
 
20% Pd(OH)2/C was added to a solution of morpholine 98 (187 mg, 0.30 mmol), 35% 
aq. formaldehyde (0.1 mL, 3.6 mmol) and acetic acid (0.1 mL, 1.8 mmol) in methanol 
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(5 mL) and was stirred under the presence of H2 (g) at room temperature and 
atmospheric pressure for 3 h. The catalyst was then filtered off and the filtrate 
concentrated in vacuo before addition of saturated aq. Na2CO3 solution (10 mL) and 
water (10 mL). The aq. layer separated and extracted with CHCl3, washed with 
saturated aq. sodium chloride solution (10 mL), dried (Na2SO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (5% 
EtOAc/
n
hexane) afforded 97 (156 mg, 81%) as a colourless oil; Rf: (5% 
EtOAc/
nhexane) 0.40; [α]18D +37.2 (c 0.86, CHCl3); max (neat) 3071 s, 2930 vs, 2889 
vs, 1960 m, 1891 m, 1825 m, 1730 m, 1667 m, 1590 s, 1472 vs, 1428 vs, 1391 s, 1361 
s, 1307 m, 1275 m, 1260 m, 1112 br, 1022 s, 1000 s, 937 s, 824 s, 739 s, 701 s, 614 s, 
505 s cm
-1
; H (400 MHz, CDCl3) 7.66-7.63 (8H, m, 8 x PhH), 7.45-7.34 (12H, m, 12 x 
PhH), 3.82-3.75 (4H, m, 2 x CH2OR), 3.69-3.63 (4H, m, 2 x CH2OR), 2.66 (2H, br, 2 x 
CHN), 2.13 (3H, s, NCH3), 1.03 (18H, s, 2 x SiC(CH3)3); C (100 MHz, CDCl3) 135.5, 
133.4, 129.7, 127.7, 69.0, 60.3, 59.5, 40.10, 26.8, 19.1; m/z (EI
+
) 637 (M
+
, 3%), 368 
(100); HRMS (ES
+
) MH
+ 
calculated for C39H52NO3Si2 638.3486, observed 638.3488. 
 
(3S,5S)-3,5-Bis(hydroxymethyl)-4-methylmorpholine, 111 
 
 
 
Tetra-n-butylammonium fluoride in THF (3.5 mL, 1M solution) was added to a stirred 
solution of morpholine 97 (310 mg, 0.48 mmol) in THF (1.5 mL) at 0
o
C, the mixture 
was then allowed to warm to room temperature and stirred overnight. The solution was 
concentrated in vacuo to afford a yellow oil and purified by flash column 
chromatography (10% MeOH/EtOAc) to afford 111 (63 mg, 80%) as a colourless oil; 
Rf: (20% MeOH/EtOAc) 0.20; [α]
22
D +30.4 (c 1.25, CHCl3); max (neat) 3312 br, 2958 
m, 2886 m, 2861 m, 1574 m, 1457 m, 1365 m, 1270 m, 1125 vs, 926 m, 883 m, 844 m, 
774 m, 698 m cm
-1
; H (400 MHz, CDCl3) 3.86 (2H, dd, J 10.8 and 5.7, CH2OR), 3.79 
(2H, dd, J 11.6 and 6.1, CH2OR), 3.73 (2H, dd, J 11.6 and 3.5, CH2OR), 3.64 (2H, dd, J 
11.2 and 3.4, CH2OR), 3.12 (2H, br), 2.84 (2H, br), 2.51 (3H, s, CH3); C (100 MHz, 
CDCl3) 67.9, 58.8, 58.2, 38.5; m/z (EI
+
) 161 (M
+
, 2%), 130 (M
+
 -CH2OH, 100); HRMS 
(ES
+
) MH
+ 
calculated for C7H16NO3 162.1130, observed 162.1129. 
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(S)-4-(1-Phenylethyl)morpholine, 112(180) 
 
 
 
Ozone (g) was bubbled through a solution of 2,5-dihydrofuran (0.98 mL, 13.0 mmol) in 
methanol (20 mL) at -50
o
C until a blue colour developed indicating consumption of the 
alkene. After removal of excess the ozone with N2 (g), Na(CN)BH3 (1.23 g, 19.5 mmol) 
was added and the solution stirred for 10 min. at -50
o
C. (S)-(-)-α-methylbenzylamine 
(0.84 mL, 6.50 mmol) in methanol (10 mL) was then via added cannula and stirring 
continued for 12 h at 0
o
C. The reaction was quenched by the addition of acetic acid (3 
mL) and concentrated in vacuo before addition of 10% aq. NaOH solution (20 mL). The 
solution was diluted with CH2Cl2 and the aq. layer separated and extracted with CH2Cl2, 
washed with saturated aq. sodium chloride solution (50 mL), dried (Na2SO4), filtered 
and concentrated in vacuo to afford a yellow oil. Purification by flash column 
chromatography over neutral alumina (5% EtOAc/
n
hexane) afforded 112 (0.59 g, 48%) 
as a colourless oil; Rf: (5% EtOAc/
nhexane) 0.50; [α]21D -40.0 (c 1.10 EtOH); H (400 
MHz, CDCl3) 7.32-7.31 (4H, m, 4 x PhH), 7.25 (1H, m, PhH), 3.69 (4H, t, J 4.8, 2 x 
CH2OR), 3.30 (1H, q, J 6.7, NCHCH3), 2.52-2.42 (2H, m, CH2NR2), 2.38-2.33 (2H, m, 
CH2NR2), 1.35 (3H, d, J 6.8, CH3); m/z (EI
+
) 191 (M
+
, 16%), 176 (M
+
 -CH3, 100). All 
data were in agreement with those reported.(180) 
 
(S)-2-Morpholin-4-yl-propan-1-ol, 113 
 
 
 
Ozone (g) was bubbled through a solution of 2,5-dihydrofuran (1.1 mL, 14.0 mmol) in 
methanol (20 mL) at -50
o
C until a blue colour developed indicating consumption of the 
alkene. After removal of excess the ozone with N2 (g), Na(CN)BH3 (0.93 g, 14.8 mmol) 
was added and the solution stirred for 10 min. at -50
o
C. (S)-(+)-2-Aminopropan-1-ol 
(0.56 mL, 7.40 mmol) in methanol (10 mL) was added dropwise and stirring continued 
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for 12 h at 0
o
C. The reaction was quenched by the addition of acetic acid (3.2 mL) and 
concentrated in vacuo before addition of 10% aq. NaOH solution (20 mL). The solution 
was diluted with CH2Cl2 and the aq. layer separated and extracted with CH2Cl2, washed 
with saturated aq. sodium chloride solution (50 mL), dried (Na2SO4), filtered and 
concentrated in vacuo to afford an orange oil. Purification by flash column 
chromatography over neutral alumina (1% MeOH/CH2Cl2) afforded 113 (0.35 g, 33%) 
as a yellow oil; Rf: (1% MeOH/CH2Cl2) 0.50; [α]
22
D +40.4 (c 0.94, CHCl3); max (ATR) 
3436 br, 2968 m, 2860 m, 1453 m, 1265 m, 1156 m, 1114 vs, 1038 s, 960 s, 916 m, 872 
m, 849 m, 731 s cm
-1
; H (400 MHz, CDCl3) 3.76-3.66 (4H, m, 2 x CH2OR), 3.42 (1H, 
dd, J 10.4 and 5.0, CHHOH), 3.32 (1H, t, J 10.4, CHHOH), 2.77 (1H, m, 
NCH(CH2OH)), 2.69-2.62 (2H, m, CH2NR2), 2.39-2.43 (2H, m, CH2NR2), 0.92 (3H, d, 
J 6.7, CH3); C (100 MHz, CDCl3) 67.3, 62.1, 60.3, 48.1, 9.5; m/z (EI
+
) 145 (M
+
, 2%), 
114 (M
+ 
-CH2OH, 100); HRMS (ES
+
) MH
+
 calculated for C7H16NO2 146.1181, 
observed 146.1186. 
 
4-Iso-propylmorpholine, 116 
 
 
 
20% Pd(OH)2/C (50 mg) was added to a solution of morpholine (100 µl, 1.15 mmol), 
acetone (0.38 mL, 5.18 mmol) and acetic acid (0.38 mL, 6.64 mmol) in methanol (5 
mL) and was stirred under the presence of H2 (g) at room temperature and atmospheric 
pressure for 4 h. The catalyst was then filtered off and the filtrate concentrated in vacuo 
before addition of saturated aq. Na2CO3 solution (10 mL) and water (10 mL). The aq. 
layer was separated and extracted with CHCl3, washed with saturated aq. sodium 
chloride solution (10 mL), dried (Na2SO4), filtered and concentrated in vacuo to afford 
116 (124 mg, 83%) as a colourless oil. The compound could be used without further 
purification; max (ATR) 2962 s, 2854 m, 2812 m, 1452 m, 1365 m, 1330 m, 1260 m, 
1177, m, 1116 vs, 1068 m, 978 s, 917 m, 873 m, 751 m cm
-1
; H (400 MHz, CDCl3) 
3.72 (4H, t, J 4.8, 2 x CH2OR), 2.59 (1H, sept., J 6.5, NCH(CH3)2), 2.51 (4H, t, J 4.4, 2 
x CH2N), 1.05 (6H, d, J 6.8, 2 x CH3); C (100 MHz, CDCl3) 67.3, 54.8, 49.4, 18.5; m/z 
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(CI
+
) 130 (MH
+
, 100%), 147 (MNH4
+
, 5); HRMS (CI
+
) MH
+
 calculated for C7H16NO 
130.1232, observed 130.1233. 
 
4-sec-Butylmorpholine, 117 
 
 
 
20% Pd(OH)2/C (50 mg) was added to a solution of morpholine (200 µl, 2.30 mmol), 2-
butanone (2.0 mL, 22.3 mmol) and acetic acid (0.65 mL, 11.4 mmol) in methanol (5 
mL) and was stirred under the presence of H2 (g) at room temperature and atmospheric 
pressure for 4 h. Afterwhich the catalyst was filtered off and the filtrate concentrated in 
vacuo before addition of saturated aq. Na2CO3 solution (10 mL) and water (10 mL). The 
aq. layer was separated and extracted with CHCl3, washed with saturated aq. sodium 
chloride solution (10 mL), dried (MgSO4), filtered and concentrated in vacuo to afford a 
colourless oil. Purification by flash column chromatography (5% MeOH/CH2Cl2) 
afforded 117 (179 mg, 54%) as a colourless oil; Rf: (5% MeOH/CH2Cl2) 0.30; max 
(ATR) 2960 m, 2854 m, 2814 m, 1454 m, 1378 w, 1357 w, 1333 w, 1253 w, 1169 m, 
1116 vs, 1069 w, 995 m, 942 w, 917 w, 864 m, 767 w, 739 w cm
-1
; H (400 MHz, 
CDCl3) 3.74-3.66 (4H, m, 2 x CH2OR), 2.56-2.44 (4H, m, 2 x CH2N), 2.38 (1H, m, 
CH(CH3)(CH2CH3)), 2.57 (1H, m, CHHCH3), 1.29 (1H, m, CHHCH3), 0.98 (3H, d, J 
6.5, CH3C(H)N), 0.90 (3H, t, J 7.4 CH2CH3); C (100 MHz, CDCl3) 67.5, 61.0, 49.0, 
25.9, 14.0, 11.1; m/z (CI
+
) 144 (MH
+
, 100%), 114 (20); HRMS (CI
+
) MH
+
 calculated 
for C8H18NO 144.1388, observed 144.1381. 
 
1-Methyl-4-(para-toluenesulfonyl)piperazine, 122 
 
 
 
Triethylamine (0.77 mL, 5.5 mmol) was added to a solution of N-methylpiperazine 
(0.55 mL, 5.0 mmol) in CH2Cl2 (15 mL) at 0
o
C and stirred for 5 min. para-
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Toluenesulfonyl chloride (0.95 g, 5.0 mmol) was then added and the mixture stirred for 
1 h at 0
o
C before being allowed to warm to room temperature and stirred for a further 
16 h. The reaction was quenched with water (50 mL) and the aq. layer separated and 
extracted with CH2Cl2, before being washed sequentially with 1M HCl (50 mL), water 
(50 mL), saturated aq. NaHCO3 solution (50 mL) and saturated aq. sodium chloride 
solution (50 mL). The organic layer was separated, dried (Na2SO4), filtered and 
concentrated in vacuo to afford 122 as a crude white solid which was recrystallised from 
diethyl ether to furnish 122 (0.96 g, 75%) as a white crystalline solid; m.p. 153-154.5
o
C 
(diethyl ether); max (ATR) 2952 w, 2853 m, 2801 m, 1601 m, 1456 m, 1343 s, 1327 m, 
1283 m, 1166 vs, 1148 vs, 1093 m, 1006 m, 939 vs, 815 s, 788 m, 711 m cm
-1
;  H (400 
MHz, CDCl3) 7.64-7.61 (2H, m, 2 x ArH), 7.31 (2H, d, J 7.3, ArH), 3.01 (4H, br, 2 x 
CH2N), 2.46 (4H, t, J 5.0, 2 x CH2N), 2.42 (3H, s, CH3), 2.26 (3H, s, CH3); C (100 
MHz, CDCl3) 143.6, 132.2, 129.6, 127.9, 54.0, 45.9, 45.7, 21.5; m/z (CI
+
) 255 (MH
+
, 
100%), 99 (M
+ 
-Ts, 10); HRMS (CI
+
) MH
+
 calculated for C12H19N2O2S 255.1167, 
observed 255.1163. 
 
(2S)-2-Methyl-4-(para-toluenesulfonyl)piperazine, 124 
 
 
 
Triethylamine (190 µl, 1.37 mmol) was added to a solution of (S)-(+)-2-
methylpiperazine (125 mg, 1.25 mmol) in CH2Cl2 (7 mL) at 0
o
C and stirred for 5 min. 
para-Toluenesulfonyl chloride (238 mg, 1.25 mmol) was then added and the mixture 
stirred for 1 h at 0
o
C before being allowed to warm to room temperature and stirred for 
a further 4 h. The reaction was quenched with water (50 mL) and the aq. layer separated 
and extracted with CH2Cl2, before being washed sequentially with 1M HCl (50 mL), 
water (50 mL), saturated aq. NaHCO3 solution (50 mL) and saturated aq. sodium 
chloride solution (50 mL). The organic layer was separated, dried (Na2SO4), filtered and 
concentrated in vacuo to afford 124 (310 mg, 97%) as a white solid. The product could 
be used without further purification; m.p. 138.5-141
oC (acetone); [α]23D +38.9 (c 0.93, 
CHCl3); max (ATR) 3352 m, 2971 m, 2922 w, 2863 w, 2821 m, 1605 m, 1452 m, 1325 
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s, 1165 vs, 1133 s, 1121 m, 997 s, 914 m, 861 m, 811 m, 754 vs, 655 vs cm
-1
;  H (500 
MHz, D6-DMSO) 7.61-7.59 (2H, m, 2 x ArH), 7.47-7.44 (2H, m, 2 x ArH), 3.41-3.37 
(2H, m, CH2NTs), 2.85 (1H, dt, J 12.1 and 2.8, CH2NTs), 2.68-2.60 (2H, m, 2-CH and 
CHHN(H)), 2.41 (3H, s, ArCH3), 2.06 (1H, td, J 11.3 and 3.1, CHHN(H)), 1.70 (1H, t, J 
10.8, CHHN(H)), 0.90 (3H, d, J 6.4, 2-CH3); C (126 MHz, D6-DMSO) 143.4, 131.9, 
129.7, 127.5, 52.3, 49.5, 45.9, 44.3, 20.9, 18.8; m/z (CI
+
) 255 (MH
+
, 100%), 99 (M
+ 
-Ts, 
10); HRMS (CI
+
) MH
+
 calculated for C12H19N2O2S 255.1167, observed 255.1164. 
 
(2S)-1,2-Dimethyl-4-(para-toluenesulfonyl)piperazine, 125 
 
 
 
20% Pd(OH)2/C (50 mg) was added to a solution of piperazine 124 (123 mg, 0.48 
mmol), 35% aq. formaldehyde (0.13 mL, 4.8 mmol) and acetic acid (0.14 mL, 2.4 
mmol) in methanol (5 mL) and was stirred under the presence of H2 (g) at room 
temperature and atmospheric pressure for 4 h. Afterwhich the catalyst was filtered off 
under argon and the filtrate concentrated in vacuo before addition of saturated aq. 
Na2CO3 solution (10 mL) and water (10 mL). The aq. layer was separated and extracted 
with CH2Cl2, washed with saturated aq. sodium chloride solution (10 mL), dried 
(MgSO4), filtered and concentrated in vacuo to afford 125 (99 mg, 77%) as a white 
solid. The product could be used without further purification; m.p. 106-108
oC; [α]23D  + 
48.9 (c 0.45, CHCl3); max (ATR) 2968 w, 2860 w, 2801 m, 1596 w, 1453 m, 1359 m, 
1339 s, 1304 m, 1285 m, 1242 w, 1166 vs, 1152 s, 1126 m, 1062 m, 1020 m, 992  m, 
968 w, 925 m, 813 m, 802 m, 761 vs, 710 m, 655 s cm
-1
; H (400 MHz, CDCl3) 7.61 
(2H, d, J 8.2, 2 x ArH), 7.31 (2H, d, J 7.9, 2 x ArH), 3.54 (1H, m, CHHX), 3.46 (1H, dt, 
J 11.0 and 2.5, 3-CH), 2.75 (1H, dt, J 11.4 and 2.9, CHHX‟), 2.46 (1H, td, J 11.1 and 
2.7, CHHX), 2.41 (3H, s, CH3), 2.34 (1H, td, J 11.3 and 3.0, CHHX‟), 2.23 (3H, s, 
ArCH3), 2.19 (1H, m, 2-CH), 2.06 (1H, t, J 10.8, 3-CH), 1.01 (3H, d, J 6.3, 2-CH3); C 
(100 MHz, CDCl3) 143.6, 132.0, 129.6, 127.8, 56.8, 54.3, 52.1, 46.0, 42.0, 21.5, 16.6; 
m/z (EI
+
) 268 (M
+
, 20%), 113 (M
+ 
-Ts, 100); HRMS (EI
+
) M
+
 calculated for 
C13H20N2O2S 268.1245, observed 268.1239. 
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2-Bromoethyl trifluoromethanesulfonate, 126(185) 
 
 
 
According to the procedure of Aggarwal,(185) trifluoromethanesulfonic anhydride (5 mL, 
29.7 mmol) was added dropwise to a stirred solution of pyridine (2.50 mL, 30.9 mmol) 
in CH2Cl2 (30 mL) at -20
o
C and allowed to stir for 10 min. 2-Bromoethanol (2.03 mL, 
28.6 mmol) was then added dropwise to the reaction mixture, the cooling bath removed 
and the reaction stirred for a further 10 min. (do not allow more time than this). The 
resulting suspension was filtered and concentrated in vacuo (keeping the temperature 
<20
o
C) and petroleum ether (30 mL) was added. The mixture was filtered again and 
concentrated in vacuo and dried under a high vacuum to afford 126 (4.10 g, 56%) as a 
colourless oil. The product was used immediately without any further purification; H 
(400 MHz, CDCl3) 4.74 (2H, t, J 6.4, CH2OTf), 3.61 (2H, t, J 6.4, CH2Br). Data was in 
agreement with that reported.(185)  
 
(2-Bromoethyl)diphenylsulfonium trifluoromethanesulfonate, 127(185) 
 
 
 
A solution of 126 (4.10 g, 16.0 mmol) in toluene (13 mL) was treated with 
diphenylsulfide (3.20 mL, 19.1 mmol) at room temperature and the resultant mixture 
was heated at 100
o
C for 5 h. The solution was allowed to cool to room temperature and 
diethyl ether (20 mL) was added to precipitate 127 (4.74 g, 67%) which was isolated by 
filtration as a grey/white powder after copious washing with diethyl ether. The product 
was used without further purification; H (400 MHz, CDCl3) 8.13-8.11 (4H, m, 4 x 
PhH), 7.81-7.72 (6H, m 6 x PhH), 4.93 (2H, t, J 5.7, CH2S
+
Ph2), 3.70 (2H, t, J 5.7, 
CH2Br). Data was in agreement with that reported.
(185)  
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Diphenylvinylsulfonium trifluoromethanesulfonate, 128(185) 
 
 
 
Sulfonium salt 127 was dissolved in THF/H2O (2:1, 15 mL) and KHCO3 (0.27 g, 2.71 
mmol) was then added and the reaction stirred at room temperature for 20 min. (do not 
allow more time than this). The solvent was immediately removed in vacuo (using a 
rotary evaporator connected to a high vacuum, keeping the temperature <20
o
C). The 
residue was redissolved in CH2Cl2 (30 mL), dried (MgSO4), filtered and concentrated in 
vacuo. The residue was again dissolved in CH2Cl2 (8.5 mL), loaded onto a plug of silica 
(4 cm deep x 2 cm wide), covered with sand (1 cm) and eluted with CH2Cl2 (330 mL) 
followed by 10% MeOH/CH2Cl2 (165 mL) to afford 128 (3.62 g, 93%) as a brown oil; 
H (400 MHz, CDCl3) 7.89-7.86 (4H, m, 4 x PhH), 7.77-7.66 (6H, m 6 x PhH), 7.52 
(1H, dd, J 16.0 and 8.8, CH2=CH-), 6.69 (1H, dd, J 8.8 and 2.3, CHH=CH), 6.50 (1H, 
dd, J 15.8 and 2.3, CHH=CH). Data was in agreement with that reported.(185)  
 
General Procedures for the Preparation of N-Tosyl-β-Amino Alcohols 129-131:  
 
Triethylamine (1.2 eq.) was added to a solution of 1,2-amino alcohol (1.0 eq.) in CH2Cl2 
(0.2-0.3 M) at 0
o
C and stirred for 5 min. para-Toluenesulfonyl chloride (1 eq.) was then 
added in one portion and the mixture stirred for 1 h at 0
o
C before being allowed to 
warm to room temperature and stirred for a further 2 h. The reaction was quenched with 
water and the aq. layer separated and extracted with CH2Cl2, before being washed 
sequentially with 1M HCl (50 mL), water (50 mL), saturated aq. NaHCO3 solution (50 
m) and saturated aq. sodium chloride solution (50 mL). The organic layer was 
separated, dried (Na2SO4), filtered and concentrated in vacuo to afford the N-tosyl-β-
amino alcohols which could be purified by recrystallisation.  
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(S)-N-(para-Toluenesulfonyl)valinol, 129(185) 
 
 
 
Following the general procedures for the preparation of N-tosyl-β-amino alcohols, using 
triethylamine (0.81 mL, 5.82 mmol), L-valinol (0.5 g, 4.85 mmol) and para-
toluenesulfonyl chloride (0.92 g, 4.85 mmol) afforded 129 (1.14 g, 91%) as a white 
solid, which could be used without further purification; m.p. 86-88.5
o
C [lit.(185) 85-87
o
C 
(EtOAc/petroleum ether)]; [α]20D -30.0 (c 1.00, CHCl3); H (400 MHz, CDCl3) 7.77 
(2H, d, J 8.2, 2 x ArH), 7.30 (2H, d, J 8.2, 2 x ArH), 4.69 (1H, d, J 8.3, NH), 3.61-3.50 
(2H, m, CH2OH), 3.05 (1H, m, CHN), 2.43 (3H, s, ArCH3), 1.88 (1H, br, OH), 1.82-
1.74 (1H, m, CH(CH3)2), 0.80 (3H, d, J 4.6, CH(CH3)(CH3)), 0.78 (3H, d, J 4.6, 
CH(CH3)(CH3)); m/z (CI
+
) 258 (MH
+
, 35%), 275 (MNH4
+
, 100). All data were in 
agreement with those reported.(185)  
 
(S)-N-(para-Toluenesulfonyl)phenylglycinol, 130(241) 
 
 
 
Following the general procedures for the preparation of N-tosyl-β-amino alcohols, using 
triethylamine (0.75 mL, 5.36 mmol), L-phenylglycinol (0.61 g, 4.47 mmol) and para-
toluenesulfonyl chloride (0.85 g, 4.47 mmol) afforded 130 (1.16 g, 89%) as a white 
solid, which could be used without further purification; m.p. 106-108
o
C [lit.(241) 104-
106
o
C (hexane/EtOAc)]; [α]23D +0.82 (c 1.00, CHCl3); H (400 MHz, CDCl3) 7.62 (2H, 
d, J 8.2, 2 x ArH), 7.23-7.22 (3H, m, 3 x PhH), 7.19 (2H, d, J 8.1, 2 x ArH), 7.12-7.08 
(2H, m, PhH), 5.16 (1H, d, J 6.5, NH), 4.40 (1H, m, CHN), 3.79-3.73 (2H, m, 
CHHOH), 2.38 (3H, s, CH3), 1.83 (1H, br, OH). All data were in agreement with those 
reported.(241)
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(1S,2R)-cis-1-(para-Toluenesulfonyl)amino-2-indanol, 131(242) 
 
 
 
Following the general procedures for the preparation of N-tosyl-β-amino alcohols, using 
triethylamine (0.56 mL, 4.02 mmol), (1S,2R)-(-)-cis-1-amino-2-indanol (0.50 g, 3.35 
mmol) and para-toluenesulfonyl chloride (0.64 g, 3.35 mmol) afforded 131 (0.89 g, 88 
%) as a white solid, which could be used without further purification; m.p. 134-136
o
C 
[lit.(242) 135-136
o
C (CHCl3/hexane)]; [α]
24
D +38.0 (c 0.90, CHCl3); H (400 MHz, 
CDCl3) 7.91 (2H, d, J 8.2, 2 x ArH), 7.38 (2H, d, J 8.1, 2 x ArH), 7.26-7.19 (3H, m, 3 x 
ArH), 7.12 (1H, d, J 7.4, ArH), 5.29 (1H, d, J 9.1, NH), 4.72 (1H, dd, J 9.1 and 4.8, 1-
H), 4.36 (1H, m, 2-H), 3.09 (1H, dd, J 16.7 and 5.0, CHHPh), 2.91 (1H, d, J 16.7, 
CHHPh), 2.49 (3H, s, CH3), 2.02 (1H, d, J 5.2, OH); C (126 MHz, CDCl3) 143.8, 
139.4, 139.3, 137.5, 129.9, 128.6, 127.3, 125.4, 124.6, 72.8, 61.3, 39.4, 21.6; m/z (CI
+
) 
304 (MH
+
, 5%), 52 (100), 321 (MNH4
+
). All data were in agreement with those 
reported.(242)  
 
General Procedures for the Preparation of Morpholines 132-134: 
 
According to the procedure reported by Aggarwal,(185) triethylamine (2.1 eq.) was added 
to a stirred solution of N-tosyl-β-amino alcohols 129-131 (1 eq.) in CH2Cl2 (0.1 M) at 
0
o
C and stirred for 10 min. Diphenylvinylsulfonium salt 128 (1.1-1.3 eq.) in CH2Cl2 
(0.2 M) was then added dropwise over 2 min. and the reaction stirred at 0
o
C for 3 h 
followed by 12 h at room temperature. The reaction was quenched by the addition of 
saturated aq. NH4Cl solution and the aq. layer separated and extracted with CH2Cl2 and 
washed with saturated aq. sodium chloride solution (20 mL). The organic layer was 
separated, dried (Na2SO4), filtered and concentrated in vacuo and purified by flash 
column chromatography over silica gel to afford the morpholines.  
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(3S)-3-Iso-propyl-4-(para-toluenesulfonyl)morpholine, 132(185) 
 
 
 
Following the general procedures for the preparation of morpholines 132-134, using 
triethylamine (0.34 mL, 2.46 mmol), N-tosyl amino alcohol 129 (300 mg, 1.17 mmol) 
and diphenylvinylsulfonium salt 128 (440 mg, 1.21 mmol), after purification by flash 
column chromatography (20% EtOAc/
n
hexane) afforded 132 (246 mg, 74%) as a 
colourless oil; Rf: (20% EtOAc/hexane) 0.75; [α]
22
D +30.0 (c 1.00, CHCl3); H (400 
MHz, CDCl3) 7.72 (2H, d, J 8.3, 2 x ArH), 7.30 (2H, d, J 8.2, 2 x ArH), 3.81 (1H, d, J 
11.9, CHHOR), 3.65-3.58 (2H, m, CHHN and CHHOR), 3.35-3.10 (4H, m, CH2OR, 
CHHN and CHN), 2.43 (3H, s, ArCH3), 2.29 (1H, m, CH(CH3)2), 0.98 (3H, d, J 6.6, 
CH(CH3)(CH3), 0.96 (CH(CH3)(CH3)). All data were in agreement with those 
reported.(185)  
 
(3S)-3-Phenyl-4-(para-toluenesulfonyl)morpholine, 133 
 
 
 
Following the general procedures for the preparation of morpholines 132-134, using 
triethylamine (0.30 mL, 2.16 mmol) N-tosyl amino alcohol 130 (300 mg, 1.03 mmol) 
and diphenylvinylsulfonium salt 128 (380 mg, 1.05 mmol), after purification by flash 
column chromatography (20% EtOAc/hexane) afforded 133 (175 mg, 54%) as a white 
solid; m.p. 164-166
o
C; Rf: 0.20 (20% EtOAc/hexane) 0.20; [α]
22
D +75.7 (c 0.93, 
CHCl3); max (ATR) 2978 m, 2926 m, 2860 m, 1602 w, 1497 m, 1452 m, 1327 s, 1277 
s, 1239 m, 1153 s, 1112 vs, 1093 m, 1043 s, 986 s, 944 s, 816 m, 767 m, 734 m, 706 m, 
687 vs cm
-1
; H (400 MHz, CDCl3) 7.59-7.56 (2H, m, 2 x ArH), 7.46-7.43 (2H, m, 2 x 
PhH), 7.31-7.25 (3H, m, 3 x PhH), 7.23 (2H, m, ArH), 4.77 (1H, br t, J 2.7, 3-CH), 4.14 
(1H, dd, J 12.0 and 2.3, 2-CHH), 3.79 (1H, dt, J 11.3 and 2.9, CHHX), 3.72 (1H, dd, J 
12.0 and 3.7, 2-CHH), 3.54 (1H, td, J 10.9 and 3.1, CHHX), 3.48 (1H, dt, J 13.6 and 
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2.7, CHHX), 3.34 (1H, ddd, J 13.9, 10.8 and 3.3, CHHX), 2.41 (3H, s, CH3); C (100 
MHz, CDCl3) 143.4, 137.6, 136.9, 129.6, 128.3, 128.3, 127.7, 127.3, 69.3, 66.1, 56.1, 
42.1, 21.5; m/z (EI
+
) 317 (M
+
, 10%), 162 (M
+ 
-Ts, 100); HRMS (EI
+
) M
+
 calculated for 
C17H19NO3S 317.1086, observed 317.1093. 
 
(4aS,9aR)-4-(para-Toluenesulfonyl)-2,3,4,4a,9,9a-hexahydro-indeno-[1,4]-oxazine, 
134 
 
 
 
Following the general procedures for the preparation of morpholines 132-134, using 
triethylamine (0.29 mL, 2.08 mmol) N-tosyl amino alcohol 131 (300 mg, 0.99 mmol) 
and diphenylvinylsulfonium salt 128 (470 mg, 1.29 mmol), after purification by flash 
column chromatography (20% EtOAc/
n
hexane) afforded 134 (241 mg, 74%) as a white 
solid; m.p. 171-173
o
C; Rf: 0.20 (20% EtOAc/
nhexane) 0.20; [α]24D +100.1 (c 0.74, 
CHCl3); max (ATR) 3066 w, 2934 m, 2878 m, 2866 m, 1601 w, 1486 w, 1379 m, 1331 
m, 1302 m, 1156 vs, 1107 s, 1087 s, 1054 m, 1036 s, 988 vs, 968 s, 913 s, 823 m, 746 s, 
736 m, 660 s cm
-1
; H (500 MHz, CDCl3) 7.84-7.82 (2H, m, 2 x ArH), 7.37-7.35 (2H, 
m, 2 x ArH), 7.25-7.20 (4H, m, 4 x ArH), 5.19 (1H, d, J 3.7, 4a-H), 4.12 (1H, t, J 3.9, 
9a-H), 3.63 (1H, m, CHHX), 3.53 (1H, dd, J 11.5 and 1.9, CHHX), 3.27 (1H, td, J 11.9 
and 2.2, CHHX), 3.16-3.10 (1H, m, CHHX), 3.00 (1H, dd, J 16.4 and 4.0, 9-HH), 2.85 
(1H, d, J 16.4, 9-HH), 2.53 (3H, s, CH3); C (126 MHz, CDCl3) 143.7, 140.3, 138.2, 
138.1, 130.0, 128.1, 127.1, 125.3, 124.1, 64.2, 60.5, 40.8, 37.9, 21.6; m/z (EI
+
) 329 (M
+
, 
15 %), 174 (M
+ 
-Ts, 100); HRMS (EI
+
) M
+
 calculated for C18H19NO3S 329.1086, 
observed 329.1084 
 
General Procedures for the Deprotection of Morpholines 132-134: 
 
According to the procedure reported by Albanese,(188) Phenol (35 eq.) and 45% 
HBr/AcOH (0.07 M in substrate) were added to N-tosyl morpholines 132-134 (1 eq.) at 
0
o
C and stirred for up to 24 h (room temperature-110
o
C). The reaction was cooled to 
0
o
C and 20% aq. NaOH was added and extracted with Et2O. The organic layer was 
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separated, dried (MgSO4), filtered and concentrated in vacuo and purified by flash 
column chromatography over silica gel to afford the deprotected morpholines.  
 
(3S)-3-Isopropylmorpholinium trifluoroacetic acetate, 135 
 
 
 
Following the general procedures for the deprotection of morpholines 132-134, using 
phenol (775 mg, 8.24 mmol), morpholine 132 (69 mg, 0.24 mmol) and 45% HBr/AcOH 
(3.4 mL) at 110
o
C for 16 h; after purification by flash column chromatography (20% 
MeOH/EtOAc to MeOH), trifluoroacetic acid (0.5 mL) was added and the solution 
concentrated in vacuo to afford 135 (12.1 mg, 39%) as a white solid; Rf: (MeOH) 0.40; 
mp 136-140
o
C; [α]24D +85.2 (c 0.61, CHCl3); max (ATR) 3324 br, 2960 m, 2864 m, 
2789 m, 1449 m, 1367 w, 1312 w, 1103 vs, 968 w, 928 m, 855 m, 768 m, 595 m cm
-
1
;H (400 MHz, CDCl3) 4.06 (1H, dd, J 12.8 and 2.8), 3.97 (1H, br d, J 12.5), 3.80 (1H, 
t, J 12.1), 3.63 (1H, t, J 12.4), 3.28 (1H, br d, J 12.3), 3.17 (1H, br), 3.00 (1H, br), 1.92 
(1H, sept., -CH(CH3)2), 1.05 (3H, d, J 6.8 , -CH(CH3)2), 0.99 (3H, d, J 6.8, CH(CH3)2); 
C (100 MHz, CDCl3) 66.9, 63.4, 60.6, 43.9, 28.3, 18.4, 18.2; m/z (CI
+
) 130 (MH
+
, 100 
%); HRMS (CI
+
) MH
+
 calculated for C7H16NO 130.1232, observed 130.1227. 
 
(3S)-3-Phenylmorpholine, 136 
 
 
 
Following the general procedures for the deprotection of morpholines 132-134, using 
phenol (360 mg, 3.82 mmol), morpholine 133 (35 mg, 0.11 mmol) and 45% HBr/AcOH 
(1.6 mL) at room temperature for 16 h; after purification by flash column 
chromatography (15% MeOH/CH2Cl2) afforded 136 (19.4 mg, quant.) as a colourless 
oil; Rf: (15% MeOH/CH2Cl2) 0.35; [α]
24
D +36.8 (c 0.87, CHCl3); max (ATR) 3429 br, 
2962 w, 2848 w, 2789 m, 1493 w, 1449 m, 1350 w, 1289 m, 1232 w, 1116 s, 1037 m, 
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984 m, 904 w, 880 s, 794 w, 756 s, 700 vs, 650 m, 590 m cm
-1
; H (400 MHz, CDCl3) 
7.42-7.26 (5H, m, PhH), 3.94 (1H, dd, J 10.1 and 3.2), 3.88 (1H, dd, J 11.3 and 2.9), 
3.84 (1H, dd, J 11.3 and 3.3), 3.69 (1H, td, J 11.3 and 2.7), 3.45 (1H, t, J 10.5), 3.12 
(1H, td, J 11.6 and 3.3), 3.00 (1H, br dt, J 11.6); C (100 MHz, CDCl3) 139.8, 128.5, 
127.9, 127.2, 73.2, 66.9, 60.4, 46.3; HRMS (ES
+
) M
+
 calculated for C10H14NO 
164.1075, observed 164.1064. 
 
(4aS,9aR)- 2,3,4,4a,9,9a-Hexahydro-indeno-[1,4]-oxazine, 137 
 
 
 
Following the general procedures for the deprotection of morpholines 132-134, using 
phenol (252 mg, 2.74 mmol), morpholine 134 (25 mg, 0.08 mmol) and 45% HBr/AcOH 
(2.3 mL) at 50
o
C for 24 h; after purification by flash column chromatography (20% 
EtOAc/hexane to 20% MeOH/EtOAc) gave recovery of starting material 134 (6 mg, 
24%) and afforded 137 (7.8 mg, 56%) as a colourless oil; Rf: (20% MeOH/EtOAc) 
0.20; [α]22D -8.9 (c 0.68, MeOH); max (ATR) 3357 br, 2907 m, 2849 m, 2677 m, 1610 
m, 1457 m, 1336 w, 1272 w, 1161 m, 1135 m, 1106 s, 1085 vs, 1018 m, 869 w, 824 w, 
739 vs cm
-1
; H (400 MHz, CDCl3) 7.42-7.41 (1H, m, ArH), 7.43-7.22 (3H, m, ArH), 
4.36-4.34 (1H, m), 4.2-4.28 (1H, m), 3.70 (1H, dt, J 11.3 and 3.7), 3.63 (1H, td, J 10.7 
and 2.2), 3.02-2.87 (3H, m); C (100 MHz, CDCl3) 141.5, 139.0, 128.1, 126.9, 125.6, 
123.8, 77.1, 64.7, 59.8, 39.9, 37.6; m/z (CI
+
) 176 (MH
+
, 100%); HRMS (CI
+
) MH
+
 
calculated for C11H14NO 176.1075, observed 176.1076. 
 
General Procedures for the Preparation of N-Methylmorpholines 138-140 from 
Morpholines 135-137 
 
20% Pd(OH)2/C was added to a solution of morpholines 135-137 (1 eq.), 35% aq. 
formaldehyde (12-45 eq.) and acetic acid (6-22 eq.) in methanol (0.02-0.3 M) and was 
stirred under the presence of H2 (g) at room temperature and atmospheric pressure for 4-
5 h. The catalyst was then filtered off under N2 (g) and the filtrate concentrated in vacuo 
before addition of saturated aq. Na2CO3 solution (10 mL). The aq. layer separated and 
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extracted with CH2Cl2, washed with saturated aq. sodium chloride solution (10 mL), 
dried (MgSO4), filtered and concentrated in vacuo. Flash column chromatography over 
silica gel afforded N-methylmorpholines 138-140. 
 
 (S)-3-Isopropyl-4-methylmorpholine, 138 
 
 
 
Following the general procedures for the preparation of N-methyl morpholines 138-140, 
using 20% Pd(OH)2/C (10 mg), morpholine 135 (55.0 mg, 0.42 mmol), 35% aq. 
formaldehyde (140 µL, 5.0 mmol) and acetic acid (145 µL, 2.5 mmol) in MeOH (1.5 
mL), for 5h, afforded 138 (21.8 mg, 36%) as a colourless oil which could be used 
without further purification; [α]20D +76.0 (c 1.21, CHCl3); max (ATR) 2960 m, 2797 m, 
1454 m, 1370 w, 1289 m, 1128 s, 1112 s, 1060 m, 1007 m, 956 m, 892 m, 785 w cm
-1
; 
H (400 MHz, CDCl3) 3.76-3.72 (2H, m), 3.58 (1H, td, J 11.5 and 2.4), 3.31 (1H, t, J 
10.9), 2.67 (1H, dt, J 11.7 and 1.8), 2.36 (1H, td, J 11.7 and 3.9), 2.22 (3H, s, NCH3), 
2.09 (1H, m, -CH(CH3)2), 1.94 (1H, dt, J 10.7 and 3.6), 0.90 (3H, d, J 7.2, -
CH(CH3)CH3), 0.86 (3H, d, J 7.2, -CH(CH3)CH3); C (100 MHz, CDCl3) 67.3, 66.8, 
66.4, 56.5, 42.5, 26.0, 19.4, 15.5; HRMS (ES
+
) MH
+
 calculated for C8H18NO 144.1388, 
observed 144.1381. 
 
(3S)-3-Phenyl-N-methylmorpholine, 139 
 
 
 
Following the general procedures for the preparation of N-methyl morpholines 138-140, 
using 20% Pd(OH)2/C (10 mg), morpholine 136 (18.5 mg, 0.11 mmol), 35% aq. 
formaldehyde (0.1 mL, 3.6 mmol) and acetic acid (0.1 mL, 1.8 mmol) for 5 h; after 
purification by flash column chromatography (30% EtOAc/hexane) afforded 139 (16.2 
mg, 83%) as a colourless oil; Rf: (30 % EtOAc / hexane) 0.25; [α]
24
D +31.9 (c 0.69, 
CHCl3); max (ATR) 3004 m, 2985 w, 2912 w, 2857 m, 2840 m, 1622 s, 1499 m, 1447 
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m ,1274 m, 1255 m, 1219 m, 1202 m, 1108 s, 1079 m, 1004 m, 925 s, 848 m, 744 s cm
-
1
; H (400 MHz, CDCl3) 7.34-7.27 (5H, m, PhH), 3.92 (1H, m), 3.80 (1H, td, J 11.5 and 
1.4), 3.72 (1H, dd, J 11.6 and 3.3), 3.41 (1H, t, J 10.9), 3.08 (1H, dd, J 10.3 and 3.1), 
2.85 (1H, d, J 11.8), 2.43 (1H, td, J 11.7 and 3.4), 2.08 (3H, s, CH3); C (100 MHz, 
CDCl3) 128.5, 128.1, 127.8, 127.4, 73.0, 69.3, 67.2, 55.5, 43.6; m/z (CI
+
) 178 (MH
+
, 
100%); HRMS (CI
+
) MH
+
 calculated for C11H16NO 178.1232, observed 178.1234. 
 
(4aS,9aR)-4-Methyl-2,3,4,4a,9,9a-hexahydro-indeno-[1,4]-oxazine, 140 
 
 
 
Following the general procedures for the preparation of N-methyl morpholines 138-140, 
using 20% Pd(OH)2/C (10 mg), morpholine 137 (14 mg, 0.08 mmol), 35% aq. 
formaldehyde (0.1 mL, 3.6 mmol) and acetic acid (0.1 mL, 1.8 mmol) for 4 h; after 
purification by flash column chromatography (Et2O) afforded 140 (11 mg, 73 %) as a 
colourless oil; Rf: (Et2O) 0.45; [α]
23
D -8.3 (c 0.72, MeOH); max (ATR) 2959 m, 2924 m, 
2876 m, 2792 w, 1463 m, 1432 m, 1365 w, 1336 w, 1288 m, 1229 m, 1133 s, 1115 vs, 
1040 m, 1003 s, 888 s, 834 m, 745 vs, 676 m, 644 m cm
-1
; H (400 MHz, CDCl3) 7.35-
7.17 (4H, m, ArH), 4.41 (1H, m), 3.94 (1H, m), 3.81 (1H, m), 3.42-3.36 (2H, m), 2.82 
(1H, dd, J 15.1 and 6.5), 2.74 (1H, m), 2.48 (3H, s, CH3), 2.43 (1H, m); C (100 MHz, 
CDCl3) 153.2, 141.3, 128.2, 128.1, 126.1, 125.9, 76.3, 66.8, 61.9, 51.5, 42.8, 33.0; m/z 
(CI
+
) 190 (MH
+
, 100%); HRMS (CI
+
) MH
+
 calculated for C12H16NO 190.1232, 
observed 190.1233. 
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General Procedures and Results for the Aziridination of Chalcone using Chiral 
1,4-Heterocycles (Catalyst Screening): trans-Phenyl-(3-phenylaziridin-2-
yl)methanone, 92(87)
 
 
 
 
O-diphenylphosphinyl hydroxylamine (1.05 eq.) was added to a solution of chiral 1,4-
heterocycle (1.05 eq.) in MeCN (0.06M) at room temperature and the mixture stirred for 
0.5 h. NaOH (2 eq.) and chalcone (1.eq.) were added sequentially and the mixture 
allowed to stir at room temperature overnight. The reaction was quenched by the 
addition of saturated aqueous NH4Cl solution and the aqueous layer separated and 
extracted with CH2Cl2, dried (Na2SO4), filtered and concentrated in vacuo. Purification 
by flash column chromatography (10% EtOAc/
n
hexane) afforded aziridine 92 as a white 
solid; Rf: (10% EtOAc/
n
hexane) 0.50; m.p. 99-101
o
C (lit.(87) 99-101
o
C); H (400 MHz, 
CDCl3) 8.00 (2H, d, J 8.8, 2 x PhH), 7.62 (2H, t, J 7.4, 2 x PhH), 7.49 (1H, t, J 7.6, 
PhH), 7.39-7.30 (5H, m, 5 x PhH), 3.52 (1H, dd, J 2.3, 2-CHN), 3.18 (1H, dd, J 2.5, 3-
CHN), 2.68 (1H, br, NH); m/z (EI
+
) 233 (M
+
, 80%), 206 (100), 105 (100). All data were 
in agreement with those reported.(87)
  
 
Entry
a
 Promoter Yield Aziridine /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 97 <5 - - 
2 111 5 14 3R,2S (+) 
3 112 <5 - - 
4 113 12 <5 3R,2S (+) 
5 125 67 23 2R,3S (-) 
6 138 40 30 2R,3S (-) 
7 139 <5 - - 
8 140 47 27 2R,3S (-) 
a
 Reactions performed on a 0.04-0.24 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis (conditions: 93:7 hexane:IPA, 
0.8 mL/min., 254 nm, AD-H) (3R,2S, tR = 16.0 min., 2R,3S, tR = 18.8 min.); 
d
 Configuration of major 
enantiomer is determined by comparison to the literature.
(192)
 
 
 
186 
 
Preparation of Cinchona Alkaloid Promoters: 
 
Where deduced, 
1
H NMR assignments for the quinuclidine moiety of cinchona alkaloid 
derivatives are given in accordance to the accepted numbering system within the 
literature and follow the scheme: 
 
 
 
9-Amino(9-deoxy)-9-epiquinine, 167(200) 
 
 
 
According to the procedure of Brunner,(200) quinine (2.5 g, 7.7 mmol) and PPh3 (2.43 g, 
9.25 mmol) were dissolved in THF (30 mL) and the solution was cooled to 0°C. 
Diisopropyl azodicarboxylate (1.67 mL, 8.48 mmol) was added in one portion before 
the dropwise addition of diphenyl phosphoryl azide (2.0 mL, 9.25 mmol) in THF (10 
mL). The mixture was allowed to warm to room temperature and stirred for 3 h before 
the addition of PPh3 (4.0 g, 15.4 mmol) in THF (10 mL). The mixture was then heated 
at 50
o
C until visible evolution of N2 (g) had ceased. H2O (2 mL) was then added and the 
solution stirred for a 16 h at room temperature. The solvents were removed in vacuo and 
the residue was dissolved in CH2Cl2 and 1M aq. HCl (1:1, 100 mL). The aq. phase was 
washed with CH2Cl2 and basified with conc. aq. NH3, extracted with CH2Cl2, dried 
(MgSO4), filtered and concentrated in vacuo to afford a tacky yellow residue. 
Purification by flash column chromatography over neutral alumina (1% MeOH/CH2Cl2) 
afforded 167 (1.36 g, 55%) as a pale yellow oil; Rf: (1% MeOH/CH2Cl2) 0.10; [α]
26
D 
+100.7 (c 0.95, CHCl3) [lit.
(200) [α]25D +80 (c 1.1, CHCl3); δH (400 MHz, CDCl3) 8.75 
(1H, d, J 4.5, ArH), 8.04 (1H, d, J 9.2, ArH), 7.66 (1H, br, ArH), 7.46 (1H, br d, J 3.5, 
187 
 
ArH), 7.39 (1H, dd, J 9.2, 2.7, ArH), 5.81 (1H, m, -CH=CH2), 5.03-4.96 (2H, m, -
CH=CH2), 4.60 (1H, br d, J 8.9, 9-CHNH2), 3.97 (3H, s, OCH3), 3.28 (1H, dd, J 13.8 
and 10.1), 3.20 (1H, m), 3.08 (1H, m), 2.85-2.77 (2H, m), 2.29 (1H, br), 1.76 (2H, br, 
NH2), 1.63 (1H, m), 1.56 (1H, m), 1.44 (1H, m), 0.78 (1H, m); m/z (EI
+
) 323 (M
+
, 3%), 
136 (100). All data were in agreement with those reported.(200)
 
 
N-(p-Toluenesulfonyl)-9-Amino(9-deoxy)-9-epiquinine, 168 
 
 
 
p-Toluenesulfonyl chloride (77 mg, 0.41 mmol) was added in one portion to a solution 
of amine 167 (88 mg, 0.27 mmol) and K2CO3 (45 mg, 0.33 mmol) in CH2Cl2 (6 mL) at 
room temperature and stirred for 16 h. The reaction mixture was diluted with CH2Cl2, 
filtered to remove solid K2CO3 and washed with saturated aq. Na2CO3 solution (3 x 10 
mL). The organic layer was then separated, dried (MgSO4), filtered and concentrated in 
vacuo to afford a white residue. Purification by flash column chromatography (CH2Cl2 
to 5% MeOH/CH2Cl2) afforded 168 (89 mg, 69%) as a white solid; Rf: (5% 
MeOH/CH2Cl2) 0.30; m.p. 64.5-67
oC; [α]22D +49.1 (c 1.43 CHCl3); max (ATR) 3211 w, 
2927 m, 2871 m, 1621 m, 1593 m, 1508 m, 1477 m, 1323 m, 1228 m, 1154 vs, 1091 s, 
1030 m, 987 m, 915 m, 854 m, 813 s, 728 m, 661 vs cm
-1
; δH (400 MHz, C2D2Cl4, 403 
K) 8.61 (1H, d, J 4.4, ArH), 8.01 (1H, d, J 9.0, ArH), 7.54 (1H, br, ArH), 7.41-7.33 (3H, 
m, 3 x ArH), 7.28 (1H, br, ArH), 6.92 (1H, br d, J 7.5, ArH), 5.73 (1H, m, -CH=CH2), 
5.05-5.00 (2H, m, -CH=CH2), 4.84 (1H, br), 4.01 (3H, s, OCH3), 3.35 (1H, dd, J 13.8 
and 10.1), 3.20 (1H, br), 3.05 (1H, m), 2.88-2.76 (2H, m), 2.39 (1H, br), 2.29 (3H, s, 
ArCH3), 1.75 (1H, m), 1.69-1.64 (2H, m), 1.42 (1H, m), 0.97 (1H, m); δC (126 MHz, 
C2D2Cl4, 403 K) 158.7, 146.7, 144.1, 142.4, 137.6, 136.7, 136.7, 131.4, 128.1, 127.4, 
126.4, 121.9, 121.6, 117.0, 102.0, 58.6, 56.3, 54.2, 41.2, 36.4, 29.3, 27.2, 24.6, 24.1, 
20.6; m/z (CI
+
) 478 (M
+
, 95%), 189 (100), 309 (98); HRMS (ES
+
) M
+
 calculated for 
C27H32N3O3S 478.2164, observed 478.2174. 
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N-(tert-Butoxycarbonyl)methanesulfonamide, 169(208) 
 
 
 
According to the procedure of Aldrich,(208) triethylamine (0.18 mL, 1.26 mmol), DMAP 
(12.8 mg, 0.11 mmol) and di-tert-butyldicarbonate (229 mg, 1.05 mmol) were added 
sequentially to a stirred solution of methanesulfonamide (100 mg, 1.05 mmol) in 
CH2Cl2 at 0
o
C. The mixture was allowed to warm to room temperature and the mixture 
stirred for 16 h. The solution was then concentrated in vacuo, diluted with EtOAc and 
washed with 1M HCl solution (5 mL) and H2O (15 mL). The organic layer was then 
separated, dried (MgSO4), filtered and concentrated in vacuo to afford a pale yellow 
solid which was recrystallised from hexane to furnish 169 (163 mg, 80%) as a white 
crystalline solid; m.p. 107-108.5
o
C (hexane) [lit.(208) 108-109
o
C (hexane)]; H (400 MHz, 
CDCl3) 7.09 (1H, br, NH), 3.27 (3H, s, SO2CH3), 1.52 (9H, s, (CH3)3). All data were in 
agreement with those reported.(208)
 
 
N-(methanesulfonyl)-9-Amino(9-deoxy)-9-epiquinine, 170 
 
 
 
Quinine (135 mg, 0.41 mmol) and PPh3 (130 mg, 0.50 mmol) were dissolved in THF (5 
mL) and the solution was cooled to 0°C. Diisopropyl azodicarboxylate (98 µL, 0.50 
mmol) was added in one portion before the dropwise addition of N-(Boc)sulfonamide 
169 (85 mg, 0.44 mmol) in THF (5 mL). The mixture was allowed to warm to room 
temperature and then heated at 40
o
C and stirred for 16 h. The reaction was concentrated 
in vacuo and passed down a silica column (EtOAc to 15% MeOH/EtOAc) to remove 
the majority of impurities. The crude N-Boc-protected sulfonamide was dissolved in 
CH2Cl2 (5 mL) and cooled to 0
o
C and trifluoroacetic acid (1 mL) was added and the 
solution warmed to room temperature and stirred for 16 h. the mixture was concentrated 
in vacuo, washed with saturated aq. NaHCO3 (15 mL), extracted with CH2Cl2, dried 
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(MgSO4), filtered and concentrated in vacuo. Purification by flash column 
chromatography (5% MeOH/CH2Cl2) afforded 170 (51 mg, 31%, two steps) as a 
colourless oil; Rf: (5% MeOH/CH2Cl2) 0.20; [α]
23
D +74.5 (c 1.10, CHCl3); max (ATR) 
3211 w, 2945 m, 1271 w, 1621 m, 1593 m, 1508 m, 1474 m, 1324 m, 1241 m, 1154 vs, 
1091 m, 1031 m, 1005 m, 950 m, 888 m, 854 m, 742 vs, 704 s, 662 vs, cm
-1
; δH (400 
MHz, CDCl3)
2
 8.82 (0.65H, d, J 4.6, ArH), 8.72 (0.35H, d, J 4.3, ArH), 8.06 (1H, t, J 
9.2, ArH), 7.84 (0.35H, d, J 2.6, ArH), 7.58 (0.65H, d, J 4.6, ArH), 7.55 (0.65H, d, J 
2.5, ArH), 7.42 (1H, td, J 9.2 and 2.6, ArH), 7.35 (0.35H, d, J 4.3, ArH), 5.74-5.58 (1H, 
m, -CH=CH2), 5.23 (0.65H, d, J 10.7, 9-CHOSO2CH3), 5.00-4.88 (2H, m, -CH=CH2), 
4.53 (0.35H, d, J 10.9, 9-CHOSO2CH3), 3.99 (1.85H, s, ArOCH3), 3.93 (1.15H, s, 
ArOCH3), 3.43-3.36 (0.35H, m), 3.09-3.01 (0.35H, m), 2.93-2.87 (0.65H, m), 2.44 
(1.85H, s, SO2CH3), 2.32 (1.15H, s, SO2CH3 and 1H, br), 1.73-1.58 (3H, m), 1.40-1.30 
(1H, m), 0.99-0.86, (1H, m); C (100 MHz, CDCl3)
2
 158.4, 157.5, 147.6, 147.4, 145.4, 
144.8, 143.7, 141.2, 140.9, 139.7, 132.3, 131.8, 128.7, 126.9, 124.2, 122.3, 121.6, 
119.9, 114.8, 102.9, 100.8, 62.8, 61.0, 55.9, 55.7, 55.6, 42.2, 41.7, 40.3, 39.9, 39.6, 
39.3, 29.7, 27.8, 27.7, 27.6, 27.5, 27.4, 26.4, 25.3; m/z (CI
+
) 402 (MH
+
, 100%); HRMS 
(CI
+
) MH
+
 calculated for C21H28N3O3S 402.1851, observed 402.1844. 
 
Quinine mesylate, 171(209) 
 
 
 
According to the procedure of Hoffmann,(209) methanesulfonyl chloride (0.57 mL, 7.4 
mmol) was added to a stirred solution of quinine (2.0 g, 6.2 mmol) and triethylamine 
(2.0 mL, 14.2 mmol) in THF (5 mL) and heated under reflux for 4 h after which time a 
deep orange colour prevailed. The reaction was allowed to cool to room temperature 
and saturated aq. NaHCO3 (20 mL) was added. The aq. layer was extracted with 
                                                          
2
 When elevated temperature 
1
H NMR spectra were attempted partial resonance coalescence was 
observed, however, this was coupled with significant product decomposition. As a further result multiple 
signals in the 
13
C NMR spectra are observed.  
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CH2Cl2, dried (MgSO4), filtered and concentrated in vacuo. The crude product was 
purified by flash column chromatography (10% MeOH/EtOAc) to afford 171 (2.44 g, 
98%) as a white foam; Rf: (10% MeOH/EtOAc) 0.35; [α]
23
D -61.5 (c 1.30, CHCl3); δH 
(400 MHz, CDCl3) 8.81 (1H, d, J 4.4, ArH), 8.06 (1H, d, J 9.2, ArH), 7.48-7.32 (3H, m, 
ArH), 6.18 (1H, br, 9-CHOSO2CH3), 5.85 (1H, m, -CH=CH2), 5.04-5.00 (2H, m, -
CH=CH2), 3.98 (3H, s, OCH3), 3.41 (1H, br), 3.10 (1H, br), 2.98 (1H, dd, J 13.6 and 
10.1), 2.68-2.53 (5H, m, SO2CH3 and 2 x -CH-), 2.28 (1H, br), 2.07 (1H, br), 1.91 (1H, 
m), 1.74 (1H, m), 1.68-1.52 (2H, m). All data were in agreement with those reported.(93) 
 
9-Epiquinine, 159(209) 
 
 
 
According to the procedure of Hoffmann,(209) quinine mesylate 171 (2.44 g, 6.05 mmol) 
and L-tartaric acid (0.91 g, 6.05 mmol) in H2O (25 mL) were heated under reflux for 1 
h. The solution was then cooled to room temperature and quenched with saturated aq. 
NaHCO3 (20 mL). The mixture was extracted with CHCl3, dried (MgSO4) and 
concentrated in vacuo. The crude product was purified by flash column chromatography 
(MeOH) to afford 171 (1.56 g, 79%) as a white foam; Rf: (MeOH) 0.15; [α]
23
D +34.9 (c 
0.86, CHCl3); δH (400 MHz, CDCl3) 8.66 (1H, d, J 4.5, ArH), 7.97 (1H, d, J 9.2, ArH), 
7.60 (1H, d, J 2.6, ArH), 7.34 (1H, d, J 4.5, ArH), 7.31 (1H, dd, J 9.3 and 2.8, ArH), 
5.68 (1H, m, -CH=CH2), 5.03-4.56 (4H, m, 9-CHOH, CH=CH2 and CHOH), 3.87 (3H, 
s, OCH3), 3.19 (1H, dd, J 13.8 and 10.0), 3.14-3.03 (2H, m), 2.74-2.68 (2H, m), 2.25 
(1H, br), 1.64 (1H, br), 1.55-1.51 (2H, m), 1.39 (1H, m), 0.89 (1H, dd, J 13.8 and 7.5); 
δC (100 MHz, CDCl3) 157.2, 147.4, 144.6, 144.3, 141.2, 131.4, 128.0, 121.2, 120.0, 
114.4, 102.4, 71.2, 61.3, 55.7, 55.3, 40.5, 39.7, 27.8, 27.0, 25.0. All data were in 
agreement with those reported.(93) 
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(3R,4S)-8-[(6-Methoxyquinolin-4-yl)methylene]-5-vinylquinuclidine, 173 
 
 
 
Epiquinine, 159, (150 mg, 0.46 mmol) and PPh3 (145.5 mg, 0.55 mmol) were dissolved 
in THF (3 mL) and the solution was cooled to 0°C. Diisopropyl azodicarboxylate (100 
µL, 0.51 mmol) was added in one portion before the dropwise addition of diphenyl 
phosphoryl azide (119 µL, 0.55 mmol) in THF (1 mL). The mixture was allowed to 
warm to room temperature and stirred for 3 h before the addition of PPh3 (242 mg, 0.92 
mmol) in one portion and the mixture was heated at 50
o
C for 3 h. H2O (1 mL) was then 
added and the solution stirred for a 16 h at room temperature. The solvents were 
removed in vacuo and the residue was dissolved in CH2Cl2 and 1M aq. HCl (1:1, 10 
mL). The aq. phase was washed with CH2Cl2 and basified with conc. aq. NH3, extracted 
with CH2Cl2, dried (MgSO4), filtered and concentrated in vacuo to an off-white foam. 
Purification by flash column chromatography (7% MeOH/EtOAc) afforded 173 (63.4 
mg, 47%) as a colourless oil; Rf: (7% MeOH/EtOAc) 0.45; [α]
22
D +55.2 (c 0.58, 
CHCl3); max (ATR) 2933 m, 2865 m, 1619 s, 1579 m, 1506 s, 1468 m, 1430 m, 1357 
m, 1257 m, 1227 vs, 1106 w, 1084 m, 1031 s, 913 s, 840 s, 729 s, 713 s, 676 w cm
-1
; δH 
(400 MHz, CDCl3) 8.70 (1H, d, J 4.6, ArH), 7.97 (1H, d, J 9.2, ArH), 7.82 (1H, d, J 4.6, 
ArH), 7.33 (1H, dd, J 9.1 and 2.7, ArH), 7.27 (1H, s, ArH), 6.42 (1H, s, -CH=CR2), 
5.98-5.89 (1H, br m, -CH=CH2), 5.10-5.05 (2H, m, -CH=CH2), 3.95 (3H, s, OCH3), 
3.28 (1H, dd, J 13.8 and 9.5), 3.07-2.93 (2H, m), 2.80-2.71 (2H, m), 2.44-2.38 (2H, m), 
2.02-1.99 (1H, m), 1.73-1.65 (2H, m); C (100 MHz, CDCl3) 157.3, 154.3, 147.9, 144.6, 
140.8, 139.7, 131.5, 127.7, 121.5, 120.9, 114.8, 1114.4, 102.1, 55.5, 53.78, 47.8, 39.7, 
30.5, 29.7, 27.2; m/z (CI
+
) 307 (MH
+
, 100%); HRMS (CI
+
) MH
+
 calculated for 
C20H23N2O 402.1810, observed 402.1815. 
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Epiquinine Mesylate, 174 
 
 
 
Methane sulfonylchloride (24 µL, 0.30 mmol) was added to a stirred solution of 
epiquinine, 159, (82.5 mg, 0.25 mmol) and triethylamine (71 µL, 0.51 mmol) in THF (5 
mL) and the solution stirred at room temperature for 4 h. Saturated aq. NaHCO3 (10 
mL) was added and the aq. layer was extracted with CH2Cl2, dried (MgSO4), filtered 
and concentrated in vacuo. The crude product was purified by flash column 
chromatography (10% MeOH/EtOAc) to afford 174 (67 mg, 66%) as a white solid; Rf: 
(10% MeOH/EtOAc) 0.45; m.p. 158-162
oC; [α]24D +42.1 (c 0.38, CHCl3); max (ATR) 
3012 w, 2934 m, 1621 m, 1594 m, 1508 m, 1480 m, 1437 m, 1356 m, 1231 s, 1165 vs, 
1089 m, 1028 m, 983 m, 859 vs, 817 s, 782 m, 712 m, 673 m cm
-1;  δH (400 MHz, 
CDCl3)
3
 8.81 (1H, br, ArH), 8.07 (1H, d, J 9.3, ArH), 7.47 (2H, br, 2 x ArH), 7.43 (1H, 
dd, J 9.2 and 2.6, ArH), 6.34 (0.66H, br, 9-CHOSO2CH3), 5.79 (1.33H, br, CH=CH2 and 
9-CHOSO2CH3), 5.06-5.02 (2H, br m, -CH=CH2), 3.99 (3H, s, OCH3), 3.51-3.23 (2H, 
br), 3.07 (3H, br s, -SO2CH3), 2.93-2.84 (2H, br m), 2.35 (1H, br), 1.73 (1H, br), 1.68-
1.56 (2H, br m), 1.44 (1H, br), 0.78 (1H, m); C (100 MHz, CDCl3) 158.5, 147.4, 144.8, 
140.6, 139.7, 132.0, 127.3, 122.2, 119.6, 114.8, 100.4, 76.4, 59.8, 55.5, 41.1, 39.1, 39.0, 
27.5, 27.2, 24.8; m/z (CI
+
) 403 (MH
+
, 20%), 309 (MH
+
-OSO2CH3, 100); HRMS (CI
+
) 
MH
+
 calculated for C21H27N2O4S 403.1692, observed 403.1703. 
 
 
 
 
                                                          
3
 Whilst an 
1
H NMR spectrum was also recorded at 400 MHz in D6-DMSO at 340 K, and led to the 
observation of two distinct resonances of 1H being observed for CHSO2CH3 and CH=CH2, partial product 
decomposition was also observed leading to incomplete characterisation at this temperature. 
Distinguishable resonances include; δH (400 MHz, D6-DMSO, 298K) 6.26 (0.66H, br), 5.87 (1.33H, br); 
δH (400 MHz, D6-DMSO, 340K) 6.12 (1H, br, 9-CHSO2CH3), 5.86 (1H, m, -CH=CH2). 
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9-Amino-(9-deoxy)-quinine, 172 
 
 
 
Epiquinine, 159, (1.03 g, 3.70 mmol) and PPh3 (1.16 g, 4.44 mmol) were dissolved in 
THF (23 mL) and the solution was cooled to 0°C and diisopropyl azodicarboxylate 
(1.10 mL, 5.55 mmol) was added dropwise. After 5 min. diphenyl phosphoryl azide 
(1.20 mL, 5.55 mmol) was added dropwise and the mixture was allowed to warm to 
room temperature and stirred for 1 h and then at 45
o
C for 2 h. PPh3 (1.16 g, 4.44 mmol) 
was then added in one portion and the mixture heated at 45
o
C until visible evolution of 
N2 (g) had ceased. H2O (2 mL) was then added and the solution stirred for a 16 h at 
room temperature. The solvents were removed in vacuo and the residue was dissolved 
in CH2Cl2 and 1M aq. HCl (1:1, 100 mL). The aq. phase was washed with CH2Cl2 and 
basified with conc. aq. NH3, extracted with CH2Cl2, dried (MgSO4), filtered and 
concentrated in vacuo to afford a yellow oil. The crude oil was then purified by mass 
triggered reverse phase chromatography (0.05% NH3HOAc in MeCN/H2O) and finally 
washed with saturated aq. K2CO3 solution, extracted with CH2Cl2, dried (MgSO4), 
filtered and concentrated in vacuo to afford 172 (263 mg, 22%) as a pale orange oil; 
[α]19D -55.1 (c 0.65, CHCl3); max (ATR) 3275 br, 2937 s, 2863 m, 1620 vs, 1589 m, 
1508 vs, 1472 m, 1431 m, 1358 w, 1226 vs, 1028 s, 911 s, 827 vs, 713 m cm
-1; δH (400 
MHz, CDCl3) 8.74 (1H, d, J 4.6, ArH), 8.01 (1H, d, J 9.2, ArH), 7.45 (1H, d, J 2.6, 
ArH), 7.37-7.34 (2H, m, 2 x ArH), 5.91 (1H, m, CH=CH2), 5.08-5.02 (2H, m, 
CH=CH2), 4.70 (1H, br d, J 6.3, CHNH2), 3.97 (3H, s, OCH3), 3.21 (1H, q, J 8.4), 3.08 
(1H, br), 3.06 (1H, dd, J 13.7 and 10.0), 2.58 (1H, m), 2.30 (1H, br), 2.12 (1H, m), 2.05-
1.47 (2H, br, NH2), 1.91 (1H, m), 1.69 (1H, m), 1.58 - 1.49 (2H, m); C (100 MHz, 
CDCl3); 157.8, 149.1, 147.9, 144.8, 141.7, 132.0, 127.6, 121.2, 118.3, 114.6, 101.2, 
60.6, 56.2, 55.7, 53.6, 42.0, 39.6, 27.8, 27.7, 26.2; m/z HRMS (ES
+
) MH
+
 calculated for 
C20H26N3O 342.2076, observed 324.2065. 
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N-(p-Toluenesulfonyl)-9-Amino(9-deoxy)-quinine, 175 
 
 
 
para-Toluenesulfonyl chloride (136 mg, 0.71 mmol) was added in one portion to a 
solution of amine 172 (166 mg, 0.51 mmol) and K2CO3 (138 mg, 0.61 mmol) in CH2Cl2 
(4 mL) at room temperature and stirred for 18 h. The reaction mixture was diluted with 
CH2Cl2, filtered to remove solid K2CO3 and washed with saturated aq. Na2CO3 solution. 
The organic layer was then separated, dried (Na2SO4), filtered and concentrated in 
vacuo to afford an orange residue. Purification by flash column chromatography (5% 
MeOH/CH2Cl2) afforded 175 (174 mg, 71%) as a white solid; Rf: (5% MeOH/CH2Cl2) 
0.30; m.p. 75-78
oC; [α]22D +96.6 (c 0.58, CHCl3); max (ATR) 3285 w, 3083 w, 2942 m, 
2871 m, 1622 m, 1600 m, 1510 m, 1450 m, 1318 s, 1223 s, 1155 vs, 1091 s, 1029 m, 
912 m, 811 s, 664 vs cm
-1
; δH (400 MHz, CDCl3) 8.47 (1H, d, J 4.6, ArH), 7.80 (1H, d, 
J 9.2, ArH), 7.25 (1H, dd, J 9.2 and 2.5 ArH), 7.22-7.18 (4H, m, 4 x ArH), 6.63 (2H, d, 
J 8.1, 2 x ArH), 5.85 (1H, m, -CH=CH2), 5.16 (1H, br, 9-CHNTs), 5.04-5.00 (2H, m, -
CH=CH2), 3.95 (3H, s, -OCH3), 3.30 (1H, br, -CH-), 3.17-2.88 (2H, br, 2 x -CH-), 2.68-
2.47 (2H, br, 2 x -CH-), 2.27 (1H, br, -CH-), 2.16 (1H, br, -CH-), 2.09 (3H, s, PhCH3), 
1.89 (1H, br, -CH-), 1.81-1.60 (2H, br, 2 x -CH-), 1.51 (1H, br, -CH-); C (126 MHz, 
CDCl3) 157.6, 147.0, 144.5, 144.1, 142.8, 140.9, 136.5, 131.1, 128.3, 127.2, 126.3, 
121.4, 118.8, 114.8, 101.0, 60.1, 56.0, 55.8, 54.1, 41.8, 39.1, 27.4, 26.9, 25.8, 21.0; 
HRMS (ES
+
) MH
+
 calculated for C27H32N3O3S 478.2164, observed 478.2157. 
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9-Fluoro(9-deoxy)-quinine, 176 
 
 
 
The title compound was obtained by washing the corresponding dihydrochloride salt 
(kindly prepared and donated by Prof. R. Gilmour)(213) with 1M aq. NaOH. The solution 
was diluted with CH2Cl2 and the organic layer was then separated, dried (Na2SO4), 
filtered and concentrated in vacuo to afford amine 176 (14.7 mg) as a colourless oil; 
[α]23D -31.1 (c 0.90 CHCl3); max (ATR) 3350 w, 2950 m, 2900 w, 1600 s, 1575 m, 
1500 s, 1450 m, 1400 m, 1250 m, 1200 vs, 1100 m, 1050 s, 1000 m, 900 m, 850 s, 800 
s, 750 s, 600 s cm
-1
; δH (400 MHz, CDCl3) 8.77 (1H, d, J 4.5, ArH), 8.04 (1H, d, J 9.2, 
ArH), 7.46 (1H, d, J 4.5, ArH), 7.39 (1H, dd, J 9.2 and 2.7, ArH), 7.16 (1H, br s, ArH), 
6.50 (1H, br d, J 48.6, 9-CHF), 5.70 (1H, m, -CH=CH2), 5.00-4.94 (2H, m, -C=CH2), 
3.97 (3H, s, OCH3), 3.49 (1H, m, -CH-), 3.32-3.21 (2H, m, 2 x-CH-), 2.86 (1H, m, -CH-
), 2.78 (1H, m, -CH-), 2.39 (1H, m, -CH-), 1.90-1.78 (3H, m, 3 x -CH-), 1.63 (1H, m, -
CH-), 1.50 (1H, m, -CH-); C (100 MHz, CDCl3) 158.3, 147.3, 144.3, 141.6, 140.7, 
131.9, 125.4 (d, 
3
JF,C 5.5), 122.2, 117.4 (d, 
3
JF,C 11.2), 115.1, 100.7, 92.5 (d, 
1
JF,C 
174.0), 59.3 (d, 
2
JF,C 21.6), 56.5, 56.1, 43.4 (d, 
3
JF,H 5.6), 39.2, 27.6, 26.9, 20.0 (d, 
3
JF,C 
5.5); F (376 MHz, CDCl3) -176.4 (dd, 
2
JF,H 48.9 and 
3
JF,H 11.3); F (376 MHz, CDCl3) 
-198.1 (br); HRMS (ES
+
) MH
+
 calculated for C20H24N2OF 327.1868, observed 
327.1873. 
 
9-Fluoro(9-deoxy)-epiquinine, 177 
 
 
 
The title compound was obtained by washing the corresponding dihydrochloride salt 
(kindly prepared and donated by Prof. R. Gilmour)(213) with 1M aq. NaOH. The solution 
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was diluted with CH2Cl2 and the organic layer was then separated, dried (Na2SO4), 
filtered and concentrated in vacuo to afford amine 177 (15.6 mg) as a colourless oil; 
[α]23D +25.3 (c 1.19, CHCl3); max (ATR) 2936 m, 2865 m, 1621 vs, 1508 vs, 1475 s, 
1455 m, 1433 m, 1361 m, 1227 vs, 1081 m, 1029 vs, 981 vs, 911 s, 853 vs, 748 vs, 717 
m, 635 s cm
-1; δH (400 MHz, CDCl3) 8.77 (1H, d, J 4.4, ArH), 8.05 (1H, d, J 9.1, ArH), 
7.42-7.38 (3H, m, 3 x ArH), 5.86 (1H, dd, J 48.4 and 9.2, 9-CHF), 5.76 (1H, m, -
CH=CH2), 5.04-4.95 (2H, m, -C=CH2), 3.94 (3H, s, OCH3), 3.53 (1H, m, -CH-), 3.35-
3.25 (2H, m, 2 x-CH-), 2.89 (1H, m, -CH-), 2.79 (1H, m, -CH-), 2.31 (1H, m, -CH-), 
1.72 (1H, m, -CH-), 1.63-1.59 (2H, m, 2 x -CH-), 1.41 (1H, m, -CH-), 0.94 (1H, dd, J 
13.6 and 7.7, -CH-); C (100 MHz, CDCl3) 157.8, 147.1, 144.7, 141.2, 140.2 (d, 
2
JF,C 
18.5), 131.7, 126.8 (d, 
4
JF,C 1.3), 121.7, 120.0 (d, 
3
JF,C 6.8), 114.4, 101.6, 91.2 (d, 
1
JF,C 
179.4), 59.0 (d, 
2
JF,C 19.5), 55.7, 55.4, 41.3, 39.2, 27.7, 27.0, 24.3 (d, 
3
JF,C 4.4); F (376 
MHz, CDCl3) -176.4 (dd, 
2
JF,H 48.9 and 
3
JF,H 11.3); HRMS (ES
+
) MH
+
 calculated for 
C20H24FN2O 326.1873, observed 327.1871. 
 
β-Isocupreidine, 179(216) 
 
 
 
According to the procedure of Hatakeyama,(216) KBr (7.3 g, 61.6 mmol) was added to a 
solution of quinidine (2.0 g, 6.16 mmol) in 85% H3PO4 (30 mL) and the mixture heated 
for 10 days at 100
o
C. After being cooled to room temperature, the mixture was added 
dropwise to an ice-cooled solution of 25% KOH (200 mL). The pH was adjusted to ca. 
8 with 25% NH4OH and extracted with CHCl3. The combined organics were washed 
with saturated aq. sodium chloride solution (50 mL), dried (MgSO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (10% 
EtOAc/
n
hexane containing 1% Et3N to 20% EtOAc/
n
hexane containing 1% Et3N) 
afforded 179 as a pale orange solid. The compound was dissolved in NH3/MeOH and 
filtered to remove insoluble precipitates and the solution concentrated in vacuo and the 
residual solid recrystallised from MeOH/H2O to afford 179 (156 mg, 54%) as a white 
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crystalline solid; m.p. 258-260
o
C (MeOH/H2O) [lit.
(216) 258-259
o
C (MeOH/H2O); [α]
26
D 
+7.9  (c 0.67, MeOH) [lit.(216) [α]22D +8.6 (c 1.0, MeOH)]; H (400 MHz, CDCl3) 8.71 
(1H, d, J 4.3, ArH), 8.03 (1H, br, ArH), 7.97 (1H, d, J 9.0, ArH), 7.65 (1H, dd, J 4.4 and 
0.9, ArH), 7.25 (1H, dd, J 9.0 and 2.5, ArH), 6.01 (1H, s, CHOR), 4.8 (1H, br, ArOH), 
3.69 (1H, d, J 13.6), 3.45 (1H, d, J 6.2), 3.20 (1H, dd, J 12.8 and 8.3), 3.06 (1H, m), 
2.78 (1H, d, J 13.6), 2.21 (1H, m), 1.87 (1H, ddd, J 12.8, 6.6 and 2.2), 1.80-1.66 (3H, 
m, -CH2CH3 and 1 x -CH-), 1.62 (1H, m), 1.24 (1H, dd, J 12.8 and 6.2), 1.05 (3H, t, J 
7.4, -CH2CH3); C (126 MHz, CDCl3) 156.4, 146.8, 143.2, 142.3, 131.2, 127.3, 122.2, 
106.4, 77.1, 72.6, 56.2, 54.0, 46.5, 32.8, 27.4, 23.4, 23.3, 7.3; m/z (EI
+
) 310 (M
+
, 55 %), 
253 (100). All data were in agreement with those reported.(216)
 
 
O-Methyl-β-isocupreidine, 180(216) 
 
 
 
TMSCH2N2 (0.11 mL, 2.0M in hexanes, 0.21 mmol) was added dropwise to a solution 
of  β-ICD, 179 (50 mg, 0.16 mmol) in benzene/MeOH (2 mL, 3:2) and stirred for 3 h at 
room temperature. After this time the reaction was concentrated in vacuo and the 
residue purified by flash column chromatography (5% MeOH/CH2Cl2) to afford 180 
(22.4 mg, 43%) as a colourless oil; Rf: (5% MeOH/CH2Cl2) 0.60; [α]
22
D -8.7 (c 0.69, 
MeOH) [lit.(216) [α]19D -8.2 (c 1.02, MeOH)]; H (400 MHz, CDCl3) 8.78 (1H, d, J 4.5, 
ArH), 8.01 (1H, d, J 9.2, ArH), 7.71 (1H, d, J 4.4, ArH), 7.34 (1H, dd, J 9.2 and 2.6, 
ArH), 7.17 (1H, d, J 7.2, ArH), 5.96 (1H, s, -CHOR), 3.97 (3H, s, OCH3), 3.62 (1H, d, J 
13.5), 3.56 (1H, d, J 6.0), 3.06-3.03 (2H, m), 2.71 (1H, d, J 13.5), 2.17 (1H, m), 1.80 
(1H, m), 1.73-1.62 (3H, m, -CH2CH3 and 1 x -CH-), 1.55 (1H, m), 1.28 (1H, dd, J 12.6 
and 6.3), 1.03 (3H, t, J 7.4, -CH2CH3). All data were in agreement with those 
reported.(216)
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O-Benzyl-β-isocupreidine, 181 
 
 
 
NaH (7.7 mg, 60% dispersion in mineral oil, 0.19 mmol) was added to a solution of β-
ICD 179 (40.0 mg, 0.13 mmol) in THF (1 mL) at 0
o
C and stirred for 10 min. Benzyl 
bromide (16.8 µL, 0.14 mmol) was then added dropwise to the solution before the 
addition of TBAI (7 mg, 0.02 mmol). The mixture was then heated to 40
o
C and stirred 
for 20 h. The reaction was quenched by the addition of saturated aq. NH4Cl solution and 
diluted with EtOAc. The aq. layer separated and extracted with EtOAc, dried (Na2SO4), 
filtered and concentrated in vacuo. Purification by flash column chromatography (5% 
MeOH/CH2Cl2) afforded aryl ether 181 (10.5 mg, 20%) as a colourless oil; Rf: (5% 
MeOH/CH2Cl2) 0.35; [α]
22
D +10.3 (c 0.58, CHCl3); max (ATR) 2942 w, 2878 w, 1619 
m, 1597 w, 1509 m, 1456 m, 1225 s, 1010 M, 909 m, 853 m, 730 vs cm
-1
; H (400 
MHz, CDCl3) 8.76 (1H, d, J 4.5, ArH), 8.04 (1H, d, J 9.2, ArH), 7.72 (1H, d, J 4.3, 
ArH), 7.54-7.52 (2H, m, 2 x ArH), 7.45-7.30 (5H, m, 5 x ArH), 5.96 (1H, s, -CHOR), 
5.28 (1H, d, J 11.5, -CHHPh), 5.22 (1H, d, J 11.5, -CHHPh), 3.62 (1H, d, J 13.4), 3.52 
(1H, d, J 5.6), 3.07-3.00 (2H, m), 2.72 (1H, d, J 13.5), 2.18 (1H, m), 1.81-1.50 (5H, m, -
CH2CH3 and 3 x -CH-), 1.27 (1H, dd, J 12.6 and 6.3), 1.05 (3H, t, J 7.4, -CH2CH3); C 
(126 MHz, CDCl3) 157.0, 147.7, 144.1, 142.7, 136.5, 131.9, 128.5, 128.0, 127.9, 126.4, 
122.0, 119.4, 102.1, 77.0, 72.9, 70.6, 56.3, 54.6, 46.6, 32.9, 27.4, 24.0, 23.4, 7.3; HRMS 
(ES
+
) MH
+
 calculated for C26H29N2O2 401.2229, observed 401.2238. 
 
tert-Butyl-(naphthalen-2-yloxy)-diphenyl-silane, 189 
 
 
 
tert-Butyl(chloro)diphenylchlorosilane (150 µL, 0.59 mmol) was added dropwise to a 
solution of 2-naphthol (77.5 mg, 0.54 mmol) and imidazole (73.5 mg, 1.08 mmol) in 
DMF (2 mL) at room temperature and the mixture was stirred for 18 h. The reaction 
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was quenched by the addition of water (2 mL). The aq. layer separated and extracted 
with EtOAc, washed with saturated aq. NaCl solution, dried (Na2SO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (5% 
EtOAc/
n
hexane) afforded silanol 189 (164 mg, 79%) as a viscous colourless oil; Rf: (5% 
EtOAc/
n
hexane) 0.30; max (ATR) 3070 w, 2938 w, 2864 w, 1634 m, 1603 m, 1515 m, 
1467 s, 1432 m, 1358 w, 1269 s, 1257 vs, 1222 s, 1178 s, 1111 s, 971 vs, 292 s, 821 s, 
742 s, 700 vs cm
-1
; δH (400 MHz, CDCl3) 7.91-7.89 (4H, m, 4 x ArH), 7.79 (1H, d, J 
8.7, ArH), 7.71 (1H, d, J 8.7, ArH), 7.59 (1H, d, J 8.2, ArH), 7.54-7.35 (8H, m, 8 x 
ArH), 7.22-7.18 (2H, m, 2 x ArH), 1.27 (9H, s, -C(CH3)3); C (100 MHz, CDCl3) 153.4, 
135.5, 134.4, 132.9, 129.9, 129.1, 129.0, 127.8, 127.5, 126.7, 126.0, 123.6, 121.6, 
114.6, 26.6, 19.5; m/z (EI
+
) 382 (M
+
, 45%), 325 (M
+
-C(CH3)3, 100); HRMS (EI
+
) M
+
 
calculated for C26H26OSi 382.1753, observed 382.1751. 
 
O-tert-Butyldiphenylsilyl-β-isocupreidine, 182 
 
 
 
tert-Butyldiphenylchlorosilane (185 µL, 0.71 mmol) was added dropwise to a solution 
of β-ICD, 179 (55.0 mg, 0.18 mmol) and imidazole (72.4 mg, 1.06 mmol) in DMF (0.7 
mL) at room temperature and the mixture was stirred for 20 h. The reaction was 
quenched by the addition of water (2 mL). The aq. layer separated and extracted with 
EtOAc, washed copiously with water, dried (Na2SO4), filtered and concentrated in 
vacuo. Purification by flash column chromatography (5% MeOH/CH2Cl2) afforded 
silanol 182 (94.0 mg, 96%) as a viscous colourless oil; Rf: (5% MeOH/CH2Cl2) 0.35; 
[α]22D +14.5 (c 3.30, CHCl3); max (ATR) 3075 w, 2942 m, 2861 m, 1622 m, 1597 w, 
1504 m, 1464 m, 1428 m, 1234 s, 1109 s, 1011 m, 958 m, 825 s, 749 s, 699 vs cm
-1
; H 
(400 MHz, CDCl3) 8.73 (1H, d, J 8.7, ArH), 8.83-8.79 (3H, m, 3 x ArH), 7.72-7.70 (2H, 
m, 2 x ArH), 7.61 (1H, d, J 4.4, ArH), 7.46-7.32 (6H, m, 6 x ArH), 7.26 (1H, s, ArH), 
7.15 (1H, dd, J 9.1 and 2.6, ArH), 5.61 (1H, s, -CHOR), 3.39 (1H, d, J 13.5), 3.12 (1H, 
d, J 5.9), 2.97-2.85 (2H, m), 2.60 (1H, d, J 13.6), 2.07 (1H, m), 1.70-1.55 (4H, m, -
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CH2CH3 and 2 x -CH-), 1.45 (1H, m), 1.14-1.16 (10H, m, -C(CH3)3 and -CH-), 0.99 
(3H, t, J 7.4, -CH2CH3); C (100 MHz, CDCl3) 153.7, 147.9, 143.8, 143.4, 135.7, 135.7, 
132.5, 132.1, 131.2, 130.0, 129.9, 127.9, 127.8, 126.5, 124.2, 119.1, 109.9, 77.1, 73.1, 
56.0, 54.8, 46.7, 32.9, 27.3, 26.6, 24.3, 23.7, 19.4, 7.3; HRMS (ES
+
) MH
+
 calculated for 
C35H41N2O2Si 549.2937, observed 549.2931. 
 
General Procedures and Results for the Aziridination of Chalcone using Cinchona 
Alkaloid Promoters (Catalyst Screening): trans-Phenyl-(3-phenylaziridin-2-
yl)methanone, 92(87)
 
 
 
 
O-diphenylphosphinyl hydroxylamine (1.05 eq.) was added to a solution of cinchona 
alkaloid (1.05 eq.) in CH2Cl2 (0.06M) at room temperature and the mixture stirred for 
0.5 h. NaH (60% dispersion in mineral oil, 2 eq.) and 
i
PrOH (2 eq.) and chalcone (1.eq.) 
were added sequentially and the mixture allowed to stir at room temperature overnight. 
The reaction was quenched by the addition of saturated aqueous NH4Cl solution and the 
aqueous layer separated and extracted with CH2Cl2, dried (Na2SO4), filtered and 
concentrated in vacuo. Purification by flash column chromatography (10% 
EtOAc/
n
hexane) afforded aziridine 92 as a white solid; Rf: (10% EtOAc/
n
hexane) 0.50; 
m.p. 99-101
o
C (lit.(87) 99-101
o
C); H (400 MHz, CDCl3) 8.00 (2H, d, J 8.8, 2 x PhH), 
7.62 (2H, t, J 7.4, 2 x PhH), 7.49 (1H, t, J 7.6, PhH), 7.39-7.30 (5H, m, 5 x PhH), 3.52 
(1H, dd, J 2.3, 2-CHN), 3.18 (1H, dd, J 2.5, 3-CHN), 2.68 (1H, br, NH); m/z (EI
+
) 233 
(M
+
, 80%), 206 (100), 105 (100). All data were in agreement with those reported.(87)
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Entry
a
 Promoter Yield Aziridine /%
b
 ee /%
c
 Aziridine Enantiomer
d
 
1 Hydroquinine-4-
chlorobenzoate, 163 
26 36 2R,3S (-) 
2 Hydroquinidine-4-
chlorobenzoate, 164 
40 17  3R,2S (+) 
3 (DHQ)2AQN, 165 <5 - - 
4 (DHQD)2AQN, 166 <5 - - 
5 167 62 <5 3R,2S (+) 
6 170 <5 - - 
7 168 <5 - - 
8 173 <5 - - 
9 172 42 35 3R,2S (+) 
10 175 <5 - - 
11 176 <5 - - 
12 177 8 10 3R,2S (+)- 
13 179 28 5 2R,3S (-) 
14 180 54 37 2R,3S (-) 
15 181 47 43 2R,3S (-) 
16 182 17 20 2R,3S (-) 
a
 Reactions performed on a 0.03-0.13 mmol scale; 
b
 Isolated yield after purification by column 
chromatography; 
c
 Enantiomeric excess (ee) measured by HPLC analysis (conditions: 93:7 hexane:IPA, 
0.8 mL/min., 254 nm, AD-H) (3R,2S, tR = 16.0 min., 2R,3S, tR = 18.8 min.); 
d
 Configuration of major 
enantiomer is determined by comparison to the literature.
(192)
 
 
General Procedures and Results for the Asymmetric Aziridination of Alkyl 
Substituted Enones 61, 62 and 65 with Quinine:
 
 
O-diphenylphosphinyl hydroxylamine (2.0 eq.) was added to a solution of quinine (1.05 
eq.) in CH2Cl2 (0.06M) at room temperature and the mixture stirred for 0.5 h. NaH 
(60% dispersion in mineral oil, 3 eq.) and 
i
PrOH (3 eq.) were then added sequentially 
followed by the enone substrate (1.eq.) as a solution in CH2Cl2 (0.12 M) and the 
mixture allowed to stir at room temperature overnight. The reaction was quenched by 
the addition of saturated aqueous NH4Cl solution and the aqueous layer separated and 
extracted with CH2Cl2, dried (Na2SO4), filtered and concentrated in vacuo. Purification 
by flash column chromatography afforded the aziridines.  
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2-Methyl-1-[(2R,3S)-3-Phenyl-aziridin-2-yl]-propan-1-one 
 
 
 
Following the general procedures for the asymmetric aziridination of enones 61, 62 and 
65, using quinine (40.9 mg, 0.126 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH 
(27.6 µL, 0.36 mmol), NaH (14.4 mg, 0.36 mmol) and trans-4-methyl-1-phenyl-pent-1-
en-3-one (20.9 mg, 0.12 mmol), in CH2Cl2 (3.0 mL), after purification by flash column 
chromatography (15% EtOAc/
n
hexane) afforded the title compound (8.4 mg, 37%) as a 
colourless oil; Rf: (15% EtOAc/
n
hexane) 0.30; H (400 MHz, CDCl3); 7.35-7.27 (5H, m, 
5 x PhH), 2.98 (1H, d, J 2.1, CHN), 2.86 (1H, d, J 2.2, CHN), 2.84 (1H, sep., J 6.9, -
CH(CH3)2), 2.28 (1H, br, NH), (6H, d, J 6.9, -CH(CH3)2); 58% ee; Enantiomeric excess 
(ee) measured by HPLC analysis (conditions: 93:7 hexane:IPA, 0.8 mL/min., 254 nm, 
AD-H) (tR (major) = 7.8 min., tR (minor) = 8.7 min.), configuration of major enantiomer 
assigned 2R,3S in analogy to the aziridination of chalcone with quinine. All data were in 
agreement for those reported for the racemate. 
 
2,2-Dimethyl-1-[(3R,2S)-3-phenyl-aziridin-2-yl]-propan-1-one 
 
 
 
Following the general procedures for the asymmetric aziridination of enones 61, 62 and 
65, using quinine (38.3 mg, 0.12 mmol), DppONH2 (52.2 mg, 0.22 mmol), 
i
PrOH (25.7 
µL, 0.34 mmol), NaH (13.4 mg, 0.34 mmol) and enone 62 (21.1 mg, 0.11 mmol), in 
CH2Cl2 (3.0 mL), after purification by flash column chromatography (20% 
EtOAc/
n
hexane) afforded the title compound (3.9 mg, 17%) as a white solid; Rf: (20% 
EtOAc/
n
hexane) 0.55; m.p. 54-56
o
C; H (400 MHz, CDCl3); 7.35-7.27 (5H, m, 5 x 
PhH), 3.00 (1H, d, J 2.3, CHN), 2.91 (1H, d, J 2.3, CHN), 2.19 (1H, br, NH), 1.23 (9H, 
s, -(CH3)3; 49% ee; Enantiomeric excess (ee) measured by HPLC analysis (conditions: 
98:2 hexane:IPA, 0.5 mL/min., 254 nm, AD-H) (tR (major) = 14.4 min., tR (minor) = 
20.5 min.), configuration of major enantiomer assigned 2R,3S in analogy to the 
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aziridination of chalcone with quinine. All data were in agreement for those reported for 
the racemate. 
 
(2R,3S)-2-Phenyl-1-aza-spiro[2.5]octan-4-one 
 
 
 
Following the general procedures for the asymmetric aziridination of enones 61, 62 and 
65, using quinine (40.9 mg, 0.126 mmol), DppONH2 (56.0 mg, 0.24 mmol), 
i
PrOH 
(27.6 µL, 0.36 mmol), NaH (14.4 mg, 0.36 mmol) and 2-benzylidenecyclohexanone 
(22.4 mg, 0.12 mmol), in CH2Cl2 (3.0 mL), after purification by flash column 
chromatography (15% EtOAc/
n
hexane) afforded the title compound (1.4 mg, 6%) as a 
white solid; Rf: (15% EtOAc/
n
hexane) 0.20; m.p. 87-88
o
C; H (400 MHz, CDCl3); 7.40-
7.24 (5H, m, 5 x PhH), 3.10 (1H, s, 2-H), 2.76 (1H, br, NH), 2.70 (1H, ddt, J 16.8, 4.6 
and 2.4, -C(O)CHH-), 2.43 (1H, ddd, J 16.9, 12.9 and 6.6, -C(CO)HH-), 2.04 (1H, m, -
C(O)CH2HH-), 1.84 (1H, td, J 13.7 and 4.1, -C(N)CHH-), 1.80-1.64 (2H, m, -
C(O)CH2CHH- and -C(N)CH2CHH-), 1.46-1.32 (2H, m, -C(N)CHH- and C(N)CH2HH-
); 76% ee; Enantiomeric excess (ee) measured by HPLC analysis (conditions: 93:7 
hexane:IPA, 0.8 mL/min., 254 nm, AD-H) (tR (major) = 8.6 min., tR (minor) = 10.9 
min.), configuration of major enantiomer assigned 2R,3S in analogy to the aziridination 
of chalcone with quinine. All data were in agreement for those reported for the 
racemate. 
 
N-Aminoquininium trifluoroacetate, 190 
 
 
 
Quinine (198 mg, 0.61 mmol) was dissolved in THF (3 mL) and DppONH2 (142 mg, 
0.61 mmol) was added in one portion. A thick white precipitate was formed after 5 min. 
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and a further portion of THF (2 mL) was added and the mixture allowed to stir for a 
further 2 h. The slurry was then filtered, washed with THF and dried under vacuum. 
The crude solid was then purified by mass triggered reverse phase chromatography 
(0.05% TFA in MeCN/H2O) and dried under vacuum over P2O5 to afford 190 (67.1 mg, 
25%) as a colourless solid; [α]24D -38.1 (c 0.64, MeOH); m.p. 262-265
o
C; max (ATR) 
3172 br, 2933 m, 2861 w, 1674 s, 1590 m, 1508 s, 1469 m, 1448 m, 1430 m, 1325 w, 
1240 vs, 1227 s, 1135 m, 1101 s, 1030 s, 989 w, 905 m, 884 w, 822 s, 806 w, 760 w, 
718 m cm
-1
;
 H (400 MHz, CD3OD) 9.01 (1H, d, J 5.6, ArH), 8.31 (1H, d, J 5.5, ArH), 
8.26-8.19 (1H, m, ArH), 7.84-7.77 (2H, m, ArH), 6.68 (1H, s, 9-CH), 5.81 (1H, m, -
CH=CH2), 5.14 (2H, m, -CH=CH2), 4.40-4.29 (1H, br), 4.07 (3H, s, OCH3), 3.92 (1H, t, 
J 11.0), 3.87-3.79 (1H, br), 3.70-3.58 (2H, m), 3.08-2.98 (1H, m), 2.56-2.46 (2H, m), 
2.18-2.07 (2H, m), 1.80 (1H, t, J 1.9); C (100 MHz, CDCl3); 161.8, 155.0, 144.0, 
138.3, 138.0, 128.5, 127.6, 126.6, 121.4, 118.1, 103.2, 73.4, 69.4, 65.2, 59.4, 57.0, 41.2, 
28.3, 26.9, 20.5; F (376 MHz, CDCl3) -77.1;  m/z (ES
+
) 340 (M
+
, 55%), 189 (100); 
HRMS (ES
+
) M
+
 calculated for C20H26N3O2 340.2025, observed 340.2009. 
 
N-Amino-N-methylmorpholinium trifluoroacetate, 191 
 
 
 
NMM (109 µL, 0.98 mmol) was added dropwise to a stirred solution of DppONH2 (343 
mg, 1.47 mmol) in THF (3 mL). A thick white precipitate was formed after 5 min. and a 
further portion of THF (2 mL) was added and the mixture allowed to stir for a further 3 
h. The slurry was then filtered, washed with THF and dried under vacuum. The crude 
solid was then purified by mass triggered reverse phase chromatography (0.05% TFA in 
MeCN/H2O) and dried under vacuum over P2O5 to afford 191 (40.1 mg, 18%) as a 
white solid; m.p. 152-154 
o
C; max (ATR) 3428 br, 2931 m, 2859 w, 1674 vs, 1466 m, 
1430 m, 1189 vs, 1121 vs, 1013 m, 900 m, 835 m, 801 s, 723 s cm
-1
; H (400 MHz, 
CD3OD) 4.16 (2H, ddd, J 12.9, 10.0 and 2.5, -CH2-), 3.91 (2H, dt, J 13.3 and 3.2, -
CH2), 3.63 (2H, ddd, J 12.9, 9.7 and 3.5, -CH2-), 3.56-3.48 (2H, m, -CH2-), 3.44 (3H, s, 
-CH3); C (100 MHz, CDCl3); 64.7, 62.2, 58.7; F (376 MHz, CDCl3) -76.9; m/z HRMS 
(ES
+
) M
+
 calculated for C5H13N2O 117.1028, observed 117.1018.  
205 
 
 
 
4 Appendices  
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4.1 X-Ray Structure and Crystal Data for (2S)-2-Methyl-4-(para-
toluenesulfonyl)piperazine, 124 
 
 
 
X-Ray Structure of (2S)-2-Methyl-4-(para-toluenesulfonyl)piperazine, 124 
 
Crystal data and structure refinement for 124: 
 
Identification code AA0804 
Empirical formula C12 H18 N2 O2 S 
Formula weight 254.34 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 6.0667(2) Å α = 90° 
 b = 13.5445(4) Å β = 90° 
 c = 15.8536(6) Å γ = 90° 
Volume, Z 1302.70(8) Å3, 4 
Density (calculated) 1.297 Mg/m3 
Absorption coefficient 0.241 mm-1 
F(000) 544 
Crystal colour / morphology Colourless blocks 
Crystal size 0.26 x 0.23 x 0.19 mm3 
θ range for data collection 3.90 to 32.24° 
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Index ranges -8<=h<=8, -20<=k<=20, -23<=l<=23 
Reflns collected / unique 19786 / 4338 [R(int) = 0.0331] 
Reflns observed [F>4σ (F)] 3914 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.78876 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4338 / 1 / 159 
Goodness-of-fit on F2 1.116 
Final R indices [F>4σ (F)] R1 = 0.0416, wR2 = 0.0966 
 R1+ = 0.0416, wR2+ = 0.0966 
 R1- = 0.0427, wR2- = 0.0992 
R indices (all data) R1 = 0.0480, wR2 = 0.1001 
Absolute structure parameter x+ = 0.04(6), x- = 0.96(6) 
Largest diff. peak, hole 0.447, -0.190 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
 
Bond lengths [Å] and angles [°] for 124: 
 
N(1)-C(6) 1.459(2) 
N(1)-C(2) 1.463(2) 
C(2)-C(7) 1.515(2) 
C(2)-C(3) 1.529(2) 
C(3)-N(4) 1.474(2) 
N(4)-C(5) 1.4751(19) 
N(4)-S(8) 1.6377(13) 
C(5)-C(6) 1.514(2) 
S(8)-O(10) 1.4340(12) 
S(8)-O(9) 1.4378(13) 
S(8)-C(11) 1.7569(16) 
C(11)-C(16) 1.395(2) 
C(11)-C(12) 1.399(2) 
C(12)-C(13) 1.387(2) 
C(13)-C(14) 1.395(2) 
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C(14)-C(15) 1.395(2) 
C(14)-C(17) 1.510(2) 
C(15)-C(16) 1.388(2) 
 
C(6)-N(1)-C(2) 111.23(15) 
N(1)-C(2)-C(7) 110.57(17) 
N(1)-C(2)-C(3) 108.01(14) 
C(7)-C(2)-C(3) 110.76(15) 
N(4)-C(3)-C(2) 108.51(13) 
C(3)-N(4)-C(5) 112.65(13) 
C(3)-N(4)-S(8) 117.64(10) 
C(5)-N(4)-S(8) 115.57(9) 
N(4)-C(5)-C(6) 108.28(13) 
N(1)-C(6)-C(5) 108.93(14) 
O(10)-S(8)-O(9) 119.08(8) 
O(10)-S(8)-N(4) 107.23(7) 
O(9)-S(8)-N(4) 106.52(8) 
O(10)-S(8)-C(11) 108.26(8) 
O(9)-S(8)-C(11) 107.69(7) 
N(4)-S(8)-C(11) 107.57(7) 
C(16)-C(11)-C(12) 120.11(15) 
C(16)-C(11)-S(8) 119.55(12) 
C(12)-C(11)-S(8) 120.31(12) 
C(13)-C(12)-C(11) 119.62(15) 
C(12)-C(13)-C(14) 121.03(16) 
C(13)-C(14)-C(15) 118.55(15) 
C(13)-C(14)-C(17) 121.07(17) 
C(15)-C(14)-C(17) 120.36(16) 
C(16)-C(15)-C(14) 121.35(15)  
C(15)-C(16)-C(11)        119.33(15)  
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4.2 Attempted pKa Measurement of N-Aminomorpholinium and N-
Aminoquininium Trifluoroacetate Salts 
 
As has been discussed in the introductory section of this thesis, our methodology 
requires bases with a sufficiently high pKaH value, such as hydroxide or alkoxide bases 
(pKaH ca. 15.5-17), in order to promote successful aziridination via deprotonation of the 
intermediate hydrazinium salt. In order to gain further insight into the choice of base for 
aziridination the potential measurement of the pKa value of the aminated hydrazinium 
salts of both NMM and quinine, via potentiometric titrations, was therefore attractive. 
Access to equipment in order to conduct potentiometric titrations was available, 
however, the techniques employed had upper limits of ca. pH = 12.5. Potentiometric 
titrations were undertaken by David Adams (Syngenta) in June 2009. 
For this potential examination, synthesis of the salts was undertaken by simply 
stirring either NMM or quinine with DppONH2 in THF. The crude salts were then 
filtered, washed and then purified by mass triggered reverse phase chromatography 
(0.05% TFA in MeCN/H2O) and dried under vacuum over P2O5 (Figure 7). 
 
 
Figure 7. Isolated Hydrazinium Salts 190 and 191 for Examination in Potentiometric Titrations 
 
Whilst the techniques employed had upper limits of ca. pH = 12.5 and it was 
believed that the pKa values of the hydrazinium salts were likely to be beyond the 
equipment limits, titrations were conducted for both 190 and 191. A short data summary 
is now presented. Graphs, calculated values and data subsequently follow. In short, both 
salts had pKa values of the hydrazinium moiety greater than the upper limit of the 
available equipment. 
 
N-Aminoquininium Trifluoroacetate, 190: Two potentiometric titrations were 
conducted and two pKa value sets of 4.31 and 4.34 and 12.28 and 12.01 were obtained. 
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Furthermore potentiometric titrations with UV detection gave two pKa values of 4.35 
and 12.18. The value at ca. 4.3 could be attributed to the aromatic N of the quinoline 
(which was further supported by correlation to parent alkaloid quinine and also by ACD 
calculations), but assignment of the value at ca. 12.2 was more ambiguous although 
ACD calculations indicated that this was to be attributed to the hydroxyl moiety. 
[ACDpKa DB calculations (see www.acdlabs.com/products/phys_chem_lab/pka/) 
indicated values of 4.8 and 11.9] 
 
As a result of this ambiguity quinine was submitted for potentiometric titrations in order 
to determine to determine whether the pKa value at ca. 12.2 obtained for 190 belongs to 
that of the hydroxyl or of the hydrazinium moiety. 
 
Quinine: Values for both the pKaH of the quinoline ring (4.3) and the quinuclidine 
moiety (8.6; note, lower than parent quinuclidine due to the presence of the 
neighbouring hydroxyl moiety) for quinine are well known in the literature,(243) but data 
is less clear for that of the hydroxyl moiety. Potentiometric titrations with quinine 
determined two accurate values at 4.20 and 8.42 which correlate with both literature 
(4.3 and 8.6) and ACD calculations (4.8, 9.0) for the quinoline N and quinuclidine N. 
ACD calculations further predicted a pKa of 12.8 for the hydroxyl moiety. In addition 
potentiometric titrations showed an obvious curve in the data at ca. pH 12 indicating 
there is a pKa >12 which could not be accurately measured with the available 
equipment. This further suggested that the pKa value at ca. 12.2 measured for N-
Aminoquininium 190 can be assigned to an acidic OH, indicating that the hydrazinium 
moiety has a higher pKa value than this, beyond the limits of the available equipment. 
 
N-Amino-N-morpholinium Trifluoroacetate, 191: Erroneous results (no value could 
be obtained). Potentiometric titrations gave no reliable results suggesting that the pKa 
was too high to measure (i.e. >12.5). 
 
Data follows overleaf.  
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N-Aminoquininium Trifluoroacetate, 190: 
 
WORKSHEET J8466-084.xls
18th Jun 2009
Saved in UKJHRA03\L\CHEMDES\CROSSPHASE\CURRENT BOOK INDEX\J8318\
WORK CARRIED OUT ON 26th May 2009 - UV, & 2nd June - potentiometry
pKa measurement of CSCD698377 - EDC/MISC/09/001
All files, (Trays, Blanks, data & multi-sets), saved in J8318\spectra\<dir>
Electrode used = KFP-0681
26th May 2009 2nd Jun 2009
Blank calibration successful Blank calibration successful
Four plus   = 0.089 Four plus   = 0.094
Four plus S = 1.0033 Four plus S = 1.0055
Four plus JH = 2.2 Four plus JH = 1.4
Four plus  JOH = -0.5 Four plus  JOH = -1.1
CSCD698377
S02F726937D
MWT = 454.47
DPAS-titration - 26th May 2009
MWT = 454.47
Stock [] = 0.002200M => 1000ppm
Stock solvent = MeCN
Volume added = 0.25mls
Starting Titration volume = 10mls
Starting % MeCN = 2.5
Titration 1 [] = 55uM => 25ppm
pH range = 2 => 12.2
Data had to be analysed seperately to obtain 2 pKa values
l-range used for titration = 235-390nm BOTH pKas
pH-clip for titration ~1.8 -> ~6 LOWER pKa
pH-clip for titration ~8 -> ~12.2 UPPER pKa
Titration 
No.
Ionic 
strength
% MeOH pKa Date Temp C
4.31
12.28
LOWER pKa
UPPER pKa
IONIC stength = 0.01M KCl
Filename
1 0.027 == 09E-2607.SDS 26th July
Room
temp
Chiral
O O
FF
F
N
O
O
N
+
H
N
11.93
4.77
??
Is this real??
212 
 
 
 
J8466/085
Repeat titration
Idenitical in all ways except high pH -> low pH
Titration Ionic % MeOH pKa Date Temp C
4.34
12.01
LOWER pKa
UPPER pKa
Potentiometric titration conducted 2nd June
DPAS-titration - 2nd June 2008
MWT = 454.47
Sample Weight = 10.92mgs
Actual ai weight = 7.97mg
Starting Titration volume = 10mls
Titration 1 [] = 1.75mM
pH range = 2 => 13
Titration 
No.
Ionic 
strength
% MeOH pKa Date Temp C
4.35
12.18
Filename
2 0.029 == 09E-2608.SDS 26th July
Room
temp
2nd June
Room
temp
Filename
1 0.028 == 09F-0202.SDS
Lower pKa - both values very similar = 4.31/4.34
Upper pKa - a high degree of extrapolation making values somewhat 
approx but reasonably consistent 12.28/12.01 => 12.15 +/- 0.2
NOTE ** Sample 27% 
Calculated [] = 1.87mM => 107% actual
Good FIT => Reliable results, consistent with UV data
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CSCD698377 - Spectral pKa LOW pH->high pH
Title : CSCD698377 A
Filename : C:\990279\Q2_2009\May_26\09E-2607.SDS
Analyst : david
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (up)
Assay date : 26 May 2009 at 15:13 (Assay duration  0:48:10) (Assay location 8)
Last modified : 26 May 2009 at 16:02
Four-Plus parameters. Source file : C:\990279\Q2_2009\May_26\09E-2606.SDS
à 0.089
S 1.0033
jÁ 2.2
jÂÁ -0.5
4.339 A+H=AH
logK values imported from file : 
1.000 A concentration factor  (0.000055 M)
0.9979 HCl concentration factor. Source : C:\990279\Q2_2009\May_26\09E-2606.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
0.000000 Acidity error
Form of compounds introduced : AH
AH (0.0002500g, 454.47 g/mol)
GOF : 99.99
Assay Temperature : 25.0¦C
Average ionic strength : 0.010 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 10.68 mL
Aqueous volume range : 10.34 - 11.06 mL
pH range : 1.84 - 12.09
pH clip range : full pH range
Number of points collected : 43
Number of points considered : 43
pH7 buffer : 7.000, -15.28 mV, 25.5¦C
Initial pH : 5.911
Volume of HCl added for start pH : 0.33833 mL
Point pH HCl vol KOH vol ORG vol drift time
1 1.969 0.33833 0.00042 0 0.0018 14
2 1.969 0.33833 0.00083 0 0.0022 16
3 2.174 0.33833 0.11833 0 0.0022 15
4 2.418 0.33833 0.20292 0 0.0021 13
5 2.627 0.33833 0.24542 0 0.0015 12
6 2.856 0.33833 0.27458 0 0.0008 12
7 3.091 0.33833 0.29208 0 0.0008 12
8 3.32 0.33833 0.30208 0 0.0006 12
9 3.55 0.33833 0.30875 0 0.0006 12
10 3.798 0.33833 0.31333 0 0.0005 12
11 4.019 0.33833 0.31667 0 0.0009 12
12 4.251 0.33833 0.32 0 0.0007 12
13 4.469 0.33833 0.32333 0 0.0008 12
14 4.692 0.33833 0.32708 0 0.0008 12
15 4.937 0.33833 0.33083 0 0.0008 12
16 5.178 0.33833 0.33417 0 0.0007 12
17 5.401 0.33833 0.33667 0 0.0003 12
18 5.625 0.33833 0.33875 0 0.0004 12
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19 5.859 0.33833 0.34042 0 0.0019 12
20 6.085 0.33833 0.34167 0 0.0022 15
21 6.321 0.33833 0.34333 0 0.0022 14
22 6.55 0.33833 0.34542 0 0.0011 12
23 6.776 0.33833 0.3475 0 0.0012 12
24 6.999 0.33833 0.35 0 0.0007 12
25 7.245 0.33833 0.35292 0 0.0007 12
26 7.481 0.33833 0.355 0 0.0011 12
27 7.743 0.33833 0.35708 0 0.002 12
28 8.062 0.33833 0.35833 0 0.0032 27
29 8.426 0.33833 0.35917 0 0.0041 36
30 9.17 0.33833 0.36 0 0.0044 40
31 9.683 0.33833 0.36083 0 0.0039 34
32 9.938 0.33833 0.36167 0 0.0034 29
33 10.205 0.33833 0.36333 0 0.003 23
34 10.444 0.33833 0.36583 0 0.0013 12
35 10.655 0.33833 0.36958 0 0.0015 13
36 10.868 0.33833 0.37542 0 0.0021 13
37 11.089 0.33833 0.38542 0 0.0018 14
38 11.303 0.33833 0.40208 0 0.0018 14
39 11.511 0.33833 0.42833 0 0.0014 14
40 11.722 0.33833 0.47208 0 0.0016 14
41 11.933 0.33833 0.545 0 0.0019 14
42 12.139 0.33833 0.66458 0 0.0017 14
43 12.208 0.33833 0.72042 0 0.0019 14
CSCD698377 - Spectral pKa HIGH pH->LOW pH
Title : CSCD698377 B
Filename : C:\990279\Q2_2009\May_26\09E-2608.SDS
Analyst : david
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (down)
Assay date : 26 May 2009 at 16:02 (Assay duration  0:40:24) (Assay location 10)
Last modified : 26 May 2009 at 16:43
Four-Plus parameters. Source file : C:\990279\Q2_2009\May_26\09E-2606.SDS
à 0.089
S 1.0033
jÁ 2.2
jÂÁ -0.5
4.346 A+H=AH
logK values imported from file : 
1.000 A concentration factor  (0.000055 M)
0.9979 HCl concentration factor. Source : C:\990279\Q2_2009\May_26\09E-2606.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
0.000000 Acidity error
Form of compounds introduced : AH
AH (0.0002500g, 454.47 g/mol)
GOF : 99.99
Assay Temperature : 25.0¦C
Average ionic strength : 0.010 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 10.81 mL
Aqueous volume range : 10.41 - 11.18 mL
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pH range : 1.85 - 12.14
pH clip range : full pH range
Number of points collected : 42
Number of points considered : 42
pH7 buffer : 7.000, -15.65 mV, 25.5¦C
Initial pH : 5.800
Volume of KOH added for start pH : 0.40917 mL
Point pH HCl vol KOH vol ORG vol drift time
1 12.247 0.00042 0.40917 0 0.0052 47
2 12.256 0.00083 0.40917 0 0.0022 17
3 12.021 0.16125 0.40917 0 0.0013 14
4 11.786 0.25458 0.40917 0 0.002 14
5 11.559 0.30708 0.40917 0 0.0017 14
6 11.327 0.33917 0.40917 0 0.0018 14
7 11.115 0.35667 0.40917 0 0.0022 15
8 10.88 0.36833 0.40917 0 0.0016 15
9 10.651 0.375 0.40917 0 0.0018 14
10 10.406 0.37917 0.40917 0 0.0016 15
11 10.162 0.38167 0.40917 0 0.002 15
12 9.884 0.38333 0.40917 0 0.0024 17
13 9.389 0.38458 0.40917 0 0.0034 29
14 8.762 0.38542 0.40917 0 0.0043 40
15 8.253 0.38625 0.40917 0 0.0044 39
16 7.945 0.3875 0.40917 0 0.0037 32
17 7.65 0.38875 0.40917 0 0.0033 27
18 7.419 0.39083 0.40917 0 0.0031 26
19 7.186 0.39292 0.40917 0 0.0034 26
20 6.948 0.39583 0.40917 0 0.0037 29
21 6.73 0.39833 0.40917 0 0.0034 28
22 6.498 0.40083 0.40917 0 0.0038 31
23 6.222 0.40292 0.40917 0 0.0043 37
24 5.964 0.405 0.40917 0 0.0039 31
25 5.729 0.40667 0.40917 0 0.0032 28
26 5.447 0.40875 0.40917 0 0.0026 19
27 5.213 0.41125 0.40917 0 0.0023 17
28 4.968 0.41458 0.40917 0 0.0022 15
29 4.74 0.41833 0.40917 0 0.0018 15
30 4.497 0.42208 0.40917 0 0.0022 14
31 4.269 0.42583 0.40917 0 0.002 14
32 4.042 0.42917 0.40917 0 0.002 14
33 3.821 0.4325 0.40917 0 0.0018 13
34 3.603 0.43625 0.40917 0 0.0016 12
35 3.375 0.44208 0.40917 0 0.0013 12
36 3.148 0.45125 0.40917 0 0.0008 12
37 2.93 0.46583 0.40917 0 0.0009 12
38 2.714 0.48917 0.40917 0 0.001 12
39 2.501 0.52708 0.40917 0 0.0015 12
40 2.285 0.59125 0.40917 0 0.0021 15
41 2.075 0.69625 0.40917 0 0.002 14
42 1.974 0.77 0.40917 0 0.0019 13
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CSCD698377 - POTIENTIOMETRIC pKa
Title : CSCD698377 POTY
Filename : C:\990279\Q2_2009\Jun_02\09F-0202.SDS
Analyst : david
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (up)
Assay date : 02 Jun 2009 at 10:35 (Assay duration  0:37:43) (Assay location 3)
Last modified : 18 Jun 2009 at 15:41
Four-Plus parameters. Source file : C:\990279\Q2_2009\Jun_02\09F-0201.SDS
à 0.094
S 1.0055
jÁ 1.4
jÂÁ -1.1
12.184 X2+H=X2H
4.345 X2H+H=X2H2
10.102 CO3+H=HCO3
6.229 HCO3+H=H2CO3
logK values imported from file : 
0.781 X2 concentration factor  (0.002403 M)
1.000 CO3 concentration factor  (0.029 mM)
0.9970 HCl concentration factor. Source : C:\990279\Q2_2009\Jun_02\09F-0201.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
0.001876 Acidity error
Form of compounds introduced : X2H H2CO3
X2H (0.0109200g, 454.47 g/mol)
H2CO3 (0.0000179g, 62.03 g/mol)
GOF : 0.80
Assay Temperature : 25.0¦C
Average ionic strength : 0.027 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 11.25 mL
Aqueous volume range : 10.29 - 14.27 mL
pH range : 1.87 - 13.06
pH clip range : 2.21 - 12.34
Number of points collected : 48
Number of points considered : 32
pH7 buffer : 7.000, -14.30 mV, 25.5¦C
Initial pH : 3.658
Volume of HCl added for start pH : 0.28833 mL
Point pH HCl vol KOH vol ORG vol drift time
*1 1.993 0.28833 0.00042 0 0.0022 15
*2 1.994 0.28833 0.00083 0 0.002 16
*3 2.204 0.28833 0.11333 0 0.0021 16
4 2.41 0.28833 0.18083 0 0.0021 14
5 2.62 0.28833 0.22333 0 0.0019 12
6 2.862 0.28833 0.2525 0 0.0013 12
7 3.114 0.28833 0.27 0 0.0009 12
8 3.351 0.28833 0.28 0 0.0008 12
9 3.591 0.28833 0.28708 0 0.0011 12
10 3.807 0.28833 0.29208 0 0.0009 12
11 4.04 0.28833 0.29708 0 0.0011 12
12 4.297 0.28833 0.30333 0 0.0008 12
13 4.562 0.28833 0.30958 0 0.0009 12
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14 4.787 0.28833 0.31458 0 0.0006 12
15 5.065 0.28833 0.31958 0 0.0005 12
16 5.316 0.28833 0.3225 0 0.0008 12
17 5.564 0.28833 0.32458 0 0.002 14
18 5.865 0.28833 0.32583 0 0.0028 22
19 6.237 0.28833 0.32667 0 0.0044 38
20 7.609 0.28833 0.3275 0 0.0204 101
21 8.891 0.28833 0.32792 0 0.0045 38
22 9.35 0.28833 0.32833 0 0.0037 32
23 9.728 0.28833 0.32917 0 0.0032 25
24 9.99 0.28833 0.33042 0 0.003 23
25 10.232 0.28833 0.33208 0 0.0016 12
26 10.451 0.28833 0.33458 0 0.0012 13
27 10.675 0.28833 0.33875 0 0.0021 13
28 10.891 0.28833 0.34542 0 0.0021 14
29 11.111 0.28833 0.35667 0 0.0019 14
30 11.317 0.28833 0.37417 0 0.0017 15
31 11.526 0.28833 0.40333 0 0.0014 15
32 11.729 0.28833 0.45 0 0.0013 15
33 11.952 0.28833 0.53667 0 0.0022 14
34 12.165 0.28833 0.68 0 0.0018 14
35 12.376 0.28833 0.93 0 0.002 13
*36 12.508 0.28833 1.18 0 0.0016 13
*37 12.604 0.28833 1.43042 0 0.0016 12
*38 12.678 0.28833 1.68083 0 0.0008 12
*39 12.738 0.28833 1.93125 0 0.0008 12
*40 12.788 0.28833 2.18167 0 0.0003 12
*41 12.831 0.28833 2.43208 0 0.0004 12
*42 12.868 0.28833 2.6825 0 0.0003 12
*43 12.9 0.28833 2.93291 0 0.0009 12
*44 12.929 0.28833 3.18333 0 0.0006 12
*45 12.955 0.28833 3.43375 0 0.0016 12
*46 12.978 0.28833 3.68417 0 0.0009 12
*47 12.999 0.28833 3.93458 0 0.001 12
*48 13.004 0.28833 3.98458 0 0.0013 12
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Title : Quinine for Pullin
Filename : C:\990279\Q3_2009\Jul_14\09G-1402.SDS
Analyst : danielle
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (up)
Assay date : 14 Jul 2009 at  9:52 (Assay duration  0:35:10) (Assay location 27)
Last modified : 27 Jul 2009 at 17:17
Four-Plus parameters. Source file : C:\990279\Q2_2009\Jul_14\09G-1401.SDS
à 0.085
S 1.0049
jÁ 0.4
jÂÁ -0.5
8.421 B+H=BH
4.196 BH+H=BH2
-24.998 BH2+H=BH3
10.105 CO3+H=HCO3
6.23 HCO3+H=H2CO3
logK values imported from file : 
1.010 B concentration factor  (0.001600 M)
1.000 CO3 concentration factor  (0.025 mM)
0.9937 HCl concentration factor. Source : C:\990279\Q2_2009\Jul_14\09G-1401.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
0.000003 Acidity error
Form of compounds introduced : B H2CO3
B (0.0051900g, 324.42 g/mol)
H2CO3 (0.0000153g, 62.03 g/mol)
GOF : 2.41
Assay Temperature : 25.0¦C
Average ionic strength : 0.026 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 10.62 mL
Aqueous volume range : 10.32 - 11.02 mL
pH range : 1.84 - 12.07
pH clip range : 2.40 - 12.37
Number of points collected : 40
Number of points considered : 37
pH7 buffer : 7.000, -15.76 mV, 25.5¦C
Initial pH : 7.399
Volume of HCl added for start pH : 0.31667 mL
Point pH HCl vol KOH vol ORG vol drift time
*1 1.944 0.31667 0.00042 0 0.0177 102
*2 1.998 0.31667 0.00083 0 0.0064 58
*3 2.259 0.31667 0.11083 0 0.0039 34
4 2.501 0.31667 0.17083 0 0.0032 27
5 2.738 0.31667 0.20583 0 0.0027 20
6 2.966 0.31667 0.22583 0 0.0021 16
7 3.214 0.31667 0.23917 0 0.002 14
8 3.473 0.31667 0.2475 0 0.0021 14
9 3.709 0.31667 0.25375 0 0.002 13
10 3.976 0.31667 0.26 0 0.002 14
11 4.261 0.31667 0.26625 0 0.0018 13
12 4.494 0.31667 0.27125 0 0.0017 14
13 4.782 0.31667 0.27625 0 0.0017 14
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14 5.052 0.31667 0.27958 0 0.0018 14
15 5.372 0.31667 0.28208 0 0.0014 13
16 5.805 0.31667 0.28375 0 0.0025 19
17 6.282 0.31667 0.28458 0 0.0051 46
18 6.821 0.31667 0.28542 0 0.0066 59
19 7.25 0.31667 0.28667 0 0.0037 31
20 7.568 0.31667 0.28833 0 0.001 13
21 7.862 0.31667 0.29083 0 0.0015 13
22 8.118 0.31667 0.29417 0 0.0015 14
23 8.352 0.31667 0.29792 0 0.0013 14
24 8.589 0.31667 0.3025 0 0.0019 14
25 8.85 0.31667 0.30708 0 0.0017 14
26 9.084 0.31667 0.31083 0 0.0009 14
27 9.356 0.31667 0.31417 0 0.0015 13
28 9.627 0.31667 0.31625 0 0.001 13
29 9.898 0.31667 0.31875 0 0.0029 22
30 10.163 0.31667 0.32042 0 0.0012 13
31 10.413 0.31667 0.32333 0 0.0017 14
32 10.638 0.31667 0.32708 0 0.0016 15
33 10.868 0.31667 0.33375 0 0.0017 16
34 11.08 0.31667 0.34375 0 0.0021 15
35 11.294 0.31667 0.36042 0 0.0014 16
36 11.499 0.31667 0.38667 0 0.0018 16
37 11.706 0.31667 0.43042 0 0.0021 16
38 11.928 0.31667 0.51042 0 0.0021 16
39 12.146 0.31667 0.64708 0 0.0019 16
40 12.21 0.31667 0.70375 0 0.0019 15
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N-Amino-N-morpholinium Trifluoroacetate, 191: 
 
Continued overleaf. 
CSCD701639
S02F733000M
MWT = 230.22
Potentiometric titrations conducted 25th June
Potentiometric titration 1 - 25th June 2009
MWT = 230.22
Sample Weight = 36.6mgs
Stock solution = 6100ppm [36.6mgs/6mls 1:1 MeOH:H2O]
Stock solution = 0.026M
Volume added = 2.0mls
Starting Titration volume = 10mls
Titration 1 [] = 5.2mM => 1220ppm
pH range = 2 => 13
N
+
O
N
F
F
F
O
O Chiral
O O
FF
F
N
O
O
N
+
H
N
NOTE ** Previous work conducted on analogue 
CSCD698377 [J8466/084]
2 pKas measured : 4.31/12.28
NOTE ** Sample 10% 
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Titration 
No.
Ionic 
strength
% MeOH pKa Date Temp C
1 0.021 == U 25th June ==
Potentiometric titration 2 - 25th June 2009
Stock solution = 6100ppm [36.6mgs/6mls 1:1 MeOH:H2O]
An additional 2mls MeCN added to stock =>
Stock solution = 0.017M
Volume added = 4.0mls
Starting Titration volume = 10mls
Titration 1 [] = 6.8mM => 1595ppm
pH range = 2 => 13
Titration 
No.
Ionic 
strength
% MeOH pKa Date Temp C
2 0.021 == U 25th June ==
Filename
09F-2505.SDS
Filename
09F-2506.SDS
AUTO-REFINEMENT
pKa = 9.03, calculated [ ] = 7% actual!!
Obviously issues with this result. 8 data-points 
above pH10 have been excluded f rom the auto-
ref inement process
MANUAL REFINEMENT
Concentration fixed @ 90% [taking 
account of 10% H2O]
pKa = 14.06
Obviously not a reliable result 
Given the possibility that these problems may be due to issues with solubility in stock solution concentration 
[i.e. sample had not completely dissolved which could explain why the auto -ref ined value = 7% actual 
concentration] the stock solution was diluted.
NOTE ** Sample 10% 
AUTO-REFINEMENT
pKa = 12.13, calculated [ ] = 100% actual!!
Obviously issues with this result. No deviation f rom 
calculated FIT/theoretical curve.
From these titrations suggestion is that the pKa is too 
high to measure, >12.
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First Potentiometric pKa
Title : PULLIN POTY
Filename : C:\990279\Q2_2009\Jun_25\09F-2505.SDS
Analyst : david
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (up)
Assay date : 25 Jun 2009 at 13:41 (Assay duration  0:35:16) (Assay location 8)
Last modified : 30 Jun 2009 at 11:45
Four-Plus parameters. Source file : C:\990279\Q2_2009\Jun_25\09F-2502.SDS
à 0.089
S 1.0058
jÁ 1.3
jÂÁ -1
12 A+H=AH
logK values imported from file : 
1.000 A concentration factor  (0.005299 M)
0.9919 HCl concentration factor. Source : C:\990279\Q2_2009\Jun_25\09F-2502.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
0.000000 Acidity error
Form of compounds introduced : AH
AH (0.0122000g, 230.22 g/mol)
GOF : 99.99
Assay Temperature : 25.0¦C
Average ionic strength : 0.010 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 11.28 mL
Aqueous volume range : 10.24 - 14.47 mL
pH range : 1.87 - 13.01
pH clip range : full pH range
Number of points collected : 44
Number of points considered : 44
pH7 buffer : 7.000, -16.61 mV, 25.5¦C
Initial pH : 4.914
Volume of HCl added for start pH : 0.24333 mL
Point pH HCl vol KOH vol ORG vol drift time
1 1.991 0.24333 0.00042 0 0.0021 17
2 1.995 0.24333 0.00083 0 0.0025 19
3 2.21 0.24333 0.09458 0 0.0026 19
4 2.475 0.24333 0.16208 0 0.0021 16
5 2.723 0.24333 0.19708 0 0.0016 13
6 2.97 0.24333 0.21708 0 0.0013 13
7 3.234 0.24333 0.22875 0 0.0016 13
8 3.513 0.24333 0.23542 0 0.0011 13
9 3.796 0.24333 0.23917 0 0.0012 13
10 4.205 0.24333 0.24125 0 0.0007 13
11 5.026 0.24333 0.2425 0 0.0061 59
12 6.239 0.24333 0.24292 0 0.0043 40
13 7.155 0.24333 0.24333 0 0.0076 72
14 7.794 0.24333 0.24375 0 0.0048 44
15 8.201 0.24333 0.24458 0 0.0038 34
16 8.587 0.24333 0.24542 0 0.0034 27
17 8.995 0.24333 0.24708 0 0.0012 13
18 9.337 0.24333 0.24917 0 0.001 13
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19 9.692 0.24333 0.25125 0 0.0019 13
20 10.049 0.24333 0.25375 0 0.001 13
21 10.331 0.24333 0.25667 0 0.0012 13
22 10.572 0.24333 0.26042 0 0.0017 13
23 10.803 0.24333 0.26667 0 0.0012 14
24 11.028 0.24333 0.27667 0 0.002 14
25 11.261 0.24333 0.29333 0 0.0017 15
26 11.47 0.24333 0.32 0 0.0018 14
27 11.694 0.24333 0.36667 0 0.0015 14
28 11.916 0.24333 0.44667 0 0.0013 14
29 12.128 0.24333 0.58 0 0.0016 14
30 12.347 0.24333 0.82375 0 0.0018 13
31 12.484 0.24333 1.07375 0 0.0017 14
32 12.582 0.24333 1.32417 0 0.0016 13
33 12.657 0.24333 1.57458 0 0.0007 13
34 12.717 0.24333 1.825 0 0.0007 13
35 12.767 0.24333 2.07542 0 0.0004 13
36 12.809 0.24333 2.32583 0 0.0003 13
37 12.845 0.24333 2.57625 0 0.0003 13
38 12.877 0.24333 2.82667 0 0.0006 13
39 12.905 0.24333 3.07708 0 0.0011 13
40 12.93 0.24333 3.3275 0 0.0003 13
41 12.952 0.24333 3.57792 0 0.0012 13
42 12.972 0.24333 3.82833 0 0.0015 13
43 12.99 0.24333 4.07833 0 0.0015 13
44 13 0.24333 4.22833 0 0.0016 13
2nd Potentiometric pKa
Title : PULLIN POTY
Filename : C:\990279\Q2_2009\Jun_25\09F-2506.SDS
Analyst : david
Instrument ID : 990279
Electrode ID : KFP-0882
Assay type : SAMPLE, pKa (up)
Assay date : 25 Jun 2009 at 16:15 (Assay duration  0:31:03) (Assay location 9)
Last modified : 25 Jun 2009 at 16:45
Four-Plus parameters. Source file : C:\990279\Q2_2009\Jun_25\09F-2502.SDS
à 0.089
S 1.0058
jÁ 1.3
jÂÁ -1
18.353 A+H=AH
10.128 CO3+H=HCO3
6.242 HCO3+H=H2CO3
logK values imported from file : 
1.000 A concentration factor  (0.007071 M)
1.000 CO3 concentration factor  (0.174 mM)
0.9919 HCl concentration factor. Source : C:\990279\Q2_2009\Jun_25\09F-2502.SDS
0.9931 KOH concentration factor. Source : C:\990279\Q2_2009\May_26\KHP MULTISET.MDS
-0.000345 Acidity error
Form of compounds introduced : AH H2CO3
AH (0.0162800g, 230.22 g/mol)
225 
 
 
H2CO3 (0.0001081g, 62.03 g/mol)
GOF : 16.83
Assay Temperature : 25.0¦C
Average ionic strength : 0.020 M
Salt type used : 0.01 M KCl:isa
Total volume of aqueous phase : 10.00 mL
Average aqueous volume : 10.72 mL
Aqueous volume range : 10.23 - 12.59 mL
pH range : 1.84 - 13.02
pH clip range : 2.98 - 10.12
Number of points collected : 37
Number of points considered : 15
pH7 buffer : 7.000, -16.17 mV, 25.5¦C
Initial pH : 4.642
Volume of HCl added for start pH : 0.22917 mL
Point pH HCl vol KOH vol ORG vol drift time
*1 1.956 0.22917 0.00042 0 0.0032 29
*2 1.965 0.22917 0.00083 0 0.0033 27
*3 2.224 0.22917 0.10083 0 0.0029 22
*4 2.479 0.22917 0.155 0 0.0022 16
*5 2.72 0.22917 0.18417 0 0.0016 13
*6 2.959 0.22917 0.20083 0 0.001 13
7 3.21 0.22917 0.21083 0 0.0008 13
8 3.484 0.22917 0.21667 0 0.0009 13
9 3.828 0.22917 0.21958 0 0.0005 13
10 4.317 0.22917 0.22167 0 0.0028 24
11 4.767 0.22917 0.22208 0 0.0054 50
12 5.883 0.22917 0.2225 0 0.0018 17
13 6.711 0.22917 0.22292 0 0.0024 29
14 7.565 0.22917 0.22375 0 0.0043 40
15 8.057 0.22917 0.22417 0 0.0036 32
16 8.384 0.22917 0.22542 0 0.0032 26
17 8.716 0.22917 0.22708 0 0.0027 21
18 9.07 0.22917 0.22917 0 0.0025 21
19 9.459 0.22917 0.23167 0 0.0026 22
20 9.803 0.22917 0.23375 0 0.003 24
21 10.115 0.22917 0.23542 0 0.0029 25
*22 10.417 0.22917 0.2375 0 0.0031 24
*23 10.693 0.22917 0.24083 0 0.0014 13
*24 10.975 0.22917 0.2475 0 0.0012 13
*25 11.229 0.22917 0.2575 0 0.0019 13
*26 11.476 0.22917 0.27417 0 0.0013 14
*27 11.717 0.22917 0.30333 0 0.0016 14
*28 11.96 0.22917 0.35542 0 0.0018 14
*29 12.193 0.22917 0.44708 0 0.002 15
*30 12.414 0.22917 0.60542 0 0.0017 15
*31 12.607 0.22917 0.85542 0 0.0024 17
*32 12.727 0.22917 1.10542 0 0.0021 15
*33 12.813 0.22917 1.35583 0 0.0016 13
*34 12.877 0.22917 1.60625 0 0.0012 13
*35 12.928 0.22917 1.85667 0 0.0003 13
*36 12.97 0.22917 2.10708 0 0.0002 13
*37 13.004 0.22917 2.3575 0 0.0006 13
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